,Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
0,prerank,extracellular matrix organization (GO:0030198),-0.8476202550489613,-1.9311958700237941,0.0,0.0,0.0,74/221,4.89%,LOXL1;LOXL3;LOX;ADAMTS2;COL14A1;COL3A1;SPARC;TIMP2;FBLN5;CTSS;SPP1;COL8A2;POSTN;COL5A2;FN1;ELN;COL1A1;CYP1B1;MMP14;COMP;COL1A2;COL8A1;ITGB2;MMP2;MFAP5;SERPINE1;COL5A1;COL12A1;LCP1;MFAP2;FBN1;P4HA3;BGN;COL11A1;LOXL2;COL16A1;ITGA11;TNC;ADAMTSL2;ACAN;MMP12;CTSK;LUM;ITGB5;ADAMTS12;MATN4;CAPG;SH3PXD2B;COL9A2;TIMP1;ITGAX;BMP1;ADAM12;COL6A1;FBN2;ITGAM;COL18A1;SLC39A8;ADAM8;MMP19;ITGB7;THBS1;CD44;TGFB2;COL2A1;MMP16;TGFBI;MMP11;COL6A2;ADAMTSL3;LOXL4;DPT;P3H1;CRTAP
1,prerank,extracellular structure organization (GO:0043062),-0.8405944310047062,-1.8822656260082071,0.0,0.0,0.0,55/166,4.60%,LOXL1;LOX;ADAMTS2;COL14A1;COL3A1;SPARC;FBLN5;SPP1;COL8A2;POSTN;COL5A2;FN1;ELN;COL1A1;MMP14;COMP;COL1A2;COL8A1;ITGB2;MMP2;MFAP5;SERPINE1;COL5A1;MFAP2;FBN1;BGN;COL11A1;COL16A1;ITGA11;TNC;ADAMTSL2;ACAN;MMP12;LUM;ITGB5;ADAMTS12;MATN4;COL9A2;ITGAX;ADAM12;COL6A1;FBN2;ITGAM;COL18A1;SLC39A8;MMP19;ITGB7;THBS1;CD44;COL2A1;MMP16;TGFBI;MMP11;COL6A2;ADAMTSL3
2,prerank,external encapsulating structure organization (GO:0045229),-0.8426757946754417,-1.8790275497639324,0.0,0.0,0.0,55/165,4.60%,LOXL1;LOX;ADAMTS2;COL14A1;COL3A1;SPARC;FBLN5;SPP1;COL8A2;POSTN;COL5A2;FN1;ELN;COL1A1;MMP14;COMP;COL1A2;COL8A1;ITGB2;MMP2;MFAP5;SERPINE1;COL5A1;MFAP2;FBN1;BGN;COL11A1;COL16A1;ITGA11;TNC;ADAMTSL2;ACAN;MMP12;LUM;ITGB5;ADAMTS12;MATN4;COL9A2;ITGAX;ADAM12;COL6A1;FBN2;ITGAM;COL18A1;SLC39A8;MMP19;ITGB7;THBS1;CD44;COL2A1;MMP16;TGFBI;MMP11;COL6A2;ADAMTSL3
3,prerank,mitochondrial translation (GO:0032543),0.8168525200453703,1.8248189285595968,0.0,0.0,0.0,73/104,16.11%,GFM1;MRPL42;QRSL1;MRPL55;PTCD3;GATB;MRPS36;TUFM;MRPL18;MRPL39;MTIF2;NDUFA7;MRPS31;MRPL30;MRPL51;MRPL28;MRPL45;GFM2;TSFM;MRPL47;MRPL3;MRPS35;MRPL4;MRPL12;MRPS27;MRPL1;MRPL9;MRPL38;MRPL14;MRPL41;LARS2;MRPS9;MRPL44;MRPS28;MRPS23;MRPL37;MRPL19;OXA1L;MRPL2;MRPL50;IARS2;MRPS2;MRRF;MRPL15;MRPL49;MRPS33;MRPL16;MRPL46;MRPS24;MRPS15;MRPS7;MRPL34;MRPL21;MRPL58;MRPS21;MRPL53;FASTKD2;MRPS17;MRPS18A;MRPS14;MRPS5;MRPS30;MRPS22;MRPS18B;MRPL35;GADD45GIP1;EARS2;DAP3;MRPS34;MRPS25;ERAL1;MTRF1;MRPL10
4,prerank,neutrophil degranulation (GO:0043312),-0.8036755563871317,-1.8060576578777479,0.0,0.0,0.0,96/357,7.79%,CLEC4D;GUSB;TIMP2;CTSS;CTSA;ITGB2;LGALS3;CD68;ARHGAP45;TYROBP;HEXB;GLIPR1;NCKAP1L;C3AR1;CTSZ;TCIRG1;CD53;HVCN1;ANPEP;PTPRC;DOK3;S100A11;PTPN6;HPSE;CD300A;IRAG2;DPP7;FGR;TLR2;FCER1G;RAB31;CTSH;ITGAX;PLAC8;GLA;TNFRSF1B;CLEC12A;HK3;CTSD;SLC11A1;ITGAM;ATP8B4;NPC2;ADAM8;DOCK2;CYBB;GM2A;COTL1;CD44;SIRPA;CYBA;PLAU;CLEC5A;CD14;GRN;NFAM1;EEF1A1;VAT1;PTX3;PRKCD;PADI2;TXNDC5;MAN2B1;ANXA3;RAP2B;DYNLL1;LAIR1;PRDX4;C5AR1;STXBP2;ARPC5;PTAFR;PRCP;KCNAB2;CTSB;APRT;GGH;CSTB;CAP1;ASAH1;CDA;ANXA2;APAF1;CD63;TICAM2;GALNS;ALDH3B1;PLEKHO2;PNP;GLB1;FUCA1;FGL2;ATP6AP2;RHOG;ARHGAP9;GDI2
5,prerank,neutrophil activation involved in immune response (GO:0002283),-0.8029276110621176,-1.8038577686092456,0.0,0.0,0.0,96/358,7.79%,CLEC4D;GUSB;TIMP2;CTSS;CTSA;ITGB2;LGALS3;CD68;ARHGAP45;TYROBP;HEXB;GLIPR1;NCKAP1L;C3AR1;CTSZ;TCIRG1;CD53;HVCN1;ANPEP;PTPRC;DOK3;S100A11;PTPN6;HPSE;CD300A;IRAG2;DPP7;FGR;TLR2;FCER1G;RAB31;CTSH;ITGAX;PLAC8;GLA;TNFRSF1B;CLEC12A;HK3;CTSD;SLC11A1;ITGAM;ATP8B4;NPC2;ADAM8;DOCK2;CYBB;GM2A;COTL1;CD44;SIRPA;CYBA;PLAU;CLEC5A;CD14;GRN;NFAM1;EEF1A1;VAT1;PTX3;PRKCD;PADI2;TXNDC5;MAN2B1;ANXA3;RAP2B;DYNLL1;LAIR1;PRDX4;C5AR1;STXBP2;ARPC5;PTAFR;PRCP;KCNAB2;CTSB;APRT;GGH;CSTB;CAP1;ASAH1;CDA;ANXA2;APAF1;CD63;TICAM2;GALNS;ALDH3B1;PLEKHO2;PNP;GLB1;FUCA1;FGL2;ATP6AP2;RHOG;ARHGAP9;GDI2
6,prerank,neutrophil mediated immunity (GO:0002446),-0.8017667331401945,-1.7981350450233187,0.0,0.0,0.0,98/362,8.14%,CLEC4D;GUSB;TIMP2;CTSS;CTSA;ITGB2;LGALS3;CD68;ARHGAP45;TYROBP;HEXB;GLIPR1;NCKAP1L;C3AR1;CTSZ;TCIRG1;CD53;HVCN1;ANPEP;PTPRC;DOK3;S100A11;PTPN6;HPSE;CD300A;IRAG2;DPP7;FGR;TLR2;FCER1G;RAB31;CTSH;ITGAX;PLAC8;GLA;TNFRSF1B;CLEC12A;HK3;CTSD;SLC11A1;ITGAM;ATP8B4;NPC2;ADAM8;DOCK2;CYBB;GM2A;COTL1;CD44;SIRPA;CYBA;PLAU;CLEC5A;CD14;GRN;NFAM1;EEF1A1;VAT1;PTX3;PRKCD;PADI2;TXNDC5;MAN2B1;ANXA3;RAP2B;DYNLL1;LAIR1;PRDX4;C5AR1;STXBP2;ARPC5;PTAFR;PRCP;KCNAB2;CTSB;APRT;GGH;CSTB;CAP1;ASAH1;CDA;ANXA2;APAF1;CD63;TICAM2;GALNS;ALDH3B1;PLEKHO2;PNP;GLB1;FUCA1;FGL2;ATP6AP2;RHOG;ARHGAP9;GDI2;IRAK4;PTPRJ
7,prerank,supramolecular fiber organization (GO:0097435),-0.7965398248406974,-1.795803128199755,0.0,0.0,0.0,71/266,8.74%,LOXL1;LOXL3;LOX;ADAMTS2;COL14A1;COL3A1;MFAP4;FBLN5;COL8A2;COL5A2;COL1A1;CYP1B1;COL1A2;COL8A1;LTBP2;COL5A1;COL12A1;P4HA3;COL11A1;LOXL2;COL16A1;VIM;CALCA;NPPA;DBN1;LTBP3;LUM;COL9A2;BMP1;COL6A1;MARCKSL1;COL18A1;FAT1;ACTN1;CCDC88B;MARCKS;MYO1F;TGFB2;COL2A1;TGFBI;CORO1A;COL6A2;EMILIN1;LOXL4;DPT;P3H1;CRTAP;CARMIL1;EFEMP2;PLOD2;RAC2;TPM3;TGFBR1;ARHGAP25;MYO1G;COL7A1;COL4A6;COL6A3;MYO5A;TPM2;RHOG;CORO1C;RHOC;MYO1D;MYO1C;P4HB;COL15A1;PPIB;COL27A1;MYO7A;SH3BP1
8,prerank,aerobic electron transport chain (GO:0019646),0.9033475831574936,1.7930849629385057,0.0,0.0039968710821555245,0.01,59/69,8.09%,UQCRC2;SDHA;NDUFS1;NDUFB1;NDUFS3;NDUFB8;COX6A2;NDUFB10;UQCRFS1;NDUFA9;COX10;NDUFA10;NDUFV3;NDUFS2;NDUFB2;NDUFS7;NDUFA4;NDUFS6;CYC1;UQCRC1;UQCR11;COX5A;NDUFS8;NDUFAB1;SDHC;SDHD;AFG1L;NDUFAF1;COX6B1;NDUFV2;NDUFV1;NDUFA3;UQCRH;NDUFA8;UQCRQ;NDUFB5;NDUFS4;NDUFA5;NDUFA6;COX5B;NDUFA13;NDUFB9;COX4I1;NDUFA7;NDUFB11;NDUFB7;NDUFA12;NDUFB6;NDUFB3;NDUFA11;COX6C;CYCS;COX7B;NDUFC1;NDUFA1;COX7C;UQCRB;NDUFS5;NDUFA2
9,prerank,glucose metabolic process (GO:0006006),0.8571670652424461,1.7850633408201604,0.0,0.002664580721437016,0.01,13/44,4.10%,FBP2;SORD;PPARGC1A;ENO3;MDH1;SLC25A11;MDH2;KCNJ11;GOT1;SLC25A13;GOT2;SLC25A12;PGAM2
10,prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.9029754515105674,1.7740172174325755,0.0,0.0019984355410777623,0.01,59/70,8.09%,UQCRC2;SDHA;NDUFS1;NDUFB1;NDUFS3;NDUFB8;COX6A2;NDUFB10;UQCRFS1;NDUFA9;COX10;NDUFA10;NDUFV3;NDUFS2;NDUFB2;NDUFS7;NDUFA4;NDUFS6;CYC1;UQCRC1;UQCR11;COX5A;NDUFS8;NDUFAB1;SDHC;SDHD;AFG1L;NDUFAF1;COX6B1;NDUFV2;NDUFV1;NDUFA3;UQCRH;NDUFA8;UQCRQ;NDUFB5;NDUFS4;NDUFA5;NDUFA6;COX5B;NDUFA13;NDUFB9;COX4I1;NDUFA7;NDUFB11;NDUFB7;NDUFA12;NDUFB6;NDUFB3;NDUFA11;COX6C;CYCS;COX7B;NDUFC1;NDUFA1;COX7C;UQCRB;NDUFS5;NDUFA2
11,prerank,collagen fibril organization (GO:0030199),-0.9032245843481198,-1.759577153179638,0.0,0.0,0.0,31/72,5.17%,LOXL1;LOXL3;LOX;ADAMTS2;COL14A1;COL3A1;COL8A2;COL5A2;COL1A1;CYP1B1;COL1A2;COL8A1;COL5A1;COL12A1;P4HA3;COL11A1;LOXL2;COL16A1;LUM;COL9A2;BMP1;COL6A1;COL18A1;TGFB2;COL2A1;COL6A2;LOXL4;DPT;P3H1;CRTAP;PLOD2
12,prerank,mitochondrial translational elongation (GO:0070125),0.8197145721261432,1.7348607983978024,0.0,0.007993742164311049,0.04,61/89,15.42%,GFM1;MRPL42;MRPL55;PTCD3;MRPS36;TUFM;MRPL18;MRPL39;MRPS31;MRPL30;MRPL51;MRPL28;MRPL45;GFM2;TSFM;MRPL47;MRPL3;MRPS35;MRPL4;MRPL12;MRPS27;MRPL1;MRPL9;MRPL38;MRPL14;MRPL41;MRPS9;MRPL44;MRPS28;MRPS23;MRPL37;MRPL19;OXA1L;MRPL2;MRPL50;MRPS2;MRPL15;MRPL49;MRPS33;MRPL16;MRPL46;MRPS24;MRPS15;MRPS7;MRPL34;MRPL21;MRPL58;MRPS21;MRPL53;MRPS17;MRPS18A;MRPS14;MRPS5;MRPS30;MRPS22;MRPS18B;MRPL35;GADD45GIP1;DAP3;MRPS34;MRPS25
13,prerank,mitochondrial translational termination (GO:0070126),0.8060040210425018,1.7323257023553027,0.0,0.00666145180359254,0.04,63/89,16.50%,MRPL42;MRPL55;PTCD3;MRPS36;MRPL18;MRPL39;MRPS31;MRPL30;MRPL51;MRPL28;MRPL45;GFM2;MRPL47;MRPL3;MRPS35;MRPL4;MRPL12;MRPS27;MRPL1;MRPL9;MRPL38;MRPL14;MRPL41;MRPS9;MRPL44;MRPS28;MRPS23;MRPL37;MRPL19;OXA1L;MRPL2;MRPL50;MRPS2;MRRF;MRPL15;MRPL49;MRPS33;MRPL16;MRPL46;MRPS24;MRPS15;MRPS7;MRPL34;MRPL21;MRPL58;MRPS21;MRPL53;MRPS17;MRPS18A;MRPS14;MRPS5;MRPS30;MRPS22;MRPS18B;MRPL35;GADD45GIP1;DAP3;MRPS34;MRPS25;ERAL1;MTRF1;MRPL10;CHCHD1
14,prerank,dicarboxylic acid metabolic process (GO:0043648),0.8659602006467196,1.7259524597719014,0.0,0.0068517789979808995,0.04,15/45,4.80%,PHYH;SDHA;IDH2;MDH1;ALDH5A1;DLST;OGDH;MDH2;GOT1;L2HGDH;GOT2;ME3;DGLUCY;MRPS36;SHMT1
15,prerank,mitochondrion organization (GO:0007005),0.7292759382601698,1.71436555214454,0.0,0.010991395475927692,0.08,72/150,12.90%,MTFP1;COX7A1;PPARGC1A;NDUFS1;CLUH;PINK1;NIPSNAP2;HK2;MIGA2;HSPD1;DNAJA3;SLC25A4;MFN2;AFG1L;MTX2;PHB;TRAK1;PRDX3;SIRT3;OPA1;ADCK1;ALAS1;CHCHD3;SIRT5;FMC1;RHOT2;PTCD2;ATPAF1;IMMP2L;BCS1L;TWNK;TIMM23;ESRRA;CYCS;OMA1;CHCHD10;SAMM50;MTFR1;MYH14;HSD17B10;HIGD1A;MTFR1L;AGTPBP1;TMEM70;SPG7;COX7A2;TFB1M;TOMM5;MFN1;AFG3L2;CHCHD2;TIMM44;OXA1L;MIEF2;MGME1;TRAK2;TIMM17A;TIMM10;TFB2M;TOMM40;TFAM;NUBPL;PHB2;MPV17;TIMM8B;AIFM1;DNM1L;SUPV3L1;HIGD2A;GABPA;PRKN;TIMM22
16,prerank,translational elongation (GO:0006414),0.7858133965111962,1.7138004590845894,0.0,0.011546516459560403,0.1,63/103,15.42%,GFM1;MRPL42;MRPL55;PTCD3;MRPS36;EEF1A2;TUFM;MRPL18;MRPL39;MRPS31;MRPL30;MRPL51;MRPL28;MRPL45;GFM2;TSFM;MRPL47;MRPL3;MRPS35;MRPL4;MRPL12;MRPS27;MRPL1;MRPL9;MRPL38;MTRES1;MRPL14;MRPL41;MRPS9;MRPL44;MRPS28;MRPS23;MRPL37;MRPL19;OXA1L;MRPL2;MRPL50;MRPS2;MRPL15;MRPL49;MRPS33;MRPL16;MRPL46;MRPS24;MRPS15;MRPS7;MRPL34;MRPL21;MRPL58;MRPS21;MRPL53;MRPS17;MRPS18A;MRPS14;MRPS5;MRPS30;MRPS22;MRPS18B;MRPL35;GADD45GIP1;DAP3;MRPS34;MRPS25
17,prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.8542381263953027,1.7128654728134587,0.0,0.010391864813604362,0.1,66/88,12.00%,NDUFS1;NDUFB1;NDUFS3;NDUFAF6;NDUFB8;NDUFB10;UQCRFS1;NDUFA9;NDUFA10;NDUFV3;NDUFS2;NDUFB2;UQCC1;NDUFS7;NDUFS6;NDUFS8;NDUFAB1;FOXRED1;NDUFAF1;NDUFV2;NDUFV1;NDUFA3;NDUFA8;NDUFB5;NDUFS4;ECSIT;NDUFA5;NDUFA6;NDUFA13;NDUFB9;IMMP2L;NDUFA7;NDUFB11;NDUFB7;BCS1L;NDUFA12;NDUFB6;NDUFB3;NDUFA11;OMA1;SAMM50;NDUFC1;NDUFA1;TMEM126A;NDUFS5;COX14;TIMMDC1;NDUFA2;SDHAF4;NDUFC2;NDUFAF4;LYRM7;OXA1L;COA5;TIMM21;DMAC2;SDHAF3;NUBPL;AIFM1;COX17;TTC19;TMEM126B;NDUFAF5;SDHAF2;SMIM20;SCO1
18,prerank,cellular respiration (GO:0045333),0.8920907591736782,1.7074454605680496,0.0,0.010173853663668608,0.11,31/39,9.89%,UQCRC2;ETFDH;SDHA;COQ10A;PPARGC1A;NDUFS1;ETFA;UQCRFS1;MDH2;COX10;SDHB;SLC25A13;NDUFS7;UQCRC1;NDUFS8;SDHC;ME3;SIRT3;UQCRH;ETFB;NDUFS4;NDUFA5;CYCS;UQCRB;MTFR1;MTFR1L;SDHAF4;LYRM7;OXA1L;COX15;ETFRF1
19,prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.8054013854968053,-1.7007267154654544,0.0,0.003801606178610463,0.03,18/140,8.49%,FRZB;DKK3;SFRP2;APOE;SFRP1;NKD2;TPBG;MDK;IGFBP4;SOX9;BICC1;DACT1;NKD1;DACT3;SLC9A3R1;IGFBP2;PTPRO;RBMS3
20,prerank,regulation of immune response (GO:0050776),-0.8623533936928443,-1.6973486377575726,0.0,0.003421445560749417,0.03,27/84,7.09%,COL3A1;TREM2;COL1A1;COL1A2;ITGB2;TYROBP;SPN;CD300LF;FCGR2B;CD300A;FGR;CD22;CD300LD;SLAMF7;ADCY7;ITGB7;TGFB2;COL2A1;CD276;LAIR1;CD300LB;VCAM1;NPDC1;PILRA;ITGA4;COLEC12;TREML2
21,prerank,cellular response to cytokine stimulus (GO:0071345),-0.7465227605788064,-1.6907566964711742,0.0,0.005184008425377903,0.05,83/314,11.30%,IL10RA;FN1;CCR2;COL1A2;ITGB2;VAV1;SFRP1;HCK;MMP2;CSF2RB;CRLF1;VIM;PTGIS;ANXA1;IRF8;EREG;PTPN6;ADAMTS12;TLR2;TIMP1;ITGAX;IRF5;TNFRSF1B;NUMBL;PDE1B;ITGAM;CSF1R;IL1RN;HMOX1;SOX9;AIF1;PTPN7;SIRPA;SELPLG;GBA;CCR5;CSF3R;CCL5;SDC1;PLP2;IL18;SLA;DPYSL3;PTAFR;VCAM1;CASP1;PTPN18;CXCL10;HCLS1;CX3CL1;CSF2RA;PIK3CD;ASAH1;CXCR4;IL3RA;CEBPA;TWIST1;GRAP2;MYC;CD80;CRLF2;CEBPD;GAS6;IRAK4;PTPRJ;SBNO2;HGF;BATF;RHOU;CCL8;ICAM1;IL1R1;OSMR;BIRC5;EBI3;IL1RL2;TGFB1;NPNT;FOXC1;CDK9;LRP8;ZFP36L2;INPP5D
22,prerank,translational termination (GO:0006415),0.801275311193958,1.6902345687967941,0.0,0.012656758426825827,0.16,63/95,16.50%,MRPL42;MRPL55;PTCD3;MRPS36;MRPL18;MRPL39;MRPS31;MRPL30;MRPL51;MRPL28;MRPL45;GFM2;MRPL47;MRPL3;MRPS35;MRPL4;MRPL12;MRPS27;MRPL1;MRPL9;MRPL38;MRPL14;MRPL41;MRPS9;MRPL44;MRPS28;MRPS23;MRPL37;MRPL19;OXA1L;MRPL2;MRPL50;MRPS2;MRRF;MRPL15;MRPL49;MRPS33;MRPL16;MRPL46;MRPS24;MRPS15;MRPS7;MRPL34;MRPL21;MRPL58;MRPS21;MRPL53;MRPS17;MRPS18A;MRPS14;MRPS5;MRPS30;MRPS22;MRPS18B;MRPL35;GADD45GIP1;DAP3;MRPS34;MRPS25;ERAL1;MTRF1;MRPL10;CHCHD1
23,prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.7911956585614978,-1.6857506205959727,0.0,0.004752007723263078,0.05,21/158,8.49%,FRZB;DKK3;SFRP2;APOE;SFRP1;NKD2;TPBG;MDK;IGFBP4;MDFI;LRP1;SOX9;BICC1;DACT1;NKD1;DACT3;TSKU;SLC9A3R1;IGFBP2;PTPRO;RBMS3
24,prerank,negative regulation of angiogenesis (GO:0016525),-0.8485778134641054,-1.6850585704070058,0.0,0.004386468667627457,0.05,14/65,6.86%,SERPINF1;SPARC;CCR2;SERPINE1;THBS2;ISM1;SULF1;THBS4;THBS1;TGFB2;EMILIN1;NIBAN2;CXCL10;STAB1
25,prerank,fatty acid beta-oxidation (GO:0006635),0.9073929601146968,1.6833373096521647,0.0,0.013527871354987928,0.18,24/46,6.42%,ETFDH;ACAA2;ACADM;ACAD11;HADHB;IVD;DECR1;ECI1;CRAT;HADHA;ACADVL;HADH;ACAT1;ETFA;CPT2;ACADS;ACADL;GCDH;ETFB;ABCD3;ECHS1;AUH;ACOX1;AMACR
26,prerank,cytokine-mediated signaling pathway (GO:0019221),-0.7321301160229402,-1.6808297779074486,0.0,0.004073149477082639,0.05,88/409,10.65%,IL10RA;FN1;IL7R;CCR2;COL1A2;ITGB2;VAV1;HCK;MMP2;LCP1;CSF2RB;IL21R;CRLF1;GPR35;VIM;PTK2B;ANXA1;IRF8;EREG;CD300LF;PTPN6;IFI30;FCER1G;TIMP1;ITGAX;IRF5;TNFRSF1B;NUMBL;NCAM1;ITGAM;CSF1R;IL1RN;HMOX1;CD44;SRC;PRKCD;CCR5;PLVAP;CSF3R;CCL5;SDC1;PLP2;IL18;SLA;PTAFR;VCAM1;CASP1;CAPZA1;IL33;CXCL10;CX3CL1;CSF2RA;TMSB4X;PIK3CD;SPI1;ANXA2;IL3RA;CEBPA;IL18RAP;TWIST1;GRAP2;MYC;CD80;CRLF2;CEBPD;TRAF1;TNFRSF11A;IRAK4;PTPRJ;P4HB;IFIT3;HGF;BATF;RHOU;CCL8;ICAM1;IL1R1;OSMR;ILK;MAP3K14;BIRC5;CFL1;OAS3;ISG20;EBI3;IL1RL2;TGFB1;MX1
27,prerank,regulation of cellular ketone metabolic process (GO:0010565),0.8528477525764877,1.6772995283364633,0.0,0.015416502745457025,0.21,4/57,4.91%,PDK2;PDK4;SIRT5;PPARA
28,prerank,lipid droplet organization (GO:0034389),0.9376550748945801,1.6746234662673674,0.0,0.015454568184334695,0.22,3/16,1.10%,PLIN5;FITM2;FITM1
29,prerank,positive regulation of immune response (GO:0050778),-0.9055907663870059,-1.673826579943877,0.0,0.005322248650054648,0.07,14/42,5.36%,ITGB2;PTPRC;EREG;FCGR2B;ITGAM;ADAM8;SASH3;TGFB2;TLR8;CYBA;TASL;GRN;CCL5;CD74
30,prerank,fatty acid catabolic process (GO:0009062),0.8702106021228021,1.6676321245663648,0.0,0.01948474652550818,0.32,27/58,8.41%,PHYH;ACAA2;ACADM;ACAD11;HADHB;DECR1;ECI1;HADHA;ACADVL;HADH;ACAT1;LPIN1;CPT2;MMAA;NUDT7;MMUT;ACADS;ACADL;ABCD3;ECHS1;AUH;ACOX1;MCEE;PCCA;ECI2;HSD17B10;PCCB
31,prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.8320321732095357,-1.6619793670386438,0.0,0.005702409267915695,0.08,16/95,7.51%,COL3A1;COL1A2;LTBP2;SFRP1;TGFB3;CILP;GDF15;ITGB5;LPXN;SOX9;ARRB2;TGFB2;SRC;TGFBR1;MAPK7;ADAM9
32,prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.9133756325482254,1.6567223757826612,0.0,0.023981226492933144,0.41,38/39,8.60%,NDUFS1;NDUFB1;NDUFS3;NDUFB8;NDUFB10;NDUFA9;NDUFA10;NDUFV3;NDUFS2;NDUFB2;NDUFS7;NDUFA4;NDUFS6;NDUFS8;NDUFAB1;NDUFAF1;NDUFV2;NDUFV1;NDUFA3;NDUFA8;NDUFB5;NDUFS4;NDUFA5;NDUFA6;NDUFA13;NDUFB9;NDUFA7;NDUFB11;NDUFB7;NDUFA12;NDUFB6;NDUFB3;NDUFA11;NDUFC1;NDUFA1;NDUFS5;NDUFA2;NDUFC2
33,prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.8462399626800736,-1.656452737540113,0.0,0.005366973428626536,0.08,13/57,6.86%,SERPINF1;SPARC;CCR2;THBS2;ISM1;SULF1;THBS4;THBS1;TGFB2;EMILIN1;NIBAN2;CXCL10;STAB1
34,prerank,positive regulation of cytokine production (GO:0001819),-0.7547255080506817,-1.6554450370831677,0.0,0.005702409267915695,0.08,50/223,7.83%,CYP1B1;CCR2;SERPINE1;LY9;TYROBP;PTPRC;ANXA1;EREG;HPSE;HAVCR2;FGR;TLR2;FCER1G;SULF1;MDK;IRF5;SLC11A1;CSF1R;HTR2B;CLEC7A;LAPTM5;TLR1;TLR9;CCDC88B;HMOX1;AIF1;TLR8;CYBA;CD14;NFAM1;PIK3CG;CD276;SPHK1;IL18;RUNX1;CD74;IL33;F2R;SULF2;C1QTNF3;PIK3CD;LACC1;TLR7;TMEM106A;CARD11;PNP;TWIST1;RAB7B;CD80;CRLF2
35,prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.872080448076941,1.65484897271023,0.0,0.02229833340570977,0.42,50/57,11.59%,NDUFS1;NDUFB1;NDUFS3;NDUFAF6;NDUFB8;NDUFB10;NDUFA9;NDUFA10;NDUFV3;NDUFS2;NDUFB2;NDUFS7;NDUFS6;NDUFS8;NDUFAB1;FOXRED1;NDUFAF1;NDUFV2;NDUFV1;NDUFA3;NDUFA8;NDUFB5;NDUFS4;ECSIT;NDUFA5;NDUFA6;NDUFA13;NDUFB9;NDUFA7;NDUFB11;NDUFB7;BCS1L;NDUFA12;NDUFB6;NDUFB3;NDUFA11;NDUFC1;NDUFA1;TMEM126A;NDUFS5;TIMMDC1;NDUFA2;NDUFC2;NDUFAF4;OXA1L;TIMM21;DMAC2;NUBPL;TMEM126B;NDUFAF5
36,prerank,NADH dehydrogenase complex assembly (GO:0010257),0.872080448076941,1.65484897271023,0.0,0.02229833340570977,0.42,50/57,11.59%,NDUFS1;NDUFB1;NDUFS3;NDUFAF6;NDUFB8;NDUFB10;NDUFA9;NDUFA10;NDUFV3;NDUFS2;NDUFB2;NDUFS7;NDUFS6;NDUFS8;NDUFAB1;FOXRED1;NDUFAF1;NDUFV2;NDUFV1;NDUFA3;NDUFA8;NDUFB5;NDUFS4;ECSIT;NDUFA5;NDUFA6;NDUFA13;NDUFB9;NDUFA7;NDUFB11;NDUFB7;BCS1L;NDUFA12;NDUFB6;NDUFB3;NDUFA11;NDUFC1;NDUFA1;TMEM126A;NDUFS5;TIMMDC1;NDUFA2;NDUFC2;NDUFAF4;OXA1L;TIMM21;DMAC2;NUBPL;TMEM126B;NDUFAF5
37,prerank,inflammatory response (GO:0006954),-0.808991891578924,-1.6499593094077012,0.0,0.007803296892937265,0.12,33/123,6.43%,LOXL3;CCR2;ITGB2;C3AR1;MEFV;NOX4;ANXA1;FCGR2B;TLR2;BLNK;SLC11A1;CSF1R;ADAM8;CYBB;IL1RN;TLR1;THBS1;CD44;AIF1;CYBA;CD14;NFAM1;PIK3CG;PTX3;CCR5;CCL5;C5AR1;IL18;F2R;CXCL10;CX3CL1;PIK3CD;CXCR4
38,prerank,positive regulation of response to external stimulus (GO:0032103),-0.790418290217136,-1.64921127222608,0.0,0.007983372975081972,0.13,26/96,6.62%,TREM2;CCR2;CCN4;SERPINE1;PLA2G7;EREG;LY86;TLR2;MDK;PTN;CD180;GPSM3;ADAM8;TLR9;THBS1;AIF1;TLR8;CYBA;TASL;GRN;CCL5;IL18;IL33;CX3CL1;TLR7;CEBPA
39,prerank,fatty acid metabolic process (GO:0006631),0.7174590478629598,1.6475270867310765,0.03225806451612903,0.023981226492933147,0.44,22/77,6.80%,ACADM;ACOT1;ACOT2;ECHDC3;PPARGC1A;CRAT;CPT1B;LPIN1;CPT2;LPL;MLYCD;GNPAT;NDUFAB1;CBR4;ACSL6;CD36;ABCD3;PPARA;ACOX1;ALKBH7;THEM4;ACSL1
40,prerank,positive regulation of cell migration (GO:0030335),-0.755596597169328,-1.6450453557691476,0.0,0.008689385551109631,0.15,49/211,8.40%,CXCL16;FN1;GPNMB;COL1A1;MMP14;CCR2;CCN4;PDPN;PAK1;NCKAP1L;CEMIP;PTPRC;S100A11;PTK2B;FGR;CTSH;MDK;ITGAX;SNAI1;CSF1R;CLEC7A;RTN4;FERMT3;SOX9;SEMA3D;THBS1;AIF1;TGFB2;PLAU;GRN;SRC;IGF1;CCL5;CARMIL1;SPHK1;ROR2;F2R;PIK3CD;ACTG1;GTSE1;TGFBR1;VSIR;SHTN1;GLIPR2;PDGFC;ADAM9;RHOC;MYO1C;HGF
41,prerank,regulation of angiogenesis (GO:0045765),-0.7490240513696601,-1.6372180818403912,0.0,0.010368016850755807,0.18,34/160,6.90%,SERPINF1;SPARC;SFRP2;GPNMB;CYP1B1;CCR2;SFRP1;VASH2;SERPINE1;PTGIS;ECM1;THBS2;ISM1;CTSH;SULF1;ITGAX;ADAM12;VEGFD;HMOX1;THBS4;ADGRA2;THBS1;TGFB2;GRN;ANXA3;EMILIN1;SPHK1;RUNX1;PRKCB;NIBAN2;CXCL10;PIK3CD;STAB1;TWIST1
42,prerank,fatty acid oxidation (GO:0019395),0.9020178639535871,1.6354278500129364,0.0,0.030833005490914042,0.49,22/47,8.01%,PHYH;ACAA2;ACADM;ACAD11;HADHB;PPARGC1A;DECR1;ECI1;HADHA;ACADVL;HADH;ACAT1;CPT2;ACADS;ACADL;ABCD3;ECHS1;AUH;ACOX1;ECI2;ALOX12;HSD17B10
43,prerank,regulation of glucose metabolic process (GO:0010906),0.891753453012193,1.633570448447729,0.0,0.031248264824125013,0.49,5/28,2.41%,PDK2;PDK4;RORC;MLYCD;GNB3
44,prerank,regulation of mRNA processing (GO:0050684),0.8592880894353404,1.6300397674302312,0.0,0.03406029270010794,0.52,3/31,5.23%,SRPK3;KHDRBS3;PTCD2
45,prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.8530119433166087,-1.6287468057428394,0.0,0.012396541886773249,0.22,11/76,4.29%,COL3A1;COL1A2;LTBP2;FMOD;TGFB3;GDF15;ITGB5;LPXN;ARRB2;TGFB2;SRC
46,prerank,peptidyl-lysine modification (GO:0018205),-0.8298355785527374,-1.6238867519171574,0.0,0.013780822397462929,0.25,7/90,5.17%,LOXL1;LOXL3;LOX;LOXL2;P3H3;LOXL4;PLOD2
47,prerank,regulation of Wnt signaling pathway (GO:0030111),-0.8006146068394934,-1.6222988695613914,0.0,0.014141974984430922,0.26,18/81,7.81%,FRZB;SFRP2;SFRP1;NKD2;TLR2;SULF1;MDFI;LRP1;PTK7;DACT1;RUNX1;NKD1;SULF2;GPC3;DACT3;ATP6AP2;CDK14;TSKU
48,prerank,canonical Wnt signaling pathway (GO:0060070),-0.8948716488665531,-1.6217063451914921,0.0,0.014036699736407863,0.27,5/46,2.51%,FRZB;SFRP2;CDH3;SFRP1;FZD2
49,prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.799891599236876,-1.620347343045833,0.0,0.014784024027929577,0.28,15/102,7.59%,COL3A1;COL1A2;LTBP2;GDF6;TGFB3;GDF15;ITGB5;LPXN;ARRB2;TGFB2;SRC;TGFBR1;ADAM9;INHBB;TGFB1I1
50,prerank,negative regulation of autophagy (GO:0010507),-0.8380812676651446,-1.6170548442111956,0.0,0.016292597908330556,0.3,6/49,2.92%,IL10RA;CTSA;TREM2;NUPR1;DAP;HTR2B
51,prerank,mRNA 3'-end processing (GO:0031124),-0.8172929443607428,-1.6165344946380786,0.0,0.015730784187353637,0.3,1/75,0.04%,PABPC1
52,prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.8242996774298412,-1.614745153003438,0.0,0.015966745950163945,0.31,17/75,8.37%,SERPINE1;CD68;VIM;FCGR2B;TLR2;CD180;TNFRSF1B;CX3CR1;SIRPA;CD14;CCR5;CASP1;CXCL10;TICAM2;ADAM9;CD80;SBNO2
53,prerank,Wnt signaling pathway (GO:0016055),-0.8395594886554788,-1.6119573380141912,0.0,0.0161874843734381,0.32,4/70,2.51%,FRZB;SFRP2;SFRP1;FZD2
54,prerank,regulation of inflammatory response (GO:0050727),-0.7697501544386768,-1.6117949402384162,0.0,0.01568162548676816,0.32,48/143,11.06%,CCR2;APOE;HCK;CCN4;SERPINE1;TNFAIP8L2;PLA2G7;PIK3AP1;MEFV;PTGIS;ANXA1;ADAMTS12;TLR2;MDK;TNFRSF1B;GPSM3;TLR9;CCN3;SIRPA;AOAH;GRN;GBA;PRKCD;CCL5;SPHK1;IL18;CASP1;IL33;CASP12;C1QTNF3;CX3CL1;TMSB4X;LACC1;TLR7;CEBPA;MAPK7;SBNO2;TYRO3;NLRC3;AKNA;CD200R1;IL1R1;APP;MACIR;NR1H4;IL1RL2;METRNL;BST1
55,prerank,response to interferon-gamma (GO:0034341),-0.8588363256022401,-1.6081952616292037,0.0,0.016588826961209294,0.34,11/44,6.09%,CXCL16;MEFV;IRF8;TLR2;SLC11A1;AIF1;SIRPA;CCL5;CD74;CASP1;CX3CL1
56,prerank,ribosomal large subunit biogenesis (GO:0042273),0.8155910879983508,1.6072214949460852,0.0,0.05762155810107548,0.72,1/54,0.09%,RPL3L
57,prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.8273583562791459,-1.6054688198374083,0.0,0.01744266364303624,0.37,15/60,7.59%,SFRP2;COL1A1;SFRP1;PDPN;LOXL2;TGFB3;MDK;SNAI1;VASN;TGFB2;OLFM1;TGFBR1;TWIST1;GLIPR2;TGFB1I1
58,prerank,regulation of ATP metabolic process (GO:1903578),0.787555686919736,1.6029219633500709,0.023809523809523808,0.060112941075619084,0.76,9/50,16.30%,COX7A1;PINK1;GCK;COX7A2;AK4;PRKAG1;SLC25A33;BEND3;UQCC2
59,prerank,toll-like receptor signaling pathway (GO:0002224),-0.7892295824557912,-1.6006537894126902,0.0,0.021180377280829724,0.41,18/77,6.99%,CTSS;ITGB2;PIK3AP1;CTSK;SCARA3;TLR2;ITGAM;TLR1;TLR9;TLR8;CD14;BTK;UNC93B1;LGMN;CTSB;TLR7;TICAM2;COLEC12
60,prerank,innate immune response (GO:0045087),-0.7403086823193138,-1.6006436640464106,0.0,0.02059203346747334,0.41,39/156,6.34%,CXCL16;CLEC4D;MFAP4;TREM2;HCK;TYROBP;MEFV;PTK2B;FGR;TLR2;FCER1G;IRF5;SLC11A1;NCF1;CLEC7A;CYBB;CX3CR1;TLR9;TLR8;CYBA;CLEC5A;TRIM59;BTK;SRC;PIK3CG;RNASE6;CORO1A;PTX3;CD300LB;SLA;TIFA;CD74;CFB;CAPZA1;SKP2;CXCL10;PIK3CD;FES;NCF2
61,prerank,response to cytokine (GO:0034097),-0.7933812477285078,-1.5986072719049815,0.015625,0.02311787541046903,0.45,29/117,11.07%,CXCL16;COL3A1;TIMP2;MEFV;ANXA1;PTPN6;TIMP1;SLC11A1;CSF1R;PTPN7;SRC;IKBKE;SPHK1;DPYSL3;CD74;CASP1;PTPN18;HCLS1;CXCR4;ADAM9;TNFRSF11A;TIMP3;IL1R1;OSMR;APP;IL1RL2;MX1;AFF3;CDK9
62,prerank,glucose homeostasis (GO:0042593),0.795577852001226,1.5977325519586538,0.0,0.0648722921796012,0.8,14/58,10.35%,PDK2;PDK4;PPARGC1A;SLC2A4;HK2;GCK;KCNB1;PRKAA2;WFS1;ALOX5;MLXIPL;CRY1;CAV3;INSR
63,prerank,positive regulation of signal transduction (GO:0009967),-0.7464098789230939,-1.5955740650653194,0.0,0.023109763875237284,0.46,39/186,9.80%,LOXL3;TREM2;IL7R;CDH3;SFRP1;P2RY6;PTGIS;PTPRC;PTK2B;LY86;TLR2;SULF1;CD180;CCN3;TGFB2;SRC;IGF1;FLNA;DACT1;CD74;RAB34;PRKCB;EVC;SULF2;ITGB3;TGFBR1;ITGA5;CD63;ATP6AP2;ROBO1;CD80;CRLF2;GAS6;MYO1C;HHEX;KIF7;ILK;DLG4;SMO
64,prerank,carbohydrate homeostasis (GO:0033500),0.8425500296979658,1.5937799054948885,0.0,0.07046335685577887,0.82,12/44,10.35%,PDK2;PDK4;SLC2A4;GCK;KCNB1;PRKAA2;WFS1;ALOX5;MLXIPL;CRY1;CAV3;INSR
65,prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.7859074635431456,-1.5935847299824644,0.0,0.02339449956067977,0.48,9/89,7.61%,CLEC4D;TYROBP;PAK1;FCER1G;CLEC7A;SRC;PRKCD;CARD11;MUC16
66,prerank,cellular response to lectin (GO:1990858),-0.7865243377840329,-1.5923977295699172,0.0,0.022809637071662774,0.48,9/88,7.61%,CLEC4D;TYROBP;PAK1;FCER1G;CLEC7A;SRC;PRKCD;CARD11;MUC16
67,prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.7865243377840329,-1.5923977295699172,0.0,0.022809637071662774,0.48,9/88,7.61%,CLEC4D;TYROBP;PAK1;FCER1G;CLEC7A;SRC;PRKCD;CARD11;MUC16
68,prerank,hexose biosynthetic process (GO:0019319),0.8888463688016539,1.5900898262148226,0.0,0.07108720710405184,0.84,12/32,4.10%,FBP2;SORD;PPARGC1A;ENO3;MDH1;SLC25A11;MDH2;GOT1;SLC25A13;GOT2;SLC25A12;PGAM2
69,prerank,extracellular matrix disassembly (GO:0022617),-0.8885758076262749,-1.5881050593671133,0.0,0.023340093747747957,0.51,16/39,4.43%,TIMP2;CTSS;MMP14;MMP2;LCP1;MMP12;CTSK;CAPG;SH3PXD2B;TIMP1;BMP1;ADAM8;MMP19;CD44;MMP16;MMP11
70,prerank,cellular component disassembly (GO:0022411),-0.8885758076262749,-1.5881050593671133,0.0,0.023340093747747957,0.51,16/39,4.43%,TIMP2;CTSS;MMP14;MMP2;LCP1;MMP12;CTSK;CAPG;SH3PXD2B;TIMP1;BMP1;ADAM8;MMP19;CD44;MMP16;MMP11
71,prerank,acyl-CoA metabolic process (GO:0006637),0.9049061294726982,1.587301873046475,0.0,0.07277061832338334,0.85,12/25,6.76%,ACOT1;ACACB;ACOT2;SUCLG2;SUCLA2;DLST;OGDH;MLYCD;ACSL6;ACOT13;MCEE;THEM4
72,prerank,negative regulation of multicellular organismal process (GO:0051241),-0.7463050023332369,-1.584449981607265,0.0,0.024624040020545045,0.54,33/145,12.21%,SFRP2;GPNMB;SFRP1;LOXL2;GDF15;FCGR2B;TIMP1;MDK;VASN;SLC11A1;SOX9;GRN;F2R;ARHGDIB;TIFAB;SPI1;PROCR;ROBO1;CORO1C;PTPRO;GAS6;SLAMF8;DOCK7;SPRED3;TBX18;RAB11FIP1;FOXC2;NR1H4;TGFB1;CHSY1;WNT11;BMP2;LAMA4
73,prerank,cellular response to lipopolysaccharide (GO:0071222),-0.8061354394654088,-1.582684555989439,0.0,0.02534404119073642,0.56,23/77,12.05%,HCK;SERPINE1;CD68;VIM;CD180;TNFRSF1B;CX3CR1;SIRPA;CD14;CCR5;CCL5;IL18;CASP1;CXCL10;TICAM2;ADAM9;CD80;SBNO2;TGFB1;PTPN22;STAP1;CD86;AXL
74,prerank,proteolysis (GO:0006508),-0.7640132661623924,-1.5824208450327644,0.0,0.024793083773546498,0.56,27/175,6.11%,CTSS;CTSA;AEBP1;MMP14;CPXM1;MMP2;VASH2;CTSZ;ANPEP;ACAN;MMP12;CTSK;DPP7;ADAMTS12;CTSH;BMP1;CTSD;MMP19;CAPN6;ST14;MMP16;PLAU;LGMN;PRCP;CASP1;CTSB;FAP
75,prerank,regulation of cytokine production (GO:0001817),-0.8096861511104982,-1.5793175209710912,0.015151515151515152,0.025964161347531035,0.59,23/95,6.22%,TREM2;GPNMB;CCR2;PLD4;CCN4;PTPRC;ANXA1;IRF8;EREG;FCGR2B;PLD3;FGR;TNFRSF1B;SLC11A1;HTR2B;CCDC88B;SIRPA;NFAM1;PIK3CG;CD276;IL33;C1QTNF3;PIK3CD
76,prerank,positive regulation of defense response (GO:0031349),-0.7669895005589366,-1.5725158288445154,0.01639344262295082,0.03088805020121001,0.66,20/69,6.62%,CCR2;CCN4;SERPINE1;PLA2G7;EREG;TLR2;MDK;GPSM3;ADAM8;TLR9;TLR8;CYBA;TASL;GRN;CCL5;IL18;IL33;CX3CL1;TLR7;CEBPA
77,prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.7584905369857347,-1.572372823924081,0.015384615384615385,0.03049043322844718,0.66,8/109,7.14%,FRZB;SFRP2;SFRP1;FZD2;ARRB2;ROR2;FZD1;GNG2
78,prerank,glycosaminoglycan catabolic process (GO:0006027),-0.841418952121359,-1.5720656901281156,0.0,0.029880624563878237,0.66,19/45,7.12%,GUSB;FMOD;HEXB;CEMIP;BGN;ACAN;HPSE;LUM;NAGLU;CD44;HEXA;SDC1;SGSH;HMMR;GPC3;SDC3;GALNS;GLB1;FUCA1
79,prerank,positive regulation of cell population proliferation (GO:0008284),-0.7156734171562845,-1.5704871371751319,0.0,0.030189225536024263,0.68,57/312,8.24%,FN1;SFRP2;IL7R;TMEM119;SFRP1;HCK;CCN4;PAK1;CRLF1;TCIRG1;PTPRC;TGFB3;PTK2B;CLEC11A;EREG;PTPN6;HPSE;CTSH;TIMP1;MDK;ITGAX;PTN;VEGFD;CSF1R;HTR2B;CLEC7A;HMOX1;SOX9;THBS1;AIF1;TGFB2;MEGF10;GRN;ID2;NAP1L1;IGF1;CCL5;C5AR1;LGMN;SPHK1;IL18;CD74;S100A6;OSR1;F2R;HCLS1;CX3CL1;TGFBR1;PDGFC;RHOG;MYC;E2F1;CRLF2;FGFR1;GAS6;TNFRSF11A;S1PR2
80,prerank,positive regulation of establishment of protein localization (GO:1904951),-0.923698656544812,-1.5695900232578204,0.038461538461538464,0.030266633806629455,0.69,1/18,0.33%,TREM2
81,prerank,glycolipid metabolic process (GO:0006664),-0.8201077044522217,-1.566502184164038,0.0,0.03313852933052894,0.74,16/40,11.39%,CTSA;HEXB;B4GALNT1;GLA;GM2A;GBA;GLTP;HEXA;ASAH1;GLB1;FUCA1;B3GALNT1;SUMF1;ESYT1;NAGA;ARSA
82,prerank,positive regulation of lipid storage (GO:0010884),0.8929853326121706,1.5641473012486768,0.0,0.111645932228211,0.96,5/17,1.78%,PLIN3;PLIN5;FITM2;FITM1;LPL
83,prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.874321244728299,-1.5627332349346275,0.0,0.03505925698051871,0.76,9/27,4.33%,SFRP2;CYP1B1;SERPINE1;NCKAP1L;ADA;FERMT3;TGFB2;PLAU;PIK3CG
84,prerank,gluconeogenesis (GO:0006094),0.8795385741779014,1.5622514592544459,0.0,0.11191239030035469,0.97,11/30,4.10%,FBP2;PPARGC1A;ENO3;MDH1;SLC25A11;MDH2;GOT1;SLC25A13;GOT2;SLC25A12;PGAM2
85,prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.9106659081332684,-1.5620896815147922,0.0,0.03545861762958486,0.78,5/17,5.83%,IL10RA;CYP1B1;PTK2B;CCL5;F2R
86,prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.8265654095948343,-1.5615698190075615,0.0,0.03543640045061896,0.78,21/67,8.40%,SFRP2;TREM2;ITGB2;SFRP1;PTPRC;PTK2B;PTPN6;THBS4;CD44;SRC;PRKCD;RAP2B;IGF1;CD74;HCLS1;ITGB3;ITGA5;SAMSN1;CD80;PTPRJ;HGF
87,prerank,regulation of Rho protein signal transduction (GO:0035023),-0.8155824721270967,-1.5604179131700207,0.0,0.03621530096465757,0.79,9/57,7.66%,COL3A1;APOE;GPR35;GPR65;F2R;BCR;ARHGDIB;MYO9B;ROBO1
88,prerank,regulation of cell migration (GO:0030334),-0.6996705942689536,-1.560370823467574,0.0,0.03559089922388761,0.79,61/316,8.40%,CXCL16;SFRP2;GPNMB;COL1A1;CYP1B1;MMP14;SFRP1;SERPINE1;PDPN;PAK1;CEMIP;PTK2B;ANXA1;FGR;CTSH;SULF1;MDK;ITGAX;SERPINE2;SNAI1;CSF1R;CLEC7A;FERMT3;SEMA3D;IGSF10;THBS1;AIF1;PLAU;GRN;SRC;RAP2B;IGF1;FLNA;CCL5;CARMIL1;SRGAP3;SPHK1;DPYSL3;CD74;NKD1;ROR2;F2R;CX3CL1;TMSB4X;PIK3CD;ACTG1;GTSE1;TMSB10;TGFBR1;PLXNC1;VSIR;ARHGAP4;PDGFC;ADAM9;ROBO1;CORO1C;DOCK10;RHOC;MYO1C;PTPRJ;HGF
89,prerank,ribonucleoprotein complex assembly (GO:0022618),0.7003325859940924,1.558439412801698,0.0,0.11640887026777964,0.98,2/126,1.20%,RPL3L;SRPK3
90,prerank,regulation of innate immune response (GO:0045088),-0.827858779061226,-1.5554799491070666,0.0,0.04117332793444213,0.84,12/56,8.72%,TREM2;EREG;FCGR2B;PTPN6;FGR;ADAM8;TLR8;TASL;CCL5;PTPN1;TYRO3;NLRC3
91,prerank,mesenchymal cell differentiation (GO:0048762),-0.8546313353300252,-1.5554702767811546,0.0,0.04048710580220143,0.84,18/42,12.13%,LOXL3;LOXL2;SNAI1;S100A4;HTR2B;SOX9;TGFB2;TGFBR1;FGFR1;HGF;AKNA;FAM83D;WNT4;TGFB1;FOXC1;FGFR2;BMP2;SNAI2
92,prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.7952179379711154,-1.5553859141844233,0.0,0.0398233827562637,0.84,17/65,8.80%,VAV1;HCK;PAK1;NCKAP1L;ARPC1B;FCGR2B;FGR;FCER1G;SRC;PRKCD;ARPC5;WAS;ACTG1;MYO1G;MYO1C;ARPC4;ARPC2
93,prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.7097700001794177,-1.555264189860249,0.0,0.03918107013116267,0.84,1/237,0.04%,PABPC1
94,prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.8931676134071121,1.5549171550838756,0.022222222222222223,0.11873058214638468,0.98,7/19,6.76%,ACOT1;ACOT2;ACAT1;MLYCD;ACSL6;ACOT13;THEM4
95,prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.8931676134071121,1.5549171550838756,0.022222222222222223,0.11873058214638468,0.98,7/19,6.76%,ACOT1;ACOT2;ACAT1;MLYCD;ACSL6;ACOT13;THEM4
96,prerank,positive regulation of cell motility (GO:2000147),-0.7284421949147079,-1.5531445557915882,0.0,0.04036943703953016,0.84,38/171,8.40%,CXCL16;GPNMB;COL1A1;MMP14;PDPN;PAK1;CEMIP;PTK2B;FGR;CTSH;MDK;ITGAX;SNAI1;CSF1R;CLEC7A;FERMT3;SEMA3D;THBS1;AIF1;PLAU;GRN;IGF1;CCL5;CARMIL1;SPHK1;ROR2;F2R;PIK3CD;ACTG1;GTSE1;TGFBR1;VSIR;TWIST1;PDGFC;ADAM9;RHOC;MYO1C;HGF
97,prerank,response to tumor necrosis factor (GO:0034612),-0.7917176694588709,-1.5520620367070594,0.016666666666666666,0.04062966603389932,0.84,19/67,14.03%,CXCL16;SFRP1;ADAMTS12;GBA;CCL5;SPHK1;CX3CL1;ASAH1;ADAM9;TNFRSF11A;CCL8;NPNT;AFF3;ZFP36L2;PID1;CASP3;TRADD;PYCARD;RIPK1
98,prerank,inner mitochondrial membrane organization (GO:0007007),0.8370455552099314,1.5484894022382136,0.0,0.12904183779530692,0.98,23/33,14.39%,ATP5PB;HSPA9;MTX2;APOO;IMMT;OPA1;CHCHD3;NDUFA13;GHITM;SAMM50;MICOS13;MICOS10;SPG7;AFG3L2;APOOL;TIMM29;LETM1;DNAJC11;TIMM10;TIMM8B;TIMM22;DMAC2L;ROMO1
99,prerank,aerobic respiration (GO:0009060),0.8938919165757198,1.546084178813687,0.02040816326530612,0.12967626177660146,0.98,15/18,10.57%,UQCRC2;MDH2;SDHB;NDUFS7;UQCRC1;NDUFS8;SDHC;ME3;SIRT3;UQCRH;UQCRB;MTFR1;MTFR1L;OXA1L;UQCR10
100,prerank,RNA splicing (GO:0008380),0.6818816512125495,1.544764716093493,0.0,0.1291961571421083,0.98,3/94,8.92%,PPARGC1A;IVNS1ABP;SNRPN
101,prerank,mRNA polyadenylation (GO:0006378),-0.8640837315013307,-1.5436068130735552,0.0,0.048211278356014506,0.9,1/25,0.04%,PABPC1
102,prerank,RNA polyadenylation (GO:0043631),-0.8640837315013307,-1.5436068130735552,0.0,0.048211278356014506,0.9,1/25,0.04%,PABPC1
103,prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.8640846289148298,1.543134309076898,0.038461538461538464,0.130003490988006,0.98,8/22,6.57%,HRC;DHRS7C;ANK2;RYR2;CASQ2;ATP1A2;PRKACA;TRDN
104,prerank,cellular response to organic substance (GO:0071310),-0.7720717420749654,-1.5419628932164449,0.0,0.05004502461991684,0.91,20/90,11.07%,CYP1B1;SFRP1;PTPN6;CSF1R;PTPN7;CCL5;SPHK1;IL18;DPYSL3;CASP1;PTPN18;HCLS1;CXCR4;TGFBR1;MAPK7;SLIT3;NR1H4;IL1RL2;TGFB1;CDK9
105,prerank,glycosphingolipid metabolic process (GO:0006687),-0.8203484969353777,-1.5403113617456714,0.01818181818181818,0.05098624757195209,0.91,12/35,9.32%,CTSA;HEXB;B4GALNT1;GLA;GM2A;GBA;GLTP;HEXA;ASAH1;GLB1;B3GALNT1;SUMF1
106,prerank,receptor-mediated endocytosis (GO:0006898),-0.7511650763275284,-1.5402861927099445,0.015384615384615385,0.0502473164477209,0.91,16/106,7.01%,CXCL16;SPARC;APOE;ITGB2;MARCO;FCGR2B;FCER1G;RAB31;ITGAM;LRP1;ARRB2;TPCN2;MSR1;STAB1;COLEC12;CD9
107,prerank,regulation of defense response (GO:0031347),-0.834797371180686,-1.540016671627881,0.0,0.049692423620408196,0.91,23/65,12.22%,TREM2;CCR2;APOE;HCK;PIK3AP1;ANXA1;FCGR2B;FGR;ADAMTS12;GRN;CASP1;CASP12;TMSB4X;LACC1;SBNO2;AKNA;IL1R1;IL1RL2;BST1;PTPN22;LRP8;DAGLB;ZBP1
108,prerank,protein targeting to mitochondrion (GO:0006626),0.782542305611161,1.5395130888783444,0.03225806451612903,0.13507374580207646,0.99,29/47,16.42%,MIPEP;HSPD1;MFN2;PMPCB;NDUFA13;IMMP2L;PMPCA;GRPEL1;TIMM23;SAMM50;TOMM5;TOMM40L;TIMM29;TIMM44;TIMM21;TIMM17A;TIMM10;TOMM40;TIMM8B;AIFM1;TIMM22;DNAJC15;DNAJC19;ROMO1;IMMP1L;CHCHD4;TIMM9;TOMM7;GRPEL2
109,prerank,skin development (GO:0043588),-0.8475335511157365,-1.5384168835071579,0.0,0.05075947404679886,0.92,13/42,7.51%,COL3A1;COL5A2;COL1A1;COL1A2;SPRR1A;COL5A1;ANXA1;EREG;ST14;BCR;ASAH1;SLC2A10;ADAM9
110,prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.787842636324101,-1.538100219062986,0.0,0.050212881609146526,0.92,16/64,8.80%,VAV1;HCK;PAK1;NCKAP1L;ARPC1B;FCGR2B;FGR;SRC;PRKCD;ARPC5;WAS;ACTG1;MYO1G;MYO1C;ARPC4;ARPC2
111,prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.87515833386248,-1.5370804493995711,0.019230769230769232,0.05108733782488855,0.93,6/27,4.44%,SFRP2;SFRP1;PTPRC;PTPN6;CD300A;PRKCD
112,prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.7945670270791476,-1.536883151128534,0.0,0.051167564241838125,0.93,17/67,8.80%,VAV1;HCK;PAK1;NCKAP1L;ARPC1B;FCGR2B;FGR;FCER1G;SRC;PRKCD;ARPC5;WAS;ACTG1;MYO1G;MYO1C;ARPC4;ARPC2
113,prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.8332462643282151,-1.535535308469698,0.0,0.05291835800625764,0.95,11/54,3.75%,SPARC;SFRP2;APOE;SFRP1;NUPR1;EREG;SULF1;SOX9;CDKN2B;THBS1;TGFB2
114,prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.943275948902199,-1.5333628284712515,0.0,0.055223331857709876,0.96,4/25,2.30%,FSTL1;DKK3;FST;FSTL3
115,prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.8845334905100085,-1.5332598394875314,0.0,0.05450614572968768,0.96,9/34,4.91%,EREG;LY86;CD180;ADAM8;TLR8;CYBA;TASL;GRN;CCL5
116,prerank,stem cell differentiation (GO:0048863),-0.8463691935984932,-1.5324357215435884,0.0,0.05468464272308897,0.96,7/26,8.49%,SFRP1;PTPRC;HTR2B;TGFB2;OSR1;MEOX1;BATF
117,prerank,negative regulation of signal transduction (GO:0009968),-0.714742532746115,-1.5282860123548367,0.0,0.06005575330260579,0.96,47/196,9.49%,FRZB;DKK3;SFRP2;MMP14;SFRP1;PLEK;NKD2;PTPRC;CILP;GDF15;ADAMTS12;SULF1;FSTL3;MDFI;ENPP1;CX3CR1;LRP1;TLR9;THBS1;IGFBP3;GBA;PRKCD;ARRDC1;EMILIN1;CCL5;LGMN;DACT1;NKD1;PRKCB;PTPN18;NIBAN2;SULF2;CX3CL1;GPC3;PTPN1;SLC2A10;DACT3;PIP4K2A;TSKU;SLC9A3R1;PTPRJ;RGS14;TYRO3;HHEX;LEPROT;GLIS2;KIF7
118,prerank,epithelial cell migration (GO:0010631),-0.9032075212818984,-1.5276747342373578,0.0,0.06001785754481268,0.96,7/32,6.11%,FSTL1;CYP1B1;LOXL2;LPXN;ADGRA2;ANLN;FAP
119,prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.8521401779481113,-1.5251975771248012,0.0,0.06392330389219075,0.98,3/29,5.11%,GPNMB;CDKN2B;DACT1
120,prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.8406037663493301,-1.5237938150781176,0.0,0.06550816500459249,0.98,12/37,7.59%,COL1A1;PDPN;LOXL2;TGFB3;MDK;SNAI1;TGFB2;OLFM1;TGFBR1;TWIST1;GLIPR2;TGFB1I1
121,prerank,cellular response to BMP stimulus (GO:0071773),-0.826624718209527,-1.5227099834104936,0.01639344262295082,0.06664261433588221,0.98,7/44,3.75%,GDF6;SFRP1;TGFB3;GDF15;ADAMTS12;SOX9;TGFB2
122,prerank,positive regulation of apoptotic process (GO:0043065),-0.6799224593629954,-1.5225032679149526,0.0,0.06598502152873875,0.98,41/243,12.24%,FRZB;SFRP2;CYP1B1;VAV1;SFRP1;NUPR1;FGD3;PTGIS;TGFB3;GADD45B;IRF5;CTSD;CLU;IGFBP3;TGFB2;OLFM1;RASSF2;GRN;MELK;FAP;APAF1;TGFBR1;PHLDA3;TOP2A;PREX1;E2F1;PAWR;BID;BIN1;PLEKHN1;STK17B;GADD45G;CALHM2;BOK;BTG1;FGD2;BMP2;CASP3;BAX;ZBP1;TIAM1
123,prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.9017596863079615,-1.5202896178778447,0.0,0.06842891121498833,0.99,3/21,2.78%,SFRP2;SFRP1;VASN
124,prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.8207221738827832,-1.5201164549153123,0.0,0.06789845453890316,0.99,10/58,8.72%,CYP1B1;PTGIS;HAVCR2;DAP;TLR9;ARRB2;TMSB4X;SPI1;ANXA4;NLRC3
125,prerank,striated muscle contraction (GO:0006941),0.8154212515035609,1.5189539647191805,0.0,0.1864540359825552,0.99,23/39,12.75%,SCN4B;MYL3;TNNI3;LMOD3;KLHL41;TTN;RYR2;CASQ2;PGAM2;DTNA;ATP1A2;MYH6;TPM1;TNNC1;TCAP;MYH14;CSRP3;KCNQ1;RCSD1;TNNT1;ALDOA;KCNH2;TNNT2
126,prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.9097726420778203,-1.51805019099,0.0,0.07013307950195163,0.99,6/20,3.13%,GPNMB;TYROBP;SPN;FCGR2B;CD300A;LST1
127,prerank,mitochondrial membrane organization (GO:0007006),0.8622111606503885,1.517199024462342,0.0,0.18678060959536547,0.99,17/31,10.11%,PPIF;SLC25A4;MFN2;HSPA9;MTX2;APOO;IMMT;OPA1;CHCHD3;GHITM;SAMM50;MICOS13;MICOS10;SPG7;MFN1;APOOL;DNAJC11
128,prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.847412850537727,-1.516919447247438,0.018518518518518517,0.07128011584894617,0.99,5/31,3.63%,SFRP1;LGALS3;SERPINE1;HMOX1;THBS1
129,prerank,cellular response to UV (GO:0034644),-0.7909625811223542,-1.516729716678626,0.01639344262295082,0.0708636477563456,0.99,4/66,4.44%,MFAP4;MMP2;TIMP1;PRKCD
130,prerank,extracellular matrix assembly (GO:0085029),-0.8711908568108548,-1.5167045797141667,0.03389830508474576,0.07020299409833988,0.99,5/20,5.16%,MFAP4;FBLN5;LTBP3;EMILIN1;EFEMP2
131,prerank,secondary alcohol biosynthetic process (GO:1902653),0.9011756546001461,1.5164468217516616,0.0,0.18556901452864932,0.99,1/24,0.31%,ACAA2
132,prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.8505756136131786,1.5144187678348422,0.0,0.1860868815459386,0.99,4/26,4.80%,FEM1A;PINK1;DCUN1D2;FBXW7
133,prerank,regulation of response to external stimulus (GO:0032101),-0.7995201078122592,-1.513933328818652,0.0,0.07482062270210263,1.0,29/89,12.22%,TREM2;CCR2;HCK;PIK3AP1;ANXA1;FCGR2B;FGR;ADAMTS12;ADGRA2;GRN;P2RX4;CASP1;F2R;CASP12;CX3CL1;TMSB4X;LACC1;CXCR4;SBNO2;AKNA;IL1R1;EPHB2;IL1RL2;BST1;PTPN22;LRP8;DAGLB;CYRIB;ZBP1
134,prerank,negative regulation of T cell activation (GO:0050868),-0.9057484229679127,-1.5134994976091793,0.0,0.07462718215837497,1.0,8/23,3.16%,GPNMB;LGALS3;TNFAIP8L2;NCKAP1L;SPN;FCGR2B;HAVCR2;LAPTM5
135,prerank,cellular response to interferon-gamma (GO:0071346),-0.7719302907422924,-1.5089788344276918,0.0,0.08437113067367737,1.0,15/65,6.09%,HCK;IRF8;IFI30;TLR2;IRF5;NCAM1;CD44;AIF1;SIRPA;PRKCD;CCL5;PTAFR;VCAM1;CASP1;CX3CL1
136,prerank,eye development (GO:0001654),-0.8519484205220392,-1.5081975631340399,0.0,0.08553613901873541,1.0,6/35,3.75%,COL5A2;COL5A1;FBN1;SH3PXD2B;FBN2;TGFB2
137,prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.8422716387471993,-1.5074927860051637,0.0,0.08547611365802052,1.0,4/28,7.70%,GPNMB;CDKN2B;DACT1;SUSD2
138,prerank,positive regulation of cell growth (GO:0030307),-0.7549609140447766,-1.5068222198942662,0.0196078431372549,0.08589253959798014,1.0,10/76,6.92%,CXCL16;SFRP2;MMP14;SFRP1;DBN1;TGFB2;IGF1;SPHK1;TGFBR1;SHTN1
139,prerank,cholesterol biosynthetic process (GO:0006695),0.8958542864739117,1.5064648496073554,0.0,0.2076556203138075,0.99,1/25,0.31%,ACAA2
140,prerank,negative regulation of protein localization to nucleus (GO:1900181),0.9060814236168487,1.5061661253672571,0.0,0.2037516058325505,0.99,1/17,0.02%,ILRUN
141,prerank,epithelial to mesenchymal transition (GO:0001837),-0.8505832882689911,-1.5050866703993824,0.0,0.087946435719607,1.0,16/39,12.13%,LOXL3;LOXL2;SNAI1;S100A4;SOX9;TGFB2;OLFM1;TGFBR1;FGFR1;HGF;AKNA;FAM83D;WNT4;TGFB1;BMP2;SNAI2
142,prerank,regulation of endopeptidase activity (GO:0052548),-0.8497561817511188,-1.5035541344545857,0.01694915254237288,0.0905402940905798,1.0,8/35,6.76%,SERPINF1;TIMP2;SERPINE1;TIMP1;SERPINE2;SERPING1;ATP13A2;VSIR
143,prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.6952490596578922,-1.5030986277946232,0.0,0.09077774753772865,1.0,29/217,9.59%,FRZB;DKK3;SFRP2;COL1A1;APOE;CDH3;SFRP1;NKD2;TPBG;MDK;IGFBP4;SOX9;ADGRA2;PTK7;BICC1;DACT1;NKD1;GPC3;DACT3;ATP6AP2;CDK14;SLC9A3R1;IGFBP2;PTPRO;PLEKHA4;RBMS3;HHEX;ILK;LRRK1
144,prerank,fatty acid transmembrane transport (GO:1902001),0.8712044822003282,1.5030310079071456,0.0,0.21218172136138674,0.99,7/17,7.22%,ACACB;CPT1B;CPT2;SLC25A20;CD36;ABCD3;PRKAA2
145,prerank,histone H4 acetylation (GO:0043967),0.7888792634052728,1.5014355195498137,0.02702702702702703,0.213620003369674,0.99,1/43,0.82%,APBB1
146,prerank,blood vessel diameter maintenance (GO:0097746),-0.8818240419110592,-1.5011277857387695,0.0,0.0936335601791757,1.0,2/21,2.92%,SCPEP1;HTR2B
147,prerank,positive regulation of cellular process (GO:0048522),-0.6620940296182299,-1.500448186047544,0.0,0.09417444216716217,1.0,70/414,8.26%,CXCL16;FN1;SFRP2;TREM2;IL7R;MMP14;CDH3;SFRP1;HCK;NUPR1;PDPN;PAK1;CCN2;CRLF1;TCIRG1;TGFB3;PTK2B;CLEC11A;EREG;FCGR2B;PTPN6;TLR2;FCER1G;CTSH;TIMP1;MDK;ITGAX;PTN;VEGFD;TNFRSF1B;SLC11A1;CSF1R;HTR2B;ADAM8;CLEC7A;DOCK2;LRP1;SOX9;THBS1;AIF1;TGFB2;SIRPA;CYBA;GRN;MAP1A;PRKCD;P2RX4;NAP1L1;IGF1;CCL5;P2RX7;LGMN;SPHK1;F2R;HCLS1;CX3CL1;TGFBR1;COLEC12;PDGFC;MYRF;FKBP1B;RHOG;MYC;CRLF2;FGFR1;GAS6;TNFRSF11A;PTPRJ;S1PR2;P4HB
148,prerank,synaptic vesicle exocytosis (GO:0016079),0.9020670699361751,1.4974246767262882,0.0,0.22165980876454178,0.99,2/18,2.21%,SYT7;RAB3A
149,prerank,protein processing (GO:0016485),-0.7962981648895864,-1.4960662567173972,0.0,0.10297880266177166,1.0,13/71,8.15%,CTSS;AEBP1;MMP14;CPXM1;CTSH;MMP16;LGMN;CASP1;VSIR;ECE2;MYRF;C1RL;CPZ
150,prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.6465896868984607,-1.494264251170989,0.0,0.10496862108706949,1.0,84/393,12.14%,FN1;TREM2;VAV1;NUPR1;PIK3AP1;PTPRC;ECM1;EREG;GDF15;PTPN6;HPSE;FGR;TLR2;S100A4;NCF1;HTR2B;ADAM8;CLEC7A;CX3CR1;LAPTM5;TLR9;HMOX1;RTN4;SOX9;NEK6;THBS1;TGFB2;PIK3R5;CD14;SRC;PIK3CG;UNC5B;P2RX4;IGF1;FLNA;CCL5;IKBKE;SPHK1;IL18;TIFA;CD74;LITAF;CASP1;PRKCB;ROR2;F2R;RAC2;HCLS1;CX3CL1;PIK3CD;TLR7;TGFBR1;TMEM106A;CARD11;TICAM2;PDGFC;RHOG;CD80;SLC9A3R1;RHOC;FGFR1;GAS6;SHISA5;IRAK4;PTPRJ;BID;HGF;LGALS1;ILK;MAP3K14;MST1R;APP;TSPAN6;TGFB1;BOK;MET;PDGFRB;WNT11;CD86;FGFR2;BMP2;AXL;PLCG2;BAX
151,prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.7872599215504108,-1.4941158800783585,0.0,0.10439795428953347,1.0,17/60,14.03%,LGALS3;SERPINE1;HMOX1;THBS1;SRC;UNC5B;IGF1;EYA4;TGFBR1;MAPK7;GPX1;ICAM1;TMBIM1;SNAI2;TRADD;ITGAV;RIPK1
152,prerank,response to lipopolysaccharide (GO:0032496),-0.732638772797305,-1.4921729550456364,0.0,0.10753114619498166,1.0,18/104,8.37%,SERPINE1;CD68;VIM;CD180;TNFRSF1B;SLC11A1;CX3CR1;SIRPA;CD14;CCR5;CASP1;F2R;CXCL10;TICAM2;ADAM9;CD80;TNFRSF11A;SBNO2
153,prerank,negative regulation of cell migration (GO:0030336),-0.7342889150819919,-1.4909942773181526,0.0,0.1093141097396669,1.0,27/110,11.43%,COL3A1;SFRP2;CYP1B1;SFRP1;SERPINE1;SULF1;TIMP1;LRP1;HMOX1;IGFBP3;RAP2B;SRGAP3;DPYSL3;CD74;CX3CL1;ARHGDIB;ARHGAP4;ROBO1;CORO1C;PTPRJ;MCTP1;RECK;THY1;MACIR;STK26;CHRD;WNT11
154,prerank,negative regulation of cell population proliferation (GO:0008285),-0.6685626742015222,-1.490930774931354,0.013157894736842105,0.108612243813198,1.0,41/268,8.34%,FRZB;SFRP2;TREM2;GPNMB;CYP1B1;SFRP1;NUPR1;PDPN;PAK1;NOX4;TGFB3;S100A11;PTK2B;EREG;PTPN6;CD300A;DDAH1;IGFBP7;COL18A1;HMOX1;SOX9;CDKN2B;CCN3;IGFBP3;AIF1;TGFB2;P3H3;FBLN1;P3H1;NIBAN2;ROR2;F2R;FAP;CEBPA;CGREF1;TGFB1I1;MYC;E2F1;SLC9A3R1;PTPRJ;IFIT3
155,prerank,ribosomal large subunit assembly (GO:0000027),0.8903577787953294,1.4903599849883382,0.0,0.24389070480908198,0.99,1/24,0.09%,RPL3L
156,prerank,lymphocyte chemotaxis (GO:0048247),-0.8838353902753375,-1.4897963090305466,0.03773584905660377,0.1100353788364473,1.0,11/19,9.42%,CXCL16;CH25H;ADAM8;PIK3CG;CCL5;CXCL10;CX3CL1;PIK3CD;GAS6;CCL8;CYP7B1
157,prerank,regulation of endocytosis (GO:0030100),-0.7741827850455841,-1.4889998391208905,0.0,0.1117462953786048,1.0,10/52,9.02%,APOE;LGALS3;CD22;LRP1;SRC;SPHK1;GPC3;PTPN1;RAB4B;MCTP1
158,prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.8570925354301259,-1.4877730968508707,0.015625,0.11446290603234412,1.0,9/25,11.10%,KCNN4;LGALS3;CD300A;LAPTM5;CARD11;PTPRJ;RAB29;THY1;PTPN22
159,prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.9259349982808579,-1.487440117837171,0.021739130434782608,0.11384269313244304,1.0,2/17,1.77%,TREM2;FCGR2B
160,prerank,positive regulation of neuron death (GO:1901216),-0.8414767450374924,-1.486622648456606,0.0,0.11496464399065749,1.0,9/35,4.21%,ITGB2;NUPR1;TYROBP;FCGR2B;C1QA;ITGAM;CLU;TGFB2;GRN
161,prerank,negative regulation of peptidase activity (GO:0010466),-0.880909383906251,-1.4854614821614698,0.0,0.11636952010454506,1.0,9/23,6.20%,SERPINF1;TIMP2;SERPINE1;ECM1;TIMP1;SERPINE2;LRP1;SERPING1;CSTB
162,prerank,granulocyte chemotaxis (GO:0071621),-0.8580242707906933,-1.485325937938876,0.0,0.11544877710832828,1.0,13/32,8.98%,ITGB2;LGALS3;NCKAP1L;ANXA1;FCER1G;TGFB2;PIK3CG;CCL5;CXCL10;CX3CL1;PIK3CD;PPIB;CCL8
163,prerank,Fc receptor signaling pathway (GO:0038093),-0.7625309288124009,-1.4847994209010231,0.0,0.11523825337944413,1.0,8/103,7.42%,VAV1;LAT2;PAK1;LCP2;FCER1G;BTK;CARD11;GRAP2
164,prerank,regulation of cholesterol efflux (GO:0010874),-0.9151435660746131,-1.4847991717132811,0.0,0.11424482016065582,1.0,3/25,3.24%,TREM2;APOE;LRP1
165,prerank,neutrophil migration (GO:1990266),-0.8528124584059255,-1.4842152850015544,0.0,0.11395070827681106,1.0,13/33,8.98%,ITGB2;LGALS3;NCKAP1L;FCER1G;TGFB2;PIK3CG;CCL5;CXCL10;CX3CL1;PIK3CD;IRAK4;PPIB;CCL8
166,prerank,cellular defense response (GO:0006968),-0.9085409056640736,-1.4835333103897839,0.017543859649122806,0.11404818535831387,1.0,11/23,6.34%,LSP1;TYROBP;SPN;TCIRG1;PTK2B;NCF1;CX3CR1;CLEC5A;CCR5;C5AR1;NCF2
167,prerank,response to peptide (GO:1901652),-0.8944654375079149,-1.4831409398823898,0.01694915254237288,0.11433570179199032,1.0,4/24,2.54%,MMP2;ANXA1;MMP12;IRF5
168,prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.6951870637362111,1.482795637980124,0.021739130434782608,0.26922923609399607,0.99,7/77,8.00%,SRRM4;FXR1;PRDX6;KHDRBS3;RBFOX1;RBM24;C1QBP
169,prerank,cellular response to hormone stimulus (GO:0032870),-0.7874390409105323,-1.4825621981155463,0.0,0.11461842628510546,1.0,6/53,5.72%,CTSS;SFRP1;CTSH;ATP1A3;SRC;CTSB
170,prerank,regulation of BMP signaling pathway (GO:0030510),-0.8347663555552988,-1.4825085992936182,0.016666666666666666,0.1137654212623842,1.0,4/51,2.30%,FSTL1;FST;SULF1;FSTL3
171,prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.7989636491313695,-1.480584903984534,0.015384615384615385,0.1176939880050141,1.0,10/46,7.87%,SFRP1;PLEK;PAK1;CCN2;TGFB3;GPR65;CARMIL1;CX3CL1;TGFBR1;RHOC
172,prerank,regulation of fibroblast proliferation (GO:0048145),-0.8374341516668989,-1.4792615798642241,0.0,0.12026056618677487,1.0,13/41,8.72%,FN1;SFRP1;EREG;CD300A;IGF1;SPHK1;CD74;S100A6;PDGFC;MYC;E2F1;GAS6;NLRC3
173,prerank,regulation of phosphorylation (GO:0042325),-0.7059716657033154,-1.4778330399746245,0.03076923076923077,0.12324561966140371,1.0,15/107,11.37%,FN1;NCKAP1L;EREG;SRPX2;CDKN2B;THBS1;DYNLL1;CCL5;CORO1C;SLAMF8;ILK;ANG;APP;INHBA;STAP1
174,prerank,positive regulation of growth (GO:0045927),-0.7771957842810339,-1.4777497174757614,0.020833333333333332,0.12235089325239913,1.0,7/56,6.53%,CXCL16;SFRP2;MMP14;SFRP1;TGFB2;SPHK1;TGFBR1
175,prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.6985510598337893,-1.4755148189844067,0.0,0.12662969152085807,1.0,22/129,11.30%,LAT2;PAK1;NCKAP1L;PTPRC;LCP2;SH2B2;BLNK;BTK;NFAM1;CD276;PRKCB;WAS;PIK3CD;CARD11;THEMIS2;GRAP2;PTPRJ;CD79B;THY1;PAG1;PTPN22;INPP5D
176,prerank,ribosome assembly (GO:0042255),0.7788768991434237,1.475398416083361,0.018867924528301886,0.297492600546321,1.0,1/47,0.09%,RPL3L
177,prerank,regulation of cellular response to heat (GO:1900034),0.7115417412094438,1.474633909616314,0.0,0.29469237940354387,1.0,18/76,19.51%,FKBP4;MAPT;CAMK2A;CRYAB;BAG3;HSPB8;MAPKAPK2;CAMK2B;BAG1;MTOR;HSPA8;HSPH1;YWHAE;BAG2;HSP90AB1;NDC1;CAMK2D;CHORDC1
178,prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.763858378968113,-1.474131375702622,0.0,0.12949408132810128,1.0,8/103,7.42%,VAV1;LAT2;PAK1;LCP2;FCER1G;BTK;CARD11;GRAP2
179,prerank,ubiquinone biosynthetic process (GO:0006744),0.8902385455353088,1.4736771821728791,0.0,0.29260112827855533,1.0,11/15,8.91%,COQ5;COQ10A;COQ9;NDUFA9;COQ8A;COQ3;COQ7;PDSS2;COQ2;COQ6;PDSS1
180,prerank,regulation of neurogenesis (GO:0050767),-0.8175773958949865,-1.4734909110012715,0.01639344262295082,0.12972981084508206,1.0,7/41,8.68%,SERPINF1;NUMBL;CX3CR1;NAP1L1;CX3CL1;RGS14;DOCK7
181,prerank,ubiquinone metabolic process (GO:0006743),0.8875469502319369,1.4721314524243874,0.0,0.29414010519418615,1.0,10/15,8.91%,COQ5;COQ10A;COQ9;COQ8A;COQ3;COQ7;PDSS2;COQ2;COQ6;PDSS1
182,prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.8849750345267997,-1.4703164433868143,0.0,0.13783032633613285,1.0,5/18,5.95%,CYP1B1;CCR2;HPSE;SULF1;SULF2
183,prerank,regulation of cell-substrate adhesion (GO:0010810),-0.8072744090896532,-1.4700788784479042,0.034482758620689655,0.13755965741679704,1.0,9/35,11.06%,PDPN;FBLN2;RAC2;CX3CL1;CORO1C;PTPRO;THY1;NPNT;BST1
184,prerank,negative regulation of protein metabolic process (GO:0051248),-0.7986436265680663,-1.4673988707421495,0.041666666666666664,0.14356141805790806,1.0,9/42,7.58%,TREM2;APOE;CD84;CLU;PTX3;FLNA;AZIN2;ITGB3;INHBB
185,prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.8414490040177809,-1.4667427665212498,0.03571428571428571,0.14446103478719757,1.0,5/22,5.36%,SFRP2;SNAI1;CLU;CD44;CD74
186,prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.7842173154928886,-1.4664667796518798,0.014084507042253521,0.14397511520045791,1.0,7/59,5.11%,GPNMB;ANXA1;PTPN6;CDKN2B;AIF1;ID2;DACT1
187,prerank,regulation of protein localization to nucleus (GO:1900180),0.7644152306891903,1.4649801190322835,0.022727272727272728,0.3188776419726989,1.0,2/38,1.11%,ILRUN;TFRC
188,prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.7245483580444728,-1.4649131028410762,0.0,0.1479221986214549,1.0,26/78,14.84%,PAK1;PTK2B;MDK;CSF1R;LRP1;CORO1A;PRKCD;RAC2;ARHGDIB;IQGAP3;RHOG;RHOC;SH3BP1;PDGFRB;BST1;NOTCH2;IQGAP2;TWF1;RHOD;TRPM2;PAK3;ARHGDIA;IQGAP1;BST2;EFNA5;GPM6B
189,prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.7491582242588747,-1.4648725795153357,0.0196078431372549,0.14682647863166634,1.0,8/40,8.72%,TREM2;MEFV;CLU;SRC;GBA;DACT1;PMEPA1;NLRC3
190,prerank,negative regulation of inflammatory response (GO:0050728),-0.7355131908586632,-1.4644521209345132,0.014492753623188406,0.14683703864882913,1.0,29/105,8.72%,TREM2;APOE;HCK;TNFAIP8L2;MEFV;CALCA;PTGIS;GPR176;FGR;GPR39;MDK;TNFRSF1B;ADCY7;PTH1R;CCN3;SIRPA;AOAH;GRN;SRC;GBA;PRKCD;IGF1;C1QTNF3;ADCY3;GNG2;MAPK7;TYRO3;SLAMF8;NLRC3
191,prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.7567506113019634,1.463319819128056,0.05128205128205128,0.31903595959348563,1.0,8/43,18.08%,PRDM16;GCK;NOS2;TIGAR;PRKAG1;PNPT1;KHK;NDC1
192,prerank,regulation of bone mineralization (GO:0030500),-0.8114852792483729,-1.462851053028347,0.0,0.15034381223147072,1.0,14/39,11.95%,TMEM119;TGFB3;ECM1;PTK2B;PTN;FBN2;ENPP1;P2RX7;OSR1;TWIST1;WNT4;TGFB1;BMP2K;BMP2
193,prerank,signal transduction by p53 class mediator (GO:0072331),0.8769212191655695,1.462427335226402,0.0,0.3180667934852186,1.0,1/23,0.17%,PDK2
194,prerank,B cell receptor signaling pathway (GO:0050853),-0.8696457558553531,-1.460759021892854,0.029411764705882353,0.15404769384630224,1.0,9/25,6.22%,LAT2;NCKAP1L;PTPRC;SH2B2;BLNK;BTK;NFAM1;PRKCB;PIK3CD
195,prerank,RNA stabilization (GO:0043489),-0.8497757387149623,-1.460344312536204,0.05263157894736842,0.15441632003190411,1.0,6/28,7.76%,PABPC1;SLC11A1;TENT5B;TENT5C;TENT5A;E2F1
196,prerank,regulation of ossification (GO:0030278),-0.8351679057748896,-1.460121918979639,0.03508771929824561,0.1535577352860155,1.0,8/28,6.90%,SFRP1;ECM1;MDK;PTN;ENPP1;SOX9;TGFB2;TWIST1
197,prerank,regulation of cell death (GO:0010941),-0.7603229891039712,-1.4598185700986837,0.017241379310344827,0.1535201814255885,1.0,11/74,4.91%,CCN5;CCN4;CCN2;CTSZ;TNFRSF1B;HTR2B;CLU;LRP1;CCN3;SLC25A24;CCL5
198,prerank,regulation of DNA recombination (GO:0000018),-0.8852299523996181,-1.4596670545747883,0.03571428571428571,0.15292094712833074,1.0,1/22,0.35%,IL7R
199,prerank,Rho protein signal transduction (GO:0007266),-0.7710344953045798,-1.4594584547463332,0.015384615384615385,0.15217058577878526,1.0,11/46,10.12%,COL1A2;PDPN;WAS;ARHGDIB;CDC42EP5;ARHGAP4;SHTN1;MYO9B;RHOG;RHOU;CFL1
200,prerank,positive regulation of programmed cell death (GO:0043068),-0.6665462116638028,-1.4591451363335017,0.0,0.15206424714441852,1.0,36/225,12.24%,FRZB;SFRP2;CYP1B1;VAV1;SFRP1;FGD3;TGFB3;GADD45B;IRF5;CTSD;CLEC7A;CLU;LAPTM5;IGFBP3;OLFM1;RASSF2;MELK;APAF1;PHLDA3;TOP2A;PREX1;E2F1;PAWR;BID;BIN1;PLEKHN1;STK17B;GADD45G;CALHM2;BOK;FGD2;BMP2;CASP3;BAX;ZBP1;TIAM1
201,prerank,mitochondrial gene expression (GO:0140053),0.8088460644312003,1.45800015445805,0.0,0.33491023205648013,1.0,29/41,15.23%,QRSL1;PTCD3;GATB;NDUFA7;MRPL51;GFM2;TWNK;MRPL47;MRPL12;LARS2;MRPS28;MRPL2;TEFM;IARS2;MRPS2;TFB2M;TFAM;MRPL16;MRPS24;MRPS15;MRPS7;MRPS21;FASTKD2;MRPS17;MRPS18A;MRPS14;MRPS18B;SLC25A33;MRPS34
202,prerank,negative regulation of protein catabolic process (GO:0042177),-0.8348795468322868,-1.4571148333446284,0.018867924528301886,0.1572291879525996,1.0,5/32,5.19%,TIMP2;CTSA;TIMP1;FLNA;AZIN2
203,prerank,defense response to bacterium (GO:0042742),-0.7611788136954943,-1.4569332044946148,0.03389830508474576,0.15693342766085794,1.0,26/63,13.78%,TREM2;MPEG1;SERPINE1;SPN;FGR;TLR2;FCER1G;SLC11A1;TLR9;RNASE6;PRKCD;ANXA3;STAB1;COLEC12;SLAMF8;ANG;OAS3;CFP;GSDMD;RPL39;TLR6;JCHAIN;SYK;ISG15;SELP;PYCARD
204,prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.8073324290063716,1.4551377290459082,0.0,0.34210506720144745,1.0,18/28,16.42%,HSPD1;PEX10;GRPEL1;TIMM23;TOMM40L;TIMM44;TIMM21;TIMM17A;TOMM40;AIFM1;PEX7;DNAJC15;DNAJC19;PEX6;ROMO1;CHCHD4;PEX12;GRPEL2
205,prerank,mRNA stabilization (GO:0048255),-0.8427796564747381,-1.4550078666261501,0.018867924528301886,0.16114155169334554,1.0,6/31,7.76%,PABPC1;SLC11A1;TENT5B;TENT5C;TENT5A;E2F1
206,prerank,response to organic cyclic compound (GO:0014070),-0.835739498497963,-1.452964301584929,0.04838709677419355,0.16698812004828795,1.0,6/32,5.24%,SPP1;CYP1B1;SFRP1;ANXA1;CCL5;IL18
207,prerank,neutrophil chemotaxis (GO:0030593),-0.8521066675889865,-1.4525577938618832,0.019230769230769232,0.16663281847318745,1.0,12/31,8.98%,ITGB2;LGALS3;NCKAP1L;FCER1G;TGFB2;PIK3CG;CCL5;CXCL10;CX3CL1;PIK3CD;PPIB;CCL8
208,prerank,macrophage activation (GO:0042116),-0.8442372031052938,-1.4525339753163704,0.03636363636363636,0.16567399726384396,1.0,11/26,6.54%,TREM2;ITGB2;C1QA;SLC11A1;ITGAM;CLU;TLR1;AIF1;C5AR1;CX3CL1;TMEM106A
209,prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.8068420133529752,-1.452447142211236,0.03389830508474576,0.16487893287231734,1.0,9/33,5.15%,PTGIS;GLA;DDAH1;CLEC7A;CX3CR1;CLU;SIRPA;P2RX4;ASS1
210,prerank,pyruvate metabolic process (GO:0006090),0.7931575021257746,1.4524269236931968,0.046511627906976744,0.34799424221967434,1.0,15/38,5.03%,DLAT;PDHX;PDHB;DLD;ENO3;PFKM;LDHB;SLC16A1;HK2;PDHA1;VDAC1;ME3;GCK;PGAM2;PFKFB2
211,prerank,negative regulation of cytokine production (GO:0001818),-0.6785101198370874,-1.4520939371173216,0.014492753623188406,0.16431942495704432,1.0,36/132,10.49%,FN1;TREM2;GPNMB;TYROBP;NCKAP1L;MEFV;CD84;PTPRC;ANXA1;FCGR2B;PTPN6;HAVCR2;SLC11A1;ADCY7;LAPTM5;TLR9;SSC5D;THBS1;TLR8;SIRPA;GBA;IKBKE;C1QTNF3;CX3CL1;TMSB4X;VSIR;SLC2A10;INHBB;GAS6;ANXA4;NLRC3;CD200R1;HOMER3;MACIR;NR1H4;INHBA
212,prerank,defense response to Gram-negative bacterium (GO:0050829),-0.8285341860446442,-1.451487678184244,0.04918032786885246,0.16548168071598485,1.0,6/22,4.38%,TREM2;MPEG1;SERPINE1;SLC11A1;TLR9;RNASE6
213,prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.8845117273239624,-1.4510132472225172,0.031746031746031744,0.16581421234887325,1.0,5/17,3.07%,TIMP2;APOE;TIMP1;TNFRSF1B;ADAM8
214,prerank,protein localization to centrosome (GO:0071539),0.9371607100954366,1.4505847359628996,0.0,0.35159361027617286,1.0,1/15,0.23%,NUDCD3
215,prerank,positive regulation of cell differentiation (GO:0045597),-0.6987757324993376,-1.4505484818915617,0.0,0.16665750957198772,1.0,31/182,8.40%,FRZB;SFRP2;COL1A1;GDF6;TMEM119;SFRP1;CCN4;PDPN;CCN2;LOXL2;TGFB3;MDK;PTN;FBN2;SNAI1;SOX9;IGFBP3;TGFB2;OLFM1;ID2;IGF1;IL18;MSR1;FES;KCTD11;TGFBR1;TWIST1;GLIPR2;TGFB1I1;FGFR1;HGF
216,prerank,protein maturation (GO:0051604),-0.7587220510301548,-1.4503128954689053,0.0,0.165881623447445,1.0,4/74,0.43%,CTSS;AEBP1;MMP14;CPXM1
217,prerank,negative regulation of endopeptidase activity (GO:0010951),-0.8810163587184754,-1.4500241768549718,0.02,0.1655514741602531,1.0,6/22,2.43%,SERPINF1;TIMP2;SERPINE1;ANXA8;TIMP1;SERPINE2
218,prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.9362584326823463,1.449334751287228,0.025,0.35120892992876285,1.0,5/15,2.41%,PDK2;PDK4;RORC;MLYCD;GNB3
219,prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.7535818873377663,-1.448613372953015,0.03636363636363636,0.16847371178880038,1.0,8/52,6.09%,FN1;SFRP1;PTK2B;FBLN2;MDK;FLNA;CARMIL1;CX3CL1
220,prerank,regulation of striated muscle contraction (GO:0006942),0.7811353544143278,1.4475141078847948,0.14893617021276595,0.3536279271735697,1.0,9/23,5.67%,HCN4;TNNI3K;MYL3;ANK2;MYL2;RYR2;RNF207;ATP1A2;PRKACA
221,prerank,positive regulation of cell projection organization (GO:0031346),-0.7028193233554219,-1.4469122700550459,0.029411764705882353,0.17200474747750735,1.0,19/88,9.87%,APOE;PTK2B;MDK;PTN;PTK7;TENM3;P3H1;CARMIL1;DPYSL3;ROR2;FZD1;CX3CL1;FES;PLXNC1;ROBO1;MAP6;CAMK1D;DLG4;ARSB
222,prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.8074843815382174,-1.4468707266002645,0.034482758620689655,0.17121483826916872,1.0,13/49,6.47%,CTSS;CTSK;TLR2;TLR1;TLR9;TLR8;CD14;UNC93B1;LGMN;TIFA;CTSB;LACC1;TLR7
223,prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.8211819430091817,-1.44683326196156,0.018867924528301886,0.1702930668331594,1.0,6/29,6.90%,SFRP2;SNAI1;CLU;CD44;CD74;TWIST1
224,prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.7298283753638689,-1.4461009736850696,0.038461538461538464,0.17198747952491408,1.0,21/81,8.40%,TREM2;CRLF1;NOX4;PTPRC;PTK2B;CSF1R;THBS4;CD44;SRC;IGF1;CCL5;IL18;CD74;HCLS1;ITGB3;PTPN1;ITGA5;CD80;GAS6;PTPRJ;HGF
225,prerank,platelet aggregation (GO:0070527),-0.8496144803489141,-1.4460223899542084,0.034482758620689655,0.1711422462493471,1.0,14/30,9.57%,FN1;PLEK;ACTN1;FERMT3;CSRP1;PIK3CG;RAP2B;FLNA;CLIC1;ITGB3;ACTG1;TYRO3;MYL9;ILK
226,prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.8530743206968615,-1.4457763499443466,0.01818181818181818,0.17107227803747083,1.0,5/30,5.83%,IL10RA;CYP1B1;PTPRC;CCL5;F2R
227,prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.9305786573118472,-1.4454615547291247,0.0,0.17093403781279407,1.0,1/17,0.25%,DKK3
228,prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.8719425219088466,-1.4440383887158745,0.05357142857142857,0.17388913080836896,1.0,6/17,3.16%,LGALS3;FCGR2B;CD300A;CD22;LPXN;LAPTM5
229,prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.877005145018855,-1.4439334257912464,0.10526315789473684,0.17318934016088863,1.0,4/17,8.72%,SFRP1;CD300A;MYC;NLRC3
230,prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.7121815171534722,-1.4436290804656633,0.0,0.1731767386006302,1.0,18/108,9.29%,CYP1B1;NUPR1;PTGIS;HAVCR2;DAP;MDFI;TLR9;ARRB2;ID2;FLNA;NFKBIE;ID3;TMSB4X;SPI1;GAS6;ANXA4;NLRC3;GLIS2
231,prerank,integrin-mediated signaling pathway (GO:0007229),-0.7431452893465819,-1.4415542794588967,0.06451612903225806,0.17883295337250402,1.0,16/62,4.29%,COL3A1;FN1;ITGBL1;ITGB2;HCK;PLEK;COL16A1;ITGA11;PTK2B;ITGB5;FGR;PTN;FERMT3;ITGB7;FBLN1;SRC
232,prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.817117758521831,-1.4414630914356317,0.10344827586206896,0.17811643066254318,1.0,4/18,6.90%,SNAI1;CD44;CD74;TWIST1
233,prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.635690534412796,-1.4411188252762317,0.0,0.17794184709706518,1.0,34/340,10.64%,LOXL3;DKK3;SFRP2;BASP1;SFRP1;LOXL2;CALCA;EREG;DAP;SOX9;ID2;ID3;NIBAN2;SPI1;CEBPA;TWIST1;FOXP2;ZMYND15;E2F1;GAS6;ATOH8;SBNO2;TRERF1;HHEX;GLIS2;WNT4;MDFIC;ID4;IKZF1;BIRC5;RUNX2;VDR;TGFB1;FOXM1
234,prerank,skeletal system development (GO:0001501),-0.7182930606324067,-1.4402754934103101,0.05084745762711865,0.17982481319287633,1.0,27/92,8.53%,FRZB;COL1A1;MMP14;COMP;COL1A2;FBN1;ACAN;SULF1;SH3PXD2B;COL9A2;BMP1;SOX9;PTH1R;VKORC1;CD44;TGFB2;COL2A1;MMP16;IGF1;P3H1;EVC;SULF2;TGFBR1;XYLT1;FGFR1;CDH11;PPIB
235,prerank,regulation of interleukin-8 production (GO:0032677),-0.7720505900720867,-1.4400266922910336,0.015625,0.17990606811724774,1.0,14/59,6.47%,SERPINE1;PTPRC;ANXA1;TLR2;CLEC7A;TLR1;TLR9;SSC5D;TLR8;CD14;CD74;F2R;TMSB4X;TLR7
236,prerank,translation (GO:0006412),0.6156958324561651,1.440021692191895,0.0,0.3849486461001039,1.0,45/188,13.96%,RPL3L;MRPL42;QRSL1;EIF4G1;MRPL55;PTCD3;GATB;MRPS36;EEF1A2;TUFM;MRPL18;NDUFA7;MRPL51;MRPL28;GFM2;TSFM;MRPL47;MRPL3;PPA2;MRPL9;MRPL41;LARS2;MARS2;MRPS28;MRPL37;MRPL2;IARS2;PABPC4;MRPS2;MRRF;MRPS33;MRPL16;MRPS24;YARS2;MRPS15;MRPS7;FARS2;MRPL34;MRPS21;FASTKD2;MRPS17;MRPS18A;MRPS14;MRPS5;FARSB
237,prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.8983414192004279,-1.4398183796473922,0.016666666666666666,0.17913430493348959,1.0,5/17,3.00%,LRRC17;FBN1;C1QC;FSTL3;MAFB
238,prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.8276667272631029,1.4390740262883293,0.043478260869565216,0.3833306819408852,1.0,6/16,8.64%,PPIF;SLC25A4;CAMK2A;ALKBH7;THEM4;SPG7
239,prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.7341432715548953,-1.438606330342774,0.07692307692307693,0.18202090383186897,1.0,23/66,17.51%,PTPRC;PTPN6;SPHK1;RUNX1;CD74;PTPN1;TRAF1;GAS6;AXL;ZBP1;RNASEL;SOCS3;TRADD;SYK;PYCARD;RIPK1;TNFRSF1A;IFNGR1;IRAK3;RACK1;CASP8;IKBKB;CBFB
240,prerank,regulation of T cell proliferation (GO:0042129),-0.8298654770593967,-1.4380672400913277,0.016666666666666666,0.1827362969945711,1.0,14/33,7.78%,GPNMB;LGALS3;NCKAP1L;SPN;PTPRC;ANXA1;TNFRSF1B;CCDC88B;AIF1;CD276;CCL5;VCAM1;PNP;CD80
241,prerank,response to estrogen (GO:0043627),-0.8625119436742762,-1.4377423615129867,0.017857142857142856,0.1827992665884387,1.0,1/22,0.63%,SFRP1
242,prerank,hyaluronan metabolic process (GO:0030212),-0.9020408396324276,-1.437179247002755,0.03225806451612903,0.1836303928297346,1.0,6/17,6.06%,GUSB;HEXB;CEMIP;CD44;HEXA;HMMR
243,prerank,endodermal cell differentiation (GO:0035987),-0.8411756341824632,-1.4367555633737716,0.031746031746031744,0.1836239498338886,1.0,9/28,2.49%,FN1;MMP14;COL8A1;ITGB2;MMP2;COL12A1;COL11A1;ITGB5;COL6A1
244,prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.8540246151083133,1.4366595195816074,0.0,0.3879387295801256,1.0,7/23,9.92%,PDK4;ACADVL;ACADL;PRKAA2;WDTC1;MLXIPL;CEACAM1
245,prerank,negative regulation of dephosphorylation (GO:0035305),0.8718037055551793,1.4356595378897137,0.021739130434782608,0.38787545934589884,1.0,3/16,7.41%,SH2D4A;SH3RF2;PPP1R16B
246,prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.8881917847839927,1.4354946956337136,0.021739130434782608,0.38264162860047735,1.0,8/20,5.67%,HRC;ATP2A2;ANK2;TNNI3;RYR2;CASQ2;ATP1A2;PRKACA
247,prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.805937748773647,-1.435143619364619,0.01639344262295082,0.1875459048114495,1.0,12/31,13.61%,HCK;PTK2B;MDK;CSF1R;HCLS1;ARHGDIB;FES;STAP1;NOTCH2;IQGAP2;TRPM2;ARHGDIA
248,prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.7732163603201679,-1.435028850270847,0.0,0.1867617797801339,1.0,21/58,10.23%,CCR2;TYROBP;SPN;PTPRC;HAVCR2;TLR2;ADAM8;CLEC7A;CLU;TLR1;TLR9;THBS1;CYBA;CD14;IL33;TMEM106A;TWIST1;PTPRJ;EPHB2;OAS3;APP
249,prerank,positive regulation of biomineral tissue development (GO:0070169),-0.802074920314265,-1.4345771766803557,0.06451612903225806,0.1870515567552566,1.0,6/26,5.74%,TMEM119;TGFB3;PTN;FBN2;P2RX7;OSR1
250,prerank,homotypic cell-cell adhesion (GO:0034109),-0.8346693118146163,-1.4343100457443194,0.03333333333333333,0.1865903098157332,1.0,15/34,9.57%,FN1;PLEK;ACTN1;FERMT3;MEGF10;CSRP1;PIK3CG;RAP2B;FLNA;CLIC1;ITGB3;ACTG1;TYRO3;MYL9;ILK
251,prerank,positive regulation of endocytosis (GO:0045807),-0.8228912389218137,-1.4342157596534073,0.020833333333333332,0.18588614559216488,1.0,7/39,3.24%,TREM2;APOE;SERPINE1;NCKAP1L;RAB31;CLU;LRP1
252,prerank,positive regulation of stress fiber assembly (GO:0051496),-0.787490097767501,-1.4340789073064886,0.01639344262295082,0.18494300328375224,1.0,8/41,7.87%,SFRP1;PAK1;CCN2;TGFB3;GPR65;CARMIL1;TGFBR1;RHOC
253,prerank,lipid biosynthetic process (GO:0008610),0.7129627099501263,1.433604770722391,0.075,0.38648005594408197,1.0,20/48,11.82%,FITM2;FITM1;LPL;MLYCD;DHRS11;GNPAT;NDUFAB1;CBR4;ACSL6;ABCD3;PDSS2;ACSL1;AGPAT3;PRKAA2;ALOX5;PDSS1;OXSM;ACSF3;FDFT1;GPAM
254,prerank,chondroitin sulfate metabolic process (GO:0030204),-0.847808016855482,-1.4332288447848107,0.057692307692307696,0.1867692325814108,1.0,9/24,6.36%,HEXB;BGN;DSE;HEXA;CHSY3;CHPF2;CHPF;DSEL;CHST12
255,prerank,positive regulation of histone acetylation (GO:0035066),0.8326955393942622,1.4329639683030857,0.08333333333333333,0.38427060547009545,1.0,1/18,1.05%,PPARGC1A
256,prerank,positive regulation of inflammatory response (GO:0050729),-0.7595871747512991,-1.432476175965758,0.03225806451612903,0.18839296501167466,1.0,16/58,6.62%,CCR2;CCN4;SERPINE1;NUPR1;PLA2G7;TLR2;MDK;GPSM3;ADAM8;TLR9;GRN;IL18;IL33;CX3CL1;TLR7;CEBPA
257,prerank,cardiac muscle cell action potential (GO:0086001),0.8480899290058107,1.4318603490473105,0.09090909090909091,0.3827989205444728,1.0,12/25,10.91%,SCN4B;KCNIP2;HCN4;ANK2;SLC4A3;HCN2;ATP1A2;KCNJ2;KCND3;CACNA2D1;ATP1A1;KCNQ1
258,prerank,chondrocyte differentiation (GO:0002062),-0.8063225496342491,-1.4315228449475401,0.05172413793103448,0.19048473511973704,1.0,11/25,12.64%,SULF1;SOX9;CCN3;RUNX1;OSR1;SULF2;RUNX2;TGFB1;RUNX3;BMP2;EIF2AK3
259,prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.7670332239981205,-1.4314553105414936,0.03278688524590164,0.18959756528879484,1.0,22/60,8.40%,FN1;TREM2;PIK3AP1;PTPN6;FGR;NCF1;SOX9;TGFB2;PIK3R5;SRC;PIK3CG;UNC5B;IGF1;CCL5;IL18;ROR2;F2R;HCLS1;PIK3CD;PDGFC;FGFR1;HGF
260,prerank,sphingolipid metabolic process (GO:0006665),-0.7179032806200499,-1.4313078659231857,0.016129032258064516,0.18901986089122655,1.0,21/86,9.32%,CTSA;HEXB;B4GALNT1;GLA;GM2A;PLA2G15;PLPP2;GBA;GLTP;HEXA;SPHK1;CERS6;HACD4;ASAH1;ALDH3B1;GLB1;SPTLC2;ELOVL1;SGPL1;B3GALNT1;SUMF1
261,prerank,fatty acid biosynthetic process (GO:0006633),0.7338935504371621,1.4307624487762525,0.05,0.38125709155894644,1.0,12/38,11.34%,TECR;LPL;MLYCD;NDUFAB1;CBR4;ABCD3;EPHX2;TECRL;ALOX12;ALOX5;OXSM;ACSF3
262,prerank,positive regulation of cartilage development (GO:0061036),-0.9203986985727792,-1.430679934984867,0.0,0.19029924960049546,1.0,5/15,3.31%,GDF6;LOXL2;MDK;BMP1;SOX9
263,prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.8585466078500172,-1.4304652455978795,0.01694915254237288,0.1902585092201455,1.0,4/25,3.63%,SPARC;APOE;SULF1;THBS1
264,prerank,import into cell (GO:0098657),-0.8166261092579681,-1.430290728806418,0.017543859649122806,0.18950908313166456,1.0,2/33,0.33%,IL10RA;TREM2
265,prerank,cartilage development (GO:0051216),-0.8055416088721966,-1.430084209897774,0.045454545454545456,0.18906132170739043,1.0,13/35,11.95%,SULF1;SOX9;CCN3;CD44;COL2A1;RUNX1;OSR1;SULF2;RUNX2;TGFB1;ITGB8;RUNX3;BMP2
266,prerank,regulation of platelet activation (GO:0010543),-0.8878907615963859,-1.4294468403327203,0.0,0.19008030893052313,1.0,3/17,2.14%,APOE;PLEK;FCER1G
267,prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.8529215496056572,-1.4290526133690638,0.0,0.19073977122681268,1.0,3/35,2.30%,FSTL1;FBN1;FSTL3
268,prerank,regulation of stress fiber assembly (GO:0051492),-0.7254171766149645,-1.4288399129249814,0.014925373134328358,0.19046625879637194,1.0,11/70,7.87%,SFRP1;PAK1;CCN2;TGFB3;GPR65;CARMIL1;ARAP1;WAS;ACTG1;TGFBR1;RHOC
269,prerank,positive regulation of neuron projection development (GO:0010976),-0.7280318574767518,-1.4286251128215617,0.03125,0.19002270883690786,1.0,13/64,6.27%,APOE;PTK2B;DBN1;MDK;PTN;PTK7;TENM3;P3H1;DPYSL3;ROR2;FZD1;CX3CL1;FES
270,prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.7081107211653817,-1.4281493254235098,0.014925373134328358,0.19090176152188118,1.0,15/76,10.48%,GDF6;CCN2;PTK2B;FCGR2B;GADD45B;NCF1;TLR9;TGFB2;RASSF2;SPHK1;SPI1;TRAF1;APP;GADD45G;SH3RF3
271,prerank,negative regulation of cellular catabolic process (GO:0031330),-0.7324130750100137,-1.4280068746756558,0.017543859649122806,0.19040344545570506,1.0,7/57,2.92%,IL10RA;TIMP2;TREM2;NUPR1;TIMP1;DAP;HTR2B
272,prerank,negative regulation of ossification (GO:0030279),-0.9182070728217927,-1.4277547852295935,0.0,0.19013704932124867,1.0,6/16,3.31%,SFRP1;ECM1;PTK2B;MDK;ENPP1;SOX9
273,prerank,protein localization to nucleus (GO:0034504),-0.7036415388277408,-1.4274954529612114,0.0,0.18964745278147346,1.0,2/96,1.76%,COL1A1;MMP12
274,prerank,regulation of osteoblast differentiation (GO:0045667),-0.7644725478854932,-1.4268544818809594,0.07352941176470588,0.1906795768995652,1.0,15/62,12.13%,TMEM119;CCN4;FBN2;SOX9;IGF1;TWIST1;HGF;SMOC1;WNT4;RUNX2;NPNT;CHRD;FGFR2;BMP2;SNAI2
275,prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.8351968516624927,-1.4267657499751971,0.0,0.1900244029573083,1.0,5/27,4.42%,TREM2;NUPR1;CLU;LAPTM5;GBA
276,prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.7485799209714076,-1.4263620758085478,0.014285714285714285,0.19004322008975622,1.0,15/65,12.04%,TREM2;MMP14;LGALS3;NKD2;LRP1;RHOG;STAC2;EPHB2;TGFB1;CLN3;ACTB;TMBIM1;CNPY4;ZDHHC2;PID1
277,prerank,protein homotetramerization (GO:0051289),0.7712890180883549,1.425974910161515,0.07692307692307693,0.39859207504235916,1.0,9/33,8.01%,ACACB;SOD2;CBR4;ACOT13;SHMT1;APIP;KCNJ12;KCNJ2;HSD17B10
278,prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.6768281150045116,1.4254585396228938,0.0,0.39579826067615786,1.0,16/69,18.86%,EGLN1;VEGFA;EPAS1;PSME4;EGLN3;HIGD1A;HIF1AN;NOTCH1;PSMC3;PSME3;UBC;PSMD12;PSMB7;PSMD2;CUL2;PSMA1
279,prerank,negative regulation of proteolysis (GO:0045861),-0.7798268826367236,-1.424080428737142,0.08163265306122448,0.1959303533898412,1.0,8/27,9.62%,TIMP2;ECM1;TIMP1;SERPINE2;CSTB;CST3;TIMP3;GAS1
280,prerank,positive regulation of transport (GO:0051050),-0.7388854209616316,-1.4237637946154822,0.0,0.19558988310242237,1.0,17/69,8.83%,TREM2;APOE;CDH3;ANXA1;FCGR2B;FCER1G;SLC11A1;CLEC7A;DOCK2;LRP1;SIRPA;CYBA;GPC3;ANXA2;GAS6;BID;CAMK1D
281,prerank,regulation of osteoclast differentiation (GO:0045670),-0.9305757927151241,-1.4235896765118943,0.015625,0.19508819399273114,1.0,4/16,3.00%,LRRC17;FBN1;FSTL3;MAFB
282,prerank,regulation of phosphatase activity (GO:0010921),0.826148491463985,1.4229288927892987,0.09090909090909091,0.4034175212255643,1.0,3/20,5.03%,SH2D4A;PPP1R2;SH3RF2
283,prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.8221416221354633,-1.4229144051928466,0.0392156862745098,0.1955189704013582,1.0,7/33,3.91%,TREM2;PLD4;MEFV;PLD3;ADCY7;CLEC7A;SIRPA
284,prerank,regulation of chemotaxis (GO:0050920),-0.8428016097730067,-1.4228364033842544,0.017857142857142856,0.1946965450045501,1.0,9/27,11.98%,TREM2;ADGRA2;THBS1;AIF1;P2RX4;CXCR4;TGFB1;PDGFRB;CYRIB
285,prerank,positive regulation of interleukin-2 production (GO:0032743),-0.8501242328229427,-1.422679806745249,0.05172413793103448,0.1944224278359503,1.0,8/24,7.78%,CCR2;PTPRC;ANXA1;CLEC7A;RUNX1;CARD11;PNP;CD80
286,prerank,microglial cell activation (GO:0001774),-0.8909610364000112,-1.4211474388699252,0.0425531914893617,0.1979704349616015,1.0,11/15,6.09%,TREM2;ITGB2;TYROBP;C1QA;ITGAM;CX3CR1;CLU;AIF1;GRN;C5AR1;CX3CL1
287,prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.7830418213908079,-1.4209550353135119,0.06451612903225806,0.19730871504478248,1.0,12/37,6.09%,MMP2;CCN4;P2RY6;EREG;HMOX1;THBS1;AIF1;ID2;IGF1;CCL5;IL18;CX3CL1
288,prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.7522430814378197,-1.4204604411149828,0.03333333333333333,0.19766575677289078,1.0,33/76,13.75%,FMOD;CEMIP;BGN;ACAN;LUM;HS6ST2;DSE;HEXA;SDC1;CHSY3;CHPF2;CHPF;DSEL;GPC3;CHST12;SDC3;B4GALT2;XYLT1;UST;CHST14;PRELP;SLC35D2;CHST2;CHSY1;SDC2;OMD;OGN;GPC6;CHST1;EXT1;HSPG2;XYLT2;UGDH
289,prerank,neural crest cell migration (GO:0001755),-0.8313098628369248,-1.420407904381524,0.037037037037037035,0.1967994268276021,1.0,5/25,9.90%,FN1;HTR2B;SEMA3D;CORO1C;SEMA4A
290,prerank,positive regulation of TOR signaling (GO:0032008),-0.8212689501153765,-1.4199672435808053,0.03773584905660377,0.19704992025797569,1.0,2/35,1.12%,TREM2;NCKAP1L
291,prerank,gland development (GO:0048732),-0.760649888835259,-1.4199540945687132,0.04,0.19619441287676762,1.0,15/45,12.52%,DKK3;TGFB3;ANXA1;MDK;TCF21;SOX9;TGFBR1;CEBPA;SLC9A3R1;WNT4;LSR;MET;WNT11;FGFR2;MSN
292,prerank,hemopoiesis (GO:0030097),-0.7479970957544373,-1.4196594614690292,0.03225806451612903,0.19586991100070053,1.0,13/74,5.31%,SFRP2;PLD4;SFRP1;MFAP5;PLEK;PTPRC;FST;FSTL3;CSF1R;TGFB2;SELPLG;MELK;RUNX1
293,prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.7746282258383916,-1.419150256565218,0.03278688524590164,0.1963816013635624,1.0,20/55,10.23%,CCR2;TYROBP;SPN;PTPRC;HAVCR2;TLR2;CLEC7A;CLU;TLR1;TLR9;THBS1;CYBA;CD14;IL33;TMEM106A;TWIST1;PTPRJ;EPHB2;OAS3;APP
294,prerank,regulation of RNA splicing (GO:0043484),0.707055678417697,1.418388825897842,0.04081632653061224,0.4221958032571651,1.0,5/64,3.23%,SRRM4;RBM38;RBM20;FASTK;KHDRBS3
295,prerank,regulation of peptide hormone secretion (GO:0090276),0.7727030172883701,1.4183601525566747,0.04878048780487805,0.41702418537711017,1.0,13/39,8.61%,RASL10B;SYT7;HADH;KCNJ11;GCK;KCNA5;NOS2;KCNB1;ARNTL;KCNG2;ABCC8;PICK1;ALOX5
296,prerank,hexose metabolic process (GO:0019318),0.7731393819708824,1.4182808320380196,0.0,0.41188268920982185,1.0,3/31,2.56%,FBP2;SORD;KCNJ11
297,prerank,ion homeostasis (GO:0050801),0.86530237334947,1.4178489254164834,0.0625,0.40808559681856277,1.0,4/16,3.98%,WNK2;HCN4;SLC4A3;RANGRF
298,prerank,iron-sulfur cluster assembly (GO:0016226),0.8141768412559178,1.4177655167407244,0.09090909090909091,0.40348413574360015,1.0,12/24,14.46%,ISCA1;HSPA9;CIAPIN1;NFS1;IBA57;GLRX5;ISCA2;FXN;NUBPL;ABCB7;CIAO3;NFU1
299,prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.8748130492980611,1.417700221873108,0.04081632653061224,0.39919366734121225,1.0,6/16,5.67%,HRC;ANK2;RYR2;CASQ2;ATP1A2;PRKACA
300,prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.808051075932101,-1.4175150324831434,0.017857142857142856,0.20041376572510977,1.0,9/36,11.37%,TREM2;PTPRC;IL1RN;PADI2;ROBO1;GAS6;SLIT3;OAS3;STAP1
301,prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.7483489189550044,-1.4174002410372033,0.015625,0.1996617326476545,1.0,14/85,9.25%,DKK3;ASPN;ADAMTSL2;VASN;CDKN2B;CD109;THBS1;EMILIN1;TGFBR1;PMEPA1;SLC2A10;TGFB1I1;SPRED3;LTBP4
302,prerank,metallo-sulfur cluster assembly (GO:0031163),0.8235241344939574,1.4171729039774617,0.045454545454545456,0.3967625683993411,1.0,12/22,14.46%,ISCA1;HSPA9;CIAPIN1;NFS1;IBA57;GLRX5;ISCA2;FXN;NUBPL;ABCB7;CIAO3;NFU1
303,prerank,protein tetramerization (GO:0051262),0.7427669613217528,1.416979878228078,0.02702702702702703,0.39275277766337896,1.0,13/42,11.79%,ACACB;SOD2;CBR4;ACOT13;SHMT1;APIP;KCNJ12;KCNJ2;HSD17B10;OXA1L;HOMER1;CUTC;ALDOA
304,prerank,cell-matrix adhesion (GO:0007160),-0.7346666965855793,-1.4168878874692676,0.08333333333333333,0.2002521741111295,1.0,22/80,6.78%,COL3A1;FBLN5;FN1;ITGBL1;THBS3;ITGB2;ITGA11;HPSE;ITGB5;ADAMTS12;ACTN1;FERMT3;ITGB7;CD44;SRC;EMILIN1;VCAM1;PARVG;BCR;ITGB3;CD63;ITGA4
305,prerank,positive regulation of multicellular organismal process (GO:0051240),-0.6502799225383548,-1.415999796061781,0.0,0.20129760429162485,1.0,49/227,8.53%,TREM2;COL1A1;CCR2;APOE;TMEM119;SERPINE1;MFAP2;PDPN;LOXL2;TGFB3;EREG;FGR;FST;MDK;ITGAX;BMP1;PTN;PLAC8;SNAI1;SLC11A1;HTR2B;LRP1;CCDC88B;RTN4;SOX9;DIO2;TGFB2;OLFM1;NFAM1;PIK3CG;IL18;IL33;NIBAN2;F2R;TRPV2;C1QTNF3;PIK3CD;CXCR4;TGFBR1;UCP2;TWIST1;GLIPR2;PDGFC;INHBB;TGFB1I1;TSKU;GAS6;BATF;PPIB
306,prerank,regulation of multicellular organismal development (GO:2000026),-0.8391374421180392,-1.4152541543982826,0.04838709677419355,0.20284284395871544,1.0,4/18,8.58%,HPSE;PTN;RACGAP1;CDK1
307,prerank,T cell activation (GO:0042110),-0.7651145176783647,-1.4138210153997413,0.01818181818181818,0.20574292638639827,1.0,14/45,8.82%,LCP1;PTPRC;ADA;MDK;CLEC7A;CD44;PIK3CG;CD276;CD74;PIK3CD;LFNG;TREML2;NLRC3;RAB29
308,prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.8815606792658722,1.4130472935657081,0.04081632653061224,0.40463561526964975,1.0,7/16,6.39%,SCN4B;HCN4;ANK2;HCN2;ATP1A2;CACNB2;KCNJ2
309,prerank,glycosaminoglycan metabolic process (GO:0030203),-0.78992161128168,-1.4129754634391258,0.0,0.20740621319587174,1.0,12/40,7.40%,GUSB;HPSE;HS6ST2;NAGLU;HEXA;SDC1;SGSH;GPC3;SDC3;GLB1;FUCA1;XYLT1
310,prerank,positive regulation of bone mineralization (GO:0030501),-0.8025561439255059,-1.4127619046952775,0.07017543859649122,0.20734663479020327,1.0,6/25,5.74%,TMEM119;TGFB3;PTN;FBN2;P2RX7;OSR1
311,prerank,negative regulation of cellular process (GO:0048523),-0.620017134436029,-1.4122570129361056,0.0,0.2080378960110647,1.0,56/405,7.84%,FRZB;CCN5;SFRP2;TREM2;GPNMB;CYP1B1;SFRP1;CCN4;NUPR1;PDPN;CCN2;SPN;NOX4;TGFB3;S100A11;PTK2B;EREG;FCGR2B;PTPN6;TLR2;MDK;TNFRSF1B;DDAH1;LPXN;IGFBP7;COL18A1;HTR2B;ENPP1;CLU;ACTN1;RTN4;CDKN2B;CCN3;IGFBP3;TGFB2;TGFBI;P3H3;SIRPA;FBLN1;TMEM98;EMILIN1;P3H1;NIBAN2;ROR2;F2R;ARHGDIB;CDA;CEBPA;PLXNC1;DACT3;CD9;CGREF1;TGFB1I1;MYC;SUSD2;SLC9A3R1
312,prerank,negative regulation of MAP kinase activity (GO:0043407),-0.7777099394580341,-1.4110690886307535,0.03636363636363636,0.2110140442633956,1.0,9/39,8.21%,APOE;NPPA;CD300A;UCHL1;GBA;PRKCD;PTPN1;PTPRJ;RGS14
313,prerank,positive regulation of macroautophagy (GO:0016239),0.7522168587205763,1.4099854306886326,0.046511627906976744,0.41069025919466295,1.0,12/45,8.47%,KDR;PINK1;SLC25A4;VDAC1;FYCO1;GPSM1;SH3GLB1;EPM2A;OPTN;PRKAA2;BAG3;HSPB8
314,prerank,aortic valve morphogenesis (GO:0003180),-0.8184977934931007,-1.409857703795381,0.03636363636363636,0.21421224380344173,1.0,9/30,10.59%,ELN;NPPA;SNAI1;SOX9;EMILIN1;TWIST1;ROBO1;SLIT3;TGFB1
315,prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.8593492807773406,-1.4098436365816813,0.03636363636363636,0.21333428958150402,1.0,4/17,5.95%,CYP1B1;HPSE;SULF1;SULF2
316,prerank,positive regulation of cholesterol efflux (GO:0010875),-0.922598772337853,-1.4094669224813512,0.03333333333333333,0.2136928714450821,1.0,3/19,3.24%,TREM2;APOE;LRP1
317,prerank,sterol metabolic process (GO:0016125),-0.7841368880658095,-1.4092029169028881,0.0,0.213363107286219,1.0,9/41,9.42%,CYP1B1;APOE;CH25H;SOAT1;GBA;LIPA;ABCG1;TSKU;CYP7B1
318,prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.8642069208361535,-1.408790103501509,0.05454545454545454,0.21396219389871707,1.0,5/18,4.21%,NUPR1;TYROBP;ITGAM;TGFB2;GRN
319,prerank,cotranslational protein targeting to membrane (GO:0006613),-0.7068430308628127,-1.408730905246547,0.0,0.21334290333410547,1.0,59/90,26.28%,ARL6IP1;RPL3;RPS12;RPL34;SEC61A1;RPL6;RPS4X;TRAM1;RPS16;RPL27A;RPL17;RPL39;RPS8;RPS20;RPL13A;RPS26;RPS23;RPS5;RPL37A;RPL15;RPS19;RPL12;RPL41;RPL36A;RPL35A;RPL10A;RPL35;RPL14;RPS18;SSR2;RPS27A;RPL4;RPL22;SIL1;RPS21;RPL11;RPS3;RPS10;RPS24;RPL18A;RPL19;RPL32;RPL31;RPS7;RPS6;RPS27;RPLP1;RPS11;RPL7;RPS14;RPL23;RPL38;RPS28;RPL37;RPL26;RPL5;RPL13;SSR1;RPL28
320,prerank,regulation of vasculature development (GO:1901342),-0.8644831731607716,-1.4081213964991546,0.017543859649122806,0.21398532405364995,1.0,5/21,3.44%,GPNMB;SFRP1;VASH2;HMOX1;ADGRA2
321,prerank,cardiac muscle cell development (GO:0055013),0.8301526371566785,1.4080597820163128,0.025,0.4149309886219131,1.0,14/22,12.50%,MYL2;TTN;FHOD3;MYLK3;VEGFA;MYH6;ACTC1;TCAP;PDLIM5;ALPK2;CSRP3;LRRC10;NKX2-5;ALPK3
322,prerank,positive regulation of T cell differentiation (GO:0045582),-0.8529226837618801,-1.407652632632902,0.0784313725490196,0.21457420190410195,1.0,5/18,6.82%,NCKAP1L;MDK;ADAM8;VSIR;PNP
323,prerank,eye morphogenesis (GO:0048592),-0.8836459014840348,-1.4073630797637735,0.0,0.21434350130577232,1.0,8/19,5.42%,COL5A2;MFAP5;COL5A1;MFAP2;FBN1;FBN2;TENM3;NKD1
324,prerank,apoptotic cell clearance (GO:0043277),-0.8853629266609292,-1.406900022144996,0.04477611940298507,0.21478279594048988,1.0,12/23,8.38%,TREM2;TYROBP;ANXA1;LRP1;THBS1;MEGF10;TXNDC5;RAC2;ITGB3;RHOG;GAS6;TYRO3
325,prerank,lymphocyte differentiation (GO:0030098),-0.7391107351502315,-1.406703790367531,0.016129032258064516,0.21464818885979325,1.0,16/50,12.06%,PTPRC;BLNK;NFAM1;VCAM1;PIK3CD;LFNG;ITGA4;TPD52;PTPRJ;CD79B;HHEX;LYL1;IKZF1;PTPN22;AXL;PLCG2
326,prerank,negative regulation of cell motility (GO:2000146),-0.7025077309018551,-1.4064547394345288,0.047619047619047616,0.214372730154839,1.0,21/86,11.43%,SFRP2;CYP1B1;SFRP1;SERPINE1;SULF1;FBLN1;RAP2B;SRGAP3;DPYSL3;CD74;WAS;CX3CL1;ARHGAP4;ROBO1;PTPRJ;MCTP1;RECK;THY1;STK26;CHRD;WNT11
327,prerank,cellular response to tumor necrosis factor (GO:0071356),-0.6913490731368589,-1.406451877578977,0.01639344262295082,0.21348689242692642,1.0,25/128,15.25%,SFRP1;PTK2B;ADAMTS12;TNFRSF1B;GBA;PLVAP;CCL5;CX3CL1;TMSB4X;ASAH1;TRAF1;TNFRSF11A;CCL8;ILK;MAP3K14;NPNT;ZFP36L2;PID1;TRADD;AIM2;TNFRSF13B;PYCARD;RIPK1;TNFRSF1A;PSMB8
328,prerank,regulation of interleukin-6 production (GO:0032675),-0.7273044554733594,-1.4062426141145,0.030303030303030304,0.21303074623102336,1.0,28/75,10.23%,TREM2;TYROBP;NCKAP1L;EREG;PTPN6;TLR2;CLEC7A;TLR1;TLR9;AIF1;TLR8;SIRPA;CYBA;GBA;CD74;IL33;F2R;C1QTNF3;CX3CL1;TLR7;TMEM106A;TWIST1;RAB7B;GAS6;NLRC3;CD200R1;POU2F2;APP
329,prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.7813034571594409,-1.4060458400030889,0.10526315789473684,0.2128120442362308,1.0,9/39,5.40%,HCK;IRF8;IFI30;IRF5;NCAM1;CD44;PRKCD;PTAFR;VCAM1
330,prerank,maintenance of protein localization in organelle (GO:0072595),0.8221540641451425,1.4057892394749263,0.11904761904761904,0.41898234792251016,1.0,4/19,10.14%,PINK1;HK2;CHCHD10;HSPA5
331,prerank,protein-containing complex assembly (GO:0065003),-0.6402296078912899,-1.4057233739661459,0.0,0.21273477840305896,1.0,41/220,14.19%,TSPAN4;FN1;NCKAP1L;CTSZ;COL16A1;MEFV;PTK2B;CAPG;SH3PXD2B;LPXN;FERMT3;SOX9;SEC16B;P2RX7;CD74;CAPZA1;WAS;CX3CL1;COL7A1;MYC;SLC9A3R1;TRAF1;BIN2;WDR19;DLG4;SKAP2;CTSC;BOK;GSDMD;SLC2A1;PLEKHA7;TIAM1;WIPF1;STING1;TRADD;AIM2;JCHAIN;TLE3;RIPK1;LAMC1;TAPBP
332,prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.8654404346881468,1.4054301681730248,0.05128205128205128,0.41567459254417455,1.0,4/15,4.91%,PLIN5;PINK1;SIRT5;PPARA
333,prerank,heart contraction (GO:0060047),0.8191025976765899,1.4048227634077928,0.0,0.4141476979734634,1.0,15/35,7.57%,SCN4B;MYL3;MYL2;TNNI3;TTN;RYR2;CASQ2;ATP1A2;MYH6;TPM1;TNNC1;ACTC1;TRDN;SGCG;TCAP
334,prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.8417449302082811,-1.4045245684565175,0.05357142857142857,0.21562524800874708,1.0,8/29,8.38%,TREM2;CD300LF;CD300A;TLR9;CD14;TICAM2;RAB7B;TYRO3
335,prerank,positive regulation of lymphocyte activation (GO:0051251),-0.8180796205163341,-1.404226507639862,0.09615384615384616,0.21572191173847874,1.0,7/19,3.91%,CCR2;TYROBP;NCKAP1L;CLEC7A;TLR9;CCDC88B;SIRPA
336,prerank,ventricular cardiac muscle tissue development (GO:0003229),0.7988115519563342,1.4038487267876072,0.09523809523809523,0.4138093860391686,1.0,9/22,7.48%,HOPX;MYL3;MYL2;TNNI3;PROX1;MYH6;TPM1;TNNC1;DSG2
337,prerank,regulation of biomineral tissue development (GO:0070167),-0.8301621552237466,-1.4028137930744782,0.08064516129032258,0.2185770262129298,1.0,7/19,11.49%,ECM1;ENPP1;SOX9;TWIST1;GAS6;TGFB1;BMP2K
338,prerank,negative regulation of cell adhesion (GO:0007162),-0.753473525236572,-1.40199920319295,0.03125,0.21998933103453075,1.0,12/58,8.03%,CYP1B1;SERPINE1;SPN;PTPRC;MDK;LPXN;TGFBI;FBLN1;CX3CL1;ARHGDIB;PLXNC1;PTPRO
339,prerank,chaperone-mediated protein complex assembly (GO:0051131),0.8123321473198245,1.4019924030881987,0.021739130434782608,0.4159381225056354,1.0,3/18,3.60%,HOPX;HSPD1;NDUFAF1
340,prerank,negative regulation of blood coagulation (GO:0030195),-0.8512781390488535,-1.401786634648767,0.037037037037037035,0.2195655664518259,1.0,5/18,5.05%,APOE;SERPINE1;SERPINE2;PLAU;SERPING1
341,prerank,membrane depolarization during action potential (GO:0086010),0.8809476622813939,1.4017594005470126,0.07142857142857142,0.4124597179780929,1.0,6/17,6.39%,SCN4B;HCN4;SCN4A;HCN2;ATP1A2;KCNJ2
342,prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.902338270859815,-1.401183964659687,0.0784313725490196,0.22073549182099156,1.0,5/16,5.83%,IL10RA;IL7R;CYP1B1;CCL5;F2R
343,prerank,"wound healing, spreading of cells (GO:0044319)",-0.8538162032787913,-1.4010245239225898,0.07547169811320754,0.22035738671017077,1.0,8/21,7.87%,COL5A1;LCP1;PDPN;MMP12;CD44;FLNA;ITGA5;RHOC
344,prerank,establishment of protein localization to mitochondrion (GO:0072655),0.7640202766274788,1.4009443109377835,0.06451612903225806,0.4108611564022238,1.0,23/41,16.42%,PINK1;HK2;HSPD1;MFN2;GRPEL1;TIMM23;TOMM5;TOMM40L;TIMM44;TIMM21;TIMM17A;TIMM10;TOMM40;TIMM8B;AIFM1;TIMM22;DNAJC15;DNAJC19;ROMO1;CHCHD4;TIMM9;TOMM7;GRPEL2
345,prerank,O-glycan processing (GO:0016266),-0.8024228124667587,-1.400661572870768,0.03278688524590164,0.22043305391389525,1.0,7/31,8.87%,GALNT6;GCNT4;GXYLT2;B3GNT8;GALNT10;MUC16;GCNT1
346,prerank,positive regulation of protein kinase activity (GO:0045860),-0.6658139996693612,-1.4004916081779264,0.016666666666666666,0.2199244141279612,1.0,19/119,8.20%,PAK1;CALCA;NOX4;PTPRC;PTK2B;EREG;LCP2;SLC11A1;CSF1R;CLU;TGFB2;RASSF2;SRC;PRKCD;CCL5;ITGB3;PTPN1;GAS6;TPX2
347,prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.8796663008848031,-1.400480702045731,0.016129032258064516,0.21910669022367835,1.0,6/18,8.82%,KCNN4;PTPRC;NFAM1;PRKCB;CARD11;RAB29
348,prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.7355171025032579,-1.4002023876362006,0.01639344262295082,0.21878540558385917,1.0,14/70,10.95%,CTSS;FCGR2B;IFI30;FCER1G;CTSD;DYNLL1;LGMN;CD74;CAPZA1;RACGAP1;CLTA;KIF15;KIF11;CENPE
349,prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.7446049108425301,-1.3997246856022236,0.0,0.21908789537509557,1.0,14/53,16.03%,LGALS3;THBS1;SRC;IGF1;TGFBR1;FGFR1;TRAF1;BID;TRADD;ITGAV;PYCARD;RIPK1;ACVR1;CASP8
350,prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.8310812004731294,1.3994966817091337,0.05,0.41227300013382945,1.0,11/20,9.73%,COQ10A;PPARGC1A;NDUFS1;ACADVL;COX10;SLC25A13;NDUFS4;CYCS;SDHAF4;LYRM7;COX15
351,prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.7404763263791584,1.399145642362272,0.047619047619047616,0.4097844667388927,1.0,5/45,6.85%,SRRM4;FXR1;KHDRBS3;RBFOX1;RBM24
352,prerank,positive regulation of macrophage migration (GO:1905523),-0.9099350183966624,-1.3989440649260942,0.0,0.22089100086647073,1.0,7/16,6.09%,TREM2;MDK;CSF1R;THBS1;P2RX4;CCL5;CX3CL1
353,prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.7202909387904424,-1.3989094549241279,0.06349206349206349,0.22012620795606608,1.0,26/87,8.72%,FN1;TREM2;PIK3AP1;PTPN6;FGR;NCF1;SOX9;TGFB2;PIK3R5;SRC;PIK3CG;UNC5B;IGF1;CCL5;IL18;ROR2;F2R;HCLS1;PIK3CD;PIP4K2A;TWIST1;PDGFC;SLC9A3R1;FGFR1;HGF;NLRC3
354,prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.6670001550277366,-1.3978593782968847,0.046153846153846156,0.2228764730021511,1.0,26/125,9.18%,VAV1;ARHGAP45;FGD3;TAGAP;ARHGAP30;ARHGAP22;SRC;ARHGAP19;ARAP1;SRGAP3;ARHGAP11A;RAC2;ARHGAP15;BCR;ARHGDIB;ARHGAP25;RACGAP1;ARHGAP4;PREX1;MYO9B;RHOG;ARHGAP9;RHOC;RHOU;SH3BP1;GMIP
355,prerank,positive regulation of protein localization to membrane (GO:1905477),-0.7271135088724378,-1.3971498164176561,0.013888888888888888,0.224207371292532,1.0,12/80,8.35%,TREM2;ITGB2;LGALS3;NKD2;CEMIP;ITGAM;LRP1;RHOG;E2F1;MYO1C;STAC2;BID
356,prerank,positive regulation of monooxygenase activity (GO:0032770),-0.9096174231862635,-1.397123183398271,0.016129032258064516,0.22348220749220743,1.0,3/18,2.92%,APOE;CDH3;HTR2B
357,prerank,regulation of signal transduction (GO:0009966),-0.6821425196807634,-1.3970689231969025,0.0,0.22276255824549748,1.0,26/143,11.06%,TREM2;SULF1;TIMP1;IGFBP4;NCAM1;IGFBP7;CLU;IGFBP3;SRC;RUNX1;RGS16;CX3CL1;PTPN1;LFNG;CD63;CASTOR1;CD80;IGFBP2;RGS14;ILK;GAS1;MDFIC;APP;KAZALD1;TGFB1;BST1
358,prerank,regulation of protein autophosphorylation (GO:0031952),-0.7992155603412037,-1.3969737321696472,0.05357142857142857,0.2223075613082891,1.0,4/32,7.23%,GPNMB;ENPP1;RASSF2;PDGFC
359,prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.7723007665314547,-1.3964674450485526,0.0,0.2228888875361161,1.0,11/60,7.59%,GDF6;TGFB3;GDF15;SULF1;CDKN2B;THBS1;TGFB2;TGFBR1;SLC2A10;INHBB;TGFB1I1
360,prerank,regulation of mononuclear cell migration (GO:0071675),-0.8884588777560758,-1.3957416126095,0.03278688524590164,0.22363734392066364,1.0,6/18,4.91%,LGALS3;MDK;CSF1R;THBS1;AIF1;CCL5
361,prerank,positive regulation of ossification (GO:0045778),-0.8009108005307786,-1.3953537256457575,0.05263157894736842,0.2236113297193907,1.0,7/29,5.74%,TMEM119;TGFB3;PTN;FBN2;TGFB2;P2RX7;OSR1
362,prerank,receptor signaling pathway via STAT (GO:0097696),-0.8532921367245202,-1.395307099524921,0.0196078431372549,0.22290462496524185,1.0,1/21,0.44%,CCR2
363,prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.8680437285147911,-1.3951460812836975,0.04081632653061224,0.22228796871139023,1.0,6/22,7.76%,PABPC1;SLC11A1;TENT5B;TENT5C;TENT5A;E2F1
364,prerank,very long-chain fatty acid metabolic process (GO:0000038),0.8258312769440636,1.3949595992213941,0.11904761904761904,0.4229189213805814,1.0,8/20,7.04%,ACOT1;ACOT2;TECR;ACSL6;ABCD3;ACOX1;ACSL1;TECRL
365,prerank,cellular response to insulin stimulus (GO:0032869),0.6186692698714514,1.3947255555205553,0.0,0.41938302963071056,1.0,8/113,3.89%,RAB12;PDK2;PDK4;SLC2A4;LPIN1;GOT1;TBC1D4;GCK
366,prerank,platelet degranulation (GO:0002576),-0.6934557508157635,-1.3946692907655784,0.0,0.22281636213522435,1.0,38/97,12.10%,SPARC;FN1;SERPINE1;PLEK;TGFB3;ECM1;TIMP1;VEGFD;ISLR;CLU;ACTN1;FERMT3;CD109;THBS1;TGFB2;LHFPL2;IGF1;FLNA;SERPING1;STXBP2;TMSB4X;ITGB3;CD63;MAGED2;CD9;GAS6;HGF;TAGLN2;ENDOD1;TIMP3;APP;LAMP2;TGFB1;PROS1;QSOX1;TOR4A;CYRIB;ANXA5
367,prerank,tRNA aminoacylation for protein translation (GO:0006418),0.7794986024782002,1.3946331080845973,0.041666666666666664,0.4154298861513895,1.0,12/24,15.04%,PPA2;NARS2;CARS2;AARS2;LARS2;MARS2;TARS2;IARS2;YARS2;FARS2;FARSB;EARS2
368,prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.831357881652746,-1.3945788112078692,0.06896551724137931,0.22212041414065709,1.0,6/20,3.91%,CCR2;ITGB2;MDK;CCDC88B;CD44;SIRPA
369,prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.7355976041289914,-1.3942452742671103,0.01639344262295082,0.22247782040853437,1.0,14/69,10.95%,CTSS;FCGR2B;IFI30;FCER1G;CTSD;DYNLL1;LGMN;CD74;CAPZA1;RACGAP1;CLTA;KIF15;KIF11;CENPE
370,prerank,regulation of protein localization to cell periphery (GO:1904375),-0.834305864109282,-1.394036333642777,0.10526315789473684,0.22228952171853048,1.0,1/17,0.40%,MMP14
371,prerank,regulation of autophagy (GO:0010506),-0.6413892810085987,-1.3935702581875722,0.0136986301369863,0.22314318310435063,1.0,13/199,5.68%,IL10RA;CTSA;TREM2;NUPR1;MEFV;DAP;HTR2B;UCHL1;EEF1A1;GBA;ATP6V0D2;TPCN2;ATP13A2
372,prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.8873843076905085,1.3928885630207672,0.023809523809523808,0.4179354489138787,1.0,12/17,7.00%,COX6A2;COX10;NDUFA4;COX5A;AFG1L;COX6B1;COX5B;COX4I1;COX6C;CYCS;COX7B;COX7C
373,prerank,vacuolar acidification (GO:0007035),-0.8284889427492762,-1.3928682354317359,0.08163265306122448,0.22440535671775869,1.0,7/20,10.99%,TCIRG1;SLC11A1;GRN;ATP6V0D2;ATP6AP2;ATP6V0A4;CLN3
374,prerank,Golgi organization (GO:0007030),0.607056648154219,1.3928165838646511,0.0,0.4137560944247399,1.0,6/105,6.26%,DYM;DNAJC28;TANGO2;FAM174B;CLASP1;OPTN
375,prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.81181377101217,-1.3926680072742992,0.07017543859649122,0.22446005176317427,1.0,7/43,5.83%,COL3A1;VAV1;GPR35;GPR65;PIK3CG;IGF1;F2R
376,prerank,endoderm formation (GO:0001706),-0.8387094421275082,-1.3926533536698809,0.06779661016949153,0.2237732445568361,1.0,9/29,2.49%,FN1;MMP14;COL8A1;ITGB2;MMP2;COL12A1;COL11A1;ITGB5;COL6A1
377,prerank,aortic valve development (GO:0003176),-0.8161648445336277,-1.3922526383291949,0.016666666666666666,0.22403494253300435,1.0,12/34,12.13%,ELN;NPPA;SNAI1;TNFRSF1B;SOX9;EMILIN1;TWIST1;ROBO1;SLIT3;TGFB1;BMP2;SNAI2
378,prerank,regulation of myeloid cell differentiation (GO:0045637),-0.7596686049692679,-1.3915488050328557,0.046153846153846156,0.22548021162597115,1.0,8/55,6.30%,LGALS3;PTK2B;MAFB;THBS1;RUNX1;PRKCB;FES;SPI1
379,prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.73966697931977,-1.3914264925528486,0.01639344262295082,0.22512297159835748,1.0,15/71,10.95%,CTSS;FCGR2B;IFI30;FCER1G;CTSD;DYNLL1;LGMN;CD74;CAPZA1;MARCHF1;RACGAP1;CLTA;KIF15;KIF11;CENPE
380,prerank,ameboidal-type cell migration (GO:0001667),-0.7468635113680827,-1.3910832791400887,0.07407407407407407,0.2255800050610351,1.0,9/40,9.90%,HTR2B;ITGB7;SEMA3D;CCN3;GPC3;ITGA4;CORO1C;SGPL1;SEMA4A
381,prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7060393097344019,-1.390770904655539,0.030303030303030304,0.2257506988191873,1.0,55/87,26.28%,SEC61B;RPL3;RPS12;RPL34;SEC61A1;RPL6;RPS4X;RPS16;RPL27A;RPL17;RPL39;RPS8;RPS20;RPL13A;RPS26;RPS23;RPS5;RPL37A;RPL15;RPS19;RPL12;RPL41;RPL36A;RPL35A;RPL10A;RPL35;RPL14;RPS18;RPS27A;RPL4;RPL22;RPS21;RPL11;RPS3;RPS10;RPS24;RPL18A;RPL19;RPL32;RPL31;RPS7;RPS6;RPS27;RPLP1;RPS11;RPL7;RPS14;RPL23;RPL38;RPS28;RPL37;RPL26;RPL5;RPL13;RPL28
382,prerank,regulation of fatty acid oxidation (GO:0046320),0.8780053075571639,1.3906501776189257,0.0,0.41931530679722706,1.0,7/15,4.91%,PDK4;PPARGC1A;ACADVL;FABP3;MLYCD;ACADL;PPARA
383,prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.826761369985028,-1.3904453471779694,0.037037037037037035,0.22620228424601269,1.0,1/24,0.44%,CCR2
384,prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.8081223261453055,-1.3903108546947296,0.12280701754385964,0.22572705982362057,1.0,1/18,4.29%,SRC
385,prerank,cellular response to interleukin-1 (GO:0071347),-0.6586878283204154,-1.3893667736926372,0.05172413793103448,0.2274561002023355,1.0,11/119,9.50%,SFRP1;PTGIS;ADAMTS12;IL1RN;SOX9;SIRPA;CCL5;CX3CL1;IRAK4;CCL8;IL1R1
386,prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.7088570696224639,-1.3888586507229996,0.03225806451612903,0.22789698577719017,1.0,4/81,5.11%,GPNMB;CDKN2B;GPR132;DACT1
387,prerank,negative regulation of B cell activation (GO:0050869),-0.8865024929383535,-1.3879589425620147,0.03571428571428571,0.2295666783327454,1.0,7/16,7.03%,SFRP1;TYROBP;FCGR2B;CD300A;LAPTM5;ID2;SAMSN1
388,prerank,Ras protein signal transduction (GO:0007265),-0.6787461699913374,-1.387409557306879,0.03278688524590164,0.23011597399901457,1.0,16/120,7.88%,COL1A2;PDPN;AIF1;RAP2B;IGF1;SHC2;WAS;RAC2;ARHGDIB;CDC42EP5;ARHGAP4;SHTN1;MYO9B;GRAP2;RHOG;CCNA2
389,prerank,purine ribonucleotide catabolic process (GO:0009154),0.8209142405718337,1.3873785481551806,0.06818181818181818,0.4272733556845474,1.0,6/18,4.87%,FITM2;ACAT1;MLYCD;NT5C1A;NUDT7;NUDT3
390,prerank,autophagosome assembly (GO:0000045),0.6697710883664273,1.386594872834068,0.05263157894736842,0.42653987315585945,1.0,7/47,12.48%,ATP2A2;MFN2;MAP1LC3A;WIPI1;EMC6;ATG9A;UBXN2A
391,prerank,positive regulation of JNK cascade (GO:0046330),-0.7216430102378499,-1.3865807175158165,0.06060606060606061,0.23188482254859946,1.0,11/55,10.48%,CCN2;PTK2B;FCGR2B;GADD45B;NCF1;TLR9;RASSF2;TRAF1;APP;GADD45G;SH3RF3
392,prerank,"phagocytosis, engulfment (GO:0006911)",-0.8283547728654616,-1.3860158222345609,0.057971014492753624,0.23254031724955518,1.0,13/26,8.74%,ITGB2;MARCO;FCGR2B;ITGAM;THBS1;AIF1;MEGF10;RAC2;MSR1;ARHGAP25;RHOG;BIN2;SH3BP1
393,prerank,tRNA aminoacylation (GO:0043039),0.7953666974712652,1.3845707297013379,0.08333333333333333,0.43150835106194446,1.0,9/21,13.96%,QRSL1;GATB;PPA2;LARS2;MARS2;IARS2;YARS2;FARS2;FARSB
394,prerank,regulation of B cell proliferation (GO:0030888),-0.7847837996687257,-1.384270962189147,0.04,0.23632665213423806,1.0,9/33,5.36%,TYROBP;NCKAP1L;PTPRC;FCGR2B;CD300A;CD22;TLR9;SASH3;CD74
395,prerank,regulation of neuron death (GO:1901214),-0.6945541293625075,-1.3837106490810887,0.05263157894736842,0.23715773338893217,1.0,12/67,5.68%,GPNMB;ITGB2;TYROBP;CTSZ;FCGR2B;TNFRSF1B;C1QA;ITGAM;CLU;GBA;CCL5;ATP13A2
396,prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.8479151199097928,-1.3831846269339245,0.0,0.2375938987805966,1.0,7/25,6.65%,TLR2;TLR1;TLR9;RTN4;CYBA;TASL;TICAM2
397,prerank,defense response to Gram-positive bacterium (GO:0050830),-0.8166203431183752,-1.3824020606851926,0.09259259259259259,0.23922964595398702,1.0,4/22,4.38%,MPEG1;FGR;TLR2;RNASE6
398,prerank,endothelial cell migration (GO:0043542),-0.7974951750893726,-1.380886230711241,0.07575757575757576,0.24328990863046418,1.0,6/34,3.62%,FSTL1;CYP1B1;LOXL2;LPXN;ADGRA2;CCN3
399,prerank,B cell differentiation (GO:0030183),-0.8016255612464401,-1.380863354567998,0.017543859649122806,0.24250651305582013,1.0,10/35,9.36%,PTPRC;BLNK;NFAM1;VCAM1;ITGA4;TPD52;PTPRJ;CD79B;HHEX;LYL1
400,prerank,negative regulation of cell death (GO:0060548),-0.7207921103605012,-1.3798346389409093,0.03636363636363636,0.24468519767783709,1.0,10/75,5.68%,CCN5;GPNMB;CCN4;CCN2;TNFRSF1B;HTR2B;CLU;CCN3;GBA;ATP13A2
401,prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.8408041611021734,-1.3796744037590045,0.04,0.24413200483244438,1.0,3/23,7.43%,ZC3H12D;RNASE6;RNASE4
402,prerank,regulation of DNA metabolic process (GO:0051052),-0.7791015514971105,-1.3796249088224546,0.031746031746031744,0.2435443690678375,1.0,1/39,0.35%,IL7R
403,prerank,cardiac muscle contraction (GO:0060048),0.8203821215133165,1.3791707046504347,0.023809523809523808,0.45077092718938777,1.0,11/29,7.57%,SCN4B;MYL3;TNNI3;TTN;RYR2;CASQ2;ATP1A2;MYH6;TPM1;TNNC1;TCAP
404,prerank,negative regulation of T cell proliferation (GO:0042130),-0.9039638701794335,-1.3771803699682752,0.018867924528301886,0.24980354199649352,1.0,2/16,1.24%,GPNMB;SPN
405,prerank,response to interleukin-1 (GO:0070555),-0.7419372004614434,-1.377159947537238,0.06,0.2490115196594149,1.0,13/52,10.23%,SFRP1;PTGIS;ANXA1;ADAMTS12;SOX9;SIRPA;SRC;CCL5;CX3CL1;TNFRSF11A;CCL8;IL1R1;APP
406,prerank,purine ribonucleotide metabolic process (GO:0009150),0.7105673017022478,1.376171208794385,0.02631578947368421,0.4589614604905381,1.0,12/45,11.07%,ACOT1;ACOT2;ACAT1;MLYCD;ACSL6;OPA1;ACOT13;THEM4;MFN1;AK4;OXSM;AMPD3
407,prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.828109711216892,-1.375915021681601,0.03125,0.2515857651844659,1.0,9/31,11.95%,TMEM119;CCN4;FBN2;IGF1;HGF;WNT4;RUNX2;NPNT;BMP2
408,prerank,mitochondrion localization (GO:0051646),0.814820524575461,1.3758188293157063,0.06818181818181818,0.4557927191071187,1.0,6/15,15.47%,MFN2;TRAK1;MFN1;TRAK2;MUL1;MTM1
409,prerank,cellular component assembly (GO:0022607),-0.6417956720562398,-1.375558917371461,0.034482758620689655,0.25184699941665945,1.0,46/178,14.19%,TSPAN4;LCP1;NCKAP1L;PTK2B;CAPG;LPXN;RTN4;SOX9;AIF1;FLNA;DPYSL3;CD74;CAPZA1;WAS;PARVG;RAC2;FZD1;ACTG1;ARL6IP1;RHOG;SLC9A3R1;PAWR;TRAF1;GAS6;RHOU;SH3BP1;MICAL1;ILK;WDR19;DLG4;SKAP2;TGFB1;NLGN2;ACTB;QSOX1;SLC2A1;CORO1B;VMP1;WIPF1;RHOD;JCHAIN;CALD1;CHAF1B;LAMC1;NEDD9;TAPBP
410,prerank,positive regulation of neurogenesis (GO:0050769),-0.7254896829200471,-1.375268481654723,0.09375,0.25161880894678,1.0,9/56,8.63%,SERPINF1;NUMBL;CX3CR1;NAP1L1;CX3CL1;PLXNC1;ROBO1;RGS14;MAP6
411,prerank,regulation of programmed necrotic cell death (GO:0062098),-0.8005228528793548,-1.3748970132804563,0.03571428571428571,0.2520277932180444,1.0,7/20,16.63%,NUPR1;ASAH1;RIPK1;SDCBP;MLKL;CASP8;RIPK3
412,prerank,vitamin transport (GO:0051180),-0.8950949199544035,-1.3745574003696488,0.0,0.2522477511454472,1.0,2/15,6.77%,PDPN;SLC2A10
413,prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.8072932568469742,-1.3743923670888496,0.08196721311475409,0.251909037431507,1.0,5/26,7.67%,SERPINE1;MMP12;THBS1;SRC;CORO1C
414,prerank,central nervous system development (GO:0007417),-0.6381394742927887,-1.3740557998921326,0.034482758620689655,0.25205389536819567,1.0,23/161,10.27%,LOXL3;DCLK1;ACAN;CAPG;ECRG4;MARCKSL1;C1QA;ITGAM;CX3CR1;MARCKS;SOX9;ADGRA2;PHGDH;CXCR4;SNTG2;PDGFC;ATP6AP2;MYRF;SMARCA1;SH3GL1;GLIS2;SMO;LSR
415,prerank,synaptic vesicle recycling (GO:0036465),0.8059464144345382,1.3736126161155717,0.02564102564102564,0.4605283680216976,1.0,2/18,2.21%,SYT7;RAB3A
416,prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.7604474456419005,-1.3732324617647444,0.10526315789473684,0.2542277995948434,1.0,8/23,13.97%,NECTIN4;ALCAM;TENM3;VCAM1;ICAM1;ITGAL;SELP;NECTIN3
417,prerank,muscle contraction (GO:0006936),0.6662204001081362,1.3731547165461124,0.02127659574468085,0.4587967979810084,1.0,31/98,6.73%,HRC;CACNA1S;KCNIP2;HCN4;MYL3;CKMT2;MYOT;SCN4A;MYL2;TNNI3;TMOD4;LMOD3;KLHL41;CLCN1;TTN;LMOD2;SGCA;ASPH;CASQ2;PGAM2;DTNA;TRIM72;KCNJ12;MYH6;TPM1;TNNC1;MYOM2;ADRA1A;ACTC1;TRDN;CRYAB
418,prerank,retinoid metabolic process (GO:0001523),-0.7994917389291837,-1.372780096200517,0.018518518518518517,0.25480571993280066,1.0,9/34,7.74%,SCPEP1;RBP1;CYP1B1;APOE;LRP1;SDC1;GPC3;SDC3;ALDH1A3
419,prerank,regulation of interferon-gamma production (GO:0032649),-0.7601808199435841,-1.3724871960454161,0.09090909090909091,0.2548665235499298,1.0,21/48,12.05%,CCR2;HAVCR2;SLC11A1;CLEC7A;LAPTM5;TLR9;TLR8;SIRPA;CD14;CD276;IL18;TLR7;VSIR;GAS6;IL1R1;NR1H4;EBI3;INHBA;PTPN22;CYRIB;AXL
420,prerank,response to cAMP (GO:0051591),0.7715594496245793,1.3714578031070148,0.08108108108108109,0.4613842636473714,1.0,10/25,15.93%,HCN4;HCN2;NDUFS4;RAPGEF1;KCNQ1;AKAP6;AQP1;SLC26A6;PDE2A;EZR
421,prerank,aminoglycan catabolic process (GO:0006026),-0.8198550754832687,-1.3704623336229607,0.03773584905660377,0.2600079302736175,1.0,9/22,7.12%,GUSB;HPSE;NAGLU;SDC1;SGSH;GPC3;SDC3;GLB1;FUCA1
422,prerank,regulation of neuroinflammatory response (GO:0150077),-0.9038533518778104,-1.370073917941247,0.037037037037037035,0.26052540744790553,1.0,7/15,5.60%,TREM2;NUPR1;TNFRSF1B;IGF1;SPHK1;IL18;IL33
423,prerank,protein targeting to ER (GO:0045047),-0.693695871782597,-1.369921173525948,0.06451612903225806,0.26027684594830486,1.0,55/96,25.92%,EDEM1;RPL3;RPS12;RPL34;SEC61A1;RPL6;RPS4X;RPS16;RPL27A;RPL17;RPL39;RPS8;RPS20;RPL13A;RPS26;RPS23;RPS5;RPL37A;RPL15;RPS19;RPL12;RPL41;RPL36A;RPL35A;RPL10A;RPL35;RPL14;RPS18;SPCS3;RPS27A;RPL4;RPL22;RPS21;RPL11;RPS3;RPS10;RPS24;RPL18A;RPL19;RPL32;RPL31;RPS7;RPS6;RPS27;RPLP1;RPS11;RPL7;RPS14;RPL23;RPL38;RPS28;RPL37;RPL26;RPL5;RPL13
424,prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.7371251990540566,-1.3690263207044038,0.0625,0.26205738591221456,1.0,11/52,7.14%,TREM2;HCK;CALCA;GPR176;FGR;GPR39;ADCY7;PTH1R;SRC;ADCY3;GNG2
425,prerank,regulation of gluconeogenesis (GO:0006111),0.7912253313206978,1.3686719691877882,0.13043478260869565,0.46781395585013136,1.0,3/22,3.89%,PDK2;PPARGC1A;GCK
426,prerank,negative regulation of biomineral tissue development (GO:0070168),-0.8701553506961159,-1.3684613818730926,0.07936507936507936,0.26368229184425357,1.0,5/17,3.31%,ASPN;ECM1;PTK2B;ENPP1;SOX9
427,prerank,mitochondrial transport (GO:0006839),0.6916714651820938,1.368174835338003,0.06818181818181818,0.465564108373223,1.0,16/49,11.28%,PPIF;SLC25A4;MFN2;SLC25A13;MTX2;BCS1L;ABCB10;TIMM23;SPG7;TOMM5;TIMM44;OXA1L;TIMM17A;TIMM10;TOMM40;TIMM8B
428,prerank,cytoplasmic translation (GO:0002181),-0.6969383343354012,-1.3681463454379768,0.0,0.2638938295278336,1.0,55/90,26.28%,RPL3;RPS12;RPL34;RPL6;RPS4X;RPS16;RPL27A;RPL17;RPL39;RPS8;RPS20;RPL13A;RPS26;RPS23;RPS5;RPL22L1;RPL37A;RPL15;RPS19;RPL12;RPL41;RPL36A;RPL35A;RPL10A;RPL35;RPL14;RPS18;RPS27A;RPL4;RPL22;RPS21;RPL11;RPS3;RPS10;RPS24;RPL18A;RPL19;RPL32;RPL31;RPS7;RPS6;RPS27;RPLP1;RPS11;RPL7;RPS14;RPL23;RPL38;RPS28;RPL37;RPL26;RPL5;EIF4A1;RPL13;RPL28
429,prerank,positive regulation of cell development (GO:0010720),-0.8409603593342602,-1.3675595705668309,0.09090909090909091,0.2647137283426776,1.0,7/24,5.65%,SERPINF1;TYROBP;NUMBL;CLEC7A;CX3CR1;NAP1L1;NIBAN2
430,prerank,protein localization to cell surface (GO:0034394),-0.754594802209567,-1.3668967518798214,0.0625,0.2658860045485205,1.0,2/23,4.84%,FBLN5;FLNA
431,prerank,anterior/posterior pattern specification (GO:0009952),-0.8192897114761966,-1.3664539454009073,0.06349206349206349,0.26626687275373845,1.0,8/24,13.31%,BASP1;TIFAB;TGFBR1;ATP6AP2;HHEX;BMP2;WLS;PCSK5
432,prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.7375874266146767,-1.3661990867175127,0.03508771929824561,0.26632560668097227,1.0,8/67,6.11%,CTSS;CTSZ;CTSK;ADAMTS12;CTSH;LGMN;CTSB;FAP
433,prerank,cell-substrate junction assembly (GO:0007044),-0.7372363402850729,-1.3656771391228826,0.14814814814814814,0.2667027440211502,1.0,8/30,12.81%,FN1;ACTN1;SRC;BCR;THY1;RCC2;ITGB4;RHOD
434,prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.8416139447918526,-1.3655417395337262,0.07407407407407407,0.2662301292884479,1.0,4/16,3.91%,TREM2;MEFV;ADCY7;SIRPA
435,prerank,T cell differentiation (GO:0030217),-0.7792282297906427,-1.3653805092791274,0.03389830508474576,0.2658308320450576,1.0,8/30,11.24%,PTPRC;ANXA1;FCER1G;PIK3CD;SPI1;LFNG;PTPN22;ZFP36L2
436,prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.7292044375572051,-1.3653585409374414,0.05172413793103448,0.2650128910233805,1.0,15/46,17.30%,LAPTM5;SPHK1;CASP1;TRAF1;GAS6;TRADD;SYK;CASP4;PYCARD;RIPK1;TNFRSF1A;RACK1;CASP8;IKBKB;HSPA1B
437,prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.8662554600692509,-1.3652303235413858,0.07272727272727272,0.2644798408922862,1.0,7/19,5.61%,FCGR2B;CD300A;CD22;LPXN;NFAM1;RUNX1;PRKCB
438,prerank,regulation of T cell differentiation (GO:0045580),-0.8743944428877622,-1.3650900909146912,0.07272727272727272,0.2640546823693561,1.0,4/16,8.92%,CCR2;MDK;RUNX1;PRELID1
439,prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.8436938047599324,-1.3650307907646428,0.06896551724137931,0.2633887207589109,1.0,3/15,3.15%,SFRP2;SNAI1;CLU
440,prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.7484730738908453,-1.3644959857002188,0.0967741935483871,0.2643560673381464,1.0,14/42,7.78%,NCKAP1L;PTPRC;ANXA1;TLR9;CCDC88B;SASH3;AIF1;CD276;CCL5;IL18;CD74;VCAM1;PNP;CD80
441,prerank,cellular macromolecule catabolic process (GO:0044265),0.7232223987546846,1.3627900593428783,0.09302325581395349,0.48330306607586804,1.0,1/40,0.13%,RAB12
442,prerank,positive regulation of interleukin-8 production (GO:0032757),-0.7672722890338826,-1.3627103844048967,0.06666666666666667,0.2693956378388051,1.0,10/43,6.47%,SERPINE1;TLR2;CLEC7A;TLR1;TLR9;TLR8;CD14;CD74;F2R;TLR7
443,prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.7805460559053957,-1.3613460962845005,0.08955223880597014,0.2720962295391555,1.0,12/37,5.92%,CCR2;SERPINE1;PLA2G7;MDK;PTN;VEGFD;CSF1R;THBS1;AIF1;CCL5;LGMN;CXCL10
444,prerank,actin filament bundle assembly (GO:0051017),-0.7940546996163464,-1.3612195182127278,0.10526315789473684,0.27165453307636933,1.0,11/23,16.81%,LCP1;AIF1;DPYSL3;PAWR;MICAL1;CORO1B;RHOD;CALD1;NEDD9;LIMA1;PLS3
445,prerank,neuron projection development (GO:0031175),-0.6441907700392908,-1.3608682096126712,0.08064516129032258,0.27207170705298667,1.0,20/127,11.87%,NPY;APOE;VASH2;PAK1;DCLK1;NCKAP1L;DBN1;GBA;SHTN1;TSKU;DOCK10;DOCK7;RAB13;DLG4;EPHB2;APP;LRP12;SAMD14;NBL1;STMN1
446,prerank,regulation of T cell activation (GO:0050863),-0.844713560643842,-1.360617750338417,0.038461538461538464,0.27211077518574955,1.0,9/25,4.91%,GPNMB;CCR2;LGALS3;TNFAIP8L2;TNFRSF1B;LAPTM5;CCDC88B;SIRPA;CCL5
447,prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.7620293307535169,1.3604990527252745,0.19444444444444445,0.4881792363853818,1.0,5/22,13.16%,LPIN1;STARD7;PHOSPHO1;CHPT1;CSNK2A1
448,prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.7765786634515355,1.3600186870458237,0.10256410256410256,0.48553294798011026,1.0,4/19,8.38%,ATP2A2;CCDC47;WFS1;HERPUD1
449,prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.593960237673782,-1.3594936570985274,0.0,0.27483910459631883,1.0,37/404,10.64%,LOXL3;DKK3;SFRP2;BASP1;SFRP1;LOXL2;CALCA;S100A11;EREG;DAP;ENPP1;SOX9;ID2;ID3;NIBAN2;SPI1;CEBPA;TYMS;TWIST1;FOXP2;ZMYND15;E2F1;GAS6;ATOH8;SBNO2;TRERF1;HHEX;GLIS2;WNT4;MDFIC;ID4;IKZF1;BIRC5;RUNX2;VDR;TGFB1;FOXM1
450,prerank,plasma membrane invagination (GO:0099024),-0.799420631571403,-1.3592283358064088,0.08955223880597014,0.27469998931691497,1.0,9/24,8.74%,ITGB2;MARCO;FCGR2B;ITGAM;AIF1;MSR1;ARHGAP25;BIN2;SH3BP1
451,prerank,positive regulation of nervous system development (GO:0051962),-0.8395246017463445,-1.358551827766101,0.0392156862745098,0.2760845982650222,1.0,5/28,4.71%,SERPINF1;SRPX2;NUMBL;CX3CR1;NAP1L1
452,prerank,protein modification process (GO:0036211),-0.6730001666119948,-1.3584237772838372,0.04918032786885246,0.27567268472704864,1.0,5/66,5.17%,LOX;LOXL2;MAN2B1;SERP1;PLOD2
453,prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.7480823700100356,-1.3580929734148608,0.06666666666666667,0.2758687669434141,1.0,12/53,7.14%,TREM2;HCK;CALCA;GPR176;FCGR2B;FGR;GPR39;ADCY7;PTH1R;SRC;ADCY3;GNG2
454,prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.8170893871551036,-1.3580136373623415,0.03636363636363636,0.2753592804724702,1.0,4/31,2.92%,APOE;GLA;DDAH1;HTR2B
455,prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.7742844593935869,-1.3579093598333867,0.07936507936507936,0.2747858917606765,1.0,10/41,9.57%,FN1;ANTXR1;LPXN;FERMT3;ITGB7;PARVG;ITGB3;ITGA4;TYRO3;ILK
456,prerank,establishment of protein localization to organelle (GO:0072594),-0.6975480046458497,-1.3571991798198517,0.04081632653061224,0.27558310052663915,1.0,3/66,1.76%,IL10RA;CD68;MMP12
457,prerank,regulation of blood coagulation (GO:0030193),-0.8652917451028079,-1.3570070918913746,0.016129032258064516,0.27524515405134764,1.0,7/18,6.11%,APOE;SERPINE1;HPSE;SERPINE2;THBS1;F2R;FAP
458,prerank,negative regulation of response to stimulus (GO:0048585),-0.7592950274925,-1.3562851261799675,0.0847457627118644,0.2761690069868473,1.0,10/41,10.14%,COL3A1;FCGR2B;DDAH1;CLU;IGFBP3;PTPN1;TWIST1;MAPK7;MCTP1;THY1
459,prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.6238193436443638,-1.3562764217676075,0.028169014084507043,0.27543463200158586,1.0,30/184,10.55%,TREM2;ECM1;S100A4;HTR2B;CLEC7A;TLR9;HMOX1;NEK6;TRIM59;FLNA;IKBKE;TIFA;CD74;LITAF;CASP1;PRKCB;F2R;CX3CL1;TMEM106A;CARD11;TICAM2;RHOC;TRAF1;SHISA5;IRAK4;NLRC3;LGALS1;MAP3K14;NR1H4;TSPAN6
460,prerank,myeloid leukocyte differentiation (GO:0002573),-0.7460194778721044,-1.3550029316321492,0.07575757575757576,0.27856104464251746,1.0,12/50,8.49%,TREM2;TYROBP;PDE1B;CSF1R;RUNX1;PIK3CD;SPI1;CEBPA;E2F1;TNFRSF11A;SBNO2;BATF
461,prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.7623114434400431,-1.3548478212835149,0.04838709677419355,0.2781526780078993,1.0,4/38,1.80%,PAK1;DCLK1;NCKAP1L;DBN1
462,prerank,organelle transport along microtubule (GO:0072384),0.7863925797759399,1.354615732952246,0.045454545454545456,0.5057420150334379,1.0,5/28,5.07%,LRPPRC;TMEM201;TRAK1;MAPT;RHOT2
463,prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.764118836135344,-1.3541861959571302,0.11363636363636363,0.279418054127869,1.0,2/28,2.61%,SFRP1;TCF21
464,prerank,regulation of p38MAPK cascade (GO:1900744),-0.7835647122379785,-1.3540319333706305,0.034482758620689655,0.27900957208862004,1.0,6/32,6.30%,TREM2;GDF6;GADD45B;NCF1;SPHK1;SPI1
465,prerank,cholesterol transport (GO:0030301),-0.7697109091298319,-1.3537495583311348,0.05263157894736842,0.27909220216970243,1.0,11/30,12.68%,APOE;NPC2;CLU;SOAT1;STAR;MSR1;ABCG1;TSKU;NPC1;OSBPL5;ABCA1
466,prerank,negative regulation of programmed cell death (GO:0043069),-0.5986723350296218,-1.3532429377568198,0.03125,0.2794343003081195,1.0,53/283,12.10%,FSTL1;TREM2;COMP;SFRP1;HCK;NUPR1;PDPN;NCKAP1L;PTK2B;ANXA1;CTSH;ASNS;KRT18;HTR2B;LAPTM5;SOX9;THBS1;CD44;CLEC5A;SRC;TXNDC5;IGF1;FLNA;SPHK1;CD74;NIBAN2;OSR1;EVI2B;CX3CL1;ARL6IP1;MYC;GAS6;ANXA4;IFIT3;BID;HGF;CDK1;PRELID1;PLAUR;RPS6KA1;ARF4;BIRC5;CFL1;NUAK2;NR1H4;MET;CLN3;NOTCH2;WNT11;DDAH2;AXL;CASP3;ANXA5
467,prerank,response to UV (GO:0009411),-0.7062613116414075,-1.3522218430693647,0.034482758620689655,0.28191285818258216,1.0,6/88,8.70%,MFAP4;SCARA3;PRKCD;PCLAF;MYC;GPX1
468,prerank,regulation of axon extension (GO:0030516),-0.7414360848841792,-1.351459354330359,0.12280701754385964,0.28398967402254366,1.0,5/32,6.92%,APOE;DBN1;RTN4;OLFM1;SHTN1
469,prerank,cellular amino acid catabolic process (GO:0009063),0.7439062092024474,1.3509317336100715,0.0975609756097561,0.517201950289185,1.0,26/55,8.93%,DLD;IVD;ACAT1;ALDH5A1;DLST;OGDH;HIBADH;GOT1;ALDH4A1;KYAT1;BCKDHA;GOT2;GCDH;DDO;CARNMT1;NOS2;ECHS1;SHMT1;AUH;DBT;HIBCH;BCKDHB;MCCC1;HSD17B10;MCCC2;BCKDK
470,prerank,regulation of protein transport (GO:0051223),-0.8503419167304158,-1.350929363651913,0.019230769230769232,0.2848949443851892,1.0,4/24,6.51%,LCP1;P3H1;ATP13A2;PTPN1
471,prerank,B cell activation (GO:0042113),-0.738886971886793,-1.3499722096252056,0.06349206349206349,0.2862448821246695,1.0,17/49,10.04%,LAT2;FCRL1;PTPRC;BLNK;CD22;BTK;NFAM1;VCAM1;PRKCB;PIK3CD;ITGA4;TPD52;PTPRJ;CD79B;HHEX;LYL1;EPHB2
472,prerank,blood vessel endothelial cell migration (GO:0043534),0.7660019262889602,1.3499594591137916,0.14893617021276595,0.5176286769279722,1.0,3/20,4.34%,KDR;NR4A1;VEGFA
473,prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.8502346604019756,-1.3499225962319032,0.061224489795918366,0.2856650755168778,1.0,5/16,6.65%,ITGB2;PIK3AP1;ITGAM;CD14;TICAM2
474,prerank,positive regulation of mitochondrial fission (GO:0090141),0.7814346037810267,1.349771503501151,0.06666666666666667,0.5137490762407638,1.0,6/19,13.60%,KDR;PINK1;MIEF2;DNM1L;PRKN;MUL1
475,prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.703726606356265,-1.349698587484868,0.08064516129032258,0.2855677111815036,1.0,5/83,3.15%,TREM2;NUPR1;NKD2;RNF180;CLU
476,prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.6607929197017304,-1.349461966995735,0.043478260869565216,0.28540717671093135,1.0,29/109,19.07%,PABPC1;RPL3;RPS12;RPL34;RPL6;RPS4X;RPS16;RPL27A;RPL17;RPL39;RPS8;RPS20;RPL13A;RPS26;RPS23;RPS5;SMG9;RPL37A;RPL15;RPS19;RPL12;RPL41;RPL36A;RPL35A;RPL10A;RPL35;RPL14;RPS18;RPS27A
477,prerank,negative regulation of secretion by cell (GO:1903531),-0.8901189552778828,-1.3491541614387523,0.03125,0.28521576828605627,1.0,3/18,2.60%,APOE;ANXA1;TNFRSF1B
478,prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.7856994778940675,1.3483511462674906,0.08695652173913043,0.5155963695980627,1.0,3/28,7.13%,PDK2;USP28;CDIP1
479,prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.8272145462014736,-1.34824379358162,0.05555555555555555,0.2868945462791363,1.0,10/24,8.07%,FN1;EREG;IGF1;SPHK1;CD74;S100A6;PDGFC;MYC;E2F1;GAS6
480,prerank,regulation of chondrocyte differentiation (GO:0032330),-0.8781821526495823,-1.3482241920573135,0.07407407407407407,0.2861946014296303,1.0,6/19,6.53%,GDF6;LOXL2;ADAMTS12;MDK;SOX9;TGFBR1
481,prerank,leukocyte cell-cell adhesion (GO:0007159),-0.8507914344084433,-1.34788357392965,0.08,0.28653818945686876,1.0,11/20,13.50%,ITGB2;CERCAM;FERMT3;CCL5;VCAM1;ITGA4;ICAM1;ITGAL;MSN;SYK;SELP
482,prerank,actin cytoskeleton reorganization (GO:0031532),-0.7462491263934666,-1.3478633589119118,0.11864406779661017,0.28581166451916845,1.0,10/53,8.24%,PLEK;PAK1;ANTXR1;ANXA1;GPR65;PTK7;FLNA;PARVG;PTPN1;S1PR2
483,prerank,chromatin organization (GO:0006325),-0.6731705115691528,-1.3477345457159005,0.06896551724137931,0.28559044218160196,1.0,8/112,8.47%,PAK1;LOXL2;SNAI1;SOX9;PADI2;SPI1;MYC;SMARCA1
484,prerank,regulated exocytosis (GO:0045055),-0.6568786065454703,-1.3477192670921954,0.014705882352941176,0.2849017408485222,1.0,41/124,12.10%,SPARC;FN1;SERPINE1;PLEK;TGFB3;ECM1;STEAP2;RAB31;TIMP1;VEGFD;ISLR;CLU;ACTN1;FERMT3;CD109;THBS1;TGFB2;LHFPL2;IGF1;FLNA;SERPING1;STXBP2;TMSB4X;ITGB3;CD63;MAGED2;CD9;GAS6;HGF;TAGLN2;ENDOD1;TIMP3;RAB11FIP1;APP;LAMP2;TGFB1;PROS1;QSOX1;TOR4A;CYRIB;ANXA5
485,prerank,regulation of neuron apoptotic process (GO:0043523),-0.7061943265594568,-1.3472593428799604,0.03636363636363636,0.28571251681704374,1.0,13/68,5.83%,TREM2;APOE;NUPR1;CRLF1;TGFB3;PTK2B;MDK;ADAM8;TGFB2;GRN;UNC5B;LGMN;F2R
486,prerank,regulation of smooth muscle cell migration (GO:0014910),-0.8769662619601972,-1.3467166829281243,0.04918032786885246,0.28620811638966515,1.0,8/20,4.91%,CCN4;SERPINE1;S100A11;LRP1;IGFBP3;PLAU;IGF1;CCL5
487,prerank,response to estradiol (GO:0032355),-0.8708104952418787,-1.3465915049492683,0.037037037037037035,0.2858642559089911,1.0,2/19,1.65%,SFRP1;ANXA1
488,prerank,respiratory chain complex IV assembly (GO:0008535),0.8035608431346105,1.3456227740493238,0.02,0.5234910157851302,1.0,12/21,15.14%,COX10;BCS1L;COX14;OXA1L;COX15;COA5;TIMM21;COX17;SMIM20;SCO1;COA3;SCO2
489,prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.8678072165314265,-1.3451918296163958,0.06451612903225806,0.2885202737994201,1.0,5/20,7.66%,COL3A1;GPR35;GPR65;F2R;ROBO1
490,prerank,cellular response to ketone (GO:1901655),-0.7924647792615627,-1.3447564112327957,0.03389830508474576,0.288880971129221,1.0,6/29,8.97%,SPP1;SFRP1;SRC;ADCY3;GNG2;TRERF1
491,prerank,phagosome maturation (GO:0090382),-0.7645775775292301,-1.3445380021077085,0.10714285714285714,0.28871713123592563,1.0,8/29,8.40%,TCIRG1;RAB31;RAB32;CORO1A;ATP6V0D2;RAB34;ATP6V0A4;SLAMF8
492,prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.7815991798081076,-1.3440298319614628,0.05454545454545454,0.2893819412895497,1.0,12/35,11.95%,GDF6;TGFB3;GDF15;TGFB2;EMILIN1;TGFBR1;PMEPA1;INHBB;BMPER;INHBA;TGFB1;BMP2
493,prerank,sodium ion transport (GO:0006814),0.724594304452388,1.3436665478715684,0.125,0.5277835502747992,1.0,7/28,6.31%,SCN4B;HCN4;SCN4A;NDUFA9;HCN2;ATP1A2;FGF13
494,prerank,cellular response to peptide (GO:1901653),-0.7405380450158975,-1.3434539373875778,0.125,0.2900737625990144,1.0,10/43,6.78%,TREM2;VIM;FCGR2B;LRP1;ATP1A3;SRC;IGF1;LGMN;VCAM1;ITGA4
495,prerank,regulation of cartilage development (GO:0061035),-0.8345118402562781,-1.342526612513217,0.05172413793103448,0.2917681918471517,1.0,6/16,12.48%,MDK;BMP1;SOX9;WNT11;BMP2;TRPS1
496,prerank,regulation of interleukin-2 production (GO:0032663),-0.7465582516931912,-1.3423586573022661,0.1,0.2913550975287059,1.0,10/38,7.78%,CCR2;PTPRC;ANXA1;HAVCR2;CLEC7A;LAPTM5;RUNX1;CARD11;PNP;CD80
497,prerank,monocarboxylic acid metabolic process (GO:0032787),0.6362627226545997,1.341886978219542,0.027777777777777776,0.5327211749663224,1.0,30/87,8.73%,DLAT;CKM;PDHX;ACOT1;ACOT2;PDHB;DLD;ECHDC3;CKMT2;CPT1B;LPL;LDHB;SLC16A1;PDHA1;ALDH4A1;VDAC1;GNPAT;GOT2;ME3;CD36;PPARA;ALKBH7;AMACR;THEM4;PCCA;GLO1;MCCC1;ALOX12;PCCB;MCCC2
498,prerank,protein localization to plasma membrane (GO:0072659),0.5982876096946717,1.341165431465297,0.02857142857142857,0.5312615256136076,1.0,11/106,6.31%,RAB12;P2RY1;ANK2;ANK1;RAB3A;AFDN;TNIK;KCNB1;CACNB2;EFR3B;FGF13
499,prerank,positive regulation of T cell proliferation (GO:0042102),-0.7790307610630001,-1.3408864137126855,0.03389830508474576,0.29516034354301923,1.0,14/34,8.00%,CCR2;NCKAP1L;PTPRC;ANXA1;CCDC88B;AIF1;CD276;IGF1;CCL5;IL18;VCAM1;PNP;CD80;IGFBP2
500,prerank,regulation of developmental growth (GO:0048638),-0.8201244481538263,-1.3407220183815527,0.09090909090909091,0.2949219520048281,1.0,3/23,4.78%,APOE;OLFM1;IGF1
501,prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.6622900039961968,-1.3404210403728232,0.04285714285714286,0.29504687952882314,1.0,7/97,3.44%,SPARC;GPNMB;SFRP1;VASH2;PAK1;HMOX1;ADGRA2
502,prerank,lysosome organization (GO:0007040),-0.7115930010102728,-1.3402253125651422,0.05454545454545454,0.29499059658774435,1.0,12/33,14.72%,TASL;GRN;CORO1A;GBA;TPCN2;HPS1;MYO7A;ARSB;CLN3;ABCA1;ACP2;TMEM165
503,prerank,regulation of neuron migration (GO:2001222),-0.804620513560356,-1.3402240022535943,0.1320754716981132,0.2942143055440924,1.0,5/22,6.92%,COL3A1;MDK;IGSF10;CX3CL1;SHTN1
504,prerank,actin filament bundle organization (GO:0061572),-0.7911775234848918,-1.3395924197908735,0.08928571428571429,0.2951483222133793,1.0,11/23,16.81%,LCP1;AIF1;DPYSL3;PAWR;MICAL1;CORO1B;RHOD;CALD1;NEDD9;LIMA1;PLS3
505,prerank,regulation of epithelial cell proliferation (GO:0050678),-0.7048305796520034,-1.3391157407616137,0.07692307692307693,0.2958386043757938,1.0,19/68,11.81%,SFRP2;SFRP1;NUPR1;EREG;SOX9;CDKN2B;TGFB2;GRN;IGF1;C5AR1;OSR1;MYC;GPX1;NLRC3;UHRF1;TGFB1;MAGED1;RUNX3;FGFR2
506,prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.8761766188908999,-1.3387141808622585,0.046511627906976744,0.2964359491493511,1.0,2/15,1.12%,LGALS3;NCKAP1L
507,prerank,intracellular pH reduction (GO:0051452),-0.774232588542463,-1.3385296843905472,0.08928571428571429,0.29619858140064176,1.0,5/25,8.40%,TCIRG1;SLC11A1;ATP6V0D2;ATP6V0A4;SLAMF8
508,prerank,visual system development (GO:0150063),-0.7637828821169523,-1.3378796275163276,0.03508771929824561,0.29732510037438875,1.0,10/25,15.47%,SH3PXD2B;C1QA;ITGAM;TGFB2;SMOC1;FOXC1;C3;MEIS3;SALL2;SMG9
509,prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.8772346015884466,-1.3369601484367202,0.03225806451612903,0.29915489035049947,1.0,8/20,5.92%,CCR2;LGALS3;SERPINE1;PLA2G7;AIF1;CCL5;LGMN;CXCL10
510,prerank,insulin receptor signaling pathway (GO:0008286),0.6465743872164424,1.335671564036491,0.0,0.5514403094628334,1.0,2/64,0.22%,PDK2;PDK4
511,prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.7913067903069007,1.3355329712798754,0.14285714285714285,0.5477616654496952,1.0,2/17,7.22%,PPARGC1A;PRKAA2
512,prerank,vasculogenesis (GO:0001570),0.7328142288527273,1.3353221197667138,0.09302325581395349,0.5444556670967762,1.0,3/28,4.34%,KDR;TNNI3;VEGFA
513,prerank,regulation of gene silencing by miRNA (GO:0060964),0.6500608463332112,1.3343340568065882,0.10810810810810811,0.5433246627305166,1.0,2/57,3.04%,FXR1;EIF4G1
514,prerank,calcium ion import (GO:0070509),0.7894958365774091,1.3343290774108971,0.16279069767441862,0.5391128436395823,1.0,5/20,10.42%,CACNA1S;ATP2A2;CACNB2;AFG3L2;MCUR1
515,prerank,BMP signaling pathway (GO:0030509),-0.7347390653152552,-1.3340433896249673,0.07936507936507936,0.3069870663766294,1.0,4/41,3.75%,GDF6;TGFB3;GDF15;TGFB2
516,prerank,defense response to symbiont (GO:0140546),-0.6569967760602418,-1.3338116963722937,0.1111111111111111,0.3068425275658347,1.0,30/80,17.42%,PTPRC;TLR2;TLR9;TLR8;RNASE6;FLNA;SKP2;TLR7;IFIT3;MAP3K14;OAS3;ISG20;MX1;ZBP1;IFITM2;RNASEL;STING1;ISG15;PYCARD;NLRC5;BST2;LYST;MLKL;SAMHD1;PMAIP1;IFIT1;RIPK3;IRF7;MOV10;MYD88
517,prerank,regulation of phagocytosis (GO:0050764),-0.7416397109269518,-1.333740775064679,0.07692307692307693,0.30614168419319115,1.0,13/41,5.20%,TREM2;HCK;PTPRC;FCGR2B;FGR;TLR2;FCER1G;SLC11A1;CLEC7A;DOCK2;SIRPA;CYBA;SPHK1
518,prerank,regulation of protein catabolic process (GO:0042176),-0.6396088278765861,-1.3331806647928686,0.09836065573770492,0.30702356360947114,1.0,8/80,6.20%,CTSA;EEF1A1;FLNA;DACT1;AZIN2;NKD1;ATP13A2;GPC3
519,prerank,vesicle transport along microtubule (GO:0047496),0.768225429962068,1.3328382258410638,0.13333333333333333,0.5411148541995171,1.0,5/19,10.08%,FYCO1;TRAK1;KIF13A;KIF1C;TRAK2
520,prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.7998956277618112,-1.332654387005179,0.10344827586206896,0.3083384571413647,1.0,9/19,13.75%,BGN;CHSY3;CHPF2;CHPF;CHST12;XYLT1;CHSY1;XYLT2;UGDH
521,prerank,cellular response to cAMP (GO:0071320),0.7630769470537782,1.3325866752463027,0.13157894736842105,0.53771645764816,1.0,9/22,15.93%,HCN4;HCN2;RAPGEF1;KCNQ1;AKAP6;AQP1;SLC26A6;PDE2A;EZR
522,prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.7552021869743322,1.3325199872359625,0.11538461538461539,0.5338850827315622,1.0,15/32,11.27%,SCN4B;HCN4;KCNJ3;ANK2;KCNJ5;KCNA5;CACNB2;KCNJ2;DSP;DSC2;DSG2;KCND3;CACNA2D1;KCNQ1;JUP
523,prerank,positive regulation of phagocytosis (GO:0050766),-0.7596087893663482,-1.3300029321464417,0.06,0.3158727419477586,1.0,17/39,9.47%,TREM2;NCKAP1L;PTPRC;CD300LF;FCGR2B;FCER1G;RAB31;SLC11A1;CLEC7A;DOCK2;SIRPA;CYBA;GAS6;PTPRJ;C2;CAMK1D;C4B
524,prerank,positive regulation of histone modification (GO:0031058),0.7243383873753201,1.3299181868184486,0.08571428571428572,0.5407496109195977,1.0,1/28,1.05%,PPARGC1A
525,prerank,organelle fusion (GO:0048284),0.8310668016592982,1.3294142190987412,0.13953488372093023,0.5394582865064538,1.0,8/18,9.50%,MIGA2;MFN2;OPA1;CHCHD3;SPG7;MFN1;AFG3L2;MIEF2
526,prerank,intracellular lipid transport (GO:0032365),0.7726894435011398,1.3291124103576066,0.1568627450980392,0.5371202605367816,1.0,7/19,7.22%,ACACB;CPT1B;FABP3;CPT2;SLC25A20;ABCD3;PRKAA2
527,prerank,response to amyloid-beta (GO:1904645),-0.7723179374833978,-1.328867935328172,0.11475409836065574,0.3184933420629758,1.0,10/31,6.78%,TREM2;MMP2;MMP12;FCGR2B;LRP1;ATP1A3;IGF1;LGMN;VCAM1;ITGA4
528,prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.8470932211136167,-1.3287591579396567,0.09803921568627451,0.31797444572616196,1.0,6/17,4.91%,CCN4;S100A11;MDK;AIF1;IGF1;CCL5
529,prerank,regulation of supramolecular fiber organization (GO:1902903),-0.821922000054721,-1.3286604225689753,0.06779661016949153,0.31740043079593533,1.0,4/21,5.16%,AEBP1;APOE;MAP1A;EFEMP2
530,prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.7736136719222865,1.328612835586467,0.02040816326530612,0.5351105048815278,1.0,10/26,7.48%,HCN4;ATP2A2;ANK2;PLN;RYR2;RANGRF;FGF13;DSP;DSC2;DSG2
531,prerank,regulation of interleukin-12 production (GO:0032655),-0.7968488381344158,-1.328278663458322,0.07547169811320754,0.3179525167565115,1.0,9/33,3.77%,MEFV;TLR2;MDK;IRF5;CLEC7A;LAPTM5;TLR9;THBS1;TLR8
532,prerank,positive regulation of locomotion (GO:0040017),-0.7892733951983761,-1.3276536850398806,0.09230769230769231,0.3190763714797965,1.0,7/24,10.97%,TREM2;CSF1R;THBS1;AIF1;TWIST1;TGFB1;PDGFRB
533,prerank,camera-type eye development (GO:0043010),-0.8509464873381645,-1.327581222595548,0.06451612903225806,0.31850391463760275,1.0,6/17,7.81%,CYP1B1;FBN1;FBN2;TENM3;ALDH1A3;TSKU
534,prerank,positive regulation of angiogenesis (GO:0045766),-0.6757316514112558,-1.3275637166813536,0.07575757575757576,0.31787716024305984,1.0,21/97,6.90%,SFRP2;CYP1B1;VASH2;SERPINE1;PTGIS;ECM1;CTSH;MDK;ITGAX;ADAM12;VEGFD;HMOX1;THBS1;GRN;ANXA3;SPHK1;RUNX1;PRKCB;PIK3CD;ITGA5;TWIST1
535,prerank,negative regulation of interleukin-6 production (GO:0032715),-0.8372019708478919,-1.3274458872533144,0.07272727272727272,0.31736758780584795,1.0,11/21,11.10%,NCKAP1L;PTPN6;TLR9;SIRPA;GBA;C1QTNF3;CX3CL1;GAS6;NLRC3;CD200R1;PTPN22
536,prerank,positive regulation of leukocyte migration (GO:0002687),-0.8589995763072442,-1.32733341232755,0.07407407407407407,0.3168605568770511,1.0,7/15,4.80%,LGALS3;NCKAP1L;MDK;PTN;ADAM8;AIF1;PLVAP
537,prerank,protein import into mitochondrial matrix (GO:0030150),0.8055977888434228,1.3272900119031383,0.12962962962962962,0.5354640280429379,1.0,11/15,16.42%,GRPEL1;TIMM23;TOMM40L;TIMM44;TIMM21;TIMM17A;TOMM40;DNAJC15;DNAJC19;ROMO1;GRPEL2
538,prerank,positive regulation of neutrophil migration (GO:1902624),-0.827101071124977,-1.3272540590792539,0.06349206349206349,0.3163844186855514,1.0,7/17,8.83%,NCKAP1L;MDK;ADAM8;THBS4;CD74;RAC2;CAMK1D
539,prerank,regulation of actin filament polymerization (GO:0030833),-0.7010189848851959,-1.3268693338592676,0.09836065573770492,0.3165615388134241,1.0,10/60,6.28%,HCK;NCKAP1L;PTK2B;DBN1;COTL1;PRKCD;CARMIL1;SSH3;HCLS1;CDC42EP5
540,prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.6648246137782521,-1.3266353134739197,0.041666666666666664,0.3170483093463424,1.0,33/110,12.42%,VAV1;PIK3AP1;EREG;GDF15;HPSE;ADAM8;CX3CR1;RTN4;THBS1;PIK3R5;SRC;PIK3CG;P2RX4;IL18;RAC2;HCLS1;CX3CL1;PIK3CD;TGFBR1;RHOG;CD80;FGFR1;GAS6;PTPRJ;HGF;MST1R;TGFB1;MET;PDGFRB;CD86;FGFR2;AXL;MAZ
541,prerank,cardiac myofibril assembly (GO:0055003),0.8430253887371227,1.3260018731821923,0.125,0.5371447180409881,1.0,10/15,10.58%,MYL2;PROX1;TTN;FHOD3;MYLK3;ACTC1;NRAP;TCAP;NEBL;CSRP3
542,prerank,negative regulation of wound healing (GO:0061045),-0.8086059183316052,-1.3258824453595948,0.12280701754385964,0.3185182776760218,1.0,4/19,3.46%,APOE;SERPINE1;SERPINE2;CD109
543,prerank,negative regulation of protein transport (GO:0051224),-0.8873490683498031,-1.3253884970165788,0.017543859649122806,0.31947537243352314,1.0,1/17,0.51%,APOE
544,prerank,regulation of mitochondrial translation (GO:0070129),0.7954824053370002,1.3247665944198244,0.1875,0.5382261360847993,1.0,12/20,17.75%,RMND1;TSFM;MRPS27;C1QBP;MTG1;MTG2;COA3;FASTKD2;TRMT10C;RCC1L;UQCC2;RPUSD4
545,prerank,mitochondrial fusion (GO:0008053),0.8100276827188209,1.3244432296304394,0.14285714285714285,0.5355807250088404,1.0,8/16,9.50%,MIGA2;MFN2;OPA1;CHCHD3;SPG7;MFN1;AFG3L2;MIEF2
546,prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.8124336456982276,-1.3230400882872158,0.0425531914893617,0.3253315557764187,1.0,9/23,10.23%,NCKAP1L;EREG;PTH1R;THBS1;SRC;CCL5;ILK;ANG;APP
547,prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.6896086177020018,-1.3224044418181529,0.10714285714285714,0.32704994330692955,1.0,11/57,9.64%,TLR2;TLR9;TLR8;CD14;PRDX4;TIFA;TLR7;CARD11;TICAM2;NLRC3;MAP3K14
548,prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.6120495237016813,-1.322242804254179,0.02857142857142857,0.32680800303164764,1.0,30/155,12.27%,SFRP2;APOE;SFRP1;CILP;APOBEC1;HAVCR2;TGFB2;OLFM1;ID2;EMILIN1;IGF1;LGMN;RUNX1;MSR1;SPI1;SLC2A10;ROBO1;ATOH8;RBMS3;WNT4;DLG4;SMO;APP;VDR;TGFB1;ITGB8;PTPN22;NOTCH2;BMP2;UPK3B
549,prerank,myofibril assembly (GO:0030239),0.7268288083208242,1.3219056911848348,0.1111111111111111,0.5425539894500478,1.0,21/39,11.52%,MYL2;TMOD4;LMOD3;MYOZ2;KLHL41;TTN;OBSCN;LMOD2;MYPN;FHOD3;MYLK3;MYH6;TPM1;MYOM2;ACTC1;TCAP;TMOD1;CSRP3;ACTN2;TNNT1;PGM5
550,prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.624140835422038,-1.3218980215122746,0.07142857142857142,0.3269010425197329,1.0,49/163,23.75%,PABPC1;RPL3;RPS12;RPL34;RPL6;RPS4X;RPS16;RPL27A;RPL17;TENT2;RPL39;RPS8;RPS20;RPL13A;RPS26;RPS23;RPS5;SMG9;RPL37A;RPL15;RPS19;RPL12;RPL41;RPL36A;RPL35A;RPL10A;RPL35;RPL14;RPS18;RPS27A;RPL4;RPL22;RPS21;RPL11;RPS3;RPS10;RPS24;RPL18A;PARN;RPL19;RPL32;RPL31;RPS7;RPS6;RPS27;RPLP1;RPS11;DXO;UPF3A
551,prerank,monocyte chemotaxis (GO:0002548),-0.8412465042704413,-1.3212639809066304,0.1111111111111111,0.32807583831906206,1.0,8/15,8.98%,LGALS3;CALCA;ANXA1;CCL5;CX3CL1;PTPRO;TNFRSF11A;CCL8
552,prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.8469150205331131,-1.3210780613405706,0.1694915254237288,0.32805462249548006,1.0,6/18,11.37%,PLEK;CDKN2B;DYNLL1;CDA;INHBA;STAP1
553,prerank,negative regulation of endocytosis (GO:0045806),-0.8171838120160229,-1.3210022110782482,0.14285714285714285,0.32750883253017016,1.0,2/21,1.91%,LGALS3;CD300A
554,prerank,positive regulation of response to wounding (GO:1903036),-0.8129355459946427,-1.320617159198643,0.1111111111111111,0.32804004619487964,1.0,6/17,6.37%,ANXA1;MDK;PTN;CLEC7A;GRN;ACTG1
555,prerank,positive regulation of T cell migration (GO:2000406),-0.8303682141755833,-1.320610290804082,0.14035087719298245,0.32727706974268916,1.0,5/17,5.92%,CCR2;SPN;AIF1;CCL5;CXCL10
556,prerank,wound healing (GO:0042060),-0.7180073221069573,-1.3197085446155623,0.06896551724137931,0.3293963815096494,1.0,14/53,6.53%,COL3A1;MYOF;PAK1;EREG;MMP12;HPSE;SLC11A1;HMOX1;AHNAK2;TGFB2;IGF1;PRCP;ITGB3;TGFBR1
557,prerank,sphingosine metabolic process (GO:0006670),-0.8429642779485771,-1.3196873473147461,0.10909090909090909,0.3286885111837449,1.0,6/15,11.61%,PLPP2;GBA;SPHK1;ASAH1;SPTLC2;ACER3
558,prerank,regulation of protein kinase B signaling (GO:0051896),-0.6500849483969833,-1.3194291842526964,0.0,0.3287479869335703,1.0,37/144,12.42%,VAV1;PIK3AP1;EREG;GDF15;HPSE;RCN3;ADAM8;CX3CR1;RTN4;ARRB2;THBS1;PIK3R5;SRC;PIK3CG;P2RX4;IL18;RAC2;HCLS1;CX3CL1;PIK3CD;TGFBR1;PHLDA3;RHOG;CD80;SLC9A3R1;FGFR1;GAS6;PTPRJ;HGF;MST1R;TGFB1;MET;PDGFRB;CD86;FGFR2;AXL;MAZ
559,prerank,positive regulation of B cell activation (GO:0050871),-0.7307743254122083,-1.3192630748658771,0.16981132075471697,0.32850776827911465,1.0,7/37,5.36%,MMP14;NCKAP1L;PTPRC;TLR9;SASH3;BTK;CD74
560,prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.7395756694342744,-1.318906812513052,0.13432835820895522,0.3286760084707217,1.0,4/39,3.24%,TREM2;LGALS3;NKD2;LRP1
561,prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.8740408322819456,-1.318565533595368,0.07142857142857142,0.3289788985727705,1.0,2/15,5.87%,FZD2;FZD1
562,prerank,odontogenesis (GO:0042476),-0.8042999693411276,-1.3176648254477756,0.14035087719298245,0.331118096447882,1.0,8/23,11.95%,COL1A2;TGFB3;TGFB2;OSR1;INHBA;FOXC1;FGFR2;BMP2
563,prerank,epiboly involved in wound healing (GO:0090505),-0.8219991545497116,-1.317588587334557,0.11764705882352941,0.33047012007963433,1.0,5/15,7.87%,LCP1;PDPN;CD44;FLNA;RHOC
564,prerank,positive regulation of protein phosphorylation (GO:0001934),-0.5921862405319779,-1.3155642602656317,0.06451612903225806,0.3365228412777984,1.0,41/266,8.68%,SFRP2;TREM2;GPNMB;GDF6;TMEM119;MARCO;PAK1;CEMIP;PTPRC;TGFB3;PTK2B;EREG;GDF15;LCP2;FAM20A;VEGFD;CSF1R;CX3CR1;SOX9;THBS4;CD44;TGFB2;RASSF2;SRC;IGF1;SPHK1;CD74;HCLS1;CX3CL1;ITGB3;TGFBR1;ITGA5;PDGFC;NIBAN1;INHBB;CD80;GAS6;PTPRJ;S1PR2;HGF;DOCK7
565,prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.7917219120359147,-1.3150819913940912,0.13636363636363635,0.33707276618488957,1.0,3/22,2.85%,ITGB2;CEMIP;ITGAM
566,prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.7032466451269437,-1.314841343130759,0.07017543859649122,0.3370578999204629,1.0,8/67,6.34%,ITGB5;IFI30;FCER1G;NCF1;CYBB;CYBA;NCF4;NCF2
567,prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.7807533013211386,-1.3145093086497246,0.058823529411764705,0.3373636134100381,1.0,7/25,14.03%,SERPINE1;HMOX1;GPX1;ICAM1;TMBIM1;TRADD;RIPK1
568,prerank,protein-containing complex subunit organization (GO:0043933),-0.6501663233653614,-1.3134925699656668,0.05454545454545454,0.3399328739757034,1.0,14/90,9.94%,TSPAN4;NCKAP1L;PTK2B;CAPG;LPXN;SOX9;CD74;CAPZA1;WAS;SLC9A3R1;TRAF1;WDR19;DLG4;SKAP2
569,prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.7364806941398325,-1.3132299908003167,0.12307692307692308,0.33983169077746533,1.0,10/40,11.57%,TREM2;LGALS3;NKD2;LRP1;RHOG;STAC2;EPHB2;CLN3;CNPY4;ZDHHC2
570,prerank,spliceosomal snRNP assembly (GO:0000387),0.6738680288452975,1.3130931257155276,0.08888888888888889,0.5756620237482027,1.0,8/35,23.19%,PRPF19;PRMT7;PRMT5;WDR77;STRAP;SNUPN;SNRPD3;PRPF8
571,prerank,embryonic organ morphogenesis (GO:0048562),-0.8317006409979752,-1.3120314298388682,0.11290322580645161,0.34294024108906945,1.0,6/21,4.47%,MFAP5;MFAP2;FBN1;FBN2;TCF21;ID2
572,prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.6675850180398324,-1.3120245902956758,0.07692307692307693,0.34217101737084843,1.0,7/67,5.75%,TREM2;APOE;CLU;CORO1A;PRKCD;EMILIN1;SSH3
573,prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.7463712834382505,-1.3116917466939864,0.14814814814814814,0.3423821564611048,1.0,1/23,4.29%,SRC
574,prerank,embryonic skeletal system development (GO:0048706),-0.8581543534629883,-1.3111862457551267,0.16326530612244897,0.34293472825987226,1.0,6/15,7.40%,COL1A1;SULF1;OSR1;SULF2;SLC2A10;XYLT1
575,prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.6726439198383212,-1.3100531180180193,0.10714285714285714,0.3456133027263927,1.0,10/66,9.10%,APOE;CD300A;UCHL1;GBA;PRKCD;PTPN1;CEBPA;PTPRJ;RGS14;HHEX
576,prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.8100511998316243,-1.3093435036189387,0.1206896551724138,0.3472046249885405,1.0,5/15,6.36%,BGN;CHSY3;CHPF2;CHPF;CHST12
577,prerank,positive regulation of signaling receptor activity (GO:2000273),-0.7811766508052286,-1.308969113287017,0.18181818181818182,0.34784696534285736,1.0,3/25,2.88%,CCR2;EREG;NCF1
578,prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.7895273990429579,-1.3081025978211793,0.05172413793103448,0.35005224489955705,1.0,12/38,6.09%,ELN;CCN4;EREG;HMOX1;THBS1;IGFBP3;AIF1;ID2;IGF1;CCL5;IL18;CX3CL1
579,prerank,regulation of monocyte chemotaxis (GO:0090025),-0.8740109338488397,-1.3079855049743656,0.06153846153846154,0.3496696532367117,1.0,8/19,5.92%,CCR2;SERPINE1;PLA2G7;CCN3;AIF1;CCL5;LGMN;CXCL10
580,prerank,osteoclast differentiation (GO:0030316),-0.8438856767700401,-1.3076162184762588,0.08333333333333333,0.35009415623886975,1.0,7/17,8.37%,TREM2;TYROBP;CSF1R;SRC;ANXA2;TNFRSF11A;SBNO2
581,prerank,regulation of actin filament-based process (GO:0032970),-0.6811875060529005,-1.3071065215740691,0.11475409836065574,0.3509055303138303,1.0,19/61,14.84%,PAK1;LRP1;CORO1A;PRKCD;RAC2;IQGAP3;RHOG;RHOC;SH3BP1;PDGFRB;BST1;IQGAP2;CNN2;RHOD;PAK3;IQGAP1;BST2;EFNA5;GPM6B
582,prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.7130852251384174,-1.3070770179809155,0.08064516129032258,0.3501874099630223,1.0,14/60,11.48%,FBN1;ASPN;ADAMTSL2;FBN2;VASN;CD109;EMILIN1;TGFBR1;PMEPA1;SLC2A10;TGFB1I1;SPRED3;TGFB1;HTRA4
583,prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.8133075938204288,-1.3070008132651902,0.12307692307692308,0.3488123845191411,1.0,6/16,8.83%,NCKAP1L;MDK;THBS4;CD74;RAC2;CAMK1D
584,prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.8133075938204288,-1.3070008132651902,0.12307692307692308,0.3488123845191411,1.0,6/16,8.83%,NCKAP1L;MDK;THBS4;CD74;RAC2;CAMK1D
585,prerank,phospholipid catabolic process (GO:0009395),0.7680110020266712,1.3067100553492477,0.10526315789473684,0.5976859525931031,1.0,4/15,9.03%,PRDX6;SMPD1;GPCPD1;PLA2G4E
586,prerank,negative regulation of immune response (GO:0050777),-0.6791189754641821,-1.3061625083916595,0.06060606060606061,0.3499532606580334,1.0,22/83,8.72%,COL3A1;TREM2;CCR2;LGALS3;HCK;CALCA;GPR176;FCGR2B;CD300A;HAVCR2;FGR;GPR39;ADCY7;PTH1R;SRC;ADCY3;SPI1;SAMSN1;GNG2;RNF26;TYRO3;NLRC3
587,prerank,positive regulation of viral genome replication (GO:0045070),-0.8108036856137888,-1.3059586529336886,0.08196721311475409,0.3499869706186819,1.0,3/27,7.27%,PABPC1;CCL5;TOP2A
588,prerank,regulation of humoral immune response (GO:0002920),-0.7949856687546555,-1.3043418254020402,0.06896551724137931,0.3543165148710307,1.0,15/27,12.52%,C1QB;C3AR1;FCGR2B;C1QC;C1QA;CLU;C5AR1;SERPING1;CFB;C2;C4B;PROS1;CFP;CFH;C3
589,prerank,regulation of protein targeting to membrane (GO:0090313),-0.7915145075243849,-1.3028885127322631,0.13559322033898305,0.358116404852191,1.0,3/26,2.85%,ITGB2;CEMIP;ITGAM
590,prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.5663236480694807,-1.3020858084296807,0.01282051282051282,0.35971001319486057,1.0,47/374,11.95%,SPP1;COL1A1;APOE;GDF6;SFRP1;TGFB3;FZD2;SNAI1;NCF1;MAFB;SOX9;ID2;IGF1;RUNX1;CD74;NIBAN2;F2R;FZD1;TGFBR1;MYRF;TGFB1I1;RHOG;MYC;E2F1;CD80;ATOH8;SMARCA1;TRERF1;HHEX;GLIS2;LYL1;RPS6KA1;ILK;WNT4;MDFIC;ACTA2;FOXC2;NR1H4;RUNX2;INHBA;TGFB1;FOXM1;FOXC1;WNT11;CD86;RUNX3;BMP2
591,prerank,regulation of epithelial cell migration (GO:0010632),-0.6942199229818745,-1.3018008932100227,0.13793103448275862,0.3597978943430994,1.0,10/42,10.04%,CTSH;PTN;RTN4;SOX9;TGFB2;SRC;GLIPR2;CORO1C;ARSB;BMPER
592,prerank,glutathione derivative biosynthetic process (GO:1901687),0.8289000725913379,1.3015652087992604,0.17391304347826086,0.6095641869709467,1.0,3/16,6.04%,MGST3;GSTK1;GSTA4
593,prerank,glutathione derivative metabolic process (GO:1901685),0.8289000725913379,1.3015652087992604,0.17391304347826086,0.6095641869709467,1.0,3/16,6.04%,MGST3;GSTK1;GSTA4
594,prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.6035404580745793,-1.3012832681567623,0.07142857142857142,0.36062036210298853,1.0,35/140,15.37%,ECM1;S100A4;HTR2B;CLEC7A;TLR9;HMOX1;NEK6;FLNA;IKBKE;TIFA;CD74;LITAF;CASP1;PRKCB;F2R;CX3CL1;TMEM106A;CARD11;TICAM2;RHOC;SHISA5;IRAK4;LGALS1;MAP3K14;TSPAN6;WLS;TLR6;TRADD;TRIM62;RIPK1;BST2;TNFRSF1A;ALPK1;PLK2;GPRC5B
595,prerank,amyloid precursor protein metabolic process (GO:0042982),-0.8319716761194174,-1.3012103232130385,0.13725490196078433,0.35992191179709127,1.0,3/17,10.99%,APOE;ABCG1;CLN3
596,prerank,organelle organization (GO:0006996),0.5235371221579395,1.3004685719737277,0.0,0.6103714907379423,1.0,54/340,9.57%,DYM;PLIN5;DNAJC28;TANGO2;PPARGC1A;FITM2;FITM1;ANK1;ARMC2;CLUH;PINK1;NIPSNAP2;DNAJA3;FAM174B;SEC31B;PEX10;AFG1L;MREG;MTX2;PHB;PRDX3;SIRT3;OPA1;ADCK1;ABCD3;CHMP4C;ALAS1;SIRT5;CLASP1;TNIK;RHOT2;PTCD2;SH3KBP1;PACSIN2;BCS1L;TPM1;FAM161B;TWNK;PEX19;OPTN;ESRRA;CYCS;CHCHD10;STRIP2;MTFR1;HSD17B10;AGTPBP1;MYO18A;SEMA6A;TFB1M;BLZF1;CHCHD2;MIEF2;LARP4
597,prerank,positive regulation of chemotaxis (GO:0050921),-0.7542971969326269,-1.299676104918703,0.1,0.3636673662764111,1.0,9/32,6.19%,TREM2;CCR2;MDK;PTN;THBS1;AIF1;P2RX4;LGMN;TMSB4X
598,prerank,cell projection assembly (GO:0030031),-0.8282248247047455,-1.2995362308365543,0.09836065573770492,0.3632925639559535,1.0,6/18,8.62%,NCKAP1L;CAPG;PARVG;RAC2;RHOG;RHOU
599,prerank,regulation of endothelial cell proliferation (GO:0001936),-0.6318375003946834,-1.2994682869582,0.09090909090909091,0.36264308454462985,1.0,12/74,6.53%,SPARC;APOE;VASH2;ECM1;SULF1;VEGFD;HTR2B;THBS4;THBS1;PIK3CD;ITGB3;TGFBR1
600,prerank,positive regulation of gene expression (GO:0010628),-0.5785558088022605,-1.2992024115360918,0.01282051282051282,0.36262309836895096,1.0,67/343,12.64%,FN1;TREM2;CDH3;TMEM119;TYROBP;VIM;EREG;FGR;TLR2;CTSH;ITGAX;SLC11A1;HTR2B;CLEC7A;CLU;TLR9;CCDC88B;SOX9;THBS1;OLFM1;SEC16B;NFAM1;PIK3CG;ID2;EMILIN1;IGF1;P2RX7;CD74;IL33;ATP13A2;OSR1;ACTG2;C1QTNF3;PIK3CD;ACTG1;TGFBR1;VSIR;SLC2A10;TWIST1;NIBAN1;ROBO1;MYC;E2F1;GAS6;MYO1C;BATF;RBMS3;RBM3;SMO;EPHB2;ACTA2;APP;INHBA;VDR;TGFB1;RPS4X;ITGB8;PTPN22;ACTB;STAP1;WNT11;BMP2;PID1;PLCG2;MAZ;MSN;EIF2AK3
601,prerank,positive regulation of vasculature development (GO:1904018),-0.6789437652013437,-1.298950053728524,0.12903225806451613,0.3628533055215829,1.0,19/84,6.90%,SFRP2;CYP1B1;VASH2;SERPINE1;PTGIS;ECM1;CTSH;ITGAX;ADAM12;VEGFD;HMOX1;THBS1;GRN;ANXA3;SPHK1;RUNX1;PRKCB;PIK3CD;TWIST1
602,prerank,regulation of protein kinase activity (GO:0045859),-0.6615215374617279,-1.2959224972729582,0.1076923076923077,0.3710683737620939,1.0,13/95,11.82%,PTPRC;PTK2B;EREG;LCP2;FGR;RASSF2;RAP2B;C5AR1;SLC9A3R1;GAS6;THY1;CENPE;SFN
603,prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.7654042911472089,-1.2953267246047313,0.2,0.3720510780433554,1.0,7/21,9.10%,EMILIN1;PRKCB;NIBAN2;ITGB3;PTPN1;ITGA5;HHEX
604,prerank,cilium assembly (GO:0060271),0.5413647309793888,1.2947561558373157,0.05555555555555555,0.6275359494976157,1.0,9/231,6.32%,NUDCD3;TUBA4A;ABLIM1;DYNLL2;INTU;RILPL1;CLASP1;PRKACA;RILP
605,prerank,amide transport (GO:0042886),-0.7983462614759832,-1.2943712100108797,0.16363636363636364,0.37434639664670083,1.0,4/19,11.77%,PDPN;GLTP;PLTP;TAP1
606,prerank,cortical actin cytoskeleton organization (GO:0030866),-0.8218708153074721,-1.2936580517022531,0.11764705882352941,0.375640012253003,1.0,3/19,1.12%,PLEK;LCP1;NCKAP1L
607,prerank,positive regulation of wound healing (GO:0090303),-0.7955175608249642,-1.2936171424998184,0.12280701754385964,0.3749736107323131,1.0,7/26,6.37%,SERPINE1;ANXA1;HPSE;CLEC7A;THBS1;F2R;ACTG1
608,prerank,second-messenger-mediated signaling (GO:0019932),-0.6951776673329895,-1.29341294324945,0.1206896551724138,0.3746556946283831,1.0,14/52,6.43%,CCR2;APOE;LAT2;CXCR6;DDAH1;HTR2B;CX3CR1;BTK;P2RX4;CCR5;GUCY1A1;SPHK1;TPCN2;CXCR4
609,prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.5948372050063027,-1.2926206903113229,0.013157894736842105,0.3761619521828966,1.0,60/263,12.64%,FN1;TREM2;CDH3;TMEM119;TYROBP;TLR2;CTSH;ITGAX;SLC11A1;CLEC7A;CLU;LAPTM5;TLR9;SOX9;ARRB2;OLFM1;SEC16B;GBA;ID2;EMILIN1;IGF1;P2RX7;CD74;IL33;ATP13A2;OSR1;ACTG2;PIK3CD;ACTG1;ANXA2;PTPN1;TGFBR1;CD63;VSIR;SLC2A10;TWIST1;MAPK7;ROBO1;MYC;E2F1;GAS6;RBMS3;RAB29;SMO;EPHB2;ACTA2;APP;INHBA;VDR;TGFB1;ITGB8;PTPN22;STAP1;WNT11;BMP2;PID1;PLCG2;MAZ;MSN;EIF2AK3
610,prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.6815245517907629,-1.2921332338367801,0.09090909090909091,0.37694891608946157,1.0,25/60,20.22%,SEPTIN5;ANLN;RACGAP1;SEPTIN11;RHOC;MYH10;CKAP2;CEP55;SEPTIN1;STMN1;AURKB;BIN3;SNX18;SEPTIN8;NUSAP1;SNX33;UNC119;KIF20A;SPIRE1;SEPTIN9;INCENP;PLK1;CUL7;ESPL1;MITD1
611,prerank,phagosome acidification (GO:0090383),-0.7884146993761743,-1.2919916409258851,0.1016949152542373,0.37653069712276016,1.0,5/20,11.88%,TCIRG1;ATP6V0D2;ATP6V0A4;SLAMF8;ATP6V1A
612,prerank,transcription by RNA polymerase III (GO:0006383),0.6876850791651272,1.2916000611489171,0.05263157894736842,0.6377709964607086,1.0,4/27,19.98%,IVNS1ABP;ZC3H8;GTF3C1;POLR2L
613,prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.7425990054688089,-1.2915872005492037,0.06060606060606061,0.37694638431089067,1.0,1/41,0.04%,PABPC1
614,prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.7080280475109,-1.2914099835430382,0.19607843137254902,0.3766764905710136,1.0,6/34,5.93%,CRLF1;CSF1R;IGF1;CCL5;IL18;HCLS1
615,prerank,negative regulation of chemotaxis (GO:0050922),-0.7371104941481488,-1.2910640413441403,0.09259259259259259,0.3770413512529556,1.0,7/25,12.28%,SEMA3D;THBS1;AIF1;ROBO1;SEMA4A;ANGPT2;CORO1B
616,prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.7945388776402245,1.2901377536358345,0.08695652173913043,0.6393920745923428,1.0,12/18,18.73%,BCS1L;COX14;OXA1L;COA5;TIMM21;COX17;SMIM20;SCO1;COA3;SCO2;COA8;COX20
617,prerank,mononuclear cell differentiation (GO:1903131),-0.8015885406432355,-1.2898152619253358,0.19402985074626866,0.37956889664348004,1.0,4/17,2.89%,TREM2;IRF8;PDE1B;CSF1R
618,prerank,ncRNA metabolic process (GO:0034660),0.7715689937168251,1.2895882687611129,0.13636363636363635,0.6379006247120217,1.0,2/23,6.93%,MAPT;MOV10L1
619,prerank,protein localization to cell periphery (GO:1990778),0.5825599961550668,1.2894308755211987,0.08333333333333333,0.6342055041618965,1.0,10/108,6.31%,RAB12;P2RY1;ANK2;ANK1;RAB3A;TNIK;KCNB1;CACNB2;EFR3B;FGF13
620,prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.5815426453253567,-1.2889022329614217,0.058823529411764705,0.3817459685227647,1.0,1/259,0.04%,PABPC1
621,prerank,regulation of immune effector process (GO:0002697),-0.8033543048763281,-1.2888735308759611,0.09259259259259259,0.38103232373639645,1.0,15/24,12.52%,C1QB;C3AR1;FCGR2B;C1QC;C1QA;CLU;C5AR1;SERPING1;CFB;C2;C4B;PROS1;CFP;CFH;C3
622,prerank,response to growth factor (GO:0070848),-0.7530570234868412,-1.288765774112405,0.10526315789473684,0.38049084212656115,1.0,5/33,7.69%,SFRP1;SPHK1;TGFBR1;MAPK7;MYC
623,prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.8385584352285254,-1.2886298488636534,0.10909090909090909,0.38009632008212685,1.0,3/19,7.42%,TREM2;TICAM2;RAB7B
624,prerank,type I interferon signaling pathway (GO:0060337),-0.7096734158787638,-1.2872206626766176,0.125,0.38312987237107676,1.0,16/40,17.42%,IRF8;IRF5;IFIT3;OAS3;ISG20;MX1;IFITM2;RNASEL;ISG15;BST2;PSMB8;SAMHD1;IFNAR1;IFIT1;IRF7;MYD88
625,prerank,cellular response to type I interferon (GO:0071357),-0.7096734158787638,-1.2872206626766176,0.125,0.38312987237107676,1.0,16/40,17.42%,IRF8;IRF5;IFIT3;OAS3;ISG20;MX1;IFITM2;RNASEL;ISG15;BST2;PSMB8;SAMHD1;IFNAR1;IFIT1;IRF7;MYD88
626,prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.6444502560888307,-1.2870948498378743,0.09836065573770492,0.3824926956008662,1.0,19/89,6.53%,CDH3;SFRP1;VASH2;ECM1;MMP12;MDK;PTN;VEGFD;HTR2B;RTN4;SOX9;THBS4;GRN;IGF1;C5AR1;OSR1;PIK3CD;ITGB3;TGFBR1
627,prerank,negative regulation of DNA binding (GO:0043392),0.7752265690944322,1.2869146635710491,0.12962962962962962,0.6402882292795198,1.0,1/21,0.02%,ILRUN
628,prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.8167378337783348,-1.2867892729923474,0.06521739130434782,0.38245592725190547,1.0,3/23,3.25%,TREM2;TLR2;TLR9
629,prerank,protein O-linked glycosylation (GO:0006493),-0.6915988140099231,-1.2865606859564613,0.1016949152542373,0.38237159383940134,1.0,9/71,8.87%,GALNT6;GCNT4;GXYLT2;B3GNT8;GALNT16;PLOD2;GALNT10;MUC16;GCNT1
630,prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.8004579348190172,-1.2865073333671886,0.13114754098360656,0.381739990782849,1.0,3/17,5.11%,APOE;GBA;DACT1
631,prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.6595838288226966,-1.2863264869277486,0.08928571428571429,0.38144365994632734,1.0,12/74,6.28%,APOE;HCK;PLEK;PAK1;NCKAP1L;PTK2B;CLU;CARMIL1;EFEMP2;CX3CL1;FES;CDC42EP5
632,prerank,regulation of wound healing (GO:0061041),-0.7696085980372275,-1.286209042737437,0.09523809523809523,0.380958876123083,1.0,7/29,6.37%,SERPINE1;ANXA1;CLEC7A;CD109;PLAU;F2R;ACTG1
633,prerank,positive regulation of organelle assembly (GO:1902117),-0.7364530665439526,-1.2854292561372054,0.11940298507462686,0.38210874384884047,1.0,4/41,6.89%,LCP1;CAPG;SDC1;PIP4K2A
634,prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.8022046134550458,-1.2852347521537788,0.13333333333333333,0.3817662651911426,1.0,6/18,6.09%,CEMIP;P2RX4;P2RX7;F2R;CXCL10;CX3CL1
635,prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.8000719184416756,-1.2845724429266177,0.06896551724137931,0.3826976401661934,1.0,2/24,5.31%,PAK1;RUNX1
636,prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.6600500138977303,-1.284425351007109,0.08955223880597014,0.3822612992133506,1.0,13/66,6.34%,VAV1;NCKAP1L;PTK2B;SULF1;VEGFD;NCF1;CYBB;CYBA;SRC;NCF4;SHC2;ITGB3;NCF2
637,prerank,positive regulation of cell adhesion (GO:0045785),-0.6695553494637931,-1.2840615791329986,0.125,0.3827184886849262,1.0,12/55,8.26%,SFRP2;NCKAP1L;FBLN2;MDK;FSTL3;ADAM8;TGFB2;MEGF10;CCL5;ADAM9;PTPRJ;P4HB
638,prerank,peptide biosynthetic process (GO:0043043),0.553236229719568,1.28309613359734,0.09375,0.6510458896044442,1.0,29/140,14.73%,RPL3L;MRPL42;EIF4G1;MRPL55;MRPS36;EEF1A2;MRPL18;MRPL51;MRPL28;MRPL3;MRPL9;MRPL41;MRPL37;PABPC4;MRRF;MRPS33;YARS2;MRPS15;MRPS7;MRPL34;MRPS21;MRPS17;MRPS18A;MRPS14;MRPS5;FARSB;MRPS18B;CARNS1;MRPL35
639,prerank,organic anion transport (GO:0015711),0.6524036976743381,1.2828251186521828,0.13043478260869565,0.6478564672257546,1.0,5/43,2.65%,SLC25A42;CYB5R2;SLC4A3;SLC25A4;SLCO5A1
640,prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.7635471076084287,-1.2818129587999711,0.07462686567164178,0.38846638577488923,1.0,7/22,11.06%,NCKAP1L;MDK;THBS4;CD74;RAC2;CAMK1D;BST1
641,prerank,regulation of cell growth (GO:0001558),-0.599797451507747,-1.2817974251253643,0.06451612903225806,0.3877170891586942,1.0,13/170,6.86%,CXCL16;FRZB;SFRP2;MMP14;SFRP1;ENPP1;RTN4;CCN3;TGFB2;SPHK1;CDA;TGFBR1;DACT3
642,prerank,intracellular protein transmembrane transport (GO:0065002),0.7214301616843727,1.2816692651695656,0.11764705882352941,0.648421420850857,1.0,21/39,16.42%,HSPD1;RTN2;PEX10;GRPEL1;TIMM23;TOMM40L;TIMM44;HSPA5;TIMM21;TIMM17A;TOMM40;AIFM1;PEX7;AKT2;DNAJC15;DNAJC19;PEX6;ROMO1;CHCHD4;PEX12;GRPEL2
643,prerank,negative regulation of neuron death (GO:1901215),-0.6759591156512303,-1.281534856267361,0.07142857142857142,0.3878804439047277,1.0,14/70,5.83%,GPNMB;APOE;CRLF1;TGFB3;PTK2B;MDK;TNFRSF1B;ADAM8;GRN;UNC5B;GBA;LGMN;ATP13A2;F2R
644,prerank,regulation of viral entry into host cell (GO:0046596),-0.770429096764133,-1.2806224166090954,0.16,0.38992841822608826,1.0,7/24,14.35%,PTX3;CD74;P4HB;LGALS1;IFITM2;TRIM62;CIITA
645,prerank,negative regulation of axonogenesis (GO:0050771),0.7247402215041396,1.2804899061669812,0.20833333333333334,0.6487229217960121,1.0,1/21,0.26%,EFNB3
646,prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.7822238431565341,-1.2798810384824635,0.2,0.38891816407816915,1.0,6/17,19.49%,BUB1B;CDC20;BUB1;KNTC1;PLK1;MAD2L1
647,prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.7822238431565341,-1.2798810384824635,0.2,0.38891816407816915,1.0,6/17,19.49%,BUB1B;CDC20;BUB1;KNTC1;PLK1;MAD2L1
648,prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.7822238431565341,-1.2798810384824635,0.2,0.38891816407816915,1.0,6/17,19.49%,BUB1B;CDC20;BUB1;KNTC1;PLK1;MAD2L1
649,prerank,spindle assembly checkpoint signaling (GO:0071173),-0.7822238431565341,-1.2798810384824635,0.2,0.38891816407816915,1.0,6/17,19.49%,BUB1B;CDC20;BUB1;KNTC1;PLK1;MAD2L1
650,prerank,regulation of calcium-mediated signaling (GO:0050848),-0.8448444040734999,-1.2793694620574105,0.17391304347826086,0.3898604736258645,1.0,5/15,4.50%,TREM2;PLEK;CD22;CLEC7A;P2RX4
651,prerank,negative regulation of transport (GO:0051051),-0.7012420839185284,-1.2793390847974597,0.16666666666666666,0.3891434453637307,1.0,5/40,6.23%,LGALS3;FCGR2B;TLR2;SIRPA;ITGB3
652,prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.7419107428403529,-1.2788971135309226,0.16326530612244897,0.38982908910805564,1.0,6/26,5.93%,CRLF1;CSF1R;IGF1;CCL5;IL18;HCLS1
653,prerank,regulation of cell morphogenesis (GO:0022604),-0.760374217515363,-1.278802118144613,0.10909090909090909,0.3894127196451344,1.0,3/25,3.66%,SPARC;PDPN;CD44
654,prerank,cell junction assembly (GO:0034329),-0.6851435986389793,-1.2787975099664006,0.15789473684210525,0.38863233343342074,1.0,16/57,15.16%,FN1;FLNA;CAPZA1;ACTG1;FARP1;CDH11;SH3BP1;RAB29;ILK;NLGN2;ACTB;VMP1;SDK1;GJA4;CDC42;TLN1
655,prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.7326061848469769,1.2783452654172192,0.19607843137254902,0.6537557285971585,1.0,10/22,10.22%,SUCLA2;COX10;FECH;ALAS1;ABCB10;ALAD;UROS;COX15;FXN;CPOX
656,prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.8494004769257906,-1.2783032033176533,0.12903225806451613,0.3890183602572087,1.0,1/15,0.04%,PABPC1
657,prerank,cilium organization (GO:0044782),0.5537872793660219,1.278272377740372,0.043478260869565216,0.6499721872462281,1.0,8/164,6.32%,NUDCD3;ABLIM1;ARMC2;DYNLL2;INTU;RILPL1;FAM161B;RILP
658,prerank,positive regulation of histone methylation (GO:0031062),0.706538313956732,1.2772908877174427,0.1875,0.6503085213544869,1.0,1/19,5.59%,AUTS2
659,prerank,chromatin remodeling (GO:0006338),-0.6375449948542167,-1.2771383846084974,0.07272727272727272,0.3918158415942712,1.0,7/90,14.43%,PAK1;SOX9;MYC;SMARCA1;ACTB;CHD3;PADI4
660,prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.7789336642618961,-1.2766512874699678,0.10909090909090909,0.39226214509893376,1.0,9/27,11.95%,GDF6;TGFB3;GDF15;TGFB2;TGFBR1;INHBB;INHBA;TGFB1;BMP2
661,prerank,negative regulation of gene expression (GO:0010629),-0.5700230843635727,-1.2759940279912447,0.0136986301369863,0.3931374723514522,1.0,40/260,13.39%,SFRP2;GPNMB;APOE;SFRP1;CILP;FCGR2B;HAVCR2;SLC11A1;ZC3H12D;TGFB2;OLFM1;ID2;EMILIN1;IGF1;LGMN;RUNX1;MSR1;SPI1;TYMS;SLC2A10;ROBO1;ATOH8;RBMS3;WNT4;SMO;APP;VDR;TGFB1;ITGB8;PTPN22;ZFP36L2;NOTCH2;ENC1;BMP2;UPK3B;EIF2AK3;RPL13A;CREB3L1;SLC24A3;RPS26
662,prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.7695850786246093,1.2753332634158423,0.15384615384615385,0.6544376788144401,1.0,10/27,7.57%,MYL3;MYL2;TNNI3;PROX1;TTN;MYH6;TPM1;TNNC1;ACTC1;TCAP
663,prerank,keratan sulfate metabolic process (GO:0042339),-0.7979694866220738,-1.2750927047917033,0.12244897959183673,0.39471081293751376,1.0,14/28,13.12%,FMOD;HEXB;ACAN;LUM;HEXA;GALNS;GLB1;B4GALT2;PRELP;SLC35D2;CHST2;OMD;OGN;CHST1
664,prerank,cellular protein localization (GO:0034613),-0.5789940595762337,-1.2748428845449407,0.058823529411764705,0.3948325593305746,1.0,24/259,9.76%,FBLN5;CTSA;RAB31;RAB32;SH3PXD2B;ARL11;LAPTM5;SEPTIN5;UNC93B1;FLNA;ARL4C;TMED3;STXBP2;CD74;CD63;TICAM2;SEPTIN11;MYO7A;RAB29;ARFGAP3;HHEX;ARL5C;ARF4;TBC1D9
665,prerank,positive regulation of interferon-gamma production (GO:0032729),-0.7530854521452136,-1.2746230634412268,0.12962962962962962,0.39470589367486025,1.0,15/30,13.78%,CCR2;SLC11A1;CLEC7A;TLR9;TLR8;CD14;CD276;IL18;TLR7;IL1R1;EBI3;PTPN22;CYRIB;ISG15;PYCARD
666,prerank,regulation of chemokine production (GO:0032642),-0.7805138519021325,-1.2741857602752062,0.14814814814814814,0.3954120319977202,1.0,10/27,6.47%,TREM2;TLR2;CSF1R;TLR9;HMOX1;AIF1;IL18;CD74;IL33;TLR7
667,prerank,proteoglycan biosynthetic process (GO:0030166),0.7378075996884526,1.2735196231065147,0.20454545454545456,0.6579693860959628,1.0,1/21,0.24%,GAL3ST3
668,prerank,regulation of MAPK cascade (GO:0043408),-0.6120507891225911,-1.2733605885200265,0.07142857142857142,0.39692360573523416,1.0,18/116,9.04%,FN1;PAK1;PTPRC;GDF15;PTPN6;LAPTM5;TLR9;IGF1;P2RX7;CD74;ROR2;F2R;CX3CL1;TMEM106A;ATP6AP2;FGFR1;PTPRJ;FAM83D
669,prerank,regulation of actin filament bundle assembly (GO:0032231),-0.7637051152317501,-1.273319695055481,0.15517241379310345,0.39616620143818226,1.0,4/24,6.37%,PLEK;WAS;CX3CL1;ACTG1
670,prerank,peptide catabolic process (GO:0043171),-0.8277970207137021,-1.2726399866718818,0.11475409836065574,0.39731257044336526,1.0,2/17,2.18%,ANPEP;CTSH
671,prerank,regulation of blood circulation (GO:1903522),0.7757234590942984,1.2725826005931826,0.125,0.6581514381949429,1.0,12/23,12.75%,KCNIP2;PLN;KCNJ12;MYH6;TPM1;KCNG2;FXYD1;S100A1;CAV3;KCNQ1;DMPK;TNNT2
672,prerank,positive regulation of phosphatase activity (GO:0010922),-0.7971968804015505,-1.2725602194880374,0.11666666666666667,0.3967582370087565,1.0,5/18,11.95%,PLEK;CD300A;PDGFRB;CALM2;BMP2
673,prerank,cell projection organization (GO:0030030),-0.7959897203400782,-1.2721830852654767,0.13114754098360656,0.39723072060445536,1.0,7/24,8.62%,PLEK;NCKAP1L;CAPG;PARVG;RAC2;RHOG;RHOU
674,prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.7270506350508383,-1.271688401868026,0.15517241379310345,0.39825715253583527,1.0,10/26,18.90%,SFRP1;THBS1;BID;INHBA;PYCARD;RIPK1;PMAIP1;TNFSF12;PML;PPP2R1B
675,prerank,positive regulation of cell death (GO:0010942),-0.6899052909536858,-1.2715177845731878,0.12727272727272726,0.397970477156949,1.0,7/44,3.24%,ITGB2;TYROBP;FCGR2B;C1QA;ITGAM;CLU;LRP1
676,prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.8228767769425173,-1.2713789719158466,0.109375,0.397751350916636,1.0,6/16,11.06%,MDK;CSF1R;THBS1;CCL5;CAMK1D;BST1
677,prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.6725502269551594,-1.2709908702069952,0.15254237288135594,0.398218247209446,1.0,12/49,6.09%,APOE;CRLF1;TGFB3;PTK2B;MDK;ADAM8;CX3CR1;GRN;UNC5B;LGMN;F2R;CX3CL1
678,prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.7976793015029034,-1.2707264620630627,0.12727272727272726,0.39810978745870235,1.0,3/19,7.23%,GPNMB;RASSF2;PDGFC
679,prerank,positive regulation of epithelial cell migration (GO:0010634),-0.6436227782401169,-1.2706899329374703,0.058823529411764705,0.3974733378906642,1.0,16/81,8.35%,SPARC;PTK2B;CTSH;RTN4;SOX9;THBS1;TGFB2;GRN;SRC;PIK3CG;ANXA3;PIK3CD;ITGB3;GLIPR2;ADAM9;ATOH8
680,prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.8289270359175211,-1.270649846839012,0.18518518518518517,0.3968393409221177,1.0,2/16,13.87%,CELF4;SRSF9
681,prerank,positive regulation of peptide hormone secretion (GO:0090277),0.7861315211560086,1.2703727832257754,0.14634146341463414,0.6625488137413637,1.0,2/21,3.89%,RASL10B;GCK
682,prerank,regulation of mitochondrial fission (GO:0090140),0.7332378325673172,1.269828692991054,0.13333333333333333,0.6600686365189038,1.0,7/25,13.60%,KDR;PINK1;MAPT;MIEF2;DNM1L;PRKN;MUL1
683,prerank,positive regulation of interferon-beta production (GO:0032728),-0.7173665058553405,-1.2698252665628496,0.10526315789473684,0.3986642048573214,1.0,9/34,14.92%,TLR2;IRF5;TLR9;TLR8;TLR7;OAS3;STING1;ISG15;DHX58
684,prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.7654540757543724,-1.269639731490655,0.15789473684210525,0.3986213925863524,1.0,9/26,17.04%,DBN1;COTL1;WAS;HCLS1;SH3BP1;PAK3;PLEKHG2;CTTN;ABITRAM
685,prerank,regulation of cell size (GO:0008361),-0.7886378520857626,-1.2695233005375306,0.1111111111111111,0.39818547474238897,1.0,2/22,0.86%,VAV1;PLEK
686,prerank,regulation of interferon-beta production (GO:0032648),-0.6905633032779487,-1.2691903678675318,0.07272727272727272,0.3983836134437928,1.0,12/46,14.92%,TLR2;IRF5;TLR9;TLR8;SIRPA;TLR7;NLRC3;OAS3;STING1;ISG15;PYCARD;DHX58
687,prerank,regulation of muscle contraction (GO:0006937),0.7749557123776839,1.268970153468999,0.16,0.6591203766391018,1.0,6/18,7.80%,MYL3;MYL2;ATP1A2;TPM1;TNNC1;PPP1R12B
688,prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.7847073144114668,1.26879579933067,0.13043478260869565,0.655486857473506,1.0,7/20,15.90%,DUSP18;PPM1B;DUSP8;PPM1A;PDP1;DUSP1;DUSP10
689,prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.7515996058308285,1.2687742843788992,0.13043478260869565,0.6516575199097642,1.0,9/24,7.48%,HCN4;ATP2A2;ANK2;RYR2;RANGRF;FGF13;DSP;DSC2;DSG2
690,prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.7219820003966482,-1.2684559996896918,0.17543859649122806,0.3998868911428055,1.0,13/21,21.36%,ITGB3;DLG4;APP;ITGAV;ARF6;PICALM;SDCBP;UNC119;RIN3;ANKRD13A;APOC2;LRPAP1;APOC1
691,prerank,morphogenesis of an epithelium (GO:0002009),-0.775302794488256,-1.2684065089647987,0.15384615384615385,0.3992338191457319,1.0,7/19,14.48%,SOX9;ACTG1;SLC9A3R1;TBX18;ACTB;FGFR2;SOX8
692,prerank,regulation of macrophage chemotaxis (GO:0010758),-0.8041676043046437,-1.2675892713006878,0.19047619047619047,0.40133686520577755,1.0,6/18,8.40%,PTK2B;MDK;CSF1R;THBS1;CCL5;SLAMF8
693,prerank,sister chromatid segregation (GO:0000819),-0.7499024219983783,-1.2674489013294044,0.18333333333333332,0.400986494592827,1.0,12/25,20.17%,CDCA8;TOP2A;KNSTRN;NCAPG2;NDC80;SMC4;NUSAP1;SPAG5;KIFC1;DSN1;PLK1;ESPL1
694,prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.7815994398304571,1.267208034444001,0.14893617021276595,0.6537739127240108,1.0,9/16,21.60%,EMC9;UBL4A;EMC6;EMC2;MMGT1;EMC4;SGTA;EMC1;BAG6
695,prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.7205126491513284,-1.2666552148784418,0.18181818181818182,0.40232225387953685,1.0,13/29,14.37%,CD300LF;LAPTM5;CD74;CASP1;CXCR4;TICAM2;GAS6;AXL;ZBP1;CASP4;RIPK1;NLRC5;EDN1
696,prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.7225863682718633,1.266397096708317,0.19607843137254902,0.6529326440008858,1.0,13/24,12.92%,SCN4B;ANK2;RYR2;KCNA5;KCNJ2;GPD1L;CACNA2D1;CAV3;ATP1A1;KCNQ1;GJA1;KCNH2;SNTA1
697,prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.6239754571743575,-1.2662013557166654,0.15789473684210525,0.4029846277348966,1.0,17/78,9.22%,CDH3;ITGB2;EMB;CD84;ITGAM;TGFB2;NECTIN4;ALCAM;TENM3;PTPRF;VCAM1;TRO;MILR1;FGFRL1;ROBO1;CDH11;ICAM1
698,prerank,icosanoid metabolic process (GO:0006690),-0.7796174350181928,-1.2660216107825328,0.12903225806451613,0.40259009431484805,1.0,5/31,4.05%,CYP1B1;DPEP2;PTGIS;TBXAS1;ALOX5AP
699,prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.6830852436360346,-1.265936288577864,0.1206896551724138,0.402089656891336,1.0,12/59,9.57%,FN1;ANTXR1;LPXN;ACTN1;FERMT3;ITGB7;PARVG;ITGB3;SPI1;ITGA4;TYRO3;ILK
700,prerank,respiratory system development (GO:0060541),-0.8046393444534062,-1.265749289583825,0.0967741935483871,0.4019126652439227,1.0,4/22,2.61%,LOXL3;BASP1;PDPN;TCF21
701,prerank,regulation of cellular component movement (GO:0051270),-0.6888568209823462,-1.265718608514319,0.18181818181818182,0.40128699215944064,1.0,7/45,7.01%,PDPN;EREG;ACTN1;ARAP1;FES;TGFBR1;CD9
702,prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.7534611217681255,-1.2656352311527843,0.15254237288135594,0.40072773443409054,1.0,5/21,6.30%,GDF6;GADD45B;NCF1;SPHK1;SPI1
703,prerank,regulation of keratinocyte proliferation (GO:0010837),-0.8350275767241749,-1.265490751718786,0.09230769230769231,0.40040505898788964,1.0,6/17,12.13%,CDH3;MDK;VDR;NOTCH2;FGFR2;SNAI2
704,prerank,regulation of response to biotic stimulus (GO:0002831),-0.7883300512583126,-1.265434521812323,0.13793103448275862,0.39978570050323875,1.0,4/28,6.09%,TREM2;FCGR2B;FGR;CX3CL1
705,prerank,positive regulation of viral process (GO:0048524),-0.7289807685497816,-1.2651168473513161,0.09375,0.399763313407736,1.0,7/55,13.04%,PABPC1;CCL5;TYRO3;MDFIC;CDK9;AXL;ADARB1
706,prerank,regulation of complement activation (GO:0030449),-0.7478141231529529,-1.264772985891348,0.08620689655172414,0.40016498048492405,1.0,14/25,12.52%,C1QB;C3AR1;C1QC;C1QA;CLU;C5AR1;SERPING1;CFB;C2;C4B;PROS1;CFP;CFH;C3
707,prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.7610396249300988,-1.2645678187801008,0.21428571428571427,0.3999303806043582,1.0,6/18,11.87%,PLEK;ADA;CCL5;RGS14;MET;STMN1
708,prerank,diterpenoid metabolic process (GO:0016101),-0.7417432544388852,-1.2638448590040614,0.25,0.40147073249559057,1.0,6/27,6.68%,RBP1;APOE;LRP1;SDC1;GPC3;SDC3
709,prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.7780739619991194,-1.263520272302535,0.13793103448275862,0.40169836820751775,1.0,7/19,5.55%,C3AR1;PSTPIP1;MEFV;P2RX4;P2RX7;IL18;CASP1
710,prerank,regulation of gene silencing by RNA (GO:0060966),0.6564913500145243,1.2635038817592241,0.10526315789473684,0.6567490272889236,1.0,8/47,20.27%,EIF4G1;POLR2C;POLR2E;NDC1;POLR2B;PUM1;POLR2L;POLR2F
711,prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.6564913500145243,1.2635038817592241,0.10526315789473684,0.6567490272889236,1.0,8/47,20.27%,EIF4G1;POLR2C;POLR2E;NDC1;POLR2B;PUM1;POLR2L;POLR2F
712,prerank,mitotic cytokinesis (GO:0000281),-0.6590160679301925,-1.2627712158005782,0.10714285714285714,0.40337706887802166,1.0,18/44,21.08%,ANLN;RACGAP1;RHOC;MYH10;CKAP2;CEP55;STMN1;SNX18;NUSAP1;SNX33;UNC119;KIF20A;INCENP;PLK1;CUL7;ESPL1;MITD1;RTKN
713,prerank,dendritic spine organization (GO:0097061),-0.7888086730337687,-1.262735411730937,0.23214285714285715,0.402739218093125,1.0,5/22,10.04%,TREM2;LGMN;DOCK10;DLG4;EPHB2
714,prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.776077961860614,-1.2625313988184428,0.18181818181818182,0.4024391481871679,1.0,3/21,4.78%,VAV1;SRC;IGF1
715,prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.7772431593621681,-1.2620160656696897,0.18,0.4031446405372325,1.0,4/17,4.78%,APOE;CLU;RTN4;IGF1
716,prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.8124889940834189,-1.261517334225001,0.17857142857142858,0.4039728763424525,1.0,4/19,9.03%,DOK1;RTN4;ARAP1;PLAUR
717,prerank,cardiac muscle cell contraction (GO:0086003),0.802898050607905,1.261133646435762,0.2222222222222222,0.6613892136064566,1.0,4/15,10.20%,SCN4B;KCNJ2;CACNA2D1;ATP1A1
718,prerank,kidney development (GO:0001822),-0.6837956778445335,-1.2610960496560761,0.16417910447761194,0.4042351403522833,1.0,8/44,6.53%,GDF6;CTSH;SULF1;TCF21;TGFB2;OSR1;SULF2;TGFBR1
719,prerank,positive regulation of T cell activation (GO:0050870),-0.7323793473265602,-1.260088494838323,0.1346153846153846,0.4063695013332914,1.0,13/41,7.78%,CCR2;NCKAP1L;PTPRC;ANXA1;MDK;CCDC88B;AIF1;SIRPA;CD276;CCL5;VCAM1;PNP;CD80
720,prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.8053895109191256,1.2588303080636103,0.2,0.6669460947957554,1.0,3/15,4.34%,KDR;NR4A1;VEGFA
721,prerank,negative regulation of protein phosphorylation (GO:0001933),-0.6333951825446841,-1.2582863750777542,0.08620689655172414,0.4109058481580053,1.0,27/131,13.79%,SFRP2;SFRP1;PTPRC;PTPN6;ENPP1;IGFBP3;SIRPA;RASSF2;FBLN1;PRKCD;EMILIN1;PMEPA1;TWIST1;SAMSN1;NIBAN1;CORO1C;SPRED3;EPHB2;THY1;TGFB1;CALM2;SFN;PID1;UBASH3B;PRR5L;DNAJC10;LYN
722,prerank,dendrite morphogenesis (GO:0048813),-0.7766263665888139,-1.2573263474965886,0.14814814814814814,0.4128129589296932,1.0,10/28,17.04%,PTN;FARP1;DOCK10;MAP6;DLG4;EPHB2;SDC2;PAK3;CDC42;ABITRAM
723,prerank,regulation of small molecule metabolic process (GO:0062012),0.7539203022825682,1.2572853726483562,0.18181818181818182,0.6700961103944882,1.0,9/25,6.02%,PDK2;PDK4;ACADVL;RORC;MLYCD;GNB3;ACADL;PPARA;EPHX2
724,prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.809185453571749,-1.2569698670080325,0.14035087719298245,0.4128295929168005,1.0,2/15,1.91%,PTPRC;CD300A
725,prerank,response to interferon-alpha (GO:0035455),-0.7352051549184356,-1.2566942908884797,0.18181818181818182,0.4127841839264046,1.0,5/15,16.11%,GAS6;AXL;IFITM2;BST2;IFNAR1
726,prerank,negative regulation of innate immune response (GO:0045824),-0.7485370580335279,-1.2558508437395626,0.1724137931034483,0.4144919402045918,1.0,12/30,15.81%,GRN;SERPING1;TYRO3;SLAMF8;NLRC3;OAS3;ISG15;NLRC5;DHX58;IRAK3;SAMHD1;RPS19
727,prerank,natural killer cell activation (GO:0030101),-0.8131983185748203,-1.2557024377592874,0.09836065573770492,0.41421724505318297,1.0,4/16,6.22%,IL21R;PTPRC;SLAMF7;PIK3CD
728,prerank,epidermal cell differentiation (GO:0009913),-0.7826416995011435,-1.2555523831616933,0.14545454545454545,0.4138407936812763,1.0,7/24,7.51%,SPRR1A;ANXA1;EREG;ST14;BCR;ASAH1;ADAM9
729,prerank,chemokine-mediated signaling pathway (GO:0070098),-0.7565344206997323,-1.2553856255015587,0.20967741935483872,0.4135887700323171,1.0,6/24,6.09%,CCR2;GPR35;PTK2B;CCL5;CXCL10;CX3CL1
730,prerank,cellular response to nutrient levels (GO:0031669),0.5947283821496389,1.2552357958652174,0.10256410256410256,0.6754940521476103,1.0,11/54,8.50%,PDK2;PDK4;LPL;EIF4G1;PPARA;KCNB1;PRKAA2;MAP1LC3A;RRAGD;CLEC16A;WIPI1
731,prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.8280785795428188,-1.2547483294590605,0.19298245614035087,0.4138232274103551,1.0,1/15,0.35%,IL7R
732,prerank,cellular response to interleukin-7 (GO:0098761),-0.8280785795428188,-1.2547483294590605,0.19298245614035087,0.4138232274103551,1.0,1/15,0.35%,IL7R
733,prerank,positive regulation of glial cell differentiation (GO:0045687),-0.8437233079830219,-1.254217165574998,0.11764705882352941,0.4144294792814722,1.0,9/16,11.95%,MDK;PTN;SERPINE2;TNFRSF1B;ID2;CXCR4;BIN1;TGFB1;BMP2
734,prerank,regulation of interleukin-1 beta production (GO:0032651),-0.6813184747797818,-1.2536514378339418,0.125,0.4152983206833459,1.0,12/46,6.54%,TYROBP;MEFV;CLEC7A;CX3CR1;TLR8;SIRPA;IGF1;P2RX7;CASP1;F2R;CX3CL1;TMEM106A
735,prerank,regulation of NMDA receptor activity (GO:2000310),-0.7572464667009806,-1.2536447479268324,0.23076923076923078,0.41455803847178907,1.0,6/18,10.23%,CCR2;PTK2B;GRIA3;DLG4;EPHB2;APP
736,prerank,regulation of MAP kinase activity (GO:0043405),-0.6503822788636163,-1.253522243898986,0.1,0.41416537633057443,1.0,18/73,10.97%,APOE;CD300A;HTR2B;ADAM8;PIK3R5;UCHL1;PIK3CG;GBA;PRKCD;PTPN1;PDGFC;ROBO1;FGFR1;PTPRJ;RGS14;MST1R;TGFB1;PDGFRB
737,prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.7657796856344297,-1.2524991159732173,0.12280701754385964,0.41593211429701393,1.0,4/22,7.59%,CDKN2B;THBS1;SLC2A10;TGFB1I1
738,prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.7657796856344297,-1.2524991159732173,0.12280701754385964,0.41593211429701393,1.0,4/22,7.59%,CDKN2B;THBS1;SLC2A10;TGFB1I1
739,prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.7552739987077567,-1.2523100735083563,0.13559322033898305,0.41555929061444385,1.0,2/29,3.63%,APOE;THBS1
740,prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.7216252374344183,-1.252206472002509,0.22580645161290322,0.4150668851936233,1.0,11/34,18.16%,NUPR1;SLC9A3R1;BID;BOK;BAX;BBC3;RACK1;PMAIP1;GSDME;LCK;BMF
741,prerank,regulation of anoikis (GO:2000209),0.7525833695621472,1.2515854288147843,0.11904761904761904,0.6871438932037606,1.0,1/18,0.22%,PDK4
742,prerank,cortical cytoskeleton organization (GO:0030865),-0.735985685699555,-1.2514642573731507,0.07407407407407407,0.41606467621458953,1.0,7/37,8.99%,PLEK;LCP1;NCKAP1L;RAC2;RHOG;RHOC;RAB13
743,prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.731509798787173,1.251215955716666,0.20754716981132076,0.6848424077944223,1.0,7/20,5.94%,HRC;ANK2;PLN;JPH1;JPH2;PRKACA;CACNB2
744,prerank,heterotypic cell-cell adhesion (GO:0034113),-0.7303804628173368,-1.2501820655936247,0.18518518518518517,0.41878573979196354,1.0,8/22,9.31%,ITGB2;ITGAX;ITGB7;VCAM1;ITGB3;ITGA5;ITGA4;CD200R1
745,prerank,response to insulin (GO:0032868),0.5945888444080474,1.2496508264354595,0.029411764705882353,0.6874618261307502,1.0,6/73,3.89%,RAB12;SLC2A4;LPIN1;GOT1;TBC1D4;GCK
746,prerank,regulation of Notch signaling pathway (GO:0008593),-0.645145286590585,-1.2495381743971208,0.14545454545454545,0.41995388042660675,1.0,7/66,6.52%,MMP14;CCN3;TGFB2;SRC;ARRDC1;NIBAN2;LFNG
747,prerank,regulation of neuron projection development (GO:0010975),-0.6213840021978254,-1.2495205605500577,0.08620689655172414,0.4192571361400192,1.0,21/115,10.12%,APOE;PAK1;PTK2B;DBN1;MDK;PTN;ITM2C;PTK7;TENM3;P3H1;DPYSL3;ROR2;FZD1;CX3CL1;FES;TSKU;PTPRO;RAB29;CAMK1D;ARSB;CFL1
748,prerank,autophagy of nucleus (GO:0044804),0.722209235588231,1.2493823150853698,0.21739130434782608,0.6847377017060409,1.0,6/15,24.07%,WIPI1;ATG9A;ULK1;ULK2;RB1CC1;WIPI2
749,prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.6461931203133082,-1.249297879883721,0.1724137931034483,0.4189623005387027,1.0,18/55,13.81%,CALCA;ADGRE1;GPR65;ADCY7;PTH1R;GPR161;CNR2;CXCL10;ADCY3;GNG2;ADGRD1;S1PR2;LPAR2;ADGRG2;PTGER3;ABCA1;TBXA2R;LGR5
750,prerank,positive regulation of protein binding (GO:0032092),-0.6657635473714029,-1.2492667428700568,0.19672131147540983,0.41826972595222184,1.0,8/54,13.14%,APOE;LRP1;DACT1;APP;BMP2;TIAM1;B2M;STING1
751,prerank,regulation of heart contraction (GO:0008016),0.6623773863312635,1.2486933973466716,0.10714285714285714,0.6832873163338322,1.0,26/68,10.20%,HRC;KCNIP2;HCN4;TNNI3K;ATP2A2;ANK2;PLN;KCNJ11;ASPH;RYR2;ABCC9;CASQ2;RNF207;ATP1A2;KCNJ12;PRKACA;MYH6;TPM1;KCNG2;TRDN;TMEM65;CORIN;FXYD1;S100A1;CAV3;ATP1A1
752,prerank,negative regulation of apoptotic process (GO:0043066),-0.5550015218629618,-1.2483458206197253,0.047619047619047616,0.4204058937414147,1.0,54/350,9.03%,FSTL1;TREM2;COMP;APOE;SFRP1;HCK;NUPR1;PDPN;NCKAP1L;CRLF1;TGFB3;PTK2B;ANXA1;CTSH;MDK;ASNS;KRT18;HTR2B;ADAM8;CX3CR1;SOX9;THBS1;CD44;CLEC5A;GRN;SRC;UNC5B;PRKCD;TXNDC5;IGF1;FLNA;LGMN;SPHK1;CD74;NIBAN2;OSR1;EVI2B;F2R;HCLS1;CX3CL1;ITGA5;BEX3;ARL6IP1;MYC;GAS6;ANXA4;IFIT3;BID;TYRO3;HGF;CDK1;GPX1;PRELID1;PLAUR
753,prerank,negative regulation of interleukin-8 production (GO:0032717),-0.8325966643658389,-1.2475385173671631,0.14035087719298245,0.4220974999567979,1.0,7/15,12.99%,ANXA1;TLR9;SSC5D;TMSB4X;ANXA4;PTPN22;TLR6
754,prerank,gonad development (GO:0008406),-0.7902954213481328,-1.2473461259652532,0.13793103448275862,0.4219187824247049,1.0,3/25,3.75%,BASP1;SOX9;TGFB2
755,prerank,positive regulation of cellular component organization (GO:0051130),-0.6116356363901172,-1.2469925808197677,0.1774193548387097,0.4222158862119245,1.0,18/93,10.59%,TREM2;APOE;LGALS3;TGFB3;CLEC7A;CLU;LRP1;TGFB2;GBA;RUNX1;GPC3;TGFBR1;RHOC;BID;GPX1;ATP10A;SPIDR;TGFB1
756,prerank,digestive tract development (GO:0048565),-0.7774513735312886,-1.246511918053234,0.13333333333333333,0.42292704022735567,1.0,3/23,4.17%,NPY;TGFB2;CLMP
757,prerank,regulation of macromolecule metabolic process (GO:0060255),-0.5963473270237669,-1.246170396377832,0.11666666666666667,0.4235173443824998,1.0,13/120,10.79%,TREM2;APOE;MEFV;PTPRC;AIF1;SIRPA;IGF1;MYC;TSKU;PEG3;APP;CRIP1;AFF3
758,prerank,negative regulation of response to biotic stimulus (GO:0002832),0.7671375995967883,1.2461193485171824,0.14634146341463414,0.6896258778768897,1.0,1/23,0.02%,ILRUN
759,prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.7124502997072428,-1.2457653697034703,0.2545454545454545,0.4239283325184165,1.0,3/18,8.01%,MDK;ITGA4;FGFR1
760,prerank,protein targeting to peroxisome (GO:0006625),0.7186772855811829,1.2448767994599668,0.13725490196078433,0.6905363423477928,1.0,4/28,6.19%,PXMP2;PEX10;ABCD3;PEX19
761,prerank,sensory organ development (GO:0007423),-0.7276978283669431,-1.2447298568844474,0.1206896551724138,0.4265008862796255,1.0,9/30,15.47%,SH3PXD2B;MAFB;TGFB2;MYO7A;SMOC1;FOXC1;MEIS3;SALL2;SMG9
762,prerank,regulation of endothelial cell migration (GO:0010594),-0.6491493441284781,-1.244622130364284,0.06060606060606061,0.4260023612127587,1.0,11/78,6.23%,SPARC;APOE;PTK2B;PTN;THBS1;GRN;PIK3CG;ANXA3;PRCP;PIK3CD;ITGB3
763,prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.7635183558790883,1.2441037437581517,0.23404255319148937,0.6896022270381341,1.0,5/20,6.80%,TECR;GCDH;CBR4;ACSL6;ACSL1
764,prerank,organelle assembly (GO:0070925),0.4857806367347352,1.2440774955847376,0.0,0.6859847216003884,1.0,22/328,8.95%,NUDCD3;ATP2A2;FITM2;FITM1;ABLIM1;TMOD4;LMOD3;KLHL41;LMOD2;DYNLL2;INTU;RILPL1;MAPT;CHMP4C;MYH6;RILP;CSDE1;MAP1LC3A;FARP2;WIPI1;IFT81;TMOD1
765,prerank,Notch signaling pathway (GO:0007219),-0.6678627513960984,-1.2439192142742865,0.16393442622950818,0.4271124137576992,1.0,8/52,12.13%,MDK;SNAI1;MYC;DTX4;DLGAP5;NOTCH2;BMP2;SNAI2
766,prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.788707178506106,-1.2439083068488808,0.20754716981132076,0.42641892700523604,1.0,4/15,4.78%,APOE;CLU;RTN4;IGF1
767,prerank,mitochondrial fission (GO:0000266),0.7532604305202708,1.2437978780975332,0.2826086956521739,0.683054465586103,1.0,8/16,13.60%,MTFP1;OPA1;MTFR1;MTFR1L;SLC25A46;DNM1L;PRKN;MUL1
768,prerank,regulation of cell-matrix adhesion (GO:0001952),-0.656606760025926,-1.242777654975659,0.1206896551724138,0.42930158539928326,1.0,9/49,11.06%,SFRP1;PTK2B;THBS1;PLAU;CX3CL1;ACTG1;CORO1C;THY1;BST1
769,prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.816380370319171,-1.242543714619904,0.2127659574468085,0.4293085623547744,1.0,2/16,3.62%,TMEM119;CCN3
770,prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.7837850362860479,-1.2421360863111373,0.21153846153846154,0.4295295991225235,1.0,5/17,6.77%,TGFB3;CILP;CCN3;TGFBR1;SLC2A10
771,prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.7290849424387497,-1.2420006190651214,0.13432835820895522,0.42918644200428513,1.0,7/35,4.44%,ITGB2;TYROBP;ITGAM;CLEC7A;THBS1;CYBA;PRKCD
772,prerank,positive regulation of interleukin-12 production (GO:0032735),-0.7844303803030797,-1.2417773130227232,0.17857142857142858,0.4290965994357106,1.0,6/22,3.25%,TLR2;MDK;IRF5;CLEC7A;LAPTM5;TLR9
773,prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.6333242946028284,-1.2416431720429804,0.1016949152542373,0.4286972536219133,1.0,20/72,13.81%,MARCO;CALCA;ADGRE1;GPR65;ADCY7;PTH1R;GPR161;CNR2;CXCL10;ADCY3;ADGRD1;S1PR2;LPAR2;ADGRG2;GNAI3;PTGER3;GNA15;ABCA1;TBXA2R;LGR5
774,prerank,RNA methylation (GO:0001510),0.6416965402994977,1.2413402671380782,0.17391304347826086,0.6886222080578276,1.0,14/50,25.15%,NSUN4;TFB1M;TFB2M;MTO1;TRMT10C;TRMT5;MRM2;LCMT2;METTL5;RBM15;CMTR1;METTL16;TARBP1;METTL14
775,prerank,positive regulation of proteolysis (GO:0045862),-0.6789153139836808,-1.241136440205565,0.16176470588235295,0.4294977339790469,1.0,7/44,4.42%,APOE;NKD2;CTSH;TNFRSF1B;RCN3;ADAM8;GBA
776,prerank,nitrogen compound transport (GO:0071705),-0.6247578934344614,-1.2403833546349574,0.1694915254237288,0.43095162020674543,1.0,9/92,7.25%,PDPN;SLC15A3;SLC11A1;RCN3;SLC7A2;SLC7A7;ARRDC1;SLC1A4;SLC25A45
777,prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.7292689260358783,1.240267335667282,0.2391304347826087,0.6890862229341931,1.0,6/20,6.57%,HRC;CASQ2;JPH1;JPH2;PRKACA;TRDN
778,prerank,carboxylic acid transmembrane transport (GO:1905039),0.6796254796431483,1.240228459861343,0.15151515151515152,0.6856334702101897,1.0,3/26,2.84%,SLC25A11;SLC16A1;SLC38A3
779,prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.7205901517494034,-1.2400829264319615,0.15384615384615385,0.43107131682054584,1.0,13/28,19.47%,THBS1;FBLN1;CX3CL1;CORO1C;PTPRO;RCC2;FZD7;EFNA5;JAG1;TBCD;ACTN4;GCNT2;ADAM15
780,prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.6720122344471721,-1.2399631503581177,0.15625,0.43082519396485486,1.0,17/51,18.68%,NUPR1;TGFBR1;SLC9A3R1;BID;BOK;BAX;PYCARD;RIPK1;BBC3;RACK1;PMAIP1;GSDME;LCK;FAS;BMF;TNFSF12;PML
781,prerank,keratinocyte differentiation (GO:0030216),-0.7894313744186484,-1.2384223736781017,0.2631578947368421,0.4340551054537714,1.0,7/18,7.51%,SPRR1A;ANXA1;EREG;ST14;BCR;ASAH1;ADAM9
782,prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.6919235862061717,-1.2382936580605888,0.1076923076923077,0.4337472918442496,1.0,13/57,11.95%,ADAMTS12;SULF1;FSTL3;THBS1;EMILIN1;NIBAN2;SULF2;PTPN1;HHEX;BMPER;CHRD;NBL1;BMP2
783,prerank,regulation of fat cell differentiation (GO:0045598),-0.6655340556813654,-1.2382114536429458,0.16129032258064516,0.43330656195531203,1.0,5/65,4.47%,FRZB;SFRP2;SFRP1;ENPP1;ID2
784,prerank,cytoplasmic translational initiation (GO:0002183),0.7805354649652114,1.2378795650117909,0.17647058823529413,0.6907185359013954,1.0,1/17,3.04%,EIF4G1
785,prerank,regulation of intracellular signal transduction (GO:1902531),-0.5308293403036634,-1.237187124256225,0.041666666666666664,0.43525525212794364,1.0,39/358,9.18%,TREM2;VAV1;ARHGAP45;FGD3;PAK1;TAGAP;ARHGAP30;RCN3;CLEC7A;ARHGAP22;RASSF2;GBA;ARHGAP19;ARAP1;SRGAP3;ARHGAP11A;RAC2;ARHGAP15;BCR;ARHGDIB;TMSB4X;ARHGAP25;RACGAP1;ARHGAP4;PIP4K2A;CASTOR1;ATP6AP2;PREX1;MYO9B;RHOG;ARHGAP9;RHOC;TRAF1;TPX2;CDK1;RHOU;EHMT2;FAM83D;GMIP
786,prerank,vesicle coating (GO:0006901),-0.6843445060474459,-1.2365003027150652,0.15384615384615385,0.43492275486393,1.0,4/53,10.32%,CTSZ;SEC16B;COL7A1;CTSC
787,prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.6843445060474459,-1.2365003027150652,0.15384615384615385,0.43492275486393,1.0,4/53,10.32%,CTSZ;SEC16B;COL7A1;CTSC
788,prerank,COPII vesicle coating (GO:0048208),-0.6843445060474459,-1.2365003027150652,0.15384615384615385,0.43492275486393,1.0,4/53,10.32%,CTSZ;SEC16B;COL7A1;CTSC
789,prerank,chordate embryonic development (GO:0043009),-0.6651606498225363,-1.2363229287365471,0.22807017543859648,0.43478735822457365,1.0,12/34,11.95%,COL1A1;TGFB3;SULF1;DACT1;SULF2;TGFBR1;XYLT1;FGFR1;TGFB1;WNT11;FGFR2;BMP2
790,prerank,regulation of cellular pH (GO:0030641),0.7171120689818691,1.23626948166294,0.3023255813953488,0.6936885305534767,1.0,2/17,1.80%,SLC9A2;SLC4A3
791,prerank,negative regulation of growth (GO:0045926),-0.6036508463284992,-1.2362649793204248,0.10606060606060606,0.43419773425700925,1.0,16/97,11.43%,FRZB;SFRP2;SFRP1;ENPP1;RTN4;CCN3;TGFB2;CDA;DACT3;PTPRJ;SLIT3;INHBA;TGFB1;BTG1;NOTCH2;WNT11
792,prerank,positive regulation of interleukin-6 production (GO:0032755),-0.6648345752972067,-1.2361359935556673,0.22388059701492538,0.4339505082688481,1.0,16/51,7.42%,TYROBP;EREG;TLR2;CLEC7A;TLR1;TLR9;AIF1;TLR8;CYBA;CD74;IL33;F2R;TLR7;TMEM106A;TWIST1;RAB7B
793,prerank,protein ADP-ribosylation (GO:0006471),0.6831075120325625,1.2358448067467955,0.2,0.6915214752927301,1.0,4/28,6.36%,ART3;SIRT3;SIRT5;ART1
794,prerank,modulation by host of symbiont process (GO:0051851),-0.7775031358588277,-1.2357472712708824,0.23076923076923078,0.4340817439076619,1.0,2/23,4.91%,CX3CR1;CCL5
795,prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.6384974380248148,-1.2353388715307907,0.1935483870967742,0.43464611732341213,1.0,10/65,6.28%,HCK;PLEK;NCKAP1L;PTK2B;CARMIL1;P2RX7;HCLS1;CX3CL1;FES;CDC42EP5
796,prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.791516837995845,-1.2353011173388628,0.24528301886792453,0.4340606183340184,1.0,4/16,10.59%,IGF1;NIBAN2;TWIST1;TGFB1
797,prerank,regulation of intracellular protein transport (GO:0033157),-0.7491834774846928,-1.2345910448996726,0.16417910447761194,0.4353747201190856,1.0,8/30,13.55%,LCP1;ATP13A2;PTPN1;RAB29;TGFB1;KIF20B;PRR5L;SIRT7
798,prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.6895110761371112,-1.2333990613204158,0.2631578947368421,0.4380350698169977,1.0,6/27,12.13%,SNAI1;CD44;CD74;TWIST1;SPRED3;SNAI2
799,prerank,response to lipid (GO:0033993),-0.6467504132081193,-1.2329016593109536,0.12903225806451613,0.43875778895893863,1.0,9/77,8.08%,SPP1;GPX3;ANXA1;CTSH;SLC11A1;SOX9;F2R;ABCG1;TNFRSF11A
800,prerank,negative regulation of developmental growth (GO:0048640),-0.7338294756175388,-1.2325878787082065,0.23214285714285715,0.43863679945760686,1.0,3/23,5.42%,GDF15;RTN4;NKD1
801,prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.6511385558341651,-1.2318966028627194,0.14516129032258066,0.43971081873744683,1.0,20/84,11.95%,ASPN;CILP;ADAMTSL2;FST;FSTL3;VASN;CD109;CCN3;EMILIN1;TGFBR1;PMEPA1;SLC2A10;TGFB1I1;SPRED3;BMPER;TGFB1;CHRD;HTRA4;NBL1;BMP2
802,prerank,cellular response to chemokine (GO:1990869),-0.7410700181245242,-1.231405473698301,0.125,0.44033408036464033,1.0,6/29,6.09%,CCR2;GPR35;PTK2B;CCL5;CXCL10;CX3CL1
803,prerank,negative regulation of interferon-gamma production (GO:0032689),-0.7906713775167181,-1.2309950030369952,0.18032786885245902,0.44076925926979027,1.0,7/16,12.05%,HAVCR2;LAPTM5;VSIR;GAS6;NR1H4;INHBA;AXL
804,prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.7758456567354854,-1.2307666040995597,0.1935483870967742,0.44077580432455843,1.0,6/18,12.13%,SNAI1;TGFB2;OLFM1;TGFBR1;BMP2;SNAI2
805,prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.7846898336393318,-1.2300785623903128,0.2,0.4419506265787539,1.0,4/15,12.85%,SRC;SPI1;CEBPA;SOCS3
806,prerank,lytic vacuole organization (GO:0080171),-0.6668523610529378,-1.2284435331072598,0.10714285714285714,0.44589878184571946,1.0,9/29,13.89%,GRN;GBA;TPCN2;HPS1;MYO7A;ARSB;CLN3;ABCA1;ACP2
807,prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.7382720002198343,-1.228264711197076,0.19047619047619047,0.44561971679387863,1.0,4/36,4.29%,PTK2B;EREG;SOX9;SRC
808,prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.6051926030469867,-1.228256628046137,0.08771929824561403,0.4449171036899012,1.0,16/133,9.59%,SFRP2;COL1A1;CDH3;SFRP1;TLR2;SULF1;ADGRA2;PTK7;DACT1;SULF2;GPC3;ATP6AP2;PLEKHA4;HHEX;ILK;LRRK1
809,prerank,cellular response to amyloid-beta (GO:1904646),-0.7251578974824722,-1.2281742603487613,0.18333333333333332,0.44447470494086655,1.0,10/27,10.23%,TREM2;FCGR2B;LRP1;ATP1A3;IGF1;LGMN;VCAM1;ITGA4;ICAM1;APP
810,prerank,negative regulation of cell differentiation (GO:0045596),-0.5945465875564129,-1.2281393538416898,0.13513513513513514,0.4439049692043276,1.0,17/138,7.81%,COL5A2;SFRP2;SFRP1;COL5A1;PTK2B;ADAMTS12;VASN;ENPP1;SOX9;ID2;OSR1;ITGB3;TGFBR1;TWIST1;ABCG1;E2F1;TSKU
811,prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.7905832593268738,-1.228012759294228,0.19642857142857142,0.44350235559064766,1.0,6/16,11.10%,HCK;CD14;CCL5;IL18;TGFB1;PTPN22
812,prerank,ruffle organization (GO:0031529),-0.7869087861353874,-1.22772649950935,0.2413793103448276,0.4436877796303022,1.0,4/15,4.98%,PLEK;CSF1R;AIF1;CARMIL1
813,prerank,cardiac muscle cell differentiation (GO:0055007),0.7537469197554951,1.2275947240506375,0.23684210526315788,0.7208107192224853,1.0,11/22,12.50%,TTN;VEGFA;MYH6;TCAP;ALPK2;IRX3;LRRC10;SIK1;NKX2-5;MYOCD;ALPK3
814,prerank,negative regulation of lipid storage (GO:0010888),-0.7930498310244891,-1.2272996482386629,0.24074074074074073,0.44414720275496167,1.0,3/16,7.35%,TREM2;ITGB3;ABCG1
815,prerank,branched-chain amino acid metabolic process (GO:0009081),0.734657278274262,1.2270148065512168,0.25,0.7157283577014584,1.0,17/20,11.55%,DLD;IVD;ACAT1;HIBADH;BCKDHA;ECHS1;AUH;DBT;HIBCH;BCKDHB;MCCC1;HSD17B10;MCCC2;BCKDK;ALDH6A1;ACADSB;ACAD8
816,prerank,branched-chain amino acid catabolic process (GO:0009083),0.734657278274262,1.2270148065512168,0.25,0.7157283577014584,1.0,17/20,11.55%,DLD;IVD;ACAT1;HIBADH;BCKDHA;ECHS1;AUH;DBT;HIBCH;BCKDHB;MCCC1;HSD17B10;MCCC2;BCKDK;ALDH6A1;ACADSB;ACAD8
817,prerank,macroautophagy (GO:0016236),0.56197962779475,1.2267506783565323,0.1111111111111111,0.7132877623539089,1.0,11/110,8.81%,ILRUN;PINK1;MFN2;VDAC1;DYNLL2;CHMP4C;PRKAA2;MAP1LC3A;WIPI1;TOMM5;MFN1
818,prerank,protein import into peroxisome membrane (GO:0045046),0.7340465533467497,1.2265035099687913,0.25,0.7104642270525432,1.0,3/21,6.19%,PXMP2;ABCD3;PEX19
819,prerank,keratan sulfate biosynthetic process (GO:0018146),-0.7765277077316258,-1.2262803137093683,0.20754716981132076,0.44632318693109374,1.0,10/23,13.12%,FMOD;ACAN;LUM;B4GALT2;PRELP;SLC35D2;CHST2;OMD;OGN;CHST1
820,prerank,positive regulation of cholesterol transport (GO:0032376),-0.8037288983800953,-1.2259647907610796,0.23636363636363636,0.4466674369921292,1.0,3/23,3.24%,TREM2;APOE;LRP1
821,prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.63887926555388,-1.225856374525043,0.12903225806451613,0.44619075201445135,1.0,31/96,14.31%,HCK;PTK2B;NPPA;LCP2;FGR;PTN;BLNK;CSF1R;SRC;PTPRF;SHC2;SLA;ROR2;FES;BDKRB2;FGFR1;TYRO3;MST1R;EPHB2;MET;MERTK;PDGFRB;STAP1;FGFR2;AXL;EPHB6;FRK;SYK;LYN;NEDD9;DDR1
822,prerank,regulation of interleukin-17 production (GO:0032660),-0.7606221651213845,-1.2256392652899368,0.2413793103448276,0.446042998621463,1.0,7/17,10.59%,LY9;NCKAP1L;SPHK1;IL18;VSIR;NR1H4;TGFB1
823,prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.7687287517795862,-1.22553650087389,0.17543859649122806,0.4455688260774254,1.0,2/20,10.14%,PTPRC;THY1
824,prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.6990674593143494,-1.2234492142211724,0.21818181818181817,0.4505719246667886,1.0,13/39,15.11%,PDPN;MDK;FBLN1;FLNA;CARMIL1;CORO1C;P4HB;ILK;RCC2;S100A10;NEDD9;EFNA5;CDC42
825,prerank,regulation of cation transmembrane transport (GO:1904062),0.7813485702427697,1.2234187468974915,0.2631578947368421,0.7195179495307792,1.0,5/18,8.07%,HRC;KCNIP2;RANGRF;WNK1;KCNN2
826,prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.7137654488913,-1.223360357637614,0.2033898305084746,0.450092068660914,1.0,7/23,11.51%,CEMIP;P2RY6;F2R;CXCL10;CX3CL1;THY1;CALM2
827,prerank,cytosolic calcium ion transport (GO:0060401),0.6981208974795853,1.2229315646120993,0.1956521739130435,0.7181852492976224,1.0,8/22,10.42%,ATP2A2;RYR2;JPH1;JPH2;ADRA1A;AFG3L2;CACNA2D1;MCUR1
828,prerank,regulation of mRNA stability (GO:0043488),-0.5758688771801795,-1.2219971917649854,0.14754098360655737,0.4529032375132535,1.0,9/135,8.88%,PABPC1;VIM;SLC11A1;TENT5B;PRKCD;TENT5C;TENT5A;E2F1;CARHSP1
829,prerank,cellular response to acid chemical (GO:0071229),0.7239348519169003,1.2218156540692553,0.18604651162790697,0.7182718775881701,1.0,3/22,7.51%,CPEB3;VEGFA;RRAGD
830,prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.729286799825989,-1.2214310149813254,0.2,0.45379267677302515,1.0,6/22,6.27%,ID2;RUNX1;CD74;EVI2B;HCLS1;FES
831,prerank,rRNA methylation (GO:0031167),0.736222625479982,1.2214009751576362,0.15,0.7160794230789836,1.0,4/21,10.83%,MRM3;NSUN4;TFB1M;TFB2M
832,prerank,cellular response to virus (GO:0098586),-0.7300396039061248,-1.2209311111561347,0.23636363636363636,0.45442706652565446,1.0,7/24,20.28%,CCL5;CXCL10;POU2F2;BAX;GSDME;FMR1;CCL19
833,prerank,regulation of JUN kinase activity (GO:0043506),-0.7037308663286161,-1.220807843903495,0.2037037037037037,0.4540700780464604,1.0,7/29,14.37%,PAK1;NPPA;TLR9;TNFRSF11A;PTPN22;TLR6;EDN1
834,prerank,peroxisomal membrane transport (GO:0015919),0.7231278714832062,1.2200803801440967,0.16666666666666666,0.7171699126816973,1.0,4/26,6.19%,PXMP2;PEX10;ABCD3;PEX19
835,prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.7209767302531795,-1.2199678388715551,0.17857142857142858,0.4554922880113699,1.0,6/26,7.41%,APOE;NPPA;HTR2B;SOX9;CAP1;MAPK7
836,prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.7272653084639988,-1.2196204195816345,0.2,0.4555292535624603,1.0,8/33,16.13%,TREM2;TRIM59;NLRC3;NR1H4;PYCARD;RIPK1;CASP8;RHOH
837,prerank,negative regulation of cell junction assembly (GO:1901889),-0.7814277977956694,-1.2192597922755715,0.21153846153846154,0.45599579794205597,1.0,6/22,13.19%,TLR2;THBS1;SRC;CORO1C;RCC2;PHLDB2
838,prerank,intracellular protein transport (GO:0006886),-0.5270406157947091,-1.2191914925657263,0.12903225806451613,0.4554419540061319,1.0,22/273,10.59%,CTSA;LTBP2;MMP12;RAB31;RAB32;ARL11;LAPTM5;UNC93B1;ARL4C;TMED3;STXBP2;CD74;TICAM2;MYO1C;RAB29;ARFGAP3;ARL5C;ARF4;TBC1D9;HOMER3;LAMP2;TGFB1
839,prerank,regulation of myelination (GO:0031641),-0.772647359782388,-1.2189023438844149,0.22413793103448276,0.4554609768636639,1.0,5/18,7.28%,ITGAX;PTN;TNFRSF1B;TMEM98;MYRF
840,prerank,protein targeting to lysosome (GO:0006622),-0.7695979858408221,-1.2185666439827851,0.22916666666666666,0.45569378062231297,1.0,3/19,10.55%,CLU;LAPTM5;LAMP2
841,prerank,regulation of GTPase activity (GO:0043087),-0.5641596160917384,-1.2185250282490256,0.11267605633802817,0.4551429999455581,1.0,25/149,11.96%,VAV1;SFRP1;FGD3;RGS10;CCL5;ARAP1;ARHGAP11A;F2R;RGS16;ARHGAP15;CX3CL1;PLXNC1;ARHGAP9;DOCK10;RASA4;ADAP1;SH3BP1;CCL8;GMIP;THY1;KLRK1;WNT11;DOCK11;FGD2;RCC2
842,prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.7304478337319229,-1.2177161829431404,0.19607843137254902,0.45621047832055855,1.0,12/29,19.28%,CD300LF;CD14;IKBKE;TICAM2;TLR6;RIPK1;CASP8;IRF7;IKBKB;LY96;RPS27A;CD40
843,prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.7304478337319229,-1.2177161829431404,0.19607843137254902,0.45621047832055855,1.0,12/29,19.28%,CD300LF;CD14;IKBKE;TICAM2;TLR6;RIPK1;CASP8;IRF7;IKBKB;LY96;RPS27A;CD40
844,prerank,aminoglycan biosynthetic process (GO:0006023),-0.7003724173093147,-1.2170360827385054,0.1694915254237288,0.45718446478419744,1.0,17/36,13.92%,HS6ST2;B3GNT8;HEXA;SDC1;GPC3;B3GNT9;SDC3;XYLT1;B3GALNT1;SLC35D2;SDC2;GPC6;EXT1;HSPG2;XYLT2;UGDH;B3GALT1
845,prerank,negative regulation of cellular protein localization (GO:1903828),0.6887243085412222,1.2167393587666586,0.12,0.7264412124270193,1.0,2/33,4.16%,ILRUN;MAPT
846,prerank,positive regulation of MAPK cascade (GO:0043410),-0.5659010566489245,-1.2167299223309576,0.12698412698412698,0.45732438234223727,1.0,46/165,12.06%,TREM2;GPNMB;APOE;MARCO;CCN2;P2RY6;PTPRC;PTK2B;GDF15;CSF1R;HTR2B;ADAM8;LAPTM5;TLR9;ARRB2;CD44;TGFB2;PIK3R5;PIK3CG;IGF1;CCL5;C5AR1;CD74;ROR2;F2R;CX3CL1;TMEM106A;GLIPR2;PDGFC;ROBO1;FGFR1;GAS6;PTPRJ;CCL8;ICAM1;MST1R;BMPER;APP;TGFB1;NPNT;PDGFRB;PTPN22;NOTCH2;FGFR2;BMP2;PLCG2
847,prerank,regulation of platelet aggregation (GO:0090330),-0.7710445844978959,-1.21631502271782,0.20967741935483872,0.45765806641541346,1.0,4/15,7.01%,PDPN;SERPINE2;PRKCD;CD9
848,prerank,regulation of stem cell population maintenance (GO:2000036),-0.8076559880781287,-1.2162982996650813,0.3050847457627119,0.45696833960261657,1.0,3/15,7.69%,LOXL2;PTN;MYC
849,prerank,positive regulation of biosynthetic process (GO:0009891),-0.7117554131302213,-1.2159228240874524,0.14516129032258066,0.4571607430065129,1.0,7/31,5.83%,APOE;VIM;TGFB3;CYBA;CCL5;RUNX1;F2R
850,prerank,cellular response to alcohol (GO:0097306),-0.6694056134061619,-1.2154852104464657,0.22807017543859648,0.4578621678753264,1.0,7/31,11.86%,SFRP1;ADCY7;ADCY3;GNG2;SMO;SPIDR;MAP4K1
851,prerank,mRNA modification (GO:0016556),0.6927039010552966,1.215172816286204,0.22641509433962265,0.7280212075555796,1.0,8/20,25.98%,TRMT10C;DKC1;PUS1;TRUB2;CMTR1;METTL16;METTL14;PUS3
852,prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.6375266858592757,-1.2146058096623207,0.16176470588235295,0.45938609062328833,1.0,17/67,18.41%,TGFB3;ANLN;P2RX7;ARAP1;DPYSL3;RAC2;CDC42EP5;ARPC2;DOCK11;ACTR3;CDC42;P2RY12;KCTD17;GPM6A;ACTR2;CCR7;AGRN
853,prerank,positive regulation of RNA splicing (GO:0033120),0.6453826898611427,1.2138854677240345,0.24528301886792453,0.7295073425146019,1.0,2/28,2.34%,RBM20;PRDX6
854,prerank,positive regulation of GTPase activity (GO:0043547),-0.5410211977070862,-1.2134629047007217,0.11428571428571428,0.46134330464298584,1.0,22/156,10.14%,SFRP1;ARHGAP45;RGS10;GPR65;ARHGAP22;CCL5;ARAP1;ARHGAP11A;F2R;RGS16;BCR;CX3CL1;ARHGAP25;RHOG;CORO1C;DOCK10;DOCK7;SH3BP1;CCL8;GMIP;TBC1D9;THY1
855,prerank,heme biosynthetic process (GO:0006783),0.6926485394042213,1.2120983080613794,0.22,0.7321098006582436,1.0,11/20,13.92%,COX10;FECH;ALAS1;ABCB10;ALAD;UROS;COX15;FXN;CPOX;NFE2L1;ABCB6
856,prerank,action potential (GO:0001508),0.6359559285263431,1.2118935403327786,0.1794871794871795,0.7293319610593503,1.0,9/25,12.51%,SCN4A;SLC4A3;KCND2;KCNB1;KCNJ2;MYH14;KCNQ1;AKAP6;KCNH2
857,prerank,regulation of cell-cell adhesion (GO:0022407),-0.7395423526984704,-1.211741408942694,0.13333333333333333,0.46528860897717017,1.0,7/31,4.58%,ADA;FSTL3;ADAM8;FERMT3;MEGF10;SRC;TENM3
858,prerank,regulation of sodium ion transport (GO:0002028),0.7017429720890506,1.2116580508078778,0.2391304347826087,0.7266968118261126,1.0,13/27,15.51%,WNK2;SCN4B;RANGRF;WNK1;GPD1L;ATP1A1;SIK1;NKX2-5;SNTA1;SLMAP;NKAIN1;ANK3;PKP2
859,prerank,regulation of nervous system development (GO:0051960),-0.7549642838500673,-1.2115262960978368,0.1864406779661017,0.4652397490926134,1.0,5/27,8.68%,PTN;TNFRSF1B;CX3CR1;CX3CL1;DOCK7
860,prerank,regulation of interleukin-10 production (GO:0032653),-0.7279960116207549,-1.2114932898954882,0.17857142857142858,0.4645806890108318,1.0,5/25,6.76%,TYROBP;FCGR2B;CLEC7A;TLR9;VSIR
861,prerank,T cell receptor signaling pathway (GO:0050852),-0.5826411550352741,-1.2102275289194706,0.1875,0.4672319092984725,1.0,18/111,14.53%,PAK1;PTPRC;LCP2;CD276;WAS;PIK3CD;CARD11;THEMIS2;GRAP2;PTPRJ;THY1;PAG1;PTPN22;INPP5D;PLCG2;PAK3;NFKBIZ;CSK
862,prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.7066863609220151,-1.2099973840282428,0.19148936170212766,0.467215081298678,1.0,2/20,1.63%,CCR2;PTK2B
863,prerank,regulation of carbohydrate catabolic process (GO:0043470),0.6459611813806213,1.208968968068129,0.24390243902439024,0.7332336863119735,1.0,3/38,18.08%,GCK;PRKAG1;NDC1
864,prerank,endothelial cell proliferation (GO:0001935),-0.819839000197935,-1.208276467237192,0.22641509433962265,0.47152067867395436,1.0,2/15,3.26%,LOXL2;HMOX1
865,prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.7313151955416677,-1.2081184038470534,0.21428571428571427,0.47122006312104553,1.0,3/19,4.78%,MMP2;P2RY6;IGF1
866,prerank,protein homooligomerization (GO:0051260),0.5624693488930801,1.2077067697698884,0.14285714285714285,0.7339326238802139,1.0,13/80,8.01%,ACACB;SOD2;CBR4;ACOT13;TRIM72;SHMT1;APIP;KCNJ12;POLQ;CLYBL;KCNJ2;ALAD;HSD17B10
867,prerank,negative regulation of mitochondrion organization (GO:0010823),0.6820490774171327,1.2075921229714601,0.14893617021276595,0.7308183610124181,1.0,9/29,6.60%,ACAA2;PPIF;TFRC;PINK1;MAPT;OPA1;ADCK1;GHITM;OMA1
868,prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.558752396496768,-1.2074216773245625,0.15789473684210525,0.4723048598806896,1.0,16/121,8.08%,TLR2;ADAM8;CLEC7A;CX3CR1;CLU;TLR9;BTK;SPHK1;IL18;PRKCB;CX3CL1;CARD11;IL18RAP;RAB7B;TRAF1;TNFRSF11A
869,prerank,regulation of organelle assembly (GO:1902115),-0.6087796324955441,-1.2069206827366972,0.21311475409836064,0.4726778882259573,1.0,1/65,0.66%,HCK
870,prerank,response to calcium ion (GO:0051592),0.5877579733683045,1.2065639633584537,0.14285714285714285,0.7312948104156216,1.0,15/64,10.13%,KCNIP2;PPIF;SYT7;TTN;SLC25A13;SLC25A12;RYR2;CASQ2;CLIC4;ADCY1;SMPD1;PRKAA2;D2HGDH;ITPKB;HOMER1
871,prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.6891134283076945,1.205624010520921,0.25,0.7313897017034973,1.0,2/23,3.04%,FXR1;EIF4G1
872,prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.7212733427555157,1.2048031147333118,0.27906976744186046,0.7316338192171074,1.0,5/17,11.34%,TECR;ACSL6;ACSL1;DGAT2;ACSF3
873,prerank,response to steroid hormone (GO:0048545),-0.7505855572458402,-1.2042244479825,0.22413793103448276,0.4787435702174184,1.0,4/22,3.75%,TGFB3;THBS1;ATP1A3;TGFB2
874,prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.7699793562860394,-1.203936686717499,0.2807017543859649,0.47884732810186315,1.0,7/15,11.95%,PDPN;EMILIN1;EFEMP2;RUNX1;TGFB1;COLGALT1;BMP2
875,prerank,regulation of exosomal secretion (GO:1903541),-0.7401480012250492,-1.2038651863870378,0.19298245614035087,0.47836591050216454,1.0,2/17,5.68%,SDC1;ATP13A2
876,prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.7187133081040096,-1.2033821675771548,0.2542372881355932,0.4787962673265599,1.0,2/25,2.14%,IFI30;FCER1G
877,prerank,multivesicular body assembly (GO:0036258),0.6995957892050837,1.20224352779699,0.21052631578947367,0.7368437286598118,1.0,1/28,4.44%,CHMP4C
878,prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.7317201493248382,-1.2018271751713328,0.25,0.48176354509780384,1.0,7/25,2.89%,PLD4;SFRP1;PLEK;PTPRC;FST;FSTL3;CSF1R
879,prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.6775272159151187,1.2015891679817987,0.2571428571428571,0.7356101800971818,1.0,8/22,20.73%,EPHA4;ALAD;CSNK2A1;PDCL3;HSP90AB1;HIPK2;GABARAPL2;SGTA
880,prerank,cellular response to interleukin-6 (GO:0071354),-0.7164248767570385,-1.201570553304727,0.2857142857142857,0.48184502096279824,1.0,8/23,12.85%,PTGIS;SELPLG;SRC;SPI1;CEBPA;SBNO2;PID1;SOCS3
881,prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.7399192447184815,-1.2013572683590377,0.16923076923076924,0.48170396970231166,1.0,5/25,6.89%,ENPP1;PRKCD;PRKCB;PTPN1;PIP4K2A
882,prerank,regulation of cell cycle process (GO:0010564),-0.6210239014276179,-1.2011409547779994,0.16666666666666666,0.4816145599959097,1.0,20/82,17.21%,SFRP1;SOX9;CDKN2B;MKI67;RACGAP1;DBF4;KNSTRN;PRC1;KIF11;CALM2;AURKB;KIF20B;AURKA;PLK2;CDC42;SPAG5;PLK3;BUB1;KIF20A;CEP250
883,prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.75727721998085,-1.2007959534907067,0.24561403508771928,0.48181522612586325,1.0,2/17,7.35%,APOE;ABCG1
884,prerank,lung development (GO:0030324),-0.7544630504515557,-1.199040365131744,0.24074074074074073,0.4854197166959757,1.0,4/21,2.97%,LOXL3;PDPN;TCF21;RCN3
885,prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.6873828324294167,1.198547906638628,0.27906976744186046,0.7440101503301357,1.0,3/29,4.80%,PINK1;DCUN1D2;FBXW7
886,prerank,positive regulation of chemokine production (GO:0032722),-0.6778472444403977,-1.1977474046419792,0.1875,0.48816362618124187,1.0,13/33,10.23%,TLR2;CSF1R;CLEC7A;TLR9;HMOX1;AIF1;IL18;CD74;IL33;TLR7;TWIST1;OAS3;APP
887,prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.6381559610224289,-1.1972678341090384,0.2153846153846154,0.48855730831990807,1.0,8/62,13.83%,ENPP1;RNASE6;RNASE4;ISG20;DNASE1L1;POLD4;DNA2;RFC2
888,prerank,positive regulation of filopodium assembly (GO:0051491),-0.7457266022749324,-1.1969480746772556,0.2222222222222222,0.48867868070991044,1.0,9/20,19.16%,TGFB3;ARAP1;DPYSL3;DOCK11;CDC42;GPM6A;CCR7;AGRN;FMR1
889,prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.677259617984221,-1.196419973451223,0.2545454545454545,0.48930732581696773,1.0,11/42,11.82%,THBS1;CD44;SRC;BEX3;ARL6IP1;GAS6;HGF;GPX1;PLAUR;RPS6KA1;SFN
890,prerank,regulation of epidermal cell differentiation (GO:0045604),-0.7494651559071552,-1.1956955538889393,0.2222222222222222,0.4906437414251966,1.0,7/18,17.51%,CTSK;RUNX1;SFN;CTSL;SFRP4;MAFF;CBFB
891,prerank,response to unfolded protein (GO:0006986),0.6002242669258148,1.1955691696511122,0.23404255319148937,0.7507855255798317,1.0,15/47,15.76%,HSPD1;HSPA9;OPTN;DNAJB5;BAG3;HERPUD1;HSPB8;HSPA5;DNAJB2;HSPA4L;PRKN;HSPB3;HSPB7;HSPA8;HSPH1
892,prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.7489110049297343,-1.1951218972643167,0.32786885245901637,0.491740008674375,1.0,6/16,7.40%,HPSE;SULF1;HS6ST2;SGSH;SULF2;XYLT1
893,prerank,negative regulation of cell growth (GO:0030308),-0.5962177215504019,-1.1950814443358162,0.16129032258064516,0.4910978876758591,1.0,7/103,3.75%,FRZB;SFRP2;SFRP1;ENPP1;RTN4;CCN3;TGFB2
894,prerank,histone lysine methylation (GO:0034968),0.6592396272858914,1.194141709984783,0.175,0.7532085220051067,1.0,1/28,1.62%,SMYD1
895,prerank,positive regulation of endothelial cell migration (GO:0010595),-0.6256887812102446,-1.1940166190607584,0.28125,0.49306495711252163,1.0,16/77,10.68%,SPARC;PTK2B;THBS1;GRN;PIK3CG;P2RX4;ANXA3;LGMN;TMSB4X;PIK3CD;ITGB3;FGFR1;ATOH8;FOXC2;TGFB1;MET
896,prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.6802689525282305,-1.1935450101094427,0.2222222222222222,0.4939848499835069,1.0,3/48,0.82%,TREM2;APOE;NUPR1
897,prerank,response to light stimulus (GO:0009416),0.62806571545301,1.1929344741118528,0.19047619047619047,0.7529813109934823,1.0,4/36,9.99%,CPT1B;FECH;UBE2B;CRY1
898,prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.681598961265101,-1.192346255644142,0.26666666666666666,0.4968811087390305,1.0,10/35,11.82%,THBS1;CD44;SRC;BEX3;ARL6IP1;GAS6;HGF;GPX1;RPS6KA1;SFN
899,prerank,cellular response to lipid (GO:0071396),-0.5703495585038568,-1.1922293373599377,0.1323529411764706,0.4964696703299876,1.0,23/137,8.37%,SPP1;SFRP1;SERPINE1;CD68;VIM;PTK2B;CD180;TNFRSF1B;CX3CR1;SOX9;PTK7;ATP1A3;SIRPA;CD14;CCR5;CASP1;CXCL10;ADCY3;FES;TICAM2;ADAM9;CD80;SBNO2
900,prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.5820232697366682,-1.1921640810447214,0.13114754098360656,0.49589221240695597,1.0,13/119,9.59%,SFRP2;COL1A1;CDH3;SFRP1;ADGRA2;PTK7;DACT1;GPC3;ATP6AP2;PLEKHA4;HHEX;ILK;LRRK1
901,prerank,superoxide metabolic process (GO:0006801),-0.7260312312837212,-1.190919840226545,0.25396825396825395,0.49832210770836916,1.0,9/21,7.37%,NOX4;SH3PXD2B;NCF1;CYBB;CYBA;NCF4;NCF2;SOD3;PREX1
902,prerank,negative regulation of endothelial cell migration (GO:0010596),-0.6944718152122804,-1.1906901773452006,0.21311475409836064,0.49832720991285484,1.0,2/30,3.63%,APOE;THBS1
903,prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.7159260557608714,1.1902245343905467,0.25,0.7590058185013342,1.0,9/20,13.24%,PHB;PMPCB;PMPCA;SPG7;AFG3L2;LETM1;MCUR1;PHB2;STOML2
904,prerank,ERBB signaling pathway (GO:0038127),-0.6492386345507665,-1.189866908381462,0.2222222222222222,0.49979744179141966,1.0,5/51,5.62%,PTK2B;EREG;SOX9;SRC;PTPN18
905,prerank,protein transport (GO:0015031),-0.5331132047498613,-1.1895749602563763,0.1095890410958904,0.4998003784878995,1.0,32/292,9.76%,IL10RA;CTSA;APOE;LTBP2;TCIRG1;RAB31;RAB32;RCN3;ARL11;CLU;LAPTM5;LRP1;UNC93B1;ARRDC1;RAB15;ARL4C;TMED3;ATP6V0D2;STXBP2;CD74;RAB34;PRKCB;RAB8B;TICAM2;ABCG1;ATP6V0A4;RAB29;ARFGAP3;RAB13;ARL5C;ARF4;TBC1D9
906,prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.7802022103767319,-1.1894783817916659,0.24528301886792453,0.49848008457992105,1.0,5/16,13.19%,THBS1;SRC;CORO1C;RCC2;PHLDB2
907,prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.7802022103767319,-1.1894783817916659,0.24528301886792453,0.49848008457992105,1.0,5/16,13.19%,THBS1;SRC;CORO1C;RCC2;PHLDB2
908,prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.7118127581417922,1.188965600262455,0.26666666666666666,0.7602736043061264,1.0,8/21,17.60%,ANK2;CASQ2;CAV3;ACTN2;CAB39;STK39;YWHAE;NEDD4L
909,prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.6190241698845853,1.1889315666279996,0.2558139534883721,0.7569569719736347,1.0,8/31,20.27%,RRN3;POLR1A;TAF1A;CCNH;POLR2E;POLR1E;POLR2L;POLR2F
910,prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.7220861059974263,-1.1886702263857007,0.21052631578947367,0.4998587955660904,1.0,8/28,10.14%,MDK;FSTL3;CD44;MEGF10;CCL5;CX3CL1;PLAUR;THY1
911,prerank,regulation of lipid storage (GO:0010883),0.7335411728507655,1.1883626927841724,0.28,0.7556057896031955,1.0,4/16,6.27%,PLIN5;LPL;FBXW7;ALKBH7
912,prerank,retina homeostasis (GO:0001895),-0.7813854272687887,-1.1876559060957104,0.2608695652173913,0.5019607740792223,1.0,5/15,13.32%,CDH3;ACTG1;ACTB;B2M;JCHAIN
913,prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.7308504024705141,-1.186922661831088,0.28846153846153844,0.5031158949750336,1.0,3/17,13.55%,FLNA;EIF2AK3;SIRT7
914,prerank,glycoprotein metabolic process (GO:0009100),-0.6873115547287674,-1.1868960413807823,0.22580645161290322,0.5024382917389533,1.0,5/39,9.52%,HPSE;MAN2B1;FBXO17;GCNT1;MAN2A1
915,prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.6512681977748402,-1.1868892534708135,0.19696969696969696,0.501762644067768,1.0,7/54,12.14%,CSF1R;SOX9;TWIST1;CDK1;RUNX2;CCNB1;BAX
916,prerank,transcription by RNA polymerase I (GO:0006360),0.6188504396266318,1.1867509341429978,0.2682926829268293,0.7582278560942718,1.0,8/33,20.27%,RRN3;POLR1A;TAF1A;CCNH;POLR2E;POLR1E;POLR2L;POLR2F
917,prerank,diol metabolic process (GO:0034311),-0.7446472673433004,-1.18659298508346,0.26229508196721313,0.5017627152082706,1.0,2/15,5.20%,PLPP2;SPHK1
918,prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.7374898826618224,-1.1863280596526038,0.34545454545454546,0.5016479174681518,1.0,6/18,11.51%,CEMIP;SPHK1;S1PR2;APP;TGFB1;CALM2
919,prerank,regulation of keratinocyte differentiation (GO:0045616),-0.7316763852000113,-1.1861067759675386,0.19607843137254902,0.5013040423371978,1.0,5/23,13.10%,CTSK;RUNX1;VDR;FOXC1;CTSL
920,prerank,regulation of cell adhesion (GO:0030155),-0.5922789250373832,-1.1852254608912394,0.18032786885245902,0.5029737689711924,1.0,28/102,14.01%,SPN;PTK2B;MDK;LPXN;ADAM8;TGFBI;FBLN1;PLAU;SRC;PIK3CG;CCL5;IL18;RAC2;ARHGDIB;FES;CXCR4;PLXNC1;PTPRJ;P4HB;EPHB2;CYTIP;CHRD;ZDHHC2;RHOD;ARHGDIA;ITGAV;LYN;TFE3
921,prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.7620809753439391,-1.1850065791915625,0.22,0.5020567541717706,1.0,4/15,12.13%,UNC5B;EYA4;MAPK7;SNAI2
922,prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.7620809753439391,-1.1850065791915625,0.22,0.5020567541717706,1.0,4/15,12.13%,UNC5B;EYA4;MAPK7;SNAI2
923,prerank,early endosome to late endosome transport (GO:0045022),0.7216589613836092,1.1844844635991876,0.2619047619047619,0.7624964192464166,1.0,5/19,12.66%,RILP;HOOK1;KIF16B;LMTK2;AKTIP
924,prerank,spliceosomal complex assembly (GO:0000245),0.6064129760823882,1.184387715051669,0.20930232558139536,0.7594055056095497,1.0,2/43,5.55%,SRPK3;PRPF19
925,prerank,receptor clustering (GO:0043113),-0.7186271635037413,-1.1842853299093716,0.32075471698113206,0.5033435197799642,1.0,8/22,10.14%,ITGB2;PTN;ITGB7;FLNA;ITGA4;DLG4;ITGAL;THY1
926,prerank,positive regulation of protein catabolic process (GO:0045732),-0.6056409196659308,-1.1842848093666012,0.17857142857142858,0.5026254833751426,1.0,7/70,7.51%,APOE;TNFRSF1B;ADAM8;DACT1;NKD1;GPC3;ADAM9
927,prerank,regulation of intracellular transport (GO:0032386),-0.6871081365752104,-1.184281022850097,0.15789473684210525,0.5019094926580839,1.0,4/32,9.62%,LCP1;ATP13A2;PTPN1;GAS1
928,prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.6883497138522942,-1.1836133932909554,0.21428571428571427,0.5028178459453173,1.0,2/26,2.61%,SFRP1;TCF21
929,prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.6573418780753754,1.1835190107369031,0.15,0.7599689411806024,1.0,8/29,15.28%,FKBP4;CLASP1;TRIM54;FGF13;MID1IP1;NAV3;CDH5;APC2
930,prerank,ceramide biosynthetic process (GO:0046513),-0.6813442807937132,-1.1825990962188553,0.24242424242424243,0.505084420895101,1.0,5/27,7.75%,B4GALNT1;GBA;CERS6;ASAH1;SPTLC2
931,prerank,response to molecule of bacterial origin (GO:0002237),-0.6367027783301378,-1.1822035345084962,0.20689655172413793,0.5052253726135463,1.0,10/49,11.98%,FCGR2B;IRF5;SLC11A1;TLR9;CD14;F2R;TNFRSF11A;C4B;PTPN22;CYRIB
932,prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.6218214845739305,-1.181959643531313,0.2459016393442623,0.505155921294594,1.0,17/63,11.55%,TLR2;LAPTM5;TLR9;CCN3;RASSF2;CD14;SPHK1;C1QTNF3;TMSB4X;SPI1;TLR7;NLRC3;ILK;APP;TSPAN6;PTPN22;CD86
933,prerank,smoothened signaling pathway (GO:0007224),-0.6968912074486631,-1.1819018327140736,0.3283582089552239,0.5045865966065146,1.0,8/21,22.88%,SMO;EVC2;GLI2;GLI3;TTC26;IFT27;TCTN2;B9D1
934,prerank,RNA transport (GO:0050658),0.5664946136885494,1.1816394120752787,0.13953488372093023,0.7640685218720644,1.0,2/65,3.95%,RBFOX1;EIF4E
935,prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.7233849751268935,-1.1815094548028813,0.2222222222222222,0.5048243052181072,1.0,8/22,11.92%,CYP1B1;GBA;SPHK1;ASAH1;SPTLC2;CYB5R3;ACER3;DDAH2
936,prerank,regulation of tumor necrosis factor production (GO:0032680),-0.6169144413393567,-1.1806810988343028,0.2153846153846154,0.5065090635490251,1.0,29/85,10.39%,CCR2;TYROBP;SPN;PTPRC;PTPN6;HAVCR2;TLR2;CLEC7A;CX3CR1;CLU;TLR1;TLR9;THBS1;SIRPA;CYBA;CD14;IGF1;IL33;CX3CL1;TMEM106A;VSIR;TWIST1;GAS6;PTPRJ;NLRC3;EPHB2;OAS3;APP;NR1H4
937,prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.6633315516580566,-1.180648862439247,0.23529411764705882,0.5059241754993598,1.0,9/52,8.38%,CSF1R;HTR2B;PIK3R5;PIK3CG;IGF1;PTAFR;PIK3CD;FGFR1;TYRO3
938,prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.6677104100047724,-1.179777672236282,0.2037037037037037,0.5075384856430957,1.0,10/31,11.22%,NOX4;PTPRC;CSF1R;RAP2B;PTPN1;GAS6;DLG4;THY1;APP;LRP8
939,prerank,DNA replication (GO:0006260),-0.6139529873222832,-1.1788019164054093,0.171875,0.509260387232707,1.0,26/88,25.84%,NAP1L1;PCLAF;MCM6;DBF4;CDK1;FAM111A;POLD4;DNA2;RFC2;MCM3;TBRG1;CLSPN;PTMS;ORC6;MCM5;DONSON;WDHD1;RAD50;MCM4;REV3L;POLE;RFC5;TOPBP1;RHNO1;RBBP8;CDK2
940,prerank,glial cell development (GO:0021782),-0.7240872625872977,-1.1787599284799928,0.2545454545454545,0.5087060924194189,1.0,5/19,10.23%,TLR2;MDK;MXRA8;MYRF;APP
941,prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.676645972662,1.178609041494912,0.2653061224489796,0.7708201505341336,1.0,9/30,6.94%,MYL3;MYL2;TNNI3;PROX1;RYR2;MYH6;TPM1;TNNC1;DSP
942,prerank,protein destabilization (GO:0031648),-0.6941894813841291,-1.1783470293111395,0.2653061224489796,0.5091916040409425,1.0,1/27,2.18%,CTSH
943,prerank,regulation of protein localization to membrane (GO:1905475),-0.7029034386979413,-1.1775888836062975,0.288135593220339,0.5103297401893558,1.0,6/24,12.53%,MMP14;GPC3;CLN3;ACTB;ZDHHC2;GPC6
944,prerank,rRNA modification (GO:0000154),0.7092934755311366,1.1769391858091567,0.23255813953488372,0.7731338888917361,1.0,7/20,21.13%,NSUN4;TFB1M;TFB2M;DKC1;MRM2;NOP10;METTL5
945,prerank,contractile actin filament bundle assembly (GO:0030038),-0.7475051033567278,-1.1759020275053245,0.25,0.5138053672865069,1.0,2/15,4.29%,ITGB5;SRC
946,prerank,stress fiber assembly (GO:0043149),-0.7475051033567278,-1.1759020275053245,0.25,0.5138053672865069,1.0,2/15,4.29%,ITGB5;SRC
947,prerank,negative regulation of DNA recombination (GO:0045910),0.6312595870616339,1.1758599985438254,0.2564102564102564,0.7738703723830649,1.0,10/37,23.25%,POLQ;UBQLN4;SHLD1;POLR2C;POLR2E;POLR2B;POLR2L;POLR2F;MSH2;FBH1
948,prerank,protein insertion into mitochondrial membrane (GO:0051204),0.6252464780652005,1.1756228053507267,0.2727272727272727,0.7712927515004433,1.0,8/21,15.57%,NDUFA13;SAMM50;TIMM29;TIMM10;TIMM8B;TIMM22;ROMO1;TIMM9
949,prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.7030205756571413,-1.1753967567859045,0.25862068965517243,0.5143446086472927,1.0,6/21,6.54%,DDAH1;CLEC7A;CLU;P2RX4;ASS1;TMEM106A
950,prerank,pulmonary valve development (GO:0003177),-0.7477750970537208,-1.1753387360236243,0.18333333333333332,0.5137402819728888,1.0,6/16,15.56%,TNFRSF1B;TGFB2;ROBO1;NOTCH2;TNFRSF1A;JAG1
951,prerank,regulation of mRNA catabolic process (GO:0061013),-0.5777026938666413,-1.1746611121834991,0.22580645161290322,0.5150701171244851,1.0,3/114,4.44%,PABPC1;VIM;PRKCD
952,prerank,myeloid cell development (GO:0061515),-0.7233974056063043,-1.1745438721519015,0.30357142857142855,0.5145613688912553,1.0,5/16,6.40%,NCKAP1L;TLR2;SRC;EVI2B;ANXA2
953,prerank,negative regulation of protein secretion (GO:0050709),-0.7213801039024422,-1.1742038051481678,0.31666666666666665,0.5147648565729547,1.0,5/26,7.58%,APOE;SFRP1;CCN3;F2R;INHBB
954,prerank,negative regulation of epithelial cell migration (GO:0010633),-0.688512334328908,-1.1736253106653332,0.24489795918367346,0.5155514304378662,1.0,3/27,7.67%,APOE;THBS1;CORO1C
955,prerank,mesenchyme morphogenesis (GO:0072132),-0.7536637722340854,-1.1736245225666264,0.27586206896551724,0.5148393428267642,1.0,5/15,16.78%,SOX9;TGFB2;BMP2;ACVR1;ACVRL1
956,prerank,regulation of activated T cell proliferation (GO:0046006),-0.7641266321907848,-1.1731279322586157,0.25,0.5155292593879535,1.0,5/16,16.63%,IGF1;IL18;IGFBP2;PYCARD;RIPK3
957,prerank,actomyosin structure organization (GO:0031032),0.5979503553450354,1.173008839505785,0.1951219512195122,0.777074077346117,1.0,25/70,11.52%,TMOD4;LMOD3;MYOZ2;KLHL41;TTN;OBSCN;LMOD2;MYPN;FHOD3;MYLK3;FRMD5;MYH6;TPM1;MYOM2;ACTC1;TCAP;EPB41;MYH14;MYO18A;SORBS1;TMOD1;CSRP3;ACTN2;TNNT1;PGM5
958,prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.6591325790183137,-1.1723876272099667,0.2222222222222222,0.5168299308937365,1.0,3/23,1.49%,KCNN4;CTSS;KCNJ15
959,prerank,positive regulation of fat cell differentiation (GO:0045600),-0.6766726879058618,-1.1713892051864077,0.27586206896551724,0.5190212121842936,1.0,3/41,0.63%,FRZB;SFRP2;SFRP1
960,prerank,neuron differentiation (GO:0030182),-0.6120576305378626,-1.1708339011338582,0.24615384615384617,0.5198905328710172,1.0,22/79,14.00%,FZD2;ITM2C;TGFB2;ID2;TENM3;RUNX1;FZD1;TGFBR1;ATOH8;SMARCA1;MYO7A;WNT4;RUNX2;INHBA;MET;WNT11;RUNX3;CASP3;FZD7;LDB1;UGDH;GLI2
961,prerank,cellular protein-containing complex assembly (GO:0034622),0.5213146866759648,1.1703924991513868,0.19444444444444445,0.7827035062764733,1.0,11/126,6.64%,HOPX;DNAJC28;COX7A1;HSPD1;NDUFAF1;CASQ2;PDE4DIP;MAPT;IMMP2L;OMA1;SAMM50
962,prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.5497232946395255,-1.1703872963349267,0.16176470588235295,0.5205384460119585,1.0,41/157,11.10%,FN1;TREM2;GPNMB;APOE;MARCO;CCN2;P2RY6;PTPRC;PTK2B;PTPN6;CSF1R;HTR2B;ARRB2;CD44;SIRPA;FBLN1;EMILIN1;CCL5;C5AR1;CD74;ROR2;F2R;CX3CL1;PTPN1;GLIPR2;PDGFC;SLC9A3R1;GAS6;RGS14;CCL8;FAM83D;SPRED3;TIMP3;ICAM1;EPHB2;BMPER;APP;TGFB1;NPNT;PDGFRB;PTPN22
963,prerank,cellular response to mechanical stimulus (GO:0071260),-0.6564656991925696,-1.170256793657966,0.265625,0.5202159556248132,1.0,14/43,17.42%,PIEZO2;SOX9;TLR8;CASP1;TLR7;MAP3K14;CNN2;TNFRSF1A;PTGER4;MAPK3;PIEZO1;CASP8;FAS;MYD88
964,prerank,autophagosome maturation (GO:0097352),0.6076328236628581,1.1700157216148985,0.17647058823529413,0.7805634104018964,1.0,2/29,7.37%,ATP2A2;MAP1LC3A
965,prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.7404557675905149,-1.1697278688054964,0.21875,0.5209084559156476,1.0,5/24,6.89%,ENPP1;PRKCD;PRKCB;PTPN1;PIP4K2A
966,prerank,'de novo' posttranslational protein folding (GO:0051084),0.6110696060036686,1.1686970765885736,0.23255813953488372,0.7815576555055641,1.0,7/29,15.62%,ENTPD5;HSPA9;DNAJB5;HSPA5;BAG1;CHCHD4;HSPA8
967,prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.632499897340052,-1.1684108899492314,0.25862068965517243,0.5235466082780631,1.0,7/36,15.56%,CCN3;TGFB2;SRC;ROBO1;BMP2K;TSPAN14;JAG1
968,prerank,positive regulation of MAP kinase activity (GO:0043406),-0.6207477055619463,-1.168112488155401,0.2698412698412698,0.5238592568661761,1.0,13/51,10.97%,PAK1;HTR2B;ADAM8;TLR9;PIK3R5;PIK3CG;PDGFC;ROBO1;FGFR1;TNFRSF11A;MST1R;TGFB1;PDGFRB
969,prerank,negative regulation of neurogenesis (GO:0050768),0.6419865074203415,1.1679577697433616,0.2222222222222222,0.7805872359014794,1.0,1/24,0.26%,EFNB3
970,prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.6971938026111452,1.1677535027807018,0.2127659574468085,0.7779456134864391,1.0,6/20,12.89%,PINK1;DCUN1D2;EPAS1;EGR1;DNAJB2;PRKN
971,prerank,small GTPase mediated signal transduction (GO:0007264),-0.5862966895903766,-1.1676936319710902,0.22950819672131148,0.5241710535507791,1.0,9/86,7.88%,ARHGAP30;IGF1;SHC2;RGS19;BCR;NUCB2;SHTN1;GRAP2;CCNA2
972,prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.7001678177531874,-1.1670758249239506,0.2631578947368421,0.5248544040469344,1.0,5/20,5.15%,DDAH1;CLEC7A;CLU;P2RX4;ASS1
973,prerank,neural crest cell development (GO:0014032),-0.6759576759227733,-1.167042357975082,0.2542372881355932,0.5243117391010745,1.0,7/33,15.75%,HTR2B;SEMA3D;CORO1C;SEMA4A;SNAI2;SOX8;SEMA3F
974,prerank,sarcomere organization (GO:0045214),0.6701016528695387,1.1667571182209406,0.27450980392156865,0.7779014864332484,1.0,14/24,11.35%,MYOZ2;TTN;OBSCN;LMOD2;MYPN;FHOD3;MYLK3;MYH6;TPM1;MYOM2;TCAP;CSRP3;ACTN2;TNNT1
975,prerank,positive regulation of cellular component movement (GO:0051272),-0.7212095260776908,-1.1664846105077724,0.26153846153846155,0.5251477908167898,1.0,5/22,6.90%,PDPN;CSF1R;TUBB2B;TGFBR1;TWIST1
976,prerank,protein localization to lysosome (GO:0061462),-0.7243039633992184,-1.1661132804175738,0.2833333333333333,0.5254097905145412,1.0,3/27,5.68%,LAPTM5;RTN4;ATP13A2
977,prerank,respiratory tube development (GO:0030323),-0.7484857478729044,-1.1652858840043383,0.1864406779661017,0.52689027013778,1.0,3/19,2.61%,LOXL3;PDPN;TCF21
978,prerank,positive regulation of JUN kinase activity (GO:0043507),-0.7109836895146542,-1.1651533289180382,0.25,0.5264710826810814,1.0,3/20,8.08%,PAK1;TLR9;TNFRSF11A
979,prerank,regulation of protein modification process (GO:0031399),-0.6645744230565163,-1.1646101324111304,0.23076923076923078,0.5272227516125563,1.0,5/43,11.07%,FN1;CORO1C;PPIB;SPRED3;CDK9
980,prerank,RNA interference (GO:0016246),0.7300774742452605,1.164543423987823,0.34782608695652173,0.7828871232172133,1.0,6/15,22.44%,MRPL44;CELF1;DROSHA;TSNAX;TARBP2;AGO4
981,prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.6235172561422668,1.1625490012926059,0.28205128205128205,0.7870353281110896,1.0,20/49,25.39%,PPM1K;PSME4;BCKDK;PSMC3;PSME3;PSMD12;OAZ1;PSMB7;PSMD2;PSMA1;OAZ2;PSMB2;NQO1;PSME1;PSMC6;PSMD11;PSMD1;PSMD3;PSMC2;PSMA6
982,prerank,regulation of DNA replication (GO:0006275),-0.6561150315135938,-1.1618875361674088,0.28125,0.5337362852516778,1.0,4/42,8.94%,S100A11;EREG;CCNA2;EHMT2
983,prerank,regulation of TOR signaling (GO:0032006),-0.6178203309300957,-1.1614405958253995,0.288135593220339,0.5340617110594637,1.0,4/62,9.04%,TREM2;GBA;GAS6;FAM83D
984,prerank,positive regulation of dendritic spine development (GO:0060999),-0.7169372204635659,-1.1602780059317521,0.2857142857142857,0.5364863428992298,1.0,2/19,1.80%,APOE;DBN1
985,prerank,protein glycosylation (GO:0006486),-0.5683105247688025,-1.1593340524403744,0.23529411764705882,0.5382615094474731,1.0,11/101,10.60%,GALNT6;GCNT4;SLC39A8;B3GNT8;SERP1;PLOD2;B3GNT9;GALNT10;B3GALNT1;NPC1;MGAT2
986,prerank,phospholipid biosynthetic process (GO:0008654),0.6490795903284963,1.159140013208938,0.3902439024390244,0.7963683051213846,1.0,5/31,7.00%,FITM2;FITM1;GNPAT;HDHD5;AGPAT3
987,prerank,apoptotic mitochondrial changes (GO:0008637),0.6334261767709751,1.1590256291456709,0.26666666666666666,0.7934529259390227,1.0,6/29,6.76%,NDUFS1;HK2;SOD2;HSPD1;CAMK2A;THEM4
988,prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.7362238595403227,-1.1585946006325283,0.2835820895522388,0.539114639205842,1.0,4/19,5.03%,APOE;TYROBP;PTN;LGMN
989,prerank,lipid homeostasis (GO:0055088),-0.6483587602607487,-1.1584878409689376,0.2459016393442623,0.5385914102925353,1.0,7/45,7.35%,RBP1;TREM2;APOE;RCN3;ATP13A2;CEBPA;ABCG1
990,prerank,positive regulation of actin filament polymerization (GO:0030838),-0.6266735528066333,-1.1584426098549243,0.25,0.5379780978853941,1.0,7/36,9.53%,HCK;NCKAP1L;PTK2B;CARMIL1;CDC42EP5;ARPC4;BIN1
991,prerank,sodium ion transmembrane transport (GO:0035725),0.6752061298952543,1.157764282364431,0.2972972972972973,0.7946238368662479,1.0,6/32,5.50%,SCN4B;HCN4;SLC9A2;SCN4A;HCN2;ATP1A2
992,prerank,histone acetylation (GO:0016573),0.6201175838377041,1.1574043944463859,0.2962962962962963,0.7930444777377321,1.0,1/63,0.82%,APBB1
993,prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.6031779588240989,-1.1565295256716766,0.1935483870967742,0.5419648947207565,1.0,22/87,19.73%,PTK2B;TNFRSF1B;PLVAP;TMSB4X;TRAF1;TNFRSF11A;ILK;MAP3K14;TRADD;AIM2;TNFRSF13B;PYCARD;RIPK1;TNFRSF1A;PSMB8;TNFSF13;IKBKB;PSMB9;ACTN4;TNFSF12;CD40;TNFSF13B
994,prerank,endocardial cushion development (GO:0003197),-0.6963456249183129,-1.1563125121950084,0.288135593220339,0.5415768162048465,1.0,5/18,16.78%,SOX9;TGFB2;BMP2;ACVR1;ACVRL1
995,prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.7215979328703077,-1.1562896214113978,0.2631578947368421,0.5409771647162738,1.0,7/26,13.88%,SOX9;EEF1A1;KNSTRN;FOXC1;ZFP36L2;SNAI2;IQGAP1
996,prerank,regulation of Ras protein signal transduction (GO:0046578),-0.5961366547336191,-1.155984023866374,0.25,0.5408644194725464,1.0,15/71,14.40%,VAV1;TGFB2;IGF1;BCR;ARHGDIB;MYO9B;SH3BP1;RASAL3;EPHB2;FOXM1;DENND4A;NOTCH2;ARHGDIA;LYN;ARF6
997,prerank,DNA modification (GO:0006304),0.6750886104223907,1.155720854982682,0.3333333333333333,0.7954748300094898,1.0,1/19,2.46%,UNG
998,prerank,GPI anchor metabolic process (GO:0006505),0.703292505243642,1.1556093096677986,0.325,0.7927073707394122,1.0,8/22,17.99%,PYURF;PGAP2;PGAP4;PIGO;GPLD1;PIGP;DPM1;PIGG
999,prerank,epidermis development (GO:0008544),-0.7119474133242132,-1.1545819892697005,0.3508771929824561,0.5434933709691547,1.0,6/28,6.95%,SPRR1A;GJB5;EMP1;CCN2;WAS;COL7A1
1000,prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.6208286047817176,-1.1534729816797717,0.2631578947368421,0.5454649416964874,1.0,6/63,6.34%,ITGB5;NCF1;CYBB;CYBA;NCF4;NCF2
1001,prerank,atrioventricular valve morphogenesis (GO:0003181),-0.6822456843838489,-1.1533781310876252,0.288135593220339,0.5451050088529953,1.0,6/19,17.87%,TGFB2;OLFM1;SLIT3;BMP2;ACVR1;TGFBR2
1002,prerank,cellular response to unfolded protein (GO:0034620),0.6397094590868667,1.152547062916812,0.2608695652173913,0.8005345983581823,1.0,7/25,10.14%,HSPD1;HSPA9;ABCB10;OPTN;BAG3;HSPB8;HSPA5
1003,prerank,import into nucleus (GO:0051170),-0.5655778151683206,-1.1517722831978219,0.24489795918367346,0.5483515197869512,1.0,1/68,1.76%,MMP12
1004,prerank,cellular senescence (GO:0090398),-0.7180546864633495,-1.1516555868315652,0.3050847457627119,0.5479435272763377,1.0,5/24,6.30%,ECRG4;CDKN2B;PRKCD;ID2;SPI1
1005,prerank,regulation of cellular metabolic process (GO:0031323),0.6608700411078186,1.1511170463104083,0.275,0.8026487614140757,1.0,9/39,4.91%,PDK2;PDK4;ACACB;PINK1;GNB3;PM20D2;COQ7;TBC1D16;PPARA
1006,prerank,mitotic spindle organization (GO:0007052),-0.544353692328005,-1.1509398263917665,0.15151515151515152,0.5491013884764729,1.0,36/125,19.49%,NEK6;CDCA8;DYNLL1;FLNA;NUF2;BUB1B;CENPT;TPX2;SPC25;PRC1;DLGAP5;BIRC5;KIF11;CENPE;EML4;CCNB1;STMN1;RCC2;NDC80;AURKB;CDC20;ZWILCH;WDR62;AURKA;PLK2;CEP192;CENPO;BUB1;KIF3B;KIFC1;DSN1;KIF2C;INCENP;KNTC1;PLK1;MAD2L1
1007,prerank,negative regulation of hydrolase activity (GO:0051346),0.5794079622152322,1.1504722170104198,0.25,0.8011328397072534,1.0,6/39,5.69%,PLIN5;SH2D4A;EGLN1;GPSM1;SH3RF2;CAMK2A
1008,prerank,limb development (GO:0060173),-0.6978038056180664,-1.1504050438216182,0.2698412698412698,0.5499406503200172,1.0,1/17,0.40%,COMP
1009,prerank,fatty acid derivative biosynthetic process (GO:1901570),0.6940515541017318,1.1493191019684441,0.25,0.8011576808183616,1.0,6/21,8.61%,ACAT1;GCDH;CBR4;BDH1;ALOX12;ALOX5
1010,prerank,amino acid transport (GO:0006865),-0.6626685972259179,-1.149213150060699,0.30434782608695654,0.5520982615154902,1.0,9/28,13.91%,PDPN;SLC7A2;SLC7A7;SLC1A4;SLC25A45;SLC1A5;SLC43A1;SLC7A8;SLC3A2
1011,prerank,regulation of protein metabolic process (GO:0051246),-0.6387338156259287,-1.149129946859814,0.26865671641791045,0.5515376238576436,1.0,8/39,11.57%,APOE;GBA;MAPK7;PLAUR;FAM83D;LTBP4;APP;ZDHHC2
1012,prerank,regulation of cellular component size (GO:0032535),-0.686066775870175,-1.1487400143119162,0.3275862068965517,0.5517268053626673,1.0,3/28,7.84%,VAV1;ATP13A2;SLC9A3R1
1013,prerank,nuclear export (GO:0051168),0.5395362917830174,1.1484703399004708,0.23255813953488372,0.8011188823796648,1.0,2/74,3.95%,STRADB;EIF4E
1014,prerank,glycogen metabolic process (GO:0005977),0.7033373771972408,1.1483132873333861,0.32558139534883723,0.7987423000544795,1.0,9/24,11.11%,NHLRC1;PYGM;AGL;PYGB;UGP2;GYS1;PGM1;PHKA1;PPP1R3C
1015,prerank,negative regulation of response to wounding (GO:1903035),-0.7358436499230177,-1.1477819112942957,0.32786885245901637,0.553589592782505,1.0,3/15,3.46%,SERPINE1;MDK;CD109
1016,prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.7390489852245594,-1.1471549896689328,0.3191489361702128,0.554507054099467,1.0,3/15,8.26%,TREM2;MAPK7;P4HB
1017,prerank,negative regulation of axon extension (GO:0030517),-0.6650497996680051,-1.146788259455651,0.37254901960784315,0.5547214286271245,1.0,3/24,9.90%,RTN4;SEMA3D;SEMA4A
1018,prerank,leukotriene metabolic process (GO:0006691),0.668949582591685,1.146618632411364,0.3,0.8013569162592608,1.0,2/15,0.93%,MGST3;PLA2G5
1019,prerank,focal adhesion assembly (GO:0048041),-0.6503584923394665,-1.146089008253924,0.2545454545454545,0.5558583488469048,1.0,6/20,12.81%,ACTN1;SRC;BCR;THY1;RCC2;RHOD
1020,prerank,protein-containing complex disassembly (GO:0032984),-0.6240157386505827,-1.1456035674040634,0.25396825396825395,0.5564123984495574,1.0,5/45,10.99%,FZD2;FZD1;MYC;LAMP2;CLN3
1021,prerank,pulmonary valve morphogenesis (GO:0003184),-0.7230939449083017,-1.145360322793876,0.16071428571428573,0.5563710042492953,1.0,4/15,11.41%,TGFB2;GJA5;ROBO1;NOTCH2
1022,prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.7569607351048766,-1.1451964685596951,0.2711864406779661,0.5560331034400395,1.0,5/16,10.97%,PTPN1;PDGFC;PTPRJ;RGS14;PDGFRB
1023,prerank,tRNA processing (GO:0008033),0.592520638232878,1.1434574829202373,0.20930232558139536,0.8086845749518907,1.0,13/51,25.98%,AARS2;FARS2;TRMT10C;LCMT2;TRPT1;POP5;PTCD1;CDKAL1;ELAC2;RPP21;DDX1;TRNT1;PUS3
1024,prerank,endoplasmic reticulum organization (GO:0007029),-0.5684278873582905,-1.1416195154910533,0.2631578947368421,0.5644200259025023,1.0,13/64,12.64%,HMOX1;RTN4;SEC16B;SERP1;SHTN1;TRAM2;SEC61B;SEC61A1;APP;REEP4;GAK;TRAM1;EIF2AK3
1025,prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.703028633381246,-1.1403086634714963,0.36363636363636365,0.5672528939196655,1.0,5/23,11.58%,NEK6;UBE2C;DLGAP5;CENPE;CCNB1
1026,prerank,organophosphate biosynthetic process (GO:0090407),0.6753405950766183,1.1400017536682823,0.2972972972972973,0.8187028351799662,1.0,9/33,9.70%,FITM2;FITM1;GNPAT;PPIP5K2;PPIP5K1;NFS1;AGPAT3;ITPKB;IP6K3
1027,prerank,membrane organization (GO:0061024),-0.5112834704809051,-1.1399920523169524,0.2,0.5673454029145967,1.0,24/196,11.25%,IL7R;MYOF;LPCAT2;EREG;ARRB2;GLTP;SERP1;ARPC5;AZIN2;ACTG1;CORO1C;SLC9A3R1;ARPC4;ARPC2;CLTA;BIN1;DNM1;CEP55;NPC1;REEP4;MX1;GAK;CLN3;ACTB
1028,prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.5660372687744019,-1.139233057876959,0.25,0.5682638948590967,1.0,33/104,11.95%,TREM2;GPNMB;APOE;MARCO;CCN2;P2RY6;PTPRC;PTK2B;CSF1R;HTR2B;ARRB2;CD44;CCL5;C5AR1;CD74;ROR2;F2R;CX3CL1;GLIPR2;PDGFC;GAS6;TNFRSF11A;CCL8;ICAM1;BMPER;APP;TGFB1;NPNT;PDGFRB;PTPN22;NOTCH2;FGFR2;BMP2
1029,prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.6394146477334439,-1.1392258383768794,0.34615384615384615,0.5675444386881364,1.0,3/38,3.16%,PTK2B;CLU;LAPTM5
1030,prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.6254792713246285,-1.1391105917876483,0.2753623188405797,0.5672094524452711,1.0,6/55,12.14%,CSF1R;SOX9;CDK1;RUNX2;CCNB1;BAX
1031,prerank,regulation of myotube differentiation (GO:0010830),-0.7322166992183273,-1.138995511694478,0.3448275862068966,0.5666989663957764,1.0,3/22,3.62%,MMP14;TMEM119;CCN3
1032,prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.675277075842244,-1.1380903515829006,0.2542372881355932,0.5685235989039346,1.0,5/24,16.69%,SOX9;TWIST1;CHRD;TNN;CDK6
1033,prerank,stress granule assembly (GO:0034063),0.6792309453782798,1.137819098305124,0.2830188679245283,0.8235109631996083,1.0,3/20,14.19%,MAPT;CSDE1;OGFOD1
1034,prerank,negative regulation of MAPK cascade (GO:0043409),-0.5549010345292541,-1.137689560757831,0.25,0.5688336484118268,1.0,19/75,10.64%,APOE;PTPRC;CD300A;SIRPA;FBLN1;UCHL1;GBA;PRKCD;EMILIN1;P2RX7;PTPN1;MYC;SLC9A3R1;PTPRJ;RGS14;SPRED3;TIMP3;EPHB2;FOXM1
1035,prerank,cell chemotaxis (GO:0060326),-0.6696008119948361,-1.1373181264761176,0.2833333333333333,0.5689818582497447,1.0,16/43,12.28%,CCR2;CXCR6;CX3CR1;ARRB2;CCN3;PRKCD;CCR5;CX3CL1;CXCR4;RHOG;HGF;BIN2;RAB13;PDGFRB;ACKR4;CORO1B
1036,prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.637623417234047,-1.1372952338134277,0.2982456140350877,0.5683108805778133,1.0,2/26,5.65%,SRC;NIBAN2
1037,prerank,regulation of autophagy of mitochondrion (GO:1903146),0.6749787291328403,1.1372932789313874,0.3333333333333333,0.8217443010924713,1.0,3/19,4.80%,PINK1;VDAC1;FBXW7
1038,prerank,positive regulation of kinase activity (GO:0033674),-0.5823439493426253,-1.1364571302777762,0.2916666666666667,0.569846650094428,1.0,21/84,12.47%,TREM2;PTPRC;PTK2B;EREG;LCP2;CSF1R;RASSF2;CD74;ROR2;FGFR1;GAS6;TYRO3;MST1R;EPHB2;MET;MERTK;CENPE;PDGFRB;FGFR2;AXL;EPHB6
1039,prerank,regulation of cardiac muscle contraction (GO:0055117),0.646364071263591,1.1358875904970553,0.3170731707317073,0.8238801287031627,1.0,10/32,5.97%,HCN4;TNNI3K;ATP2A2;ANK2;TNNI3;PLN;RYR2;RNF207;PRKACA;ADRA1A
1040,prerank,regulation of lipid metabolic process (GO:0019216),0.5210460383429748,1.1357112226782187,0.1935483870967742,0.8213877525451306,1.0,5/74,5.43%,ACACB;RORC;GNB3;PPARA;OPA3
1041,prerank,regulation of amyloid-beta formation (GO:1902003),-0.6594104569815733,-1.1356447327360994,0.30357142857142855,0.5712326501425113,1.0,7/29,9.53%,APOE;CLU;RTN4;SLC2A13;IGF1;ABCG1;BIN1
1042,prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.5904349479258395,-1.1354679481039047,0.265625,0.5708672450508808,1.0,13/63,19.16%,GTSE1;E2F1;BATF;CDK1;FOXM1;CCNB1;SFN;BAX;AURKA;PLK2;PLK3;PML;CDKN1A
1043,prerank,positive regulation of cation channel activity (GO:2001259),-0.6563932864327604,-1.134916859718076,0.3333333333333333,0.571637435183712,1.0,3/27,1.42%,CTSS;CCR2;P2RY6
1044,prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.652645395230159,1.134461821752401,0.27450980392156865,0.8223447398917687,1.0,2/20,1.86%,PPIF;PINK1
1045,prerank,regulation of viral genome replication (GO:0045069),-0.6329282333601224,-1.1336168857795679,0.23809523809523808,0.5741490747993894,1.0,13/50,14.80%,PABPC1;CCL5;OAS3;ISG20;ZC3HAV1;MX1;FAM111A;IFITM2;RNASEL;ADARB1;ISG15;BST2;PPIA
1046,prerank,regulation of RNA metabolic process (GO:0051252),0.5797656156627257,1.1334429684062421,0.3125,0.822836764997346,1.0,4/50,2.36%,SRRM4;RBM38;RBM20;FASTK
1047,prerank,sensory perception of mechanical stimulus (GO:0050954),-0.6232744208756907,-1.1331556369842957,0.31666666666666665,0.5745068512820714,1.0,6/41,4.50%,COL1A1;CEMIP;COL11A1;PIEZO2;COL2A1;P2RX4
1048,prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.6977309569012551,-1.1325583146217728,0.37037037037037035,0.5752260063040548,1.0,6/20,12.13%,UNC5B;EYA4;MAPK7;FGFR1;INHBA;SNAI2
1049,prerank,protein acylation (GO:0043543),-0.6568865997229777,-1.1323124565376026,0.2903225806451613,0.5750604757413561,1.0,7/36,17.40%,SPHK1;ZDHHC2;ZDHHC15;PORCN;ZDHHC12;HHAT;ZDHHC20
1050,prerank,cell-cell junction organization (GO:0045216),-0.6245420069383307,-1.1321154899144963,0.2786885245901639,0.5747941813400953,1.0,15/50,15.16%,CDH3;TGFB3;CSF1R;TGFB2;NECTIN4;F2R;CDH11;ANG;TGFB1;NLGN2;SDK1;NECTIN3;GJA4;CSK;TLN1
1051,prerank,protein palmitoylation (GO:0018345),-0.7069600153298257,-1.1319959130517037,0.3582089552238806,0.574340886872805,1.0,8/25,17.40%,ZDHHC24;ZDHHC2;GOLGA7;ZDHHC15;PORCN;ZDHHC12;HHAT;ZDHHC20
1052,prerank,response to peptide hormone (GO:0043434),-0.6709027505244278,-1.1318391960434848,0.375,0.5739752479050718,1.0,2/38,4.29%,ANXA1;SRC
1053,prerank,regulation of histone acetylation (GO:0035065),0.6008584521545345,1.1318293565827495,0.3333333333333333,0.824814376855167,1.0,1/27,1.05%,PPARGC1A
1054,prerank,DNA recombination (GO:0006310),0.6161794497470078,1.131493803209373,0.36585365853658536,0.8228104150491986,1.0,7/27,23.25%,ENDOG;HMGB3;SUPV3L1;XRCC2;LIG4;MSH2;FBH1
1055,prerank,neuron projection morphogenesis (GO:0048812),-0.5721604987085578,-1.1313910354934433,0.25862068965517243,0.5744457336254871,1.0,21/94,11.81%,PAK1;DCLK1;NCKAP1L;DBN1;ALCAM;MAP1A;S100A6;FARP1;SHTN1;DOCK10;MAP6;DOCK7;DLG4;MAP1B;EPHB2;APP;SDC2;ACTB;NBL1;SLITRK4;FGFR2
1056,prerank,positive regulation of type I interferon production (GO:0032481),-0.575296614427786,-1.1310638179975623,0.29508196721311475,0.574728068510585,1.0,11/72,13.49%,TLR2;IRF5;TLR9;TLR8;CD14;TLR7;OAS3;PTPN22;ZBP1;STING1;ISG15
1057,prerank,regulation of monooxygenase activity (GO:0032768),-0.7126662806134604,-1.130857567919171,0.2549019607843137,0.5744207784212003,1.0,4/19,11.92%,DDAH1;CYGB;VDR;DDAH2
1058,prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.715008167853655,-1.1306798289022957,0.36363636363636365,0.5743437923277303,1.0,5/18,20.85%,ADAM9;TGFB1;PSEN2;MBTPS1;ADAM10
1059,prerank,regulation of cell division (GO:0051302),-0.6059591528278329,-1.1304363118084835,0.2631578947368421,0.574209689020747,1.0,10/60,12.24%,SFRP2;HTR2B;EVI2B;MYC;SUSD2;PRC1;CALM2;FGFR2;SFN;AURKB
1060,prerank,anion transmembrane transport (GO:0098656),0.5446429467777574,1.1304055089556888,0.23684210526315788,0.8236269285069768,1.0,5/49,3.11%,SLC25A42;SLC25A11;SLC25A4;SLC25A13;SLC25A12
1061,prerank,7-methylguanosine RNA capping (GO:0009452),0.6083969847230329,1.1303093319481363,0.3023255813953488,0.8177568294980972,1.0,14/31,33.14%,POLR2C;CCNH;POLR2E;POLR2B;POLR2L;POLR2F;CMTR1;GTF2H3;RNGTT;POLR2K;POLR2J;GTF2H4;GTF2H2;POLR2I
1062,prerank,7-methylguanosine mRNA capping (GO:0006370),0.6083969847230329,1.1303093319481363,0.3023255813953488,0.8177568294980972,1.0,14/31,33.14%,POLR2C;CCNH;POLR2E;POLR2B;POLR2L;POLR2F;CMTR1;GTF2H3;RNGTT;POLR2K;POLR2J;GTF2H4;GTF2H2;POLR2I
1063,prerank,actin polymerization or depolymerization (GO:0008154),-0.6127250175131053,-1.1302785280816174,0.2982456140350877,0.5738469672821961,1.0,10/42,12.50%,PSTPIP1;CAPG;AIF1;WAS;PREX1;MICAL1;ANG;CFL1;DSTN;TWF1
1064,prerank,positive regulation of heart contraction (GO:0045823),0.711903279527616,1.1292265094544205,0.37209302325581395,0.8188216787114437,1.0,5/16,5.97%,HRC;ATP2A2;RYR2;ATP1A2;ADRA1A
1065,prerank,regulation of G0 to G1 transition (GO:0070316),-0.6022213072468946,-1.128878591589657,0.3125,0.5767436742023504,1.0,6/34,10.44%,CDKN2B;APAF1;E2F1;EHMT2;PCGF2;RRM2
1066,prerank,skeletal system morphogenesis (GO:0048705),-0.7413111352236242,-1.1287844332997825,0.3090909090909091,0.5761788548402627,1.0,8/18,20.37%,FBN2;TGFBR1;FGFR1;FGFR2;SFRP4;DYNC2I1;PDGFRA;SKI
1067,prerank,response to cholesterol (GO:0070723),-0.7087969914743465,-1.128759591851146,0.3220338983050847,0.5755013993412217,1.0,6/15,17.87%,CCR5;TGFBR1;SMO;TGFB1;GRAMD1C;TGFBR2
1068,prerank,regulation of calcium ion transport (GO:0051924),0.6283115946087349,1.1284296497524942,0.24324324324324326,0.8186008007445221,1.0,13/39,10.13%,HRC;ANK2;HOMER2;PLN;CAMK2A;CACNB2;EGF;EPB41;WFS1;CAMK2B;CACNA2D1;CAV3;HOMER1
1069,prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.5600538096616624,-1.1282163532241478,0.3387096774193548,0.5761213138768358,1.0,15/94,12.93%,NPY;APOE;PLEK;CSF1R;GBA;CARMIL1;SLC9A3R1;DOCK7;RAB13;APP;LRP12;SAMD14;STMN1;CORO1B;ARFIP2
1070,prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.663134293578711,1.1280917065493827,0.3333333333333333,0.8164571395007622,1.0,8/16,21.74%,MAPT;RAPGEF1;EHD1;MAGI2;RAPGEF2;KIDINS220;AKT1;STMN2
1071,prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.7241404081239292,1.1280474031046612,0.32,0.8135033769355513,1.0,6/16,12.26%,ACADVL;ACADL;FBXW7;WDTC1;CEACAM1;SIK1
1072,prerank,negative regulation of translation (GO:0017148),0.5648490749997691,1.1280178332684883,0.2682926829268293,0.8105713332127318,1.0,6/74,8.77%,FXR1;CPEB3;SHMT1;RBM24;GAPDH;PAIP2B
1073,prerank,glycolipid biosynthetic process (GO:0009247),0.6026995225504506,1.1271414984204793,0.30952380952380953,0.8111745024831831,1.0,9/28,17.99%,PYURF;PGAP2;PGAP4;PIGO;SCCPDH;ST3GAL5;PIGP;DPM1;PIGG
1074,prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.6530382855189776,-1.1270501204189582,0.29850746268656714,0.5782612729938249,1.0,5/36,6.89%,ENPP1;PRKCD;PRKCB;PTPN1;PIP4K2A
1075,prerank,positive regulation of binding (GO:0051099),-0.5767716125720326,-1.1270348047081418,0.3064516129032258,0.5776121606895726,1.0,13/79,13.14%,APOE;LRP1;IGF1;DACT1;PLAUR;APP;MET;FOXC1;STMN1;BMP2;TIAM1;B2M;STING1
1076,prerank,positive regulation of protein polymerization (GO:0032273),-0.595348000574655,-1.1268786676762428,0.29508196721311475,0.577347660729942,1.0,7/54,6.28%,HCK;PAK1;NCKAP1L;PTK2B;CARMIL1;FES;CDC42EP5
1077,prerank,outflow tract septum morphogenesis (GO:0003148),-0.6760371643913229,-1.1266182938978546,0.35714285714285715,0.5772396601539307,1.0,8/21,21.15%,TGFB2;ROBO1;FGFR2;PARVA;ACVR1;TGFBR2;BMP4;SMAD6
1078,prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.5887238580668435,-1.1262632820871055,0.3103448275862069,0.5774007756490517,1.0,5/75,6.62%,NKD2;RNF180;CLU;LAPTM5;CEBPA
1079,prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.71823860442526,-1.1261398544840768,0.3090909090909091,0.5769820648852393,1.0,1/17,2.18%,SULF1
1080,prerank,potassium ion import across plasma membrane (GO:1990573),0.6464334747013516,1.1261157733502916,0.3111111111111111,0.811394003919047,1.0,10/22,6.39%,HCN4;KCNJ3;KCNJ11;ABCC9;KCNJ5;HCN2;SLC12A7;ATP1A2;KCNJ12;KCNJ2
1081,prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.669702495110587,-1.12603903790158,0.32,0.5765502756597831,1.0,7/31,15.18%,SERPINE1;CLU;BMP2K;C3;B2M;ARF6;PICALM
1082,prerank,adherens junction organization (GO:0034332),-0.625009769531841,-1.1257919401024516,0.2982456140350877,0.576373307586485,1.0,7/31,14.53%,CDH3;NECTIN4;CDH11;ANG;ACTB;NECTIN3;CSK
1083,prerank,epithelial cell differentiation (GO:0030855),-0.6211556665263764,-1.125425593364501,0.3442622950819672,0.5765910171121372,1.0,6/56,2.61%,FSTL1;BASP1;LGALS3;TAGLN;ANXA1;TCF21
1084,prerank,positive regulation of protein secretion (GO:0050714),-0.6119765141964516,-1.124794334364886,0.29411764705882354,0.5775535108096117,1.0,14/56,11.07%,TREM2;TGFB3;TLR2;ADAM8;TGFB2;IGF1;ATP13A2;C1QTNF3;ABCG1;ADAM9;MYH10;ANG;TGFB1;NLGN2
1085,prerank,regulation of cytoskeleton organization (GO:0051493),-0.5284086028433912,-1.124470915619624,0.25757575757575757,0.5774742784491472,1.0,26/94,16.13%,PAK1;CAPN6;LRP1;CORO1A;PRKCD;P2RX7;RAC2;IQGAP3;RHOG;RHOC;MAP6;SH3BP1;PDGFRB;CLN3;BST1;IQGAP2;RHOD;PHLDB2;PAK3;IQGAP1;BST2;EFNA5;GPM6B;SYDE1;MAPK3;RHOH
1086,prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.7354544599029572,-1.1243443080220126,0.3508771929824561,0.5770164831910856,1.0,2/15,6.78%,THBS1;ITGA4
1087,prerank,negative regulation of protein kinase activity (GO:0006469),-0.5628644744444877,-1.1243249609735035,0.2463768115942029,0.5763356393997839,1.0,10/74,14.80%,PTPRC;PTPN1;CORO1C;PTPRO;THY1;SFN;ADARB1;UBASH3B;PYCARD;PPIA
1088,prerank,positive regulation of translational initiation (GO:0045948),-0.7390732362458796,-1.124287017210731,0.3684210526315789,0.5756984473179181,1.0,1/16,4.91%,CCL5
1089,prerank,endocytic recycling (GO:0032456),-0.6138541106549203,-1.1240264621124805,0.3442622950819672,0.5755380177536773,1.0,3/46,8.99%,DENND1C;ARL4C;RAB13
1090,prerank,endocardial cushion morphogenesis (GO:0003203),-0.7239368985931741,-1.1240252330622862,0.2711864406779661,0.57483356485557,1.0,6/17,17.87%,SOX9;TGFB2;BMP2;ACVR1;ACVRL1;TGFBR2
1091,prerank,response to amino acid starvation (GO:1990928),-0.5764321721561605,-1.123505273703691,0.2753623188405797,0.5754135278634441,1.0,4/67,7.07%,TCIRG1;DAP;ATP6V0D2;CASTOR1
1092,prerank,negative regulation of intracellular protein transport (GO:0090317),-0.7239246171362543,-1.1229548422178544,0.30434782608695654,0.5759224481134487,1.0,2/19,18.92%,MDFIC;RAB23
1093,prerank,blood circulation (GO:0008015),-0.645101283591573,-1.1226988640362863,0.35714285714285715,0.5757903445913215,1.0,7/38,5.92%,SCPEP1;ELN;MYOF;C3AR1;GUCY1A1;SERPING1;CXCL10
1094,prerank,regulation of mitotic cell cycle (GO:0007346),-0.5341444962196233,-1.1226384499072999,0.2898550724637681,0.5752834957666082,1.0,25/152,15.32%,ASNS;NEK6;LGMN;SPHK1;MKI67;CKS2;CKS1B;BUB1B;SLC9A3R1;UBE2C;CDK1;DLGAP5;GAS1;APP;TGFB1;BTG1;FOXC1;CDK9;CCNB1;CDC25B;KIF20B;IQGAP1;CDC20;PSMB8;SDCBP
1095,prerank,regulation of smoothened signaling pathway (GO:0008589),-0.6269489548674796,-1.1222778633983024,0.35,0.5754438549557261,1.0,9/40,11.81%,SFRP1;RAB34;EVC;GPC3;GLIS2;KIF7;GAS1;SMO;FGFR2
1096,prerank,positive regulation of developmental process (GO:0051094),-0.5653450838809329,-1.1217215437070267,0.26153846153846155,0.5759779801012099,1.0,12/124,5.65%,BASP1;APOE;TMEM119;CCN2;FST;MDK;BMP1;PTN;RTN4;SOX9;SRC;NIBAN2
1097,prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.6558978284857194,-1.121526834317097,0.35185185185185186,0.5758049280675455,1.0,5/34,5.16%,MMP2;P2RY6;TGFB3;IGF1;EFEMP2
1098,prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.7446376157984856,-1.1212818963135185,0.3728813559322034,0.5757428877337039,1.0,7/17,17.70%,CLEC7A;LAPTM5;LACC1;PLCG2;B2M;SLC7A5;CD55
1099,prerank,mRNA processing (GO:0006397),-0.4963314828853149,-1.1212204455458206,0.17142857142857143,0.5751148988777056,1.0,1/282,0.04%,PABPC1
1100,prerank,axonogenesis (GO:0007409),0.473525624108551,1.1209939062599121,0.15,0.8255646225767204,1.0,21/163,9.66%,EFNB3;LRTM1;APBB1;LGI1;RAB3A;EPHA4;SPTB;MYPN;RAP1GAP;VLDLR;GPC1;SH3KBP1;AUTS2;LGR6;PARD3;DOK4;SEMA6A;AFG3L2;NEXN;BSG;RET
1101,prerank,microtubule polymerization (GO:0046785),0.6427071356217353,1.1206009884891273,0.3333333333333333,0.8237609225990392,1.0,6/25,15.14%,MAPT;CLASP1;FGF13;TPPP;SLAIN2;TUBG1
1102,prerank,regulation of JNK cascade (GO:0046328),-0.5489521673303385,-1.1204393434180855,0.25757575757575757,0.5763363678953632,1.0,9/82,5.11%,CCN2;PTK2B;FCGR2B;GADD45B;NCF1;TLR9;SIRPA;RASSF2;DACT1
1103,prerank,regulation of DNA binding (GO:0051101),0.619810945118845,1.1202772151108116,0.32558139534883723,0.8217105212512374,1.0,1/39,0.02%,ILRUN
1104,prerank,negative regulation of cell development (GO:0010721),-0.6974299152292573,-1.1200070466894299,0.36363636363636365,0.5765769370892535,1.0,2/15,4.78%,FBN1;IGF1
1105,prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.6948107668254363,-1.11947207020257,0.3380281690140845,0.5770508003443275,1.0,6/24,8.38%,HTR2B;PIK3R5;PIK3CG;IGF1;PIK3CD;TYRO3
1106,prerank,regulation of dendritic spine development (GO:0060998),-0.6860061748110419,-1.119399821610959,0.40350877192982454,0.5765204473588886,1.0,1/15,0.51%,APOE
1107,prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.6709251582655756,-1.119241754023214,0.3076923076923077,0.5763070276253089,1.0,4/25,6.52%,MMP14;ARRDC1;NIBAN2;LFNG
1108,prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.6822637707199949,-1.1189789753952144,0.3103448275862069,0.5762997366387298,1.0,5/21,9.49%,ENPP1;GPR161;GPC3;GLIS2;KIF7
1109,prerank,peptidyl-tyrosine modification (GO:0018212),-0.6087397995303313,-1.1187762623046502,0.3181818181818182,0.5760597117588303,1.0,9/48,8.01%,HCK;PTK2B;PTPN6;FGR;CSF1R;BTK;SRC;FES;FGFR1
1110,prerank,regulation of mRNA polyadenylation (GO:1900363),0.7017779455762525,1.1187240431537888,0.4186046511627907,0.8241605680341125,1.0,1/17,2.04%,CPEB3
1111,prerank,RNA processing (GO:0006396),0.47251899110696755,1.1185315848654258,0.17857142857142858,0.8220947810773366,1.0,8/166,10.19%,SRRM4;PPARGC1A;PRKACA;RBPMS;IVNS1ABP;SNRPN;MRPL44;PABPC4
1112,prerank,vesicle organization (GO:0016050),-0.6137787763772216,-1.1174234679995034,0.3508771929824561,0.5786372800061984,1.0,6/44,12.88%,ANXA8;CORO1A;RNF26;DNM1;PI4K2B;SNX10
1113,prerank,positive regulation of autophagy (GO:0010508),0.536944418482664,1.1173119956328645,0.3,0.8235838355573042,1.0,8/75,7.22%,KDR;PINK1;SVIP;GPSM1;SH3GLB1;EPM2A;OPTN;PRKAA2
1114,prerank,regulation of cellular protein localization (GO:1903827),-0.5708258228057466,-1.1172086642835295,0.2777777777777778,0.5783813721177438,1.0,6/40,6.51%,LCP1;MAP1A;KCNAB2;ATP13A2;GPC3;PTPN1
1115,prerank,cellular response to amino acid starvation (GO:0034198),-0.577645904734815,-1.116065227605849,0.2608695652173913,0.5805816593874548,1.0,4/66,7.07%,TCIRG1;DAP;ATP6V0D2;CASTOR1
1116,prerank,ceramide metabolic process (GO:0006672),-0.6425719395940876,-1.1160611312875641,0.3387096774193548,0.5798880134383659,1.0,7/37,7.99%,PLA2G15;PLPP2;GBA;CERS6;ASAH1;SPTLC2;SGPL1
1117,prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.5404853005505547,-1.1145284947395406,0.3333333333333333,0.5830747500365444,1.0,33/99,19.49%,NEK6;CDCA8;DYNLL1;NUF2;BUB1B;CENPT;SPC25;DLGAP5;TACC3;BIRC5;KIF11;CENPE;EML4;CCNB1;STMN1;RCC2;NDC80;AURKB;CDC20;ZWILCH;WDR62;NUSAP1;AURKA;PLK2;CENPO;BUB1;KIF3B;DSN1;KIF2C;INCENP;KNTC1;PLK1;MAD2L1
1118,prerank,tRNA methylation (GO:0030488),0.6421925717258683,1.1135664028643768,0.32,0.8321741620376909,1.0,6/26,18.65%,HSD17B10;MTO1;TRMT10C;TRMT5;TRMT1L;LCMT2
1119,prerank,inositol lipid-mediated signaling (GO:0048017),-0.6633841733393055,-1.1133986225900172,0.3114754098360656,0.5853703225369572,1.0,7/40,10.97%,CSF1R;PIK3CG;IGF1;PTAFR;PIK3CD;FGFR1;PDGFRB
1120,prerank,artery development (GO:0060840),-0.6551950341880965,-1.1132615150464877,0.3728813559322034,0.5849449964038377,1.0,5/17,7.66%,GJA5;EFEMP2;TGFBR1;SLC2A10;ROBO1
1121,prerank,positive regulation of viral life cycle (GO:1903902),-0.717362737936051,-1.1127400006927253,0.3333333333333333,0.5855784413742392,1.0,5/18,12.05%,CD74;P4HB;TYRO3;LGALS1;AXL
1122,prerank,glycolytic process (GO:0006096),0.6833371668048251,1.1121625468494047,0.33962264150943394,0.8335602201550735,1.0,8/20,9.87%,ENO3;PFKM;HK2;GCK;PGAM2;PFKFB2;GAPDH;PGM1
1123,prerank,replication fork processing (GO:0031297),-0.6408028833386976,-1.1120868218908,0.35384615384615387,0.5863729207062668,1.0,5/26,15.57%,FAM111A;CDK9;MMS22L;DNA2;SAMHD1
1124,prerank,response to amino acid (GO:0043200),0.6524154474239717,1.1114573109174697,0.32608695652173914,0.8330722178516812,1.0,2/22,7.51%,CPEB3;RRAGD
1125,prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.5644539329773651,-1.1105601126849833,0.26153846153846155,0.5893166019226753,1.0,5/95,6.62%,NKD2;RNF180;CLU;MAP1A;CEBPA
1126,prerank,ERBB2 signaling pathway (GO:0038128),-0.6185051122864516,-1.1095593853806434,0.3275862068965517,0.5910236411376698,1.0,3/26,5.62%,EREG;SRC;PTPN18
1127,prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.7216498499992723,-1.1092274451465578,0.41818181818181815,0.591268982742842,1.0,8/19,11.55%,PTPRC;LAPTM5;TLR9;SASH3;LACC1;EPHB2;PTPN22;CD86
1128,prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.6581595262798112,1.1090732021114573,0.3333333333333333,0.8384422239102026,1.0,9/20,24.96%,NKX2-5;PSMC3;SRF;MED24;MED16;MED1;MED4;PSMC6;PSMC2
1129,prerank,response to hydrogen peroxide (GO:0042542),-0.6145515859382957,-1.1090530134195953,0.3064516129032258,0.5909610285522938,1.0,8/42,8.70%,CYP1B1;ANXA1;HMOX1;SIRPA;PRKCD;MAPK7;ADAM9;GPX1
1130,prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.6807890396107165,-1.108877189859193,0.3275862068965517,0.590559546827661,1.0,6/20,10.55%,CCN3;C1QTNF3;TMSB4X;SPI1;NLRC3;TSPAN6
1131,prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.7402468780132295,-1.1087589505725504,0.3442622950819672,0.5901724610723503,1.0,7/16,15.98%,SNAI1;TGFB1;NOTCH2;BMP2;SNAI2;JAG1;ACVR1
1132,prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.5651809513555262,-1.1082707796553177,0.3076923076923077,0.5907803467459701,1.0,4/76,6.62%,NKD2;RNF180;CLU;CEBPA
1133,prerank,artery morphogenesis (GO:0048844),-0.6446207015923304,-1.1076798712396483,0.38333333333333336,0.5915880636039315,1.0,5/22,10.97%,LRP1;TGFB2;GJA5;TGFBR1;PDGFRB
1134,prerank,DNA geometric change (GO:0032392),-0.686498950949348,-1.1075324679137795,0.3611111111111111,0.5911743304965854,1.0,1/21,1.65%,ANXA1
1135,prerank,protein K63-linked deubiquitination (GO:0070536),0.6059407982180731,1.1072811737916621,0.3333333333333333,0.8423440865915418,1.0,6/28,23.18%,USP13;ABRAXAS1;OTUD4;BRCC3;USP25;USP20
1136,prerank,amyloid fibril formation (GO:1990000),-0.6072818780479586,-1.106174678633224,0.39344262295081966,0.5936930888511665,1.0,10/39,14.26%,CALCA;NPPA;TGFBI;CST3;APP;MFGE8;B2M;HSPG2;RIPK1;TSPAN14
1137,prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.6894822228432991,-1.105594724042263,0.3333333333333333,0.5944678097774151,1.0,4/21,6.24%,MARCO;ADCY7;FLNA;ADCY3
1138,prerank,gene expression (GO:0010467),0.44299426401702385,1.1044961135145468,0.2777777777777778,0.8486503263460713,1.0,35/322,14.15%,RPL3L;MLF1;MRPL42;HSPD1;EIF4G1;MRPL55;EIF4E;MRPS36;EEF1A2;MRPL18;MRPL51;MRPL28;RBPMS;MRPL3;MRPL9;WDR33;MRPL41;TESC;MRPL44;MRPL37;PABPC4;MRRF;MRPS33;YARS2;MRPS15;MRPS7;MRPL34;MRPS21;FASTKD2;MRPS17;MRPS18A;MRPS14;MRPS5;FARSB;POLR2C
1139,prerank,multivesicular body organization (GO:0036257),0.6423558557746056,1.1044789335377119,0.39473684210526316,0.8457212093280164,1.0,1/29,4.44%,CHMP4C
1140,prerank,barbed-end actin filament capping (GO:0051016),-0.6845749297048673,-1.10443648303179,0.3076923076923077,0.595905103239452,1.0,2/15,5.55%,CAPG;CAPZA1
1141,prerank,actin filament capping (GO:0051693),-0.6845749297048673,-1.10443648303179,0.3076923076923077,0.595905103239452,1.0,2/15,5.55%,CAPG;CAPZA1
1142,prerank,regulation of interferon-alpha production (GO:0032647),-0.6647983283875828,-1.1023350627319304,0.36363636363636365,0.6005782770323266,1.0,6/23,8.72%,HAVCR2;IRF5;TLR9;TLR8;TLR7;NLRC3
1143,prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.48854634288334614,-1.1022118559335963,0.24358974358974358,0.6001569502087796,1.0,68/313,12.64%,COL1A1;VAV1;HCK;MMP2;PAK1;NCKAP1L;TCIRG1;ARPC1B;PTK2B;GDF15;LCP2;SH2B2;FGR;SULF1;VEGFD;BLNK;NCF1;CSF1R;CYBB;CYBA;SRC;IGF1;ATP6V0D2;ARPC5;NCF4;SHC2;SLA;ROR2;SULF2;ITGB3;FES;NCF2;ACTG1;AP3S1;COL4A6;PDGFC;BDKRB2;FGFRL1;FGFR1;PTPRJ;ATP6V0A4;RGS14;ARPC4;TYRO3;HGF;ARPC2;DNM1;MST1R;EPHB2;FOXC2;MET;MERTK;PDGFRB;FOXC1;SDC2;ACTB;STAP1;ANGPT2;FGFR2;STMN1;ATP6V1A;AXL;CASP3;FLRT2;TIAM1;PGF;EPHB6;EIF2AK3
1144,prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.6287605719024518,1.1014398433019819,0.35135135135135137,0.8520829538270309,1.0,3/21,4.92%,FKBP4;MAPT;CLASP1
1145,prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.6733275053038092,1.1010520206597714,0.40384615384615385,0.8503516102332684,1.0,5/20,4.10%,ENO3;PFKM;HK2;GCK;PGAM2
1146,prerank,regulation of cell development (GO:0060284),-0.662336934681358,-1.1009454362240751,0.3392857142857143,0.6021956864187706,1.0,7/30,11.41%,CX3CR1;ADGRA2;GRN;CX3CL1;SLAMF8;DOCK7;NOTCH2
1147,prerank,connective tissue development (GO:0061448),-0.6493367697868073,-1.1009125612816884,0.3442622950819672,0.6015079205655891,1.0,7/28,7.75%,SULF1;SH3PXD2B;SOX9;CD44;COL2A1;SULF2;SPTLC2
1148,prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.6600525216347946,-1.1007274265480986,0.390625,0.6012991651763568,1.0,4/23,6.02%,PTPRC;HTR2B;F2R;TRPV2
1149,prerank,mRNA splice site selection (GO:0006376),-0.6695279586273251,-1.1004544860690413,0.3898305084745763,0.6013160769484341,1.0,2/26,13.87%,CELF4;SRSF9
1150,prerank,regulation of tissue remodeling (GO:0034103),-0.7200818261371186,-1.0999400582831447,0.44642857142857145,0.6019547899358708,1.0,5/15,5.31%,GPNMB;MDK;THBS4;IL18;RUNX1
1151,prerank,rRNA transcription (GO:0009303),-0.6313607308758978,-1.099864497569621,0.39655172413793105,0.6014026441814772,1.0,2/17,13.55%,ANG;SIRT7
1152,prerank,cellular protein metabolic process (GO:0044267),-0.4814802898454823,-1.0997909020312382,0.2,0.6008517765422557,1.0,23/329,5.17%,LOX;FSTL1;SPP1;FN1;APOE;MMP2;FBN1;CSF2RB;LOXL2;TNC;CTSH;TIMP1;FSTL3;IGFBP4;IGFBP7;IGFBP3;MXRA8;EEF1A1;MAN2B1;IGF1;SERP1;LGMN;PLOD2
1153,prerank,phosphatidic acid biosynthetic process (GO:0006654),0.598831532110607,1.0997502916379027,0.34146341463414637,0.8519675269466411,1.0,8/32,12.91%,PLA2G5;GNPAT;DGKE;PLA2G12A;AGPAT3;GPD1L;GPAM;ACP6
1154,prerank,cellular response to growth factor stimulus (GO:0071363),-0.5247726380595404,-1.0996418668724526,0.30985915492957744,0.6005131387664467,1.0,23/129,12.28%,SFRP1;CILP;ANXA1;ADAMTS12;SOX9;CD44;EEF1A1;CCL5;LGMN;SPHK1;TGFBR1;KNSTRN;MAPK7;HGF;GAS1;WNT4;RUNX2;TGFB1;FOXC1;ZFP36L2;BMP2;SNAI2;CORO1B
1155,prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.5453617140713188,1.0992330303986204,0.2777777777777778,0.8506330579383365,1.0,12/36,11.34%,LPL;MLYCD;NDUFAB1;CBR4;ABCD3;OSBPL1A;OSBPL6;AMACR;HSD17B10;ALOX5;OXSM;ACSF3
1156,prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.6637038585383737,-1.098745444301101,0.3770491803278688,0.6019136618708701,1.0,3/29,2.61%,SFRP2;PAK1;TCF21
1157,prerank,positive regulation of protein metabolic process (GO:0051247),-0.5580216997764855,-1.098700186547653,0.3392857142857143,0.601350956592309,1.0,15/88,11.55%,APOE;CLU;TLR9;GBA;DACT1;IL18;NKD1;GPC3;MAPK7;CD80;UHRF1;APP;INHBA;TGFB1;CD86
1158,prerank,DNA biosynthetic process (GO:0071897),-0.7154439151865154,-1.0982812501239827,0.3508771929824561,0.6016173169569673,1.0,4/15,19.65%,TYMS;POLD4;PPIA;POLD3
1159,prerank,chromatin assembly (GO:0031497),-0.6294033048708114,-1.0982624245489465,0.34,0.6009906274008364,1.0,8/33,21.05%,SOX9;NAP1L1;CHAF1B;PADI4;BRD2;NPM1;CHAF1A;HMGB2
1160,prerank,regulation of cAMP-mediated signaling (GO:0043949),0.6707689162604838,1.0981209166729746,0.425531914893617,0.8516620504510847,1.0,8/16,17.94%,MGRN1;CDC34;UBE2B;PDE4D;PRKAR2A;PDE2A;PDE3A;RAPGEF2
1161,prerank,zymogen activation (GO:0031638),-0.6917911726453647,-1.0978266058244628,0.375,0.6011519177197193,1.0,6/22,7.44%,MMP14;CTSH;PLAU;LGMN;VSIR;C1RL
1162,prerank,cellular glucose homeostasis (GO:0001678),0.6125697922124361,1.0973038403457251,0.36585365853658536,0.8513471816973593,1.0,6/33,7.22%,PPARGC1A;HK2;GCK;KCNB1;PRKACA;PRKAA2
1163,prerank,generation of neurons (GO:0048699),-0.542023841199766,-1.097067142125069,0.25396825396825395,0.6022032253518042,1.0,31/106,17.79%,FZD2;ITM2C;CX3CR1;TGFB2;RUNX1;TUBB2B;FZD1;CX3CL1;RACGAP1;FGFR1;ATOH8;SMARCA1;DOCK7;WNT4;MAP1B;RUNX2;MET;LRP12;WNT11;RUNX3;CASP3;FZD7;LDB1;FZD8;BHLHE40;MTPN;CDK6;GPM6A;PER2;BRSK1;SDCCAG8
1164,prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.6116233460825675,-1.0969432311699374,0.3283582089552239,0.6019834664549442,1.0,9/48,12.35%,ANXA1;AIF1;UBE2C;CDK1;DLGAP5;CCNB1;RCC2;CDCA5;CDC25B
1165,prerank,Rac protein signal transduction (GO:0016601),-0.6468656395783804,-1.0964555641633231,0.3442622950819672,0.6025349834016213,1.0,4/18,12.24%,AIF1;RAC2;RHOG;TIAM1
1166,prerank,peptidyl-lysine methylation (GO:0018022),0.6270716917469386,1.0961451562008717,0.39473684210526316,0.8522579868718703,1.0,6/21,16.71%,SMYD1;KMT5A;EEF1AKMT1;ETFBKMT;SMYD2;ATPSCKMT
1167,prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.6947158364339296,-1.0956732297743343,0.38,0.603398414090823,1.0,5/24,9.03%,EREG;NCF1;DOK1;ARAP1;PLAUR
1168,prerank,glucose catabolic process to pyruvate (GO:0061718),0.6832960402981152,1.095454401595525,0.42,0.8486869637014832,1.0,5/19,4.10%,ENO3;PFKM;HK2;GCK;PGAM2
1169,prerank,canonical glycolysis (GO:0061621),0.6832960402981152,1.095454401595525,0.42,0.8486869637014832,1.0,5/19,4.10%,ENO3;PFKM;HK2;GCK;PGAM2
1170,prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.5988916731419146,-1.0948720224526225,0.31746031746031744,0.6042989734591436,1.0,9/53,8.01%,HCK;PTK2B;PTPN6;FGR;CSF1R;BTK;SRC;FES;FGFR1
1171,prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.5669364934242751,1.0945902494626818,0.3181818181818182,0.8491938014349424,1.0,8/37,6.57%,HRC;DHRS7C;ANK2;CASQ2;JPH1;JPH2;PRKACA;TRDN
1172,prerank,visual perception (GO:0007601),-0.6211931576861721,-1.0936868617503719,0.38596491228070173,0.6064603390823033,1.0,6/35,6.08%,COL1A1;COL11A1;COL18A1;COL2A1;RGS16;EYA4
1173,prerank,epithelium development (GO:0060429),-0.5657820154831852,-1.093521546443155,0.2923076923076923,0.6061589527846896,1.0,21/71,12.13%,LOXL3;LGALS3;TAGLN;TCF21;RCN3;SOX9;DACT1;CTSB;OSR1;MEOX1;SLC9A3R1;ANXA4;CDK1;TAGLN2;WNT4;SMO;TGFB1;CNN3;FGFR2;BMP2;SNAI2
1174,prerank,cellular response to gamma radiation (GO:0071480),0.7000585955393145,1.0931985793790413,0.3488372093023256,0.8506897491838802,1.0,7/16,22.47%,CRYAB;MAP3K20;TMEM109;YAP1;XRCC5;HSF1;TSPYL5
1175,prerank,regulation of establishment of cell polarity (GO:2000114),-0.734779493992209,-1.0925670032261465,0.3387096774193548,0.607884621685464,1.0,6/16,15.76%,PTK2B;SHTN1;CYRIB;KIF20B;RAP1B;RACK1
1176,prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.5385620059980445,-1.092418318198124,0.2948717948717949,0.6075174269661354,1.0,7/99,4.29%,LGALS3;PLEK;LCP1;CAPG;CLEC7A;CLU;SRC
1177,prerank,cellular response to osmotic stress (GO:0071470),0.6564658249984122,1.091764603027757,0.4186046511627907,0.8524430398296248,1.0,6/15,14.79%,RCSD1;OXSR1;CAB39;AQP1;ZFAND1;STK39
1178,prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.6051920133041031,-1.0917506357665858,0.3384615384615385,0.6085637090761755,1.0,13/47,22.01%,GTSE1;E2F1;CDK1;CCNB1;SFN;BAX;AURKA;PLK2;PLK3;PML;CDKN1A;PLAGL1;ARID3A
1179,prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.6822892095882347,-1.0913878057256194,0.36619718309859156,0.6086367176851857,1.0,2/21,2.06%,PTK2B;FGR
1180,prerank,positive regulation of B cell proliferation (GO:0030890),-0.6826821097521228,-1.091358667421133,0.34782608695652173,0.6080113065457231,1.0,5/22,5.36%,NCKAP1L;PTPRC;TLR9;SASH3;CD74
1181,prerank,positive regulation of intracellular protein transport (GO:0090316),-0.5345599714388637,-1.0913005571959105,0.2463768115942029,0.6075164718588507,1.0,19/133,11.82%,ITGB2;CEMIP;ITGAM;SEC16B;PRKCD;FLNA;RAC2;HCLS1;GTSE1;E2F1;GAS6;MYO1C;BID;RHOU;RAB29;LEPROT;TGFB1;ZDHHC2;SFN
1182,prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.6948387048512197,-1.0902441289118603,0.4032258064516129,0.6091127800138092,1.0,6/18,15.76%,PTK2B;SHTN1;CYRIB;KIF20B;RAP1B;RACK1
1183,prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.6650403826982748,-1.0902350224360515,0.40384615384615385,0.6084502905867559,1.0,4/15,12.13%,SNAI1;RUNX1;MYO1C;SNAI2
1184,prerank,protein ubiquitination (GO:0016567),0.42628119832408345,1.088037847142624,0.1282051282051282,0.8608194478674425,1.0,58/419,14.94%,PINK1;KLHL41;ASB12;FBXO31;PEX10;LMO7;TRIM63;NHLRC1;ASB2;ASB11;TRIM72;FBXW7;UBE2QL1;SH3RF2;MGRN1;TRIM54;PRPF19;CAND2;EPAS1;KLHL21;TRIM55;TRIM7;ANKRD9;PSME4;CDC34;UBE2B;MARCHF6;ASB5;FBXL22;FBXO40;UBE3B;KLHL24;UBR3;KLHL8;DET1;KLHL3;FBXO21;UBR2;FBXO32;KLHL12;AKTIP;LEO1;MKRN2;PRKN;KLHL7;PJA2;FBXO44;MUL1;PSMC3;PSME3;UBC;CUL4A;CUL5;UBE2G1;PSMD12;RNF10;UBE2D1;HUWE1
1185,prerank,development of primary male sexual characteristics (GO:0046546),-0.6985958339749506,-1.0879481147637982,0.43636363636363634,0.6130540491958304,1.0,5/21,10.49%,SOX9;TGFB2;LHFPL2;WNT4;INHBA
1186,prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.6270053436059589,-1.0878209684081903,0.34,0.6127100537632167,1.0,7/25,21.60%,CENPT;MIS18A;CENPO;NPM1;CENPL;ASF1B;HJURP
1187,prerank,histone methylation (GO:0016571),0.5962661357557858,1.0870992040574847,0.35714285714285715,0.8614917012228774,1.0,1/22,1.62%,SMYD1
1188,prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.6526646204838946,-1.085992662152758,0.3230769230769231,0.6158858874631289,1.0,2/29,2.06%,PTK2B;FGR
1189,prerank,protein insertion into membrane (GO:0051205),-0.6255200028885048,-1.0850370423102567,0.35294117647058826,0.6175536048119813,1.0,6/26,11.16%,HMOX1;SERP1;TRAM2;SEC61B;APP;TRAM1
1190,prerank,positive regulation of lipid catabolic process (GO:0050996),0.6993723775503033,1.0849038354085512,0.40540540540540543,0.8658387415125123,1.0,2/15,4.91%,PLIN5;PPARA
1191,prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.7538548599377625,-1.0844959189084378,0.41379310344827586,0.6177290039721918,1.0,6/17,17.40%,ZDHHC24;ZDHHC2;GOLGA7;ZDHHC15;ZDHHC12;ZDHHC20
1192,prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.7538548599377625,-1.0844959189084378,0.41379310344827586,0.6177290039721918,1.0,6/17,17.40%,ZDHHC24;ZDHHC2;GOLGA7;ZDHHC15;ZDHHC12;ZDHHC20
1193,prerank,activation of protein kinase activity (GO:0032147),-0.5222843724022644,-1.083978059245248,0.28,0.6180593363476337,1.0,13/90,8.20%,PAK1;CALCA;PTK2B;SLC11A1;ADCY7;TGFB2;PRKCD;IGF1;IL18;ITGB3;ADCY3;GAS6;TPX2
1194,prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.7124493836827712,1.0835907692509454,0.38461538461538464,0.8665163742138495,1.0,6/16,17.20%,EPHX2;ALOX12;ALOX5;GSTM1;GPX4;GSTP1
1195,prerank,regulation of exit from mitosis (GO:0007096),-0.5991229166117167,-1.0834062874588983,0.3684210526315789,0.6189125543840145,1.0,9/36,19.49%,ANLN;BUB1B;UBE2C;CDCA5;CDC20;PPP1R9B;KNTC1;RPS27A;MAD2L1
1196,prerank,synapse organization (GO:0050808),-0.5812052920698977,-1.0827243099896589,0.31666666666666665,0.6196618071135055,1.0,11/71,6.50%,C1QB;C1QC;C1QA;CX3CR1;PPFIA4;PTPRF;C5AR1;CACNB3;F2R;CX3CL1;FARP1
1197,prerank,glycerophospholipid metabolic process (GO:0006650),-0.567563473511633,-1.0821086938172473,0.36065573770491804,0.6205240708612797,1.0,4/55,3.64%,PLEK;PLA2G7;CSF1R;PLA2G15
1198,prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.6825088354459673,1.0819734563561971,0.4,0.8688198514835571,1.0,3/16,8.58%,PINK1;SOD2;TRAP1
1199,prerank,cellular response to hydrogen peroxide (GO:0070301),-0.6500321042469666,-1.0814031026974948,0.3620689655172414,0.6218171820451284,1.0,5/29,7.41%,CYP1B1;ANXA1;SIRPA;PRKCD;MAPK7
1200,prerank,nuclear transport (GO:0051169),-0.6660552270492226,-1.080755214909031,0.3269230769230769,0.6226624059702013,1.0,2/15,18.64%,RGS14;NPM1
1201,prerank,blood vessel morphogenesis (GO:0048514),-0.6116574161290035,-1.0804966881135225,0.3870967741935484,0.6227056321050655,1.0,2/44,0.36%,LOX;CYP1B1
1202,prerank,long-chain fatty acid transport (GO:0015909),0.6081878914305752,1.0804965768779782,0.38,0.8705316261888245,1.0,9/25,7.22%,ACACB;CPT1B;FABP3;CPT2;SLC25A20;CD36;ABCD3;ACSL1;PRKAA2
1203,prerank,necroptotic process (GO:0070266),-0.7008039239767693,-1.0798727596775797,0.38333333333333336,0.6236367902146109,1.0,6/15,18.47%,CD14;TICAM2;RIPK1;MLKL;RIPK3;LY96
1204,prerank,negative regulation of cellular component organization (GO:0051129),-0.5849672127896439,-1.0796338542383233,0.3793103448275862,0.6234127252097346,1.0,8/61,10.39%,LGALS3;CLU;SRC;GBA;CARMIL1;FAP;MCTP1;NR1H4
1205,prerank,phosphatidic acid metabolic process (GO:0046473),0.5988205909475254,1.0793082748719267,0.36585365853658536,0.8713178959099043,1.0,8/33,12.91%,PLA2G5;GNPAT;DGKE;PLA2G12A;AGPAT3;GPD1L;GPAM;ACP6
1206,prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.6453571855238742,1.0775121811195425,0.37777777777777777,0.8743122944405094,1.0,2/15,7.18%,CLIC4;PARD3
1207,prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.6559355431864715,-1.0771960898665485,0.45098039215686275,0.6287206844336793,1.0,3/16,11.81%,RUNX1;TGFBR1;FGFR2
1208,prerank,protein localization to organelle (GO:0033365),-0.520974079586948,-1.0765911691492807,0.2459016393442623,0.629642076992607,1.0,11/116,11.16%,COL1A1;CD68;HMOX1;SERP1;TRAM2;SEC61B;HHEX;APP;LAMP2;GAK;TRAM1
1209,prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.49379189715039934,-1.0753834841449355,0.2676056338028169,0.6318244209008871,1.0,35/187,14.37%,TLR2;FZD2;ADAM8;CLEC7A;CX3CR1;CLU;TLR9;BTK;NFAM1;ANXA3;IKBKE;SPHK1;IL18;PRKCB;FZD1;HCLS1;CX3CL1;CARD11;IL18RAP;RAB7B;TRAF1;TNFRSF11A;CAMK1D;SMO;APP;LRP8;PLCG2;TLR6;STING1;TRADD;AIM2;PYCARD;TRIM62;RIPK1;EDN1
1210,prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6385922167688073,1.0746542809452753,0.375,0.8805314623655226,1.0,1/17,1.75%,PROX1
1211,prerank,sterol biosynthetic process (GO:0016126),0.6439056129131335,1.073879795018473,0.4,0.8804757752826101,1.0,1/27,0.31%,ACAA2
1212,prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.676125049971717,-1.073591426126753,0.4,0.6354275389316588,1.0,2/19,3.00%,PTK2B;MAFB
1213,prerank,nucleosome assembly (GO:0006334),-0.6251717107753783,-1.0735863928866405,0.37254901960784315,0.63475061307325,1.0,9/31,21.28%,SOX9;NAP1L1;CHAF1B;PADI4;BRD2;NPM1;CHAF1A;HMGB2;ASF1B
1214,prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6576039947225742,1.0729855353542577,0.391304347826087,0.8806525238566159,1.0,1/16,1.75%,PROX1
1215,prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.6650923398797941,-1.0723860198735573,0.41304347826086957,0.636882327816615,1.0,4/18,15.65%,SRC;MSN;DAB2;MAPK3
1216,prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.6031239030911058,-1.0721810727513592,0.44642857142857145,0.6366579626308874,1.0,13/38,22.28%,TGFB2;MYC;FOXM1;MID1;PPIA;MAPK3;FAS;TAOK3;CARD9;EGFR;MAPK8IP1;F2RL1;RAP2A
1217,prerank,sensory perception (GO:0007600),-0.6458920023764234,-1.0721296311263333,0.3888888888888889,0.6361075219478467,1.0,6/20,8.59%,CCR2;P2RX4;C5AR1;P2RX7;TRPV2;MYO7A
1218,prerank,double-strand break repair (GO:0006302),0.46825798862284385,1.0707227931353256,0.25,0.8854547389657599,1.0,3/132,5.63%,APBB1;PRPF19;POLQ
1219,prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.5785972653589998,-1.0703301281925457,0.31746031746031744,0.6398115745156454,1.0,7/79,12.26%,STEAP2;TXNDC5;MYO5A;CLTA;APP;GOLGA7;OSBPL5
1220,prerank,MAPK cascade (GO:0000165),-0.48842493683382376,-1.069977484404197,0.2727272727272727,0.6399481803039806,1.0,30/236,11.81%,PAK1;CSF2RB;EREG;CTSH;NCAM1;HTR2B;SOX9;PTPN7;CCR5;IGF1;PLVAP;CCL5;SHC2;IL18;CSF2RA;IL3RA;MYC;RASA4;FGFR1;HGF;CDK1;RASAL3;DLG4;RASA3;TGFB1;MET;PDGFRB;ZFP36L2;GOLGA7;FGFR2
1221,prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.6559163133778199,-1.0698466970958365,0.3870967741935484,0.6395461687392782,1.0,2/24,3.72%,ANXA1;AIF1
1222,prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.6706685985482149,-1.0694372918701938,0.39344262295081966,0.6400079033391608,1.0,3/18,5.83%,PTPRC;HTR2B;F2R
1223,prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.6535748425473074,-1.0690214858992175,0.40425531914893614,0.6402312863274547,1.0,8/16,20.31%,B3GNT8;B3GNT9;B3GALNT1;EXT1;B3GALT1;NDST2;HS2ST1;CSGALNACT1
1224,prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.539164284952607,-1.068974276212862,0.4126984126984127,0.6396181598979397,1.0,14/79,11.51%,CEMIP;CSF1R;HTR2B;ADAM8;PIK3R5;SRC;PIK3CG;PDGFC;ROBO1;FGFR1;MST1R;TGFB1;PDGFRB;CALM2
1225,prerank,melanosome organization (GO:0032438),-0.6677533813104817,-1.0687126073789472,0.36363636363636365,0.639554802067808,1.0,3/22,8.82%,RAB32;HPS1;RAB29
1226,prerank,autophagosome organization (GO:1905037),0.5241061158698602,1.0686889086016977,0.375,0.8885608076938188,1.0,6/45,12.48%,ATP2A2;MAP1LC3A;WIPI1;EMC6;ATG9A;UBXN2A
1227,prerank,chromosome organization (GO:0051276),-0.5479461782744226,-1.0684773813098452,0.3181818181818182,0.6393670758209754,1.0,13/85,14.43%,CDCA8;PADI2;NUF2;TOP2A;MYC;CENPT;HHEX;NDC80;HMGN3;MTHFR;LDB1;HMGN1;PADI4
1228,prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.60840087061025,1.067772753901976,0.2857142857142857,0.8884546402940983,1.0,5/24,15.62%,HSPA9;DNAJB5;HSPA5;BAG1;HSPA8
1229,prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.6088982808754111,-1.0676662808430328,0.3275862068965517,0.6404607800667101,1.0,12/38,24.13%,PCLAF;FAAP20;POLD4;ISG15;RFC2;UBE2L6;RPS27A;POLD3;POLI;PRIMPOL;POLE;RFC5
1230,prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.6124295751521214,1.0671017550741415,0.36363636363636365,0.8874835846816799,1.0,10/28,11.02%,SCN4B;PPIF;ANK2;RANGRF;PTPN3;FXYD1;GPD1L;CAV3;HOMER1;PHB2
1231,prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.5981776057115317,-1.0670382622415457,0.42592592592592593,0.6411793950264248,1.0,5/33,6.57%,SERPINE1;CLU;ARRB2;ANXA2;CD63
1232,prerank,protein deacylation (GO:0035601),0.6419224091304842,1.0667621577618283,0.38636363636363635,0.8857573857241677,1.0,4/21,14.67%,SIRT3;SIRT5;ABHD10;LYPLA1
1233,prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.633934355993624,-1.0667493473133527,0.33962264150943394,0.6411146141235967,1.0,5/24,10.44%,ID2;TYMS;CDK14;E2F1;RRM2
1234,prerank,positive regulation of ATPase activity (GO:0032781),0.5800915202931214,1.0663750032188166,0.3902439024390244,0.8838397388571637,1.0,9/35,15.41%,MYL3;DYNLL2;RYR2;TPM1;DNAJB2;TNNT2;MYBPC3;AHSA1;PFN2
1235,prerank,granulocyte differentiation (GO:0030851),-0.7388353010172399,-1.0663430052779526,0.48214285714285715,0.6413970772216478,1.0,3/15,7.76%,SPI1;CEBPA;E2F1
1236,prerank,termination of RNA polymerase I transcription (GO:0006363),0.5886133883047852,1.065859301431729,0.4146341463414634,0.8830437322077107,1.0,7/29,20.27%,POLR1A;TAF1A;CCNH;POLR2E;POLR1E;POLR2L;POLR2F
1237,prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.6500787711168017,-1.0657973119450717,0.4032258064516129,0.6422237825448679,1.0,1/24,1.12%,NCKAP1L
1238,prerank,acylglycerol metabolic process (GO:0006639),-0.6229299503521132,-1.0650384701564148,0.4,0.6434940020293064,1.0,2/26,1.96%,APOE;APOBR
1239,prerank,regulation of cell cycle (GO:0051726),-0.4925243710477464,-1.0648396597794068,0.3333333333333333,0.6432540066704726,1.0,36/224,13.08%,SFRP1;NUPR1;PTPRC;GADD45B;SOX9;CDKN2B;NEK6;THBS1;TGFB2;ID2;TRNP1;CKS2;EVI2B;SKP2;FAP;PCLAF;TGFBR1;CKS1B;CCNB2;MYC;DLGAP5;BIN1;BIRC5;GADD45G;INHBA;TGFB1;FOXM1;CDK9;NOTCH2;CCNB1;RUNX3;FGFR2;BMP2;KIF20B;ADARB1;FBXL8
1240,prerank,inorganic cation import across plasma membrane (GO:0098659),0.573245638956406,1.0643727440725217,0.40540540540540543,0.884691074625041,1.0,11/39,6.39%,HCN4;SLC9A2;KCNJ3;KCNJ11;ABCC9;KCNJ5;HCN2;SLC12A7;ATP1A2;KCNJ12;KCNJ2
1241,prerank,positive regulation of protein transport (GO:0051222),-0.5866843066860304,-1.064186127838792,0.3709677419354839,0.6443475615200669,1.0,13/61,10.99%,TREM2;TGFB3;ADAM8;TGFB2;IGF1;ATP13A2;ABCG1;ADAM9;MYH10;RAB29;ANG;TGFB1;CLN3
1242,prerank,regulation of fibroblast migration (GO:0010762),-0.6690127212603355,-1.0639761665238,0.43548387096774194,0.6441441509037569,1.0,6/20,13.27%,THBS1;CORO1C;MACIR;TGFB1;CLN3;PRR5L
1243,prerank,protein localization to cilium (GO:0061512),-0.6277024965995802,-1.0639175380807304,0.43636363636363634,0.6436086417137591,1.0,7/23,22.39%,RAB29;WDR19;TCTN1;SNX10;TTC26;TCTN2;INVS
1244,prerank,cellular response to nitrogen compound (GO:1901699),-0.6150182385184797,-1.0632338703104545,0.39622641509433965,0.6444768222017168,1.0,3/17,19.16%,SPIDR;NR1H4;FMR1
1245,prerank,regulation of programmed cell death (GO:0043067),-0.5075494288717481,-1.062949414688604,0.3492063492063492,0.6444582750004981,1.0,26/134,14.28%,PTPN6;CLU;ACTN1;RTN4;SOX9;IGFBP3;CASP1;CTSB;SKP2;CXCL10;ASAH1;APAF1;BID;PRELID1;LGALS1;GAS1;BIRC5;STK26;MAGED1;LRP8;ACER3;BAX;TM7SF3;RIPK1;PLSCR3;TMEM219
1246,prerank,CENP-A containing chromatin organization (GO:0061641),-0.6564051340504188,-1.0626164600813435,0.43478260869565216,0.6438326644620256,1.0,6/17,21.60%,CENPT;MIS18A;CENPO;NPM1;CENPL;HJURP
1247,prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.6564051340504188,-1.0626164600813435,0.43478260869565216,0.6438326644620256,1.0,6/17,21.60%,CENPT;MIS18A;CENPO;NPM1;CENPL;HJURP
1248,prerank,neural crest cell differentiation (GO:0014033),-0.6953373400971897,-1.0622722548474985,0.43103448275862066,0.643814868924978,1.0,3/15,14.48%,HTR2B;SNAI2;SOX8
1249,prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.5818838279421374,-1.0620840950739576,0.4,0.6435156621913101,1.0,9/40,11.55%,TLR2;LAPTM5;TLR9;CD14;SPHK1;TLR7;ILK;APP;CD86
1250,prerank,regulation of trans-synaptic signaling (GO:0099177),-0.6629560401475622,-1.0614582234515315,0.44,0.6441216590858512,1.0,5/16,13.21%,CX3CR1;BCR;NLGN2;LRP8;FABP5
1251,prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.5710151819041926,-1.0613178044763347,0.4074074074074074,0.6437250787708342,1.0,8/52,10.59%,SFRP2;PAK1;CD44;HCLS1;GAS6;DOCK7;APP;TGFB1
1252,prerank,nucleosome organization (GO:0034728),-0.5674126935512666,-1.0609691554473935,0.3770491803278688,0.6437806604306362,1.0,9/52,21.05%,SOX9;NAP1L1;CHAF1B;PADI4;BRD2;NPM1;CHAF1A;SMARCD2;HMGB2
1253,prerank,regulation of double-strand break repair (GO:2000779),-0.5931425476034197,-1.0605042416746022,0.3770491803278688,0.6440920006651528,1.0,8/29,18.68%,WAS;TWIST1;SPIDR;FOXM1;SIRT7;ACTR2;SPIRE1;PML
1254,prerank,mitotic nuclear division (GO:0140014),-0.5689992249533161,-1.0591312182900086,0.35,0.6464840253064551,1.0,16/63,19.17%,CDCA8;FLNA;KNSTRN;UBE2C;TPX2;NCAPG2;KIF11;NDC80;SMC4;NUSAP1;SPAG5;CEP192;KIF3B;KIFC1;DSN1;PLK1
1255,prerank,regulation of hydrolase activity (GO:0051336),-0.5458620462377093,-1.0588619530232624,0.3582089552238806,0.6463905840302816,1.0,6/60,8.27%,VAV1;FGD3;ARHGAP15;PLXNC1;ARHGAP9;ADAP1
1256,prerank,oligosaccharide metabolic process (GO:0009311),0.6223095606032706,1.0588323817130878,0.3958333333333333,0.9002607554703408,1.0,1/27,0.24%,GAL3ST3
1257,prerank,arachidonic acid metabolic process (GO:0019369),-0.6379314040854391,-1.0582236453136038,0.46551724137931033,0.6473783096681032,1.0,4/24,5.39%,CYP1B1;PTGIS;TBXAS1;HPGDS
1258,prerank,muscle tissue morphogenesis (GO:0060415),0.6468565783938262,1.057801363485379,0.46,0.9008447810293282,1.0,6/15,12.44%,PROX1;TTN;ACTC1;TCAP;NKX2-5;NOTCH1
1259,prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.5994938791417379,-1.0576536911846026,0.4107142857142857,0.6479878174060455,1.0,4/42,8.85%,THBS1;RUNX1;RAB7B;MYL9
1260,prerank,peptide metabolic process (GO:0006518),-0.5444603979990543,-1.0564736862702029,0.32786885245901637,0.650062536650215,1.0,3/63,1.39%,AEBP1;CPXM1;ANPEP
1261,prerank,histone H4-K16 acetylation (GO:0043984),0.6183347882865501,1.0563868270684282,0.475,0.9023714674952497,1.0,8/18,31.47%,MSL1;KANSL3;MSL3;WDR5;JADE1;MSL2;KMT2A;KANSL2
1262,prerank,positive regulation of cell cycle process (GO:0090068),-0.5362281843324014,-1.0563019517882,0.3787878787878788,0.6496993387349468,1.0,16/69,15.14%,EREG;IGF1;RACGAP1;DBF4;PDGFRB;CCNB1;RCC2;NDC80;AURKB;CDC25B;KIF20B;EDN1;NUSAP1;AURKA;CDC42;SPAG5
1263,prerank,"DNA-templated transcription, initiation (GO:0006352)",0.4707320153258816,1.0561747354810567,0.3333333333333333,0.9002641796477511,1.0,27/148,16.25%,RXRG;PPARGC1A;RORC;NR4A1;NR3C2;RRN3;PPARA;ESRRB;ESRRA;ESRRG;TFB1M;POLR1A;HDAC9;TFB2M;TFAM;TBX5;NR0B2;NOTCH1;TAF6;TAF1A;POLR2C;TAF7;TAF4B;THRB;RARB;CCNH;YAP1
1264,prerank,negative regulation of cation transmembrane transport (GO:1904063),0.6729614574610382,1.0557743181439316,0.44642857142857145,0.8986896570050374,1.0,7/15,15.85%,PPIF;ATP1A2;CAV3;KCNH2;CAB39;STK39;COMMD1
1265,prerank,cellular response to peptide hormone stimulus (GO:0071375),0.5133869644492433,1.0556907235746695,0.30303030303030304,0.8961873159766497,1.0,9/83,5.67%,RAB12;SLC2A4;LPIN1;NR4A1;GOT1;TBC1D4;GCK;ADCY1;PRKACA
1266,prerank,regulation of cardiac conduction (GO:1903779),0.5530813355849246,1.0553493052546654,0.32432432432432434,0.894266084953911,1.0,14/39,8.89%,TNNI3K;ATP2A2;ANK2;KCNJ11;ASPH;RYR2;ABCC9;CASQ2;ATP1A2;PRKACA;TRDN;TMEM65;CORIN;FXYD1
1267,prerank,regulation of centrosome cycle (GO:0046605),0.6471349935015632,1.054792921753601,0.49019607843137253,0.8929206162987327,1.0,1/19,4.44%,CHMP4C
1268,prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.6261605893859288,-1.0536602361611522,0.4576271186440678,0.6551784035435778,1.0,4/31,10.49%,NCKAP1L;FES;RAB7B;INHBA
1269,prerank,metal ion transport (GO:0030001),-0.561755955052741,-1.0533717633986193,0.4426229508196721,0.6550401019006802,1.0,6/53,5.12%,KCNN4;SLC11A1;SLC39A8;CCR5;CCL5;CACNB3
1270,prerank,protein modification by small protein conjugation (GO:0032446),0.44280098746784635,1.0533275919281122,0.25806451612903225,0.8948346542036879,1.0,49/323,16.31%,PINK1;KLHL41;ASB12;PEX10;LMO7;DCUN1D2;TRIM63;ASB2;ASB11;TRIM72;FBXW7;MGRN1;TRIM54;CAND2;EPAS1;KLHL21;TRIM55;TRIM7;ANKRD9;CDC34;UBE2B;MARCHF6;ASB5;KLHL24;UBR3;KLHL8;DET1;KLHL3;UBR2;FBXO32;LEO1;MKRN2;PRKN;KLHL7;PJA2;MUL1;UBC;CUL4A;CUL5;UBE2G1;UBE2D1;HUWE1;UCHL3;ATG10;RNF14;COMMD1;MARCHF2;PEX12;SPSB4
1271,prerank,RNA catabolic process (GO:0006401),-0.5535090885175002,-1.0525938055790756,0.3469387755102041,0.6563744610669436,1.0,5/44,13.80%,ZC3H12D;RNASE6;ISG20;ZFP36L2;DNA2
1272,prerank,regulation of organelle organization (GO:0033043),0.483659902042603,1.051725958330529,0.2903225806451613,0.8973219291090503,1.0,20/72,15.93%,PINK1;PDE4DIP;MAPT;MAVS;CLIC4;RHOT2;PLXNB1;CLEC16A;CENPV;NEXN;MIEF2;DNM1L;PRKN;SAR1B;MUL1;ARMH3;RHOT1;MTM1;PDE2A;EZR
1273,prerank,cellular response to catecholamine stimulus (GO:0071870),0.5942408274468819,1.0513165782068032,0.425,0.8960280350621971,1.0,6/20,12.89%,RYR2;PRKACA;KCNQ1;ADCY6;GABPA;PRKN
1274,prerank,neuron development (GO:0048666),-0.5196341029571573,-1.0512415944950821,0.3770491803278688,0.6589477500332686,1.0,13/103,11.87%,NPY;APOE;TGFB2;GBA;TENM3;RUNX1;DOCK7;RAB13;APP;LRP12;SAMD14;RUNX3;STMN1
1275,prerank,regulation of intracellular pH (GO:0051453),0.652691196299158,1.0507264080007184,0.3953488372093023,0.894838876641862,1.0,2/19,1.80%,SLC9A2;SLC4A3
1276,prerank,cation transport (GO:0006812),0.5343379252670596,1.050482611298828,0.38095238095238093,0.893149747621497,1.0,24/75,9.43%,SCN4B;KCNIP2;CNGB3;HCN4;KCNJ3;SCN4A;KCNN1;NDUFA9;ABCC9;KCNK3;KCNJ5;KCNA5;SLC47A1;ATP1A2;KCNJ12;KCNG2;FGF13;KCNJ2;ABCC8;KCNN2;ANO10;SLC25A29;KCND3;KCNJ8
1277,prerank,error-free translesion synthesis (GO:0070987),0.6155682238363682,1.049498492011062,0.4166666666666667,0.8939026252777469,1.0,4/22,17.45%,POLDIP2;UBC;NPLOC4;VCP
1278,prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.6268700679987528,1.0489037331492779,0.5,0.8930906410841689,1.0,10/30,10.12%,WNK2;SCN4B;RANGRF;PRKCE;FGF13;PTPN3;WNK1;FXYD1;GPD1L;CAV3
1279,prerank,positive regulation of lamellipodium organization (GO:1902745),-0.6158285267532041,-1.0485713605174536,0.40298507462686567,0.6643216473849325,1.0,8/25,15.11%,SRC;CARMIL1;RAC2;CORO1C;ARPC2;CORO1B;ACTR3;CDC42
1280,prerank,response to organonitrogen compound (GO:0010243),-0.578166831452024,-1.048376707037992,0.3888888888888889,0.6641021021254897,1.0,2/26,2.97%,IRF5;RCN3
1281,prerank,positive regulation of nuclear division (GO:0051785),-0.6589269344343152,-1.0479917703262758,0.463768115942029,0.6643997816158466,1.0,6/18,15.03%,EREG;IGF1;PDGFRB;EDN1;NUSAP1;AURKA
1282,prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.6138314873124842,1.0479691712579131,0.475,0.8934562537002867,1.0,4/22,3.56%,HOMER2;FHL2;MYOZ2;CAMTA1
1283,prerank,circulatory system development (GO:0072359),-0.5262096601446097,-1.0479244011343931,0.38333333333333336,0.6639525199396745,1.0,12/102,6.53%,COL3A1;FN1;FBN1;SH3PXD2B;TCF21;SOX9;PDLIM2;TGFB2;PDLIM3;ID2;OSR1;TGFBR1
1284,prerank,negative regulation of microtubule depolymerization (GO:0007026),0.6116170477162669,1.047856137675569,0.4318181818181818,0.8910755631100522,1.0,6/20,15.28%,CLASP1;TRIM54;FGF13;MID1IP1;NAV3;APC2
1285,prerank,cellular response to chemical stress (GO:0062197),-0.5246188393259449,-1.0463452807021252,0.38095238095238093,0.6663723940715109,1.0,16/86,8.70%,GPX3;NOX4;NCF1;CYBB;PYCR1;AIF1;CYBA;SLC25A24;GPX7;NCF4;ATP13A2;NCF2;SOD3;ALDH3B1;GPX8;GPX1
1286,prerank,negative regulation of type I interferon production (GO:0032480),0.590612437009006,1.0459983822000822,0.35555555555555557,0.8939906229414175,1.0,3/37,6.03%,ILRUN;MAVS;PPM1B
1287,prerank,cellular response to interleukin-12 (GO:0071349),-0.5806681646073906,-1.045839218112826,0.41818181818181815,0.6667865492498313,1.0,11/38,15.11%,LCP1;SIRPA;CAPZA1;ANXA2;P4HB;CFL1;CNN2;MSN;RAP1B;PPIA;CDC42
1288,prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.4956030807708651,1.0447172832360603,0.3125,0.8952754020996793,1.0,3/89,5.67%,TUBA4A;CLASP1;PRKACA
1289,prerank,receptor metabolic process (GO:0043112),-0.5809263449932105,-1.0447108661775686,0.375,0.668779516323611,1.0,10/49,10.65%,ITGB2;FCER1G;RAB31;LRP1;ARRB2;LGMN;CD9;DNM1;TGFB1;MX1
1290,prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.6353815981007506,-1.0440881782430649,0.509090909090909,0.6694293747913524,1.0,7/30,14.80%,CX3CR1;CX3CL1;TGFBR1;TRAF1;MAZ;PYCARD;PPIA
1291,prerank,synaptic vesicle endocytosis (GO:0048488),-0.6364517419517872,-1.0431824781001797,0.4489795918367347,0.67062721434361,1.0,5/23,15.18%,DNM1;MX1;GAK;NLGN2;PICALM
1292,prerank,regulation of mitochondrial membrane potential (GO:0051881),0.573695254915833,1.042872198775721,0.37209302325581395,0.8980188867486828,1.0,5/31,6.90%,NDUFS1;PINK1;PRDX3;MAPT;PPA2
1293,prerank,RNA destabilization (GO:0050779),0.6412490527273734,1.042346726632197,0.48936170212765956,0.8969497476285063,1.0,6/17,25.15%,RBM24;CELF1;PUM1;METTL16;FTO;METTL14
1294,prerank,central nervous system neuron differentiation (GO:0021953),-0.6394078999298849,-1.041238945158914,0.3898305084745763,0.6748049795808605,1.0,1/17,0.44%,NPY
1295,prerank,glutathione metabolic process (GO:0006749),0.6102587757351685,1.0411302952604367,0.35294117647058826,0.8977677780712275,1.0,7/30,13.54%,MMACHC;GSTK1;GSTA4;CHAC2;HAGH;GSTM1;ETHE1
1296,prerank,negative regulation of ion transport (GO:0043271),0.6672597117747241,1.0409608473845944,0.4375,0.8957679635854949,1.0,3/16,3.79%,WNK2;PLN;CASQ2
1297,prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.5717592851078179,-1.0408848313986572,0.40384615384615385,0.675041317809439,1.0,6/35,8.14%,SFRP1;COL16A1;PTK2B;EFEMP2;CX3CL1;PTPRJ
1298,prerank,regulation of establishment of planar polarity (GO:0090175),-0.5289264907304031,-1.0407713951159154,0.3770491803278688,0.6745747781986949,1.0,10/80,15.25%,FZD2;ARRB2;DACT1;ROR2;FZD1;WNT11;TIAM1;FZD7;CDC42;PSMB8
1299,prerank,positive regulation of cell cycle (GO:0045787),-0.5514225759106702,-1.0406391610333112,0.3870967741935484,0.674180566002379,1.0,9/57,12.35%,NUPR1;ASNS;TGFB2;LGMN;SPHK1;APP;CCNB1;FGFR2;CDC25B
1300,prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.6039663457338387,-1.040586657852902,0.5185185185185185,0.6736208548111577,1.0,4/21,19.12%,WAS;SIRT7;ACTR2;KMT5C
1301,prerank,membrane fusion (GO:0061025),-0.6336153146607083,-1.040343911747223,0.45454545454545453,0.6735844853868032,1.0,1/30,0.73%,MYOF
1302,prerank,regulation of protein-containing complex assembly (GO:0043254),-0.5114877383298568,-1.0402807556937657,0.4153846153846154,0.6729909915005617,1.0,7/93,4.42%,APOE;LGALS3;HCK;CLEC7A;CLU;SRC;GBA
1303,prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.6203881681677768,-1.0398505177701838,0.3958333333333333,0.6732277409012161,1.0,10/32,11.37%,NOX4;EREG;NCF1;CSF1R;SRC;PTPN1;GAS6;DLG4;LRP8;STAP1
1304,prerank,steroid metabolic process (GO:0008202),-0.5984883236972304,-1.039845795139455,0.40350877192982454,0.672529371875385,1.0,8/34,10.51%,CYP1B1;STAR;LGMN;LIPA;TSPO;CYP7B1;NPC1;VDR
1305,prerank,regulation of DNA biosynthetic process (GO:2000278),-0.6260828339311298,-1.0389284668410637,0.4603174603174603,0.673676130755918,1.0,4/25,10.97%,NIBAN2;MYC;HGF;PDGFRB
1306,prerank,negative regulation of protein depolymerization (GO:1901880),0.5802171670886789,1.038549567731805,0.4222222222222222,0.8996699697265983,1.0,6/23,15.28%,CLASP1;TRIM54;FGF13;MID1IP1;NAV3;APC2
1307,prerank,negative regulation of organelle assembly (GO:1902116),-0.5779007586782983,-1.0375062988026786,0.4,0.6764379689549269,1.0,1/29,0.82%,NUPR1
1308,prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.6321629668401774,1.0360458482785122,0.40476190476190477,0.9043882169919958,1.0,5/19,6.57%,HRC;ANK2;CASQ2;ATP1A2;TRDN
1309,prerank,regulation of macroautophagy (GO:0016241),0.4600722814795934,1.0355890592515085,0.35,0.9028978249834472,1.0,10/99,8.25%,KDR;PINK1;GPSM1;SH3GLB1;PRKACA;EPM2A;PRKAA2;RRAGD;CLEC16A;GAPDH
1310,prerank,pore complex assembly (GO:0046931),-0.6075177956807423,-1.035412840841326,0.4,0.6807391117576546,1.0,4/17,12.23%,RTN4;P2RX7;GSDMD;PLEKHA7
1311,prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.6411097043282464,-1.0353020023574093,0.49230769230769234,0.6802243782708939,1.0,7/29,15.03%,EREG;IGF1;DLGAP5;PDGFRB;EDN1;NUSAP1;AURKA
1312,prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.68056582374788,-1.0341382683173777,0.46296296296296297,0.6821352609712898,1.0,3/19,6.07%,NUPR1;PLEK;C1QTNF3
1313,prerank,sensory perception of sound (GO:0007605),-0.5847052813243633,-1.0329368882863985,0.4166666666666667,0.6837482650852974,1.0,4/41,3.81%,COL1A1;CEMIP;COL11A1;COL2A1
1314,prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.6069626581327937,-1.0319103069718099,0.46774193548387094,0.6852757287894402,1.0,6/25,9.22%,SERPINE1;NUPR1;MDK;MAPK7;GAS6;ICAM1
1315,prerank,epithelial tube morphogenesis (GO:0060562),-0.6263821826522884,-1.0318391289588522,0.4827586206896552,0.6847349795412018,1.0,2/27,2.89%,PAK1;CSF1R
1316,prerank,regulation of focal adhesion assembly (GO:0051893),-0.555697159852524,-1.030969984400681,0.38596491228070173,0.6858597654734202,1.0,14/51,14.84%,SFRP1;COL16A1;THBS1;SRC;ACTG1;CORO1C;PTPRJ;THY1;RCC2;PHLDB2;LDB1;S100A10;EFNA5;GPM6B
1317,prerank,telomere maintenance (GO:0000723),-0.5683708535026457,-1.0307955740213233,0.4482758620689655,0.6856473862260193,1.0,7/45,23.86%,TEP1;POLD4;DNA2;POLD3;RAD50;TEN1;ACD
1318,prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.5462684060226868,-1.0302072553946895,0.3870967741935484,0.6861138831156164,1.0,5/54,9.03%,EREG;DOK1;ARAP1;PTPRJ;PLAUR
1319,prerank,regulation of ruffle assembly (GO:1900027),-0.6333821782301496,-1.0301679517777897,0.47540983606557374,0.6855160649636767,1.0,5/18,17.32%,P2RX4;STAP1;P2RY12;EVL;ABI3
1320,prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.6303320538563155,1.029978746889253,0.46153846153846156,0.917473068058622,1.0,9/16,17.60%,PLN;CASQ2;PRKCE;CAV3;ACTN2;CAB39;STK39;YWHAE;NEDD4L
1321,prerank,actin filament polymerization (GO:0030041),-0.6266543065223881,-1.0294893033858281,0.41818181818181815,0.6863319404444284,1.0,5/24,9.89%,PSTPIP1;AIF1;WAS;PREX1;ANG
1322,prerank,regulation of protein polymerization (GO:0032271),-0.598220454744502,-1.02891472160437,0.48333333333333334,0.6868312905147211,1.0,3/30,5.93%,DBN1;COTL1;HCLS1
1323,prerank,positive regulation of cell junction assembly (GO:1901890),-0.560994488810699,-1.0285053516938931,0.42,0.687073332405311,1.0,3/38,1.87%,SFRP1;COL16A1;SRPX2
1324,prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.5993021148882236,1.0273454011497385,0.37142857142857144,0.9231617034726616,1.0,4/20,4.91%,PLA2G5;LPL;CD36;PPARA
1325,prerank,sphingolipid biosynthetic process (GO:0030148),-0.565113929515024,-1.0272424594633336,0.46774193548387094,0.6893747302112694,1.0,10/51,7.99%,PLPP2;GBA;SPHK1;CERS6;HACD4;ASAH1;ALDH3B1;SPTLC2;ELOVL1;SGPL1
1326,prerank,receptor internalization (GO:0031623),-0.6008547075942989,-1.027131336876464,0.44642857142857145,0.6890672777138249,1.0,5/38,3.49%,ITGB2;FCER1G;RAB31;LRP1;ARRB2
1327,prerank,RNA modification (GO:0009451),0.5535098780719231,1.0269556951620562,0.3877551020408163,0.921768314756709,1.0,8/48,21.50%,NSUN4;AARS2;TFB1M;MRM2;NOP10;LCMT2;CDKAL1;RBM15
1328,prerank,histone H2A ubiquitination (GO:0033522),0.6129827526107516,1.0264470069413818,0.4772727272727273,0.9209112560614778,1.0,5/17,20.15%,UBE2B;UBR2;BCOR;UBE2A;SKP1
1329,prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.4835602336778796,-1.0264388364358676,0.390625,0.6900031352859619,1.0,20/169,9.03%,TREM2;PLEK;CD22;ARRB2;CCN3;THBS1;TRIM59;SRC;P2RX7;C1QTNF3;TMSB4X;SPI1;ARHGAP25;PHLDA3;TWIST1;SLC9A3R1;PTPRJ;NLRC3;SH3BP1;PLAUR
1330,prerank,glycoprotein biosynthetic process (GO:0009101),0.4955419615627854,1.025598058796697,0.42857142857142855,0.9209982017964105,1.0,1/55,0.24%,GAL3ST3
1331,prerank,aggrephagy (GO:0035973),-0.6050487209540539,-1.0255615513044734,0.5178571428571429,0.6913315585906256,1.0,2/25,4.74%,VIM;DYNLL1
1332,prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.5237306114921241,-1.0252252978224385,0.36923076923076925,0.6914055334720383,1.0,14/68,9.38%,CTSD;CLEC7A;THBS1;CD44;SRC;CASP1;F2R;BEX3;ARL6IP1;MYC;GAS6;HGF;GPX1;RPS6KA1
1333,prerank,bone development (GO:0060348),-0.5929963711416316,-1.0252105518545311,0.4166666666666667,0.6907383344082164,1.0,7/28,5.95%,LRRC17;PTPRC;SULF1;SH3PXD2B;VKORC1;P3H1;SULF2
1334,prerank,regulation of membrane depolarization (GO:0003254),0.6606045691475507,1.025015171413825,0.5581395348837209,0.9199883660588953,1.0,6/16,12.02%,HCN4;RANGRF;PTPN3;GPD1L;CAV3;TBX5
1335,prerank,negative regulation of TOR signaling (GO:0032007),0.5632520976929029,1.024420712355261,0.35,0.9190526069537674,1.0,6/36,12.77%,ARNTL;EPM2A;PRKAA2;MAPKAPK5;UBR2;SESN1
1336,prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.6331190214243473,-1.0242216071697803,0.4827586206896552,0.6921892045027971,1.0,3/19,5.83%,PTPRC;HTR2B;F2R
1337,prerank,negative regulation of interleukin-2 production (GO:0032703),-0.6622114505475373,-1.0239619387071384,0.5263157894736842,0.6920540949827898,1.0,3/15,3.16%,PTPRC;HAVCR2;LAPTM5
1338,prerank,"DNA-templated transcription, termination (GO:0006353)",0.5020783216836949,1.0218702301162197,0.4186046511627907,0.9237087003788407,1.0,12/66,22.52%,WDR33;POLR1A;MTERF2;TAF1A;CCNH;POLR2E;PRMT5;POLR1E;POLR2L;POLR2F;SYMPK;SNRPD3
1339,prerank,positive regulation of DNA recombination (GO:0045911),0.6270950917036915,1.0216818257364904,0.46938775510204084,0.9219071876806434,1.0,1/20,1.11%,TFRC
1340,prerank,regulation of vacuole organization (GO:0044088),0.6071698814789334,1.021623045313842,0.4230769230769231,0.9195061608213162,1.0,1/20,1.19%,ENO3
1341,prerank,sensory perception of light stimulus (GO:0050953),-0.5593900257453353,-1.0215493272958391,0.4098360655737705,0.6967674611754234,1.0,6/35,6.08%,COL1A1;COL11A1;COL18A1;COL2A1;RGS16;EYA4
1342,prerank,regulation of exocytosis (GO:0017157),0.5780040233556256,1.0210366502002965,0.3783783783783784,0.9185372686382431,1.0,3/31,4.92%,RAB12;RAB3A;CLASP1
1343,prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.5616613606403156,-1.0203245294977379,0.41379310344827586,0.6989458607434543,1.0,9/44,10.59%,ANXA1;SRPX2;HMOX1;THBS1;P2RX4;TMSB4X;FGFR1;FOXC2;TGFB1
1344,prerank,mitotic metaphase plate congression (GO:0007080),-0.5786371960201555,-1.020212592030679,0.4716981132075472,0.6984702551979727,1.0,9/45,12.19%,EML3;CDCA8;NUF2;CEP55;CENPE;EML4;CCNB1;NDC80;CDCA5
1345,prerank,nucleic acid-templated transcription (GO:0097659),0.5235447468775962,1.0196363529192776,0.39473684210526316,0.9196171638746039,1.0,1/36,1.89%,MLF1
1346,prerank,negative regulation of protein localization to membrane (GO:1905476),-0.6091289614828401,-1.0195685214155832,0.48333333333333334,0.699422650368469,1.0,7/23,17.32%,TGFB1;TMBIM1;PID1;TMEM59;DAB2;PICALM;ABI3
1347,prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.5341743344374715,-1.0191325669351676,0.44642857142857145,0.6997293049861953,1.0,9/67,10.49%,BCAT1;GPR132;TYMS;DBF4;CDK14;MYC;E2F1;RRM2;INHBA
1348,prerank,endomembrane system organization (GO:0010256),0.4366232139759004,1.0183597161235363,0.4594594594594595,0.9210492722318506,1.0,8/162,6.53%,DYM;DNAJC28;TANGO2;FAM174B;SEC31B;CLASP1;OPTN;HOOK1
1349,prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.6127581356393198,-1.0179524112808231,0.48148148148148145,0.7015169347115622,1.0,9/43,13.78%,TNFRSF1B;IKBKE;PHLDA3;E2F1;BOK;CRIP1;SFN;BAX;PYCARD
1350,prerank,regulation of transferase activity (GO:0051338),0.6838985241875402,1.0177132851992605,0.43902439024390244,0.9203744644433999,1.0,1/15,1.53%,FEM1A
1351,prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.540921230732233,-1.017690418549245,0.47619047619047616,0.7014537082561245,1.0,12/75,10.59%,LGALS3;PLEK;CLEC7A;CLU;EMILIN1;SDC1;ATP13A2;CX3CL1;RHOC;BID;SPIDR;TGFB1
1352,prerank,cellular response to retinoic acid (GO:0071300),-0.6120080199260084,-1.017631803266191,0.4897959183673469,0.7008977373342248,1.0,3/22,3.69%,PTK2B;SOX9;PTK7
1353,prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.585049983661274,-1.0175318252401588,0.5192307692307693,0.7004230371669379,1.0,10/26,23.19%,MGAT2;ALG5;DPM2;STT3A;ST6GAL1;OSTC;RPN2;DDOST;UGGT1;ALG8
1354,prerank,actin filament organization (GO:0007015),-0.49817997806247527,-1.0168956032196275,0.4307692307692308,0.701104641987067,1.0,28/125,8.74%,LCP1;DBN1;CAPG;MARCKSL1;FAT1;ACTN1;MARCKS;MYO1F;AIF1;CORO1A;FLNA;CARMIL1;DPYSL3;WAS;RAC2;TPM3;ARHGAP25;MYO1G;MYO5A;TPM2;RHOG;CORO1C;RHOC;MYO1D;MYO1C;ARPC4;MYO7A;SH3BP1
1355,prerank,regulation of cell motility (GO:2000145),-0.5152284887872144,-1.016649533564618,0.423728813559322,0.7010306543893552,1.0,12/97,7.85%,EREG;SERPINE2;CSF1R;FBLN1;FLNA;WAS;TMSB4X;FES;TMSB10;PLXNC1;TWIST1;DOCK10
1356,prerank,axon guidance (GO:0007411),0.45776732556581484,1.0161658837675747,0.3939393939393939,0.9230879531021695,1.0,19/143,9.66%,EFNB3;LRTM1;LGI1;EPHA4;SPTB;MYPN;RAP1GAP;VLDLR;GPC1;VEGFA;SH3KBP1;PLXNB1;LGR6;DOK4;PTPRM;SEMA6A;NEXN;BSG;RET
1357,prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.572771566478872,-1.0158075823630672,0.46153846153846156,0.7023610117917464,1.0,2/23,1.32%,SFRP1;COL16A1
1358,prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.5779132243914687,-1.0155173774946824,0.42105263157894735,0.7022973206179611,1.0,4/34,8.14%,EREG;LGMN;PTPN18;PTPRJ
1359,prerank,organelle fission (GO:0048285),0.5890258598480719,1.0153888799032598,0.47058823529411764,0.9234770635320338,1.0,9/23,13.83%,MTFP1;OPA1;PEX19;MTFR1;MTFR1L;DNM1L;PRKN;MUL1;PEX11A
1360,prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.49631456652879324,1.015196537880469,0.4,0.9214946819052751,1.0,8/52,21.75%,PRPF19;POLQ;ABRAXAS1;XRCC5;BRCC3;NBN;POLB;LIG4
1361,prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.6161825937016304,-1.0146456833977393,0.3888888888888889,0.7035781808623334,1.0,10/20,27.97%,SPRED3;RPS20;PMAIP1;RPS7;ANKRD1;RPL23;RPL37;CDK5RAP3;SPRED1;RPS15
1362,prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.5274606956001391,-1.0143311283708583,0.39344262295081966,0.7035703123491831,1.0,8/64,12.16%,SFRP1;CD44;CCL5;FGFRL1;FGFR1;ZFP36L2;FGFR2;FLRT2
1363,prerank,calcium-mediated signaling (GO:0019722),-0.5279092572562177,-1.0143063002815054,0.4827586206896552,0.7029484413794937,1.0,17/68,9.02%,CCR2;LAT2;PTPRC;CXCR6;HTR2B;CX3CR1;BTK;P2RX4;CCR5;P2RX7;SPHK1;TPCN2;VCAM1;CXCR4;FKBP1B;PTPRJ;MCTP1
1364,prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.5906078694986286,-1.0128194874457723,0.5161290322580645,0.7049631855913306,1.0,12/32,13.78%,TYROBP;CLEC7A;TLR8;P2RX7;CASP1;TMEM106A;APP;PANX1;GSDMD;TLR6;AIM2;PYCARD
1365,prerank,male gonad development (GO:0008584),-0.6490421119315296,-1.0126596243701753,0.509090909090909,0.7046589124203483,1.0,4/21,10.49%,SOX9;TGFB2;WNT4;INHBA
1366,prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.5992254178098905,-1.0121955312187672,0.5185185185185185,0.7050807992221644,1.0,5/28,24.20%,RPS16;RPS8;RPS19;RPS21;RPS14
1367,prerank,activation of phospholipase C activity (GO:0007202),-0.6199525514693524,-1.0107300247751307,0.4915254237288136,0.7074385154142719,1.0,7/21,11.67%,P2RY6;HTR2B;C5AR1;LPAR2;ANG;CD86;GNA15
1368,prerank,activation of GTPase activity (GO:0090630),-0.5011240968734448,-1.010710688866719,0.5,0.706781948706662,1.0,10/77,9.76%,ARHGAP45;GPR65;ARHGAP22;BCR;ARHGAP25;RHOG;CORO1C;DOCK7;GMIP;TBC1D9
1369,prerank,response to glucocorticoid (GO:0051384),-0.6575238547122044,-1.010174086945464,0.5238095238095238,0.7072343863101783,1.0,5/16,11.24%,ANXA1;IL1RN;ADAM9;SLIT3;ZFP36L2
1370,prerank,cellular protein catabolic process (GO:0044257),-0.5719741250363193,-1.0095084642576269,0.43333333333333335,0.7080133930843207,1.0,9/52,6.11%,CTSS;CTSZ;TCIRG1;CTSK;ADAMTS12;CTSH;LGMN;CTSB;FAP
1371,prerank,membrane lipid biosynthetic process (GO:0046467),-0.5493429534211445,-1.009459759881827,0.463768115942029,0.7074146096755554,1.0,8/43,7.99%,PLPP2;SPHK1;CERS6;HACD4;ALDH3B1;SPTLC2;ELOVL1;SGPL1
1372,prerank,organelle disassembly (GO:1903008),0.5401277228341228,1.0091331492680402,0.35714285714285715,0.9366590093469109,1.0,11/30,20.52%,MTIF2;GFM2;RETREG1;MRRF;ZFAND1;VCP;EIF2D;ULK1;MTIF3;ULK2;RB1CC1
1373,prerank,establishment of protein localization to extracellular region (GO:0035592),0.5432149781449245,1.0090521876439036,0.4418604651162791,0.9343209161085101,1.0,3/30,2.21%,RAB12;TANGO2;RAB3A
1374,prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.40241781293595574,1.0090103361216975,0.39285714285714285,0.931863904555524,1.0,23/288,10.78%,APBB1;PPARGC1A;IGSF1;PERM1;MLF1;PHB;EIF4E;USP13;CASZ1;ESRRB;ARNTL;ESRRA;MAPKAPK5;PTP4A3;ERC1;ESRRG;GMNN;NFIL3;EIF2B4;MLXIPL;INSR;MITF;PPARGC1B
1375,prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.593966899812586,1.0087382526898794,0.48936170212765956,0.9298802700122818,1.0,2/19,0.86%,PPIF;FKBP4
1376,prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.6159053859195053,-1.0086333535868244,0.5094339622641509,0.7083947513278906,1.0,9/28,14.45%,CYP1B1;ELOVL1;GPX1;DAGLB;FADS2;EPHX1;PTGR1;PTGS1;PLA2G4A
1377,prerank,regulation of peptidase activity (GO:0052547),-0.6615130007344945,-1.0078797681112268,0.4838709677419355,0.7090914963892085,1.0,6/15,8.96%,ECM1;CTSH;RCN3;ATP13A2;CSTB;CST3
1378,prerank,peroxisome organization (GO:0007031),0.5548133968118711,1.0073218085576277,0.4782608695652174,0.9315112112236782,1.0,12/24,18.60%,PEX10;ABCD3;PEX19;PEX7;DNM1L;PEX11A;PEX6;PLAAT3;PEX12;TMEM135;LONP2;MFF
1379,prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.511182093536534,-1.0072070782404168,0.48333333333333334,0.7099218354666089,1.0,12/66,8.01%,VASH2;ECM1;MDK;VEGFD;HTR2B;HMOX1;THBS4;PIK3CD;ITGB3;TGFBR1;ITGA4;FGFR1
1380,prerank,cell cycle G1/S phase transition (GO:0044843),-0.5226221840314311,-1.0062384163434948,0.38333333333333336,0.7113460609521316,1.0,7/51,10.49%,BCAT1;GPR132;DBF4;MYC;E2F1;CCNA2;INHBA
1381,prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.5945731045430924,-1.0061647865470962,0.5,0.7107806197724839,1.0,8/28,15.11%,MDK;FLNA;CARMIL1;P4HB;ILK;S100A10;NEDD9;CDC42
1382,prerank,embryonic heart tube morphogenesis (GO:0003143),0.5184644867781164,1.006131697985117,0.38095238095238093,0.9323926998028966,1.0,6/29,14.30%,RYR2;NDRG4;NKX2-5;NOTCH1;GATA4;SRF
1383,prerank,COPII-coated vesicle budding (GO:0090114),-0.5572161038403474,-1.0057488693020056,0.4838709677419355,0.7109339979327106,1.0,4/60,10.32%,CTSZ;SEC16B;COL7A1;CTSC
1384,prerank,response to ketone (GO:1901654),-0.6008541387172238,-1.0053503176947858,0.4461538461538462,0.7110646684373461,1.0,5/16,10.59%,TGFB3;THBS1;TGFB2;SLIT3;TGFB1
1385,prerank,cellular response to calcium ion (GO:0071277),0.49887729236590844,1.005331273079221,0.4186046511627907,0.9325960117944735,1.0,7/36,9.45%,PPIF;SYT7;CLIC4;ADCY1;SMPD1;PRKAA2;ITPKB
1386,prerank,positive regulation of synapse assembly (GO:0051965),-0.6350204969555161,-1.0051600035882644,0.4897959183673469,0.7107921644490479,1.0,4/16,11.07%,SRPX2;SEMA4A;EPHB2;NLGN2
1387,prerank,striated muscle tissue development (GO:0014706),0.5967199192507227,1.0045306531496228,0.5,0.9326249157608536,1.0,10/22,13.00%,MYOZ2;NDUFV2;BVES;SGCG;MYH14;POPDC2;CSRP3;PGM5;SVIL;ZBTB18
1388,prerank,protein monoubiquitination (GO:0006513),0.5619204266845746,1.004442435733202,0.5,0.9304067738001496,1.0,7/32,16.28%,MGRN1;UBE2B;KLHL12;LEO1;PRKN;HUWE1;PEX12
1389,prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.556133661092968,-1.0039319633106536,0.3793103448275862,0.7131701379126799,1.0,9/48,11.80%,APOE;THBS1;P2RX4;PRCP;TMSB4X;FGFR1;SH3BP1;TGFB1;ANGPT2
1390,prerank,positive regulation of ion transport (GO:0043270),0.5465351728590973,1.0029821855434768,0.5,0.9319927690492572,1.0,6/31,9.18%,SCN4B;ANK2;CAMK2A;CACNB2;WFS1;GPD1L
1391,prerank,cell-cell junction assembly (GO:0007043),-0.5523988247061384,-1.0027349116147048,0.4909090909090909,0.7147727064537853,1.0,9/42,16.90%,GJA5;ACTG1;CD9;RHOC;CDH11;ACTB;GJA4;TLN1;TBCD
1392,prerank,protein localization to endoplasmic reticulum (GO:0070972),0.6304058872986789,1.002695931607064,0.5384615384615384,0.9301965344319802,1.0,2/16,3.63%,ANK2;RYR2
1393,prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.6283258031516735,-1.0025660909424996,0.4807692307692308,0.7144304182802949,1.0,2/22,2.88%,EREG;NCF1
1394,prerank,positive regulation of phospholipase C activity (GO:0010863),-0.5795377599583214,-1.001796725469615,0.4406779661016949,0.7152370850291286,1.0,9/30,11.67%,P2RY6;HTR2B;C5AR1;FGFR1;LPAR2;ANG;PDGFRB;CD86;GNA15
1395,prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.5808405770328962,-0.9997807765495955,0.4696969696969697,0.7188154182642166,1.0,8/27,15.57%,PTPN6;PTPN1;OAS3;ZBP1;RNASEL;ISG15;NLRC5;SAMHD1
1396,prerank,regulation of muscle cell differentiation (GO:0051147),-0.6073346941980088,-0.9997372969659302,0.5263157894736842,0.7181363882337849,1.0,8/27,18.58%,MEGF10;ID2;BOC;CDK9;FGFR2;CDC42;CDON;PTBP1
1397,prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.6424183838209049,-0.9994222417330887,0.4642857142857143,0.7180367038407061,1.0,5/18,20.85%,ADAM9;MYH9;BACE2;PSEN2;ADAM10
1398,prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.6495742003554619,-0.9981411748379645,0.5344827586206896,0.7198583758015561,1.0,11/16,32.02%,LIG1;MCM3;POLD3;MCM4;POLE;GINS2;GINS3;RFC3;MCM7;PCNA;GINS4
1399,prerank,positive regulation of phosphorylation (GO:0042327),-0.4650016657385497,-0.9979048808390352,0.4426229508196721,0.7196684568101618,1.0,41/192,12.52%,TREM2;GPNMB;TMEM119;MARCO;PAK1;NCKAP1L;EREG;FAM20A;VEGFD;CSF1R;SOX9;THBS1;IGF1;CCL5;P2RX7;CD74;ROR2;ITGB3;NIBAN1;FGFR1;GAS6;TYRO3;HGF;PLAUR;ILK;MST1R;ANG;EPHB2;APP;PFKFB3;TGFB1;MET;MERTK;PDGFRB;FGFR2;PFKFB4;BMP2;AXL;PGF;EPHB6;C3
1400,prerank,regulation of secretion by cell (GO:1903530),0.534335290285333,0.9978117519195087,0.5,0.9425972161203562,1.0,2/35,2.21%,RAB12;RAB3A
1401,prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.6358546309012434,-0.9976389000913953,0.5294117647058824,0.7196451579509544,1.0,3/16,15.75%,SEMA3D;SEMA4A;SEMA3F
1402,prerank,actin filament-based transport (GO:0099515),-0.6668153235865653,-0.9976047583410085,0.5614035087719298,0.7190350544464259,1.0,7/17,10.63%,MYO1F;MYO1G;MYO5A;MYO1D;MYO1C;MYO7A;MYO1E
1403,prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.563090440531854,0.9970476802454533,0.5,0.9424707506291329,1.0,9/25,24.68%,OMA1;CLPP;ZYG11B;LONP1;VCP;CUL3;BAG6;STUB1;RNF5
1404,prerank,regulation of viral life cycle (GO:1903900),-0.6182598984491132,-0.9947925531150927,0.5,0.7244438078676989,1.0,4/15,14.80%,TYRO3;AXL;TRIM62;PPIA
1405,prerank,Golgi to endosome transport (GO:0006895),0.5933070411842002,0.9945676769580678,0.4888888888888889,0.9477167543549465,1.0,3/16,18.37%,WIPI1;KIF16B;VPS13A
1406,prerank,negative chemotaxis (GO:0050919),0.5620139100762473,0.9942531403512538,0.5208333333333334,0.9461741888900618,1.0,3/26,8.45%,LRTM1;LGR6;SEMA6A
1407,prerank,phospholipid metabolic process (GO:0006644),0.5269608197593982,0.9931886110292488,0.5121951219512195,0.9467601628080972,1.0,7/45,7.00%,PLA2G5;FITM2;FITM1;LPL;GNPAT;SMPD1;AGPAT3
1408,prerank,regulation of cellular response to stress (GO:0080135),0.4690389970025496,0.9926196724939713,0.5,0.9460318934403565,1.0,13/110,9.24%,FKBP4;PINK1;EIF4G1;MAPT;CAMK2A;ARNTL;CRYAB;BAG3;HSPB8;ALOX5;MAPKAPK2;CHCHD2;CAMK2B
1409,prerank,protein import into nucleus (GO:0006606),-0.5076309270735473,-0.992201098808724,0.4897959183673469,0.7293668784363719,1.0,1/61,1.76%,MMP12
1410,prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.6781514642976423,-0.9899570125866782,0.5384615384615384,0.733761514723998,1.0,9/16,12.31%,APOE;DBN1;MCTP1;DLG4;EPHB2;APP;CLN3;ZDHHC2;NSMF
1411,prerank,heart development (GO:0007507),-0.4761162731149808,-0.9899562068034006,0.4603174603174603,0.7330518807639168,1.0,13/128,6.53%,COL3A1;FN1;FBN1;SH3PXD2B;HTR2B;SOX9;PDLIM2;TGFB2;PDLIM3;ID2;OSR1;GPC3;TGFBR1
1412,prerank,phosphatidylinositol metabolic process (GO:0046488),-0.48689238447015665,-0.9898085574557971,0.484375,0.7326962308241899,1.0,12/93,12.36%,PLEK;CSF1R;PIK3R5;PIK3CG;PIK3CD;PIP4K2A;PLEKHA4;PDGFRB;PI4K2B;INPP5D;PLCG2;PITPNM1
1413,prerank,positive regulation of peptidase activity (GO:0010952),-0.5955140916505064,-0.9895668546752869,0.4745762711864407,0.7324843781246612,1.0,5/18,8.92%,CTSH;RCN3;GRN;VSIR;PRELID1
1414,prerank,protein import (GO:0017038),-0.5002107663484452,-0.9877592595331998,0.5434782608695652,0.7359572292967839,1.0,4/81,6.21%,APOE;MMP12;CLU;RAB8B
1415,prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.45166156096420124,0.9870197275970346,0.52,0.9595443430690418,1.0,8/122,6.46%,RXRG;PPARGC1A;RORC;NR4A1;NR3C2;PPARA;ESRRB;ESRRA
1416,prerank,positive regulation of endopeptidase activity (GO:0010950),-0.587521838224174,-0.9863785734062015,0.5,0.7380170145007653,1.0,7/20,15.18%,MEFV;VSIR;PRELID1;AIM2;PYCARD;LYN;PICALM
1417,prerank,positive regulation of T cell cytokine production (GO:0002726),-0.6470144065919307,-0.9860248538531302,0.6,0.7382616749416858,1.0,4/15,17.70%,IL18;IL1R1;B2M;CD55
1418,prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.5778344646059642,-0.9853625474767724,0.6166666666666667,0.7388129176884926,1.0,6/40,10.59%,PRKCD;FLNA;HCLS1;GTSE1;GAS6;TGFB1
1419,prerank,regulation of mitotic spindle assembly (GO:1901673),-0.5959069938402115,-0.9852370624425859,0.5,0.7383442270930073,1.0,1/18,2.69%,EML3
1420,prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.4973135026600692,-0.985192281729152,0.5,0.7377341494919799,1.0,24/93,16.16%,DAP;CTSD;CLEC7A;LAPTM5;CASP1;F2R;CASP12;APAF1;BEX3;ROBO1;MYC;BID;BOK;BAX;EIF2AK3;TRADD;SYK;CASP4;PYCARD;RIPK1;BBC3;RACK1;CASP8;PMAIP1
1421,prerank,regulation of oxidative phosphorylation (GO:0002082),0.5882176867354846,0.9842706871376286,0.574468085106383,0.9648657153959338,1.0,3/15,1.86%,COX7A1;PPIF;PINK1
1422,prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.5479995507009466,-0.9842462605174441,0.41818181818181815,0.7388966517164623,1.0,10/36,15.11%,LCP1;CAPZA1;ANXA2;P4HB;CFL1;CNN2;MSN;RAP1B;PPIA;CDC42
1423,prerank,negative regulation of binding (GO:0051100),0.4981044501280139,0.9837191715779898,0.42105263157894735,0.9640536973961374,1.0,5/70,6.19%,ILRUN;PLN;XIRP1;TLE5;PEX19
1424,prerank,positive regulation of immune effector process (GO:0002699),-0.6263132633467977,-0.983143383030329,0.4666666666666667,0.7407560728890714,1.0,2/16,1.46%,CCR2;PTPRC
1425,prerank,organonitrogen compound catabolic process (GO:1901565),-0.5219875984430927,-0.9827458107051875,0.5185185185185185,0.7409093978569582,1.0,6/44,9.52%,PLA2G7;ANPEP;PLA2G15;AMDHD2;SGPL1;RENBP
1426,prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.5916740003501998,0.9826595995389426,0.4883720930232558,0.964062045837199,1.0,7/21,15.27%,LPIN1;PLAAT1;PHOSPHO1;PLA2G4E;PNPLA8;PLAAT3;PCYT2
1427,prerank,negative regulation of actin filament polymerization (GO:0030837),-0.6438050059898961,-0.9823385126743217,0.59375,0.7412041721470534,1.0,6/20,12.50%,PRKCD;SSH3;TMSB4X;TMSB10;CYRIB;TWF1
1428,prerank,muscle filament sliding (GO:0030049),0.5543721655643871,0.9818081675568444,0.5555555555555556,0.9616013848854694,1.0,13/28,11.35%,MYL3;MYL2;TNNI3;TTN;MYH6;TPM1;TNNC1;ACTC1;TCAP;TMOD1;ACTA1;ACTN2;TNNT1
1429,prerank,actin-myosin filament sliding (GO:0033275),0.5543721655643871,0.9818081675568444,0.5555555555555556,0.9616013848854694,1.0,13/28,11.35%,MYL3;MYL2;TNNI3;TTN;MYH6;TPM1;TNNC1;ACTC1;TCAP;TMOD1;ACTA1;ACTN2;TNNT1
1430,prerank,positive regulation of interleukin-1 production (GO:0032732),-0.567992994521338,-0.9816783822697489,0.5396825396825397,0.741868740402419,1.0,12/37,13.78%,TYROBP;CLEC7A;TLR8;P2RX7;CASP1;TMEM106A;APP;PANX1;GSDMD;TLR6;AIM2;PYCARD
1431,prerank,regulation of regulated secretory pathway (GO:1903305),0.5871100797219996,0.9810876139013618,0.6136363636363636,0.9614084082500228,1.0,3/16,3.29%,SYT7;RAB3A;PREPL
1432,prerank,regulation of cellular amine metabolic process (GO:0033238),0.5450639841136748,0.9794046443158562,0.5151515151515151,0.9633080583292557,1.0,23/47,28.54%,PSME4;PSMC3;PSME3;PSMD12;OAZ1;PSMB7;PSMD2;PSMA1;OAZ2;PSMB2;NQO1;PSME1;PSMC6;PSMD11;PSMD1;PSMD3;PSMC2;PSMA6;PSMB6;PSMB5;PSMC1;PSMC5;PSMB3
1433,prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.616462532467552,-0.9793118175534894,0.5254237288135594,0.7461667821830295,1.0,8/19,17.32%,TGFB1;TMBIM1;PID1;TMEM59;CSK;DAB2;PICALM;ABI3
1434,prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.6084355479227135,-0.9792134783241915,0.5303030303030303,0.7455968068339188,1.0,6/28,12.06%,PTPN6;ID2;SUSD2;E2F1;FAM83D;PLCG2
1435,prerank,vesicle transport along actin filament (GO:0030050),-0.670410734358707,-0.9787982909159872,0.5535714285714286,0.7459185791711284,1.0,7/15,10.63%,MYO1F;MYO1G;MYO5A;MYO1D;MYO1C;MYO7A;MYO1E
1436,prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.4019077190801135,0.9781511360881999,0.5384615384615384,0.9642270748635764,1.0,19/258,10.78%,APBB1;PPARGC1A;IGSF1;PERM1;MLF1;PHB;USP13;CASZ1;ESRRB;ARNTL;ESRRA;PTP4A3;ERC1;ESRRG;NFIL3;MLXIPL;INSR;MITF;PPARGC1B
1437,prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.47799688608097446,0.9771771521450643,0.46153846153846156,0.9642554497841493,1.0,12/77,14.74%,EGLN1;VEGFA;EPAS1;PSME4;EGLN3;BAG3;HIGD1A;HIF1AN;PSMC3;PSME3;UBC;PSMD12
1438,prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.5867445015658606,-0.9770570917110466,0.5,0.7489091829214114,1.0,2/18,1.32%,SFRP1;COL16A1
1439,prerank,positive regulation of DNA binding (GO:0043388),-0.623347082541699,-0.9770473117894504,0.5660377358490566,0.7482189742276378,1.0,6/24,11.04%,IGF1;NIBAN2;TWIST1;PLAUR;TGFB1;FOXC1
1440,prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.584700723841149,-0.9765386648488786,0.5737704918032787,0.7485265088602497,1.0,1/19,1.80%,DBN1
1441,prerank,nucleus organization (GO:0006997),-0.5594158665623497,-0.9760119973037028,0.5192307692307693,0.7490390496436358,1.0,4/42,10.58%,IRAG2;BIN1;CEP55;REEP4
1442,prerank,mitotic sister chromatid segregation (GO:0000070),-0.48904194215940266,-0.9757693208613442,0.48333333333333334,0.7489560547862277,1.0,25/84,19.17%,EML3;CDCA8;KNSTRN;NCAPH;CDK1;NCAPG2;PRC1;DLGAP5;CEP55;CENPE;EML4;CCNB1;SMC2;NDC80;CDCA5;SMC4;NUSAP1;SPAG5;PHF13;KIFC1;KIF22;DSN1;PSRC1;KIF2C;PLK1
1443,prerank,cellular calcium ion homeostasis (GO:0006874),0.4572264013843956,0.9756135313340946,0.45161290322580644,0.9661331307328636,1.0,16/85,10.58%,HRC;ATP2A2;ANK2;CDH23;TNNI3;PLN;RYR2;PRKACA;TRDN;CCDC47;WFS1;HERPUD1;AFG3L2;LETM1;CAV3;CSRP3
1444,prerank,amino acid import across plasma membrane (GO:0089718),-0.6243455130303148,-0.9751381406509809,0.52,0.7498668187309139,1.0,10/15,19.26%,SLC7A2;SLC1A4;SLC1A3;SLC16A2;SLC1A5;SLC7A8;SLC3A2;SLC7A5;SLC6A9;SLC1A6
1445,prerank,positive regulation of secretion by cell (GO:1903532),-0.5290997127569633,-0.9750403952805732,0.5,0.7493192363839947,1.0,12/55,10.59%,TREM2;TGFB3;ADAM8;TGFB2;P2RX4;IGF1;ATP13A2;ABCG1;ADAM9;MYH10;ANG;TGFB1
1446,prerank,regulation of protein phosphorylation (GO:0001932),-0.44919480813406837,-0.9748317501228084,0.49206349206349204,0.7491391956201684,1.0,15/212,3.95%,FN1;TREM2;GPNMB;ITGB2;TMEM119;MARCO;PAK1;FGR;FAM20A;VEGFD;CSF1R;SOX9;IGFBP3;SIRPA;FBLN1
1447,prerank,water-soluble vitamin metabolic process (GO:0006767),0.48080609157199516,0.9747732030335566,0.4523809523809524,0.9659310082956986,1.0,13/58,11.09%,MMACHC;MMAA;MMUT;MTR;MMAB;SHMT1;FLAD1;PCCA;MCCC1;PCCB;MCCC2;SLC25A19;MMADHC
1448,prerank,positive regulation of interferon-alpha production (GO:0032727),-0.6046681472931388,-0.9740577207444103,0.6140350877192983,0.7501549007855253,1.0,4/20,6.47%,IRF5;TLR9;TLR8;TLR7
1449,prerank,cellular response to organic cyclic compound (GO:0071407),-0.4867181174104326,-0.9732123103211684,0.45588235294117646,0.7511686895260418,1.0,12/104,7.14%,SPP1;CYP1B1;SFRP1;P2RY6;ATP1A3;P2RX4;CCL5;P2RX7;IL18;ADCY3;FES;GNG2
1450,prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.6109461840469157,-0.9729721646104074,0.48333333333333334,0.7511379024178715,1.0,7/18,17.32%,TGFB1;TMBIM1;PID1;TMEM59;DAB2;PICALM;ABI3
1451,prerank,positive regulation of innate immune response (GO:0045089),-0.5804672191480111,-0.972944406955383,0.6101694915254238,0.7504843112599253,1.0,6/29,6.30%,EREG;ADAM8;TLR8;TASL;CCL5;SPI1
1452,prerank,regulation of spindle organization (GO:0090224),-0.6251108865948721,-0.9725900184287255,0.515625,0.7504434969964839,1.0,4/15,18.40%,TPX2;TACC3;BORA;PSRC1
1453,prerank,sulfur compound catabolic process (GO:0044273),-0.5684984400324847,-0.9724223013122166,0.5535714285714286,0.7500919138335947,1.0,8/30,6.98%,FMOD;HEXB;BGN;ACAN;LUM;HEXA;GALNS;GLB1
1454,prerank,positive regulation of lipid kinase activity (GO:0090218),-0.6053635336997493,-0.9719827748897711,0.5373134328358209,0.7502335934115262,1.0,2/23,2.06%,PTK2B;FGR
1455,prerank,phospholipid transport (GO:0015914),-0.5546900135192294,-0.9719217597979783,0.5192307692307693,0.7496260978893976,1.0,10/43,12.68%,APOE;ATP8B4;NPC2;ABCG1;PRELID1;ATP10A;PLTP;OSBPL5;PITPNM1;ABCA1
1456,prerank,regulation of type I interferon production (GO:0032479),0.4705710679131338,0.9718792200112772,0.4857142857142857,0.9714134499673645,1.0,1/82,0.02%,ILRUN
1457,prerank,negative regulation of response to external stimulus (GO:0032102),-0.5221521378724594,-0.9707076408009234,0.5147058823529411,0.7512109198845041,1.0,16/79,8.72%,APOE;SERPINE1;TNFAIP8L2;MEFV;PTGIS;CD109;CCN3;SIRPA;AOAH;GBA;PRKCD;C1QTNF3;MAPK7;RNF26;TYRO3;NLRC3
1458,prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.5716021742019881,-0.9703133572288576,0.5172413793103449,0.7513618323966594,1.0,6/24,12.35%,ASNS;LGMN;SPHK1;APP;CCNB1;CDC25B
1459,prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.6221581368151609,0.9697183757702011,0.5777777777777777,0.974645170263384,1.0,7/17,22.44%,MRPL44;DROSHA;PUM1;TSNAX;ZC3H7B;TARBP2;AGO4
1460,prerank,chemical synaptic transmission (GO:0007268),-0.48479081806205954,-0.9684949845965526,0.5238095238095238,0.7545530362630596,1.0,10/104,5.18%,NPY;APOE;GPR176;GABRQ;HTR2B;GABRE;GABRA3;STXBP2;CACNB3;SLC1A4
1461,prerank,glycogen catabolic process (GO:0005980),0.6288004073217788,0.9673207180737486,0.5319148936170213,0.9793249465269315,1.0,4/15,10.25%,PYGM;AGL;PYGB;PHKA1
1462,prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.5674126676319384,0.9671083887534838,0.54,0.9773262786726588,1.0,2/16,7.18%,EIF4G1;PARD3
1463,prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.6555070616363586,-0.9668628930248543,0.5849056603773585,0.7573225856148522,1.0,3/15,21.84%,HHEX;POLDIP3;NXF1
1464,prerank,protein polyubiquitination (GO:0000209),0.3948790181516886,0.9661158050063946,0.5945945945945946,0.9777662092878185,1.0,48/269,20.20%,FBXO31;LMO7;NHLRC1;FBXW7;UBE2QL1;PRPF19;PSME4;CDC34;UBE2B;MARCHF6;FBXL22;FBXO40;ANAPC13;UBE3B;KLHL3;FBXO21;UBR2;FBXO32;AKTIP;PRKN;FBXO44;MUL1;PSMC3;PSME3;UBC;UBE2G1;PSMD12;UBE2D1;HUWE1;RNF14;AREL1;FBXW5;PSMB7;RNF114;SPOP;NEDD4L;ZFP91;PSMD2;RNF6;UBE3C;RMND5A;PSMA1;TTC3;UBE2A;BFAR;SKP1;RNF146;UBE2D3
1465,prerank,regulation of cellular catabolic process (GO:0031329),-0.5287706883476677,-0.9652482493746587,0.5396825396825397,0.7601615043700501,1.0,6/58,12.71%,NUPR1;TPCN2;PIP4K2A;DRAM1;BOK;GPR137B
1466,prerank,TOR signaling (GO:0031929),0.5227060144519605,0.9642376705442612,0.46808510638297873,0.9809492436229682,1.0,1/24,1.86%,PINK1
1467,prerank,cellular response to oxygen-containing compound (GO:1901701),0.3969029659297529,0.9631232363793697,0.391304347826087,0.9814181028480725,1.0,14/217,4.82%,P2RY1;PDK2;PDK4;HCN4;RORC;ABCB4;LPL;CPEB3;MTR;HCN2;PRDX3;MAPT;SHMT1;NDUFA13
1468,prerank,glutamine family amino acid metabolic process (GO:0009064),0.568782447888445,0.9620820458504277,0.5348837209302325,0.9820854537897421,1.0,7/25,4.99%,ALDH5A1;GOT1;ALDH4A1;KYAT1;GOT2;DGLUCY;OAT
1469,prerank,cellular lipid catabolic process (GO:0044242),-0.633876429847563,-0.9604259136132111,0.6470588235294118,0.769889084108185,1.0,3/17,4.18%,CYP1B1;PLA2G15;AOAH
1470,prerank,regulation of translation (GO:0006417),0.40431610995564055,0.9599619487201901,0.5897435897435898,0.9860351080222979,1.0,17/153,10.34%,FXR1;CPEB3;EIF4G1;EIF4E;SHMT1;MTIF2;TSFM;CSDE1;MAPKAPK5;MTRES1;GAPDH;TRAP1;PAIP2B;EIF2B4;LARP4;MTG1;MTG2
1471,prerank,ribosome biogenesis (GO:0042254),-0.449394748987055,-0.9595703484234192,0.5797101449275363,0.7709466009873794,1.0,44/185,26.28%,RPL3;RPL34;RPL6;RPS16;RPL27A;RPL17;RPL39;RPL13A;RPL37A;RPL15;RPS19;RPL12;RPL41;RPL36A;RPL35A;RPL10A;RPL35;NPM1;RPL14;CUL4B;RPL4;RPL22;RPL11;RPS24;RPL18A;WDR3;RPL19;RPL32;RPL31;RPS7;EIF6;RPS6;RPS27;RPLP1;RPL7;RPS14;RPL23;RPL38;RPS28;RPL37;RPL26;RPL5;RPL13;RPL28
1472,prerank,regulation of spindle assembly (GO:0090169),-0.553663900664159,-0.9594928679257122,0.5084745762711864,0.7703986777989119,1.0,1/24,2.69%,EML3
1473,prerank,DNA repair (GO:0006281),0.4045423808863059,0.9577544486538468,0.56,0.9894853894538324,1.0,42/246,23.25%,APBB1;UNG;POLQ;PSME4;UBE2B;WDR33;SLC30A9;MGME1;ABRAXAS1;BTG2;UBC;RAD23A;HUWE1;NABP1;COMMD1;XRCC2;MAPK8;VCP;NSMCE1;XRCC5;BRCC3;UBE2A;UPF1;MUS81;HUS1;PPP5C;TIMELESS;NBN;EYA3;CHD1L;POLB;LIG4;USP47;FAN1;ALKBH5;MSH2;BAP1;DOT1L;RAD23B;EXD2;PARK7;FBH1
1474,prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.511439337094871,-0.95761696871913,0.5,0.7735861890020627,1.0,6/38,6.07%,PLEK;PTGIS;SNAI1;GLA;SIRPA;C1QTNF3
1475,prerank,regulation of neuron differentiation (GO:0045664),-0.52664246194064,-0.9570044358457716,0.5263157894736842,0.7742875454098688,1.0,13/46,19.54%,ID2;KCTD11;FGFR1;BIN1;NBL1;BEND6;BMP2;TIAM1;GPRC5B;ZC4H2;CDK5RAP2;NGF;NREP
1476,prerank,myeloid cell differentiation (GO:0030099),-0.5475451738159962,-0.9563333617225255,0.578125,0.7748817050691383,1.0,12/39,15.81%,CDKN2B;RUNX1;EVI2B;HCLS1;SPI1;CEBPA;IKZF1;INHBA;CASP3;LYN;FLVCR1;RPS19
1477,prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.5750363122883037,-0.9561622750235992,0.532258064516129,0.7744379607063019,1.0,4/30,12.06%,ANXA1;AIF1;FAM83D;PLCG2
1478,prerank,regulation of translational initiation (GO:0006446),0.47002735100277937,0.9558335498166499,0.6136363636363636,0.9922805578875588,1.0,4/60,8.77%,EIF4G1;MTIF2;CSDE1;PAIP2B
1479,prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.49073674246544025,-0.9557713029914067,0.5573770491803278,0.77451295925077,1.0,9/79,15.25%,FZD2;ARRB2;ROR2;FZD1;WNT11;TIAM1;FZD7;CDC42;PSMB8
1480,prerank,regulation of synapse assembly (GO:0051963),-0.5557618161471114,-0.9552837954514972,0.54,0.774672299046347,1.0,6/24,12.53%,SRPX2;TLR2;EPHB2;APP;NLGN2;GPC6
1481,prerank,iron ion transport (GO:0006826),-0.5290660829068247,-0.9538067445951284,0.5172413793103449,0.7767620395010046,1.0,4/39,8.19%,TCIRG1;SLC11A1;ATP6V0D2;ATP6V0A4
1482,prerank,DNA duplex unwinding (GO:0032508),-0.5538864611121618,-0.9536828981927514,0.5079365079365079,0.776318197765728,1.0,2/45,6.96%,ANXA1;MCM6
1483,prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.5110428051939382,-0.9536139875484975,0.5409836065573771,0.7757593372673638,1.0,9/60,7.00%,CCR2;SLC11A1;HTR2B;SLC39A8;PTH1R;CCL5;TPCN2;ATP13A2;SLC39A6
1484,prerank,mRNA catabolic process (GO:0006402),-0.4874102812211336,-0.9533046448124711,0.44642857142857145,0.7757275603924209,1.0,2/42,11.24%,ZC3H12D;ZFP36L2
1485,prerank,regulation of calcium ion import (GO:0090279),-0.6157583982485674,-0.952715440927698,0.5555555555555556,0.7762003870598463,1.0,1/17,0.64%,LGALS3
1486,prerank,regulation of mitotic spindle organization (GO:0060236),-0.5408430795092529,-0.9525452004850622,0.49230769230769234,0.7759372257430699,1.0,7/31,19.17%,EML3;TPX2;TACC3;HSPA1B;BORA;PSRC1;PLK1
1487,prerank,carbohydrate catabolic process (GO:0016052),0.5478584679730019,0.9524127498059283,0.5636363636363636,0.9995359294309929,1.0,6/28,5.03%,ENO3;PFKM;HK2;GCK;PGAM2;PFKFB2
1488,prerank,regulation of protein localization to cell surface (GO:2000008),-0.5406247661634226,-0.9516679004847247,0.4166666666666667,0.7771853985493783,1.0,4/30,9.21%,TYROBP;MAP1A;KCNAB2;LEPROT
1489,prerank,cellular response to organonitrogen compound (GO:0071417),0.4509289942455829,0.9511525383773821,0.631578947368421,1.0,1.0,4/70,4.05%,P2RY1;HCN4;CPEB3;HCN2
1490,prerank,positive regulation of synaptic transmission (GO:0050806),-0.5392204430753844,-0.9506168734806412,0.5671641791044776,0.7788715364594483,1.0,11/36,13.69%,CCR2;PTK2B;LGMN;RGS14;DLG4;EPHB2;APP;NLGN2;ZDHHC2;NFATC4;ZDHHC12
1491,prerank,centromere complex assembly (GO:0034508),-0.5627869493852561,-0.9498932432131918,0.5272727272727272,0.7796225034553683,1.0,8/24,21.60%,CENPT;MIS18A;DLGAP5;CENPE;CENPO;NPM1;CENPL;HJURP
1492,prerank,positive regulation of DNA replication (GO:0045740),-0.6219819509311679,-0.9497219192315189,0.5806451612903226,0.7792734632216974,1.0,1/15,1.73%,EREG
1493,prerank,regulation of kinase activity (GO:0043549),-0.49436857076051427,-0.9487028448388908,0.5882352941176471,0.7809530507390976,1.0,22/73,14.31%,TREM2;FGR;CSF1R;EEF1A1;CD74;ROR2;SLC9A3R1;FGFR1;TYRO3;SLAMF8;MST1R;EPHB2;MET;MERTK;PDGFRB;FGFR2;AXL;EPHB6;LMO4;LDB1;NLRC5;DDR1
1494,prerank,membrane protein proteolysis (GO:0033619),-0.5540269061887888,-0.9484197153261911,0.5263157894736842,0.780895862567869,1.0,8/32,18.32%,CTSH;ADAM9;TGFB1;NAPSA;MYH9;BACE2;PSEN2;MBTPS1
1495,prerank,response to retinoic acid (GO:0032526),-0.5325086100675247,-0.9481676953725646,0.5789473684210527,0.7806509595226216,1.0,4/35,3.69%,PTK2B;CTSH;SOX9;PTK7
1496,prerank,nucleic acid metabolic process (GO:0090304),-0.520118257664726,-0.9478569388465131,0.5737704918032787,0.7805420276355609,1.0,3/64,13.80%,ENPP1;DNASE1L1;DNA2
1497,prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.4433246458447071,-0.9474984061633094,0.5223880597014925,0.7805374483047854,1.0,16/151,11.93%,KDELR3;CTSZ;SEC16B;DYNLL1;TMED3;CAPZA1;TICAM2;COL7A1;GAS6;RAB29;ARFGAP3;ARF4;CTSC;PROS1;BET1L;KDELR2
1498,prerank,cytoskeleton organization (GO:0007010),-0.47075730021190354,-0.9474939311928119,0.5373134328358209,0.7798252791001279,1.0,24/99,16.44%,APOE;FGD3;MDK;RAC2;ARHGAP4;RHOG;RHOC;RHOU;MICAL1;BIN1;CFL1;THY1;FGD2;CNN2;FMNL2;RHOD;AJUBA;NEDD9;DPYSL2;MAST3;FMNL3;WTIP;RHOH;SH3D19
1499,prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.4892848198434279,-0.9474884931483792,0.5409836065573771,0.7791248046602334,1.0,6/70,6.62%,APOE;CLU;RTN4;IGF1;SPHK1;TYMS
1500,prerank,folic acid metabolic process (GO:0046655),0.5902729013141567,0.9474829657812666,0.6041666666666666,1.0,1.0,2/18,4.80%,PM20D2;SHMT1
1501,prerank,microvillus assembly (GO:0030033),-0.6224242653902979,-0.9461770186350493,0.5384615384615384,0.7810431054661578,1.0,5/15,14.16%,FXYD5;RAP2B;SLC9A3R1;STK26;RAP1B
1502,prerank,regulation of erythrocyte differentiation (GO:0045646),-0.5685190296614477,-0.9460422229232154,0.5846153846153846,0.7806022339251799,1.0,6/34,13.79%,NCKAP1L;MAFB;SPI1;INHBA;LDB1;LYN
1503,prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.5821532544378559,-0.9450815874050655,0.5961538461538461,0.782080247086212,1.0,3/15,14.37%,IGF1;FGFR2;EDN1
1504,prerank,liver development (GO:0001889),-0.539716320883911,-0.9449669336056973,0.49056603773584906,0.7815252898027891,1.0,8/22,15.90%,ANXA1;CEBPA;WNT4;LSR;MET;PCK2;AURKA;PKD2
1505,prerank,mitotic spindle assembly (GO:0090307),-0.5296846352219177,-0.944874620433167,0.578125,0.7809920381016152,1.0,9/38,17.34%,FLNA;RACGAP1;TPX2;PRC1;KIF11;AURKB;CEP192;KIF3B;KIFC1
1506,prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.5940693602949152,-0.9444255723019684,0.5873015873015873,0.7811111618049379,1.0,3/15,8.10%,CD63;ROBO1;MYO1C
1507,prerank,protein localization to membrane (GO:0072657),0.40659365306370765,0.9443491580750727,0.5483870967741935,1.0,1.0,11/153,6.31%,RAB12;P2RY1;ANK2;ANK1;RAB3A;TNIK;KCNB1;SH3GLB1;CACNB2;EFR3B;FGF13
1508,prerank,regulation of cellular protein metabolic process (GO:0032268),-0.5257367026009591,-0.9441982235209436,0.6029411764705882,0.7808788343509916,1.0,7/38,10.59%,APOE;GBA;RBM3;UHRF1;APP;INHBA;TGFB1
1509,prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.5574726016440101,-0.9436647191097998,0.5384615384615384,0.78132812018055,1.0,7/31,11.51%,CEMIP;SPHK1;S1PR2;SPRED3;APP;TGFB1;CALM2
1510,prerank,histone lysine demethylation (GO:0070076),0.5548234050697681,0.9435003198452602,0.5576923076923077,1.0,1.0,8/23,31.50%,KDM6B;RIOX2;KDM1B;UTY;HR;KDM4B;KDM7A;PHF2
1511,prerank,protein O-linked mannosylation (GO:0035269),0.5711742695969896,0.9423686600102976,0.6326530612244898,1.0,1.0,9/17,26.07%,FKRP;TMTC1;FKTN;DPM1;POMGNT2;TMTC2;B4GAT1;POMT1;LARGE1
1512,prerank,regulation of cellular biosynthetic process (GO:0031326),0.5775889720980013,0.9420350198355301,0.6,1.0,1.0,2/24,1.05%,PDK4;FITM2
1513,prerank,regulation of macrophage activation (GO:0043030),-0.6423965104043508,-0.9405870940218448,0.6491228070175439,0.787159337930583,1.0,6/20,6.62%,FCGR2B;THBS1;SPHK1;CD74;IL33;CEBPA
1514,prerank,spindle assembly (GO:0051225),-0.502223892253738,-0.9403847259450739,0.59375,0.7868191519589113,1.0,11/62,19.63%,NEK6;FLNA;TPX2;KIF11;HAUS4;CEP192;STARD9;KIF3B;KIFC1;HAUS3;HAUS7
1515,prerank,regulation of filopodium assembly (GO:0051489),-0.5247266993816289,-0.9400470160913835,0.5849056603773585,0.7869633584449357,1.0,4/32,5.32%,TGFB3;PRKCD;ARAP1;DPYSL3
1516,prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.49859171887437237,-0.9398757297077764,0.6031746031746031,0.7867062336993376,1.0,15/78,6.43%,CCR2;CD52;C3AR1;GPR35;CALCA;GPR65;CXCR6;CX3CR1;P2RX4;CCR5;C5AR1;P2RX7;CACNB3;F2R;CXCR4
1517,prerank,calcium ion homeostasis (GO:0055074),-0.513794779084239,-0.9397641973253203,0.639344262295082,0.7861721577366437,1.0,8/55,5.68%,CCR2;SELENON;FAM20A;HTR2B;PTH1R;CCL5;TPCN2;ATP13A2
1518,prerank,regulation of cell junction assembly (GO:1901888),-0.565489218729562,-0.9394942907174078,0.5714285714285714,0.7861215152780989,1.0,5/21,14.16%,SNAI1;RUNX1;MYO1C;SNAI2;RAP1B
1519,prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.5561629732601633,0.9387917185521631,0.6,1.0,1.0,5/19,20.27%,POLR2C;POLR2E;POLR2B;POLR2L;POLR2F
1520,prerank,regulation of DNA recombination at telomere (GO:0072695),0.5561629732601633,0.9387917185521631,0.6,1.0,1.0,5/19,20.27%,POLR2C;POLR2E;POLR2B;POLR2L;POLR2F
1521,prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.5561227523656894,-0.9387764991477995,0.543859649122807,0.7867683808639365,1.0,6/29,9.22%,SERPINE1;THBS1;ITGA4;MAPK7;GAS6;ICAM1
1522,prerank,transition metal ion homeostasis (GO:0055076),-0.5617543215974188,-0.9385875025685387,0.5333333333333333,0.7864303800431154,1.0,3/22,5.68%,SLC11A1;HMOX1;ATP13A2
1523,prerank,lysosome localization (GO:0032418),-0.5219512187342941,-0.9383616413368502,0.5396825396825397,0.7861441746390991,1.0,5/35,8.63%,PIK3CG;RAB34;PIK3CD;MILR1;MAP6
1524,prerank,cognition (GO:0050890),-0.5427465010759207,-0.9381712923589071,0.6,0.7858277969975948,1.0,4/28,10.23%,C5AR1;SLC1A4;CBR3;APP
1525,prerank,calcium ion transport (GO:0006816),-0.48198401135410757,-0.9372263022375876,0.5522388059701493,0.7869324789723658,1.0,8/67,6.02%,KCNN4;ORAI2;P2RX4;CCR5;CCL5;P2RX7;CACNB3;TRPV2
1526,prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5629866864329482,0.9364285438695187,0.625,1.0,1.0,7/26,22.44%,MRPL44;DROSHA;PUM1;HNRNPA2B1;ZC3H7B;TARBP2;AGO4
1527,prerank,regulation of response to DNA damage stimulus (GO:2001020),0.4913209227743141,0.9354951989097183,0.575,1.0,1.0,3/35,5.19%,FXR1;MAPT;KMT5A
1528,prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.541245983256968,-0.9353305933092808,0.6181818181818182,0.7903426932883619,1.0,7/46,7.69%,MEFV;CTSD;CLEC7A;LGMN;CASP1;F2R;MYC
1529,prerank,cellular response to topologically incorrect protein (GO:0035967),0.512859966086484,0.9349417591995276,0.5714285714285714,1.0,1.0,6/30,12.89%,HSPA9;OPTN;BAG3;HSPB8;HSPA5;PRKN
1530,prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.5034988633462718,-0.9348359824759703,0.5094339622641509,0.7907272844243598,1.0,6/38,7.66%,EMB;CD84;NECTIN4;TENM3;TRO;ROBO1
1531,prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.549087179882641,-0.9346819557059654,0.640625,0.7903365981778776,1.0,8/30,26.78%,FAM111A;CDK9;MMS22L;DONSON;PRIMPOL;POLE;THOC1;MCM9
1532,prerank,histone exchange (GO:0043486),-0.5924024435404489,-0.9343824017528309,0.62,0.7904252046489642,1.0,6/25,21.60%,CENPT;MIS18A;CENPO;NPM1;CENPL;HJURP
1533,prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.5226213174969893,0.9336389194317748,0.5777777777777777,1.0,1.0,3/27,4.91%,PLIN5;FABP3;PPARA
1534,prerank,cytoplasmic microtubule organization (GO:0031122),0.49087073991758984,0.9335094680142914,0.625,1.0,1.0,11/47,15.93%,MAPT;CLASP1;HOOK1;TRDN;FIGN;TPPP;SLAIN2;MAP10;CLIP1;DCTN1;EZR
1535,prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.5282653486898448,-0.9330676025367524,0.6037735849056604,0.7926094537654023,1.0,8/19,25.67%,UBE2C;CDC20;PLK1;MAD2L1;RPL11;RPS7;RPL23;RPL5
1536,prerank,positive regulation of calcium ion transport (GO:0051928),-0.5734481310378045,-0.9327973241110479,0.603448275862069,0.7925129115714491,1.0,5/24,5.83%,LGALS3;P2RX4;CCL5;P2RX7;F2R
1537,prerank,potassium ion transport (GO:0006813),0.4923395940394334,0.9327347197592041,0.625,1.0,1.0,23/49,9.43%,KCNIP2;HCN4;SLC9A2;KCNJ3;KCNN1;KCNJ11;KCND2;ABCC9;KCNK3;KCNJ5;HCN2;KCNA5;KCNB1;ATP1A2;KCNJ12;KCNG2;KCNJ2;ABCC8;ABCB8;KCNN2;KCNV2;KCND3;KCNJ8
1538,prerank,regulation of cellular component organization (GO:0051128),-0.44316331486434485,-0.932354118570736,0.6,0.7929141691928508,1.0,9/106,9.25%,APOE;CD22;ANGPTL7;SPHK1;MKI67;PTPN1;SLC2A10;RAB4B;LTBP4
1539,prerank,cell junction organization (GO:0034330),-0.5532721329933152,-0.931941163698354,0.5964912280701754,0.7931117801185592,1.0,17/45,13.48%,TGFB3;C1QA;PPFIA4;TGFB2;FLNA;CAPZA1;RAB8B;ACTG1;SH3BP1;ILK;APP;TGFB1;NLGN2;ACTB;VMP1;PAK3;SDK1
1540,prerank,carbohydrate derivative transport (GO:1901264),-0.6011672661034339,-0.9304352867951944,0.6071428571428571,0.795235186866451,1.0,5/15,10.99%,SLC15A3;NPC2;ABCG1;PLTP;CLN3
1541,prerank,negative regulation of developmental process (GO:0051093),0.45551878628171716,0.930309314987043,0.5365853658536586,1.0,1.0,5/54,4.29%,HOPX;TFRC;PINK1;MAPT;ADCK1
1542,prerank,negative regulation of cell projection organization (GO:0031345),-0.537979972938335,-0.9302520211333889,0.543859649122807,0.7949644692911173,1.0,6/35,8.82%,APOE;ITM2C;DPYSL3;TSKU;PTPRO;RAB29
1543,prerank,clathrin-dependent endocytosis (GO:0072583),-0.5788556521124371,-0.9296227337885035,0.62,0.7956859554883323,1.0,5/23,16.92%,CLTA;GAK;PICALM;SIGLEC1;INPP5F
1544,prerank,negative regulation of neuron projection development (GO:0010977),0.48032069133307054,0.9294881617261388,0.6,1.0,1.0,3/40,2.42%,EFNB3;FKBP4;EPHA4
1545,prerank,cholesterol homeostasis (GO:0042632),-0.5389282951679163,-0.9276214794251564,0.5172413793103449,0.7987619450068718,1.0,8/42,10.50%,APOE;NPC2;SOAT1;IL18;ABCG1;TSKU;CYP7B1;NPC1
1546,prerank,regulation of cellular component biogenesis (GO:0044087),-0.560457119558665,-0.9275349272815686,0.6229508196721312,0.7982059754169963,1.0,1/31,0.51%,APOE
1547,prerank,sterol homeostasis (GO:0055092),-0.5385764853806664,-0.9271293354232013,0.5,0.798418039586327,1.0,8/43,10.50%,APOE;NPC2;SOAT1;IL18;ABCG1;TSKU;CYP7B1;NPC1
1548,prerank,maintenance of protein location in nucleus (GO:0051457),0.5547122499030311,0.9270003679756529,0.5777777777777777,1.0,1.0,8/19,27.22%,CHCHD10;SKP1;SUN1;PARK7;ARL2;ARL2BP;SUN2;SYNE1
1549,prerank,organonitrogen compound biosynthetic process (GO:1901566),0.4026234589695152,0.9260239934543525,0.625,1.0,1.0,9/110,6.04%,MGST3;PPM1L;LPIN1;GSTK1;STARD7;ALAS1;NFS1;PHOSPHO1;GSTA4
1550,prerank,regulation of cellular protein catabolic process (GO:1903362),-0.5980225793738032,-0.9253119727495269,0.6071428571428571,0.8018363886062816,1.0,2/17,12.52%,DACT1;MSN
1551,prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.5630898179978542,-0.9252992455343455,0.5957446808510638,0.8011482024300144,1.0,5/27,8.12%,TLR2;TLR1;CD14;BTK;IRAK4
1552,prerank,cellular response to amino acid stimulus (GO:0071230),0.5349653104638435,0.9252447149462925,0.625,1.0,1.0,6/28,16.64%,CPEB3;RRAGD;UBR2;SESN1;MTOR;IPO5
1553,prerank,regulation of protein import into nucleus (GO:0042306),-0.5406501270281402,-0.9252190449935965,0.5932203389830508,0.8007128819516713,1.0,5/31,10.59%,PRKCD;FLNA;HCLS1;MDFIC;TGFB1
1554,prerank,neutral amino acid transport (GO:0015804),-0.5774764054031057,-0.9244664513891131,0.625,0.8015254169754445,1.0,8/18,17.60%,SLC6A7;SLC1A4;SLC1A5;SLC43A1;SLC7A8;SLC3A2;SLC7A5;SLC6A9
1555,prerank,amide biosynthetic process (GO:0043604),-0.5523365826869311,-0.9233871619796941,0.5573770491803278,0.8028590317294519,1.0,11/29,19.00%,GBA;ASS1;CERS6;ASAH1;SPTLC2;NANP;PCSK5;ASL;CERS2;CERS5;SPTSSA
1556,prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.5453179284529731,-0.9233461131087038,0.55,0.802272763059294,1.0,8/28,13.06%,PTPN6;PTPRF;PTPN18;PTPN1;PTPRO;PTPRJ;PTPN22;UBASH3B
1557,prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.5603945830293556,-0.9225559273458631,0.5423728813559322,0.8029814760324628,1.0,5/27,5.16%,TGFB3;HMOX1;IGFBP3;AIF1;EFEMP2
1558,prerank,positive regulation of protein modification process (GO:0031401),-0.43268188542812575,-0.9223206406988295,0.603448275862069,0.8027769588538679,1.0,14/167,6.23%,TREM2;GPNMB;TMEM119;MARCO;PAK1;FAM20A;VEGFD;CSF1R;SOX9;GBA;PRKCD;CD74;NNMT;ITGB3
1559,prerank,axonal transport (GO:0098930),0.5425303226697976,0.9222369381902163,0.55,1.0,1.0,6/31,15.09%,MAPT;OPA1;SYBU;KIF1B;RAB21;DCTN1
1560,prerank,response to glucose (GO:0009749),0.526916842469944,0.9218739820485164,0.5952380952380952,1.0,1.0,6/34,9.34%,LPL;GCK;KCNB1;PRKACA;PRKAA2;EIF2B4
1561,prerank,negative regulation of defense response (GO:0031348),-0.5010075652745448,-0.9215889315348832,0.6176470588235294,0.8035640887950312,1.0,17/62,10.76%,APOE;TNFAIP8L2;MEFV;PTGIS;CCN3;SIRPA;AOAH;GBA;PRKCD;C1QTNF3;MAPK7;RNF26;TYRO3;NLRC3;MACIR;NR1H4;METRNL
1562,prerank,transport across blood-brain barrier (GO:0150104),0.46086197845291305,0.9205450625065188,0.6,1.0,1.0,14/61,10.82%,TFRC;SLC2A4;SLC4A3;SLC16A1;SLC38A3;ABCC9;CD36;ATP1A2;SLC29A2;SLC22A5;KCNJ8;INSR;SLC28A2;SLC4A4
1563,prerank,negative regulation of catabolic process (GO:0009895),-0.5291795569664278,-0.9200518781230368,0.6166666666666667,0.8061305901743486,1.0,4/34,8.96%,NUPR1;FLNA;AZIN2;CST3
1564,prerank,positive regulation of cilium assembly (GO:0045724),-0.5967678498925066,-0.9196611091548611,0.6885245901639344,0.8061737372383391,1.0,4/16,25.58%,KCTD17;SEPTIN9;CCP110;CCDC88A
1565,prerank,positive regulation of organelle organization (GO:0010638),-0.5536403578970953,-0.9193655899164893,0.559322033898305,0.8060270613195721,1.0,4/26,6.40%,TREM2;ANXA1;P2RX7;ANXA2
1566,prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.5410482600626644,-0.9193015676239427,0.559322033898305,0.8054715453236998,1.0,4/31,3.63%,ANXA1;SRPX2;HMOX1;THBS1
1567,prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.5094860168265177,-0.9187659591679932,0.6666666666666666,0.8059139252068265,1.0,8/41,15.11%,MDK;FLNA;CARMIL1;P4HB;ILK;S100A10;NEDD9;CDC42
1568,prerank,membrane assembly (GO:0071709),-0.5411677048423681,-0.9187582450808451,0.603448275862069,0.80522003079052,1.0,8/27,21.99%,ANXA2;GAK;NLGN2;S100A10;PICALM;UGCG;STX2;PTPRD
1569,prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.5835735832624449,-0.9182758256193339,0.6190476190476191,0.8052737360068661,1.0,7/17,19.10%,RNASE6;CXCL10;ANG;RPL39;RPS19;CXCL13;CXCL5
1570,prerank,histone H3 acetylation (GO:0043966),-0.5256085696814594,-0.9171099607920635,0.6129032258064516,0.8068685392725767,1.0,2/37,13.59%,SPI1;LDB1
1571,prerank,phosphorylation (GO:0016310),0.36564537447038886,0.916535516816617,0.75,1.0,1.0,25/321,9.70%,PDK2;PDK4;WNK2;TNNI3K;PINK1;FASTK;COQ8A;STRADB;DGKE;MYLK3;TNIK;PRKACA;CAMK2A;PRKCE;PRKAA2;PICK1;WNK1;MAP3K5;SIK3;BCKDK;MAPKAPK2;MAP3K20;CAMK2B;RET;IP6K3
1572,prerank,lipid modification (GO:0030258),-0.557547083627909,-0.9159538000088044,0.5614035087719298,0.8084108915807869,1.0,3/22,7.46%,PLA2G7;PLPP2;PLPPR3
1573,prerank,regulation of catabolic process (GO:0009894),-0.5934317079906496,-0.914825393423097,0.6,0.8104667041668447,1.0,4/17,16.59%,FAP;FAM83D;ZDHHC2;TMEM9
1574,prerank,lipid transport (GO:0006869),-0.47385556965048137,-0.9147874739877319,0.6206896551724138,0.8098016194450851,1.0,16/70,13.21%,APOE;NPC2;GM2A;SLC27A3;GLTP;ABCC3;SLC10A3;ABCG1;PRELID1;NR1H4;PLTP;CLN3;OSBPL5;PITPNM1;ABCA1;FABP5
1575,prerank,positive regulation of interleukin-10 production (GO:0032733),-0.5679732093896759,-0.9143670702001626,0.6415094339622641,0.8098610194518738,1.0,6/17,13.78%,CLEC7A;TLR9;PLCG2;SYK;ISG15;PYCARD
1576,prerank,post-translational protein modification (GO:0043687),-0.40302710819586735,-0.9134100407061598,0.6567164179104478,0.8112568185058187,1.0,25/276,9.43%,FSTL1;SPP1;FN1;APOE;FBN1;TNC;TIMP1;FSTL3;IGFBP4;IGFBP7;IGFBP3;MXRA8;SPSB2;SKP2;GPC3;GAS6;SHISA5;P4HB;FBXO17;CST3;RAB13;SUMF1;RCN1;PRSS23;LGALS1
1577,prerank,renal system development (GO:0072001),-0.5260520154826024,-0.9126804015047947,0.6615384615384615,0.811819316297736,1.0,10/37,14.00%,SULF1;TCF21;TGFB2;SULF2;TGFBR1;TBX18;WNT4;FOXC1;PCSK5;GLI2
1578,prerank,positive regulation of potassium ion transport (GO:0043268),-0.5220780698828712,-0.9126652512515037,0.5652173913043478,0.81115536478807,1.0,3/23,4.84%,KCNN4;KCNJ15;FLNA
1579,prerank,regulation of potassium ion transport (GO:0043266),0.5528336809012763,0.9117847446662479,0.6470588235294118,1.0,1.0,4/17,4.23%,KCNIP2;ANK2;CASQ2;KCNA5
1580,prerank,prostaglandin biosynthetic process (GO:0001516),-0.616300945793254,-0.9114922364260974,0.6041666666666666,0.8127439037798665,1.0,4/17,5.39%,PTGIS;TBXAS1;CD74;HPGDS
1581,prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.4460927410666366,-0.9109431430518123,0.6142857142857143,0.8133825814763138,1.0,15/109,10.97%,VIM;EREG;TLR2;TLR9;THBS1;TGFB2;IGF1;IL33;TMEM106A;NIBAN1;MYC;HGF;RBM3;RPS4X;PDGFRB
1582,prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.4989675517699436,-0.9104715999564901,0.6724137931034483,0.8135667224328813,1.0,21/63,17.33%,DAP;LAPTM5;CASP1;F2R;CASP12;APAF1;BEX3;ROBO1;BID;BOK;BAX;EIF2AK3;TRADD;CASP4;PYCARD;RIPK1;BBC3;RACK1;CASP8;LCK;FAS
1583,prerank,negative regulation of RNA metabolic process (GO:0051253),-0.5697025553499998,-0.9102162269497251,0.5666666666666667,0.8133270503678997,1.0,5/15,23.77%,TGFB1;RPS26;PTBP1;NUDT16;PTBP3
1584,prerank,regulation of ion transport (GO:0043269),0.4946217946849121,0.9097092228418093,0.5526315789473685,1.0,1.0,10/37,10.20%,KCNJ3;SYT7;KCNJ11;KCNJ5;KCNA5;KCNJ12;KCNJ2;WNK1;KCNJ8;ATP1A1
1585,prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.5315844772508206,-0.9088518824830949,0.609375,0.8156560901079066,1.0,6/25,22.29%,TIFA;ALPK1;CASP8;RPS27A;TNFAIP3;IRAK2
1586,prerank,amino acid transmembrane transport (GO:0003333),0.4880741569981968,0.9085890083823379,0.6388888888888888,1.0,1.0,4/29,5.15%,SLC25A13;SLC38A3;SLC25A12;SLC47A1
1587,prerank,cellular macromolecule biosynthetic process (GO:0034645),0.37646606232874974,0.9083338618074365,0.44,1.0,1.0,24/271,11.93%,RPL3L;MLF1;MRPL42;EIF4G1;MRPL55;MRPS36;ALAS1;EEF1A2;TUFM;MRPL18;MRPL51;MRPL28;TSFM;MRPL3;MRPL9;MRPL41;MRPL37;PABPC4;MRRF;MRPS33;YARS2;MRPS15;MRPS7;MRPL34
1588,prerank,positive regulation of protein ubiquitination (GO:0031398),0.44752276612558484,0.9081587808730438,0.6666666666666666,1.0,1.0,11/75,16.31%,PINK1;DCUN1D2;FBXW7;KLHL40;WFS1;CRY1;BMI1;UBE2D1;HUWE1;COMMD1;SPSB4
1589,prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.5011697603633463,-0.9080927900511182,0.5833333333333334,0.8164571945440051,1.0,5/32,10.44%,APAF1;E2F1;EHMT2;PCGF2;RRM2
1590,prerank,sulfur compound biosynthetic process (GO:0044272),-0.4650885747927906,-0.9072987178620097,0.5901639344262295,0.817443561119043,1.0,24/82,13.12%,FMOD;BGN;ACAN;LUM;DSE;CHSY3;HPGDS;CHPF2;CHPF;DSEL;CHST12;B4GALT2;SLC35B3;UST;CHST14;PRELP;CNDP2;SLC35D2;CHST2;CHSY1;OMD;OGN;PAPSS1;CHST1
1591,prerank,protein export from nucleus (GO:0006611),0.5512123276836939,0.907037285704534,0.6875,1.0,1.0,1/23,2.55%,STRADB
1592,prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.4092983584198697,0.906855500758325,0.6216216216216216,1.0,1.0,11/80,5.97%,P2RY1;HRC;CDH23;PLN;ACKR3;RYR2;CD36;ADRA1B;ATP1A2;PRKACA;ADRA1A
1593,prerank,regulation of ion transmembrane transport (GO:0034765),0.555513896519162,0.9066641025531064,0.625,1.0,1.0,11/20,12.51%,KCNJ3;KCNJ11;CASQ2;KCNJ5;KCNJ12;KCNJ2;WNK1;KCNJ8;KCNQ1;AKAP6;KCNH2
1594,prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.5151491735102929,-0.9055638874416221,0.6181818181818182,0.8199495267817779,1.0,7/30,12.31%,CD300A;GBA;PRKCD;TGFB1;PDGFRB;CALM2;NSMF
1595,prerank,regulation of lipid biosynthetic process (GO:0046890),0.5399347871253328,0.9048194933487574,0.6666666666666666,1.0,1.0,7/24,9.92%,PDK4;FITM2;PPARA;PRKAA2;SORBS1;MLXIPL;CEACAM1
1596,prerank,regulation of centrosome duplication (GO:0010824),0.5568902777651702,0.9046566200193906,0.6304347826086957,1.0,1.0,1/25,4.44%,CHMP4C
1597,prerank,protein depolymerization (GO:0051261),-0.5321936128314436,-0.904584541270034,0.559322033898305,0.8212940302617495,1.0,6/19,13.73%,MICAL1;CFL1;STMN1;DSTN;TWF1;NCKAP5L
1598,prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.5330946251468622,-0.9045469805564111,0.639344262295082,0.8206374409682936,1.0,8/29,10.99%,MYO1F;MYO1G;MYO5A;MYO1D;MYO1C;MYO7A;MYO1E;CLN3
1599,prerank,cardiac muscle tissue development (GO:0048738),0.4801107661987558,0.9044545344797668,0.6388888888888888,1.0,1.0,13/43,13.29%,HCN4;TTN;NDUFV2;ACTC1;SGCG;TCAP;CSRP3;GJA1;SIK1;NKX2-5;MYOCD;NOTCH1;GATA4
1600,prerank,potassium ion transmembrane transport (GO:0071805),0.46259957832759036,0.90366148451332,0.6744186046511628,1.0,1.0,24/57,9.43%,KCNIP2;HCN4;SLC9A2;KCNJ3;KCNN1;KCNJ11;KCND2;ABCC9;KCNK3;KCNJ5;HCN2;KCNA5;SLC12A7;KCNB1;ATP1A2;KCNJ12;KCNG2;KCNJ2;ABCC8;ABCB8;KCNN2;KCNV2;KCND3;KCNJ8
1601,prerank,peptidyl-proline modification (GO:0018208),0.5232118287952607,0.9031193957941536,0.625,1.0,1.0,2/24,0.86%,PPIF;FKBP4
1602,prerank,positive regulation of protein import into nucleus (GO:0042307),-0.5357101216487338,-0.9024283497964769,0.5909090909090909,0.8240446395469039,1.0,4/23,10.59%,PRKCD;FLNA;HCLS1;TGFB1
1603,prerank,negative regulation of stress fiber assembly (GO:0051497),-0.531482032805758,-0.9020661925332404,0.5396825396825397,0.8240519355276661,1.0,5/23,13.19%,ARAP1;WAS;MET;STMN1;PHLDB2
1604,prerank,phosphatidylserine metabolic process (GO:0006658),0.5355314562092294,0.9018912373574476,0.6428571428571429,1.0,1.0,3/20,9.03%,PLA2G5;PLA2G12A;PLA2G4E
1605,prerank,protein catabolic process (GO:0030163),0.46158972965200584,0.9017944717047844,0.5681818181818182,1.0,1.0,1/49,0.13%,RAB12
1606,prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.5378187085828583,-0.9017854786432193,0.5862068965517241,0.8239908096389233,1.0,3/23,4.42%,APOE;PTK2B;GBA
1607,prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.5087013537470952,0.9015264634974467,0.6486486486486487,1.0,1.0,4/28,19.39%,COG6;TRAPPC10;COG5;GABARAPL2
1608,prerank,negative regulation of macroautophagy (GO:0016242),-0.5353189269593941,-0.9015122470272082,0.5818181818181818,0.8237735580268966,1.0,1/23,0.82%,NUPR1
1609,prerank,positive regulation of metabolic process (GO:0009893),0.4178502044661656,0.9014806899278592,0.5609756097560976,1.0,1.0,15/79,7.28%,ACACB;PPARGC1A;DECR1;HADH;LPIN1;CPT2;MFN2;ACADL;PRDM16;CD36;VEGFA;EPAS1;OMA1;ACSL1;PYURF
1610,prerank,negative regulation of protein binding (GO:0032091),-0.4865653461269188,-0.9002668061593339,0.6206896551724138,0.8253908148733473,1.0,14/60,16.34%,CTSZ;ARRB2;PRKCD;PTPRF;DACT1;ITGA4;ACTB;BAX;AURKB;B2M;DAB2;AURKA;RACK1;IFIT1
1611,prerank,positive regulation of double-strand break repair (GO:2000781),-0.5021944001895458,-0.8992331291655755,0.5957446808510638,0.8268201007233249,1.0,6/29,19.12%,WAS;SPIDR;FOXM1;ACTR2;SPIRE1;KMT5C
1612,prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.5794828513736043,-0.899199497743341,0.62,0.8261724566673826,1.0,8/16,15.39%,CLU;SLC2A13;ABCG1;CASP3;LYN;IFNGR1;PICALM;GSAP
1613,prerank,polyol metabolic process (GO:0019751),-0.5051364568447068,-0.8977975185163761,0.6101694915254238,0.8282603495540006,1.0,1/39,0.46%,PLD4
1614,prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.5114377717978256,-0.8974953758139377,0.6271186440677966,0.8281765030380066,1.0,7/30,15.75%,SEMA3D;FLNA;SH3BP1;SEMA4A;MET;ARHGDIA;SEMA3F
1615,prerank,positive regulation of mitochondrion organization (GO:0010822),0.4369330672503699,0.8970189863914851,0.6744186046511628,1.0,1.0,6/50,6.63%,PPIF;KDR;PPARGC1A;PINK1;ADCK1;CHCHD10
1616,prerank,muscle organ development (GO:0007517),-0.46531544030553185,-0.8966922587598377,0.6666666666666666,0.8290545344846016,1.0,7/45,7.06%,TAGLN;ITGA11;TCF21;IGF1;EVC;CXCL10;COL6A3
1617,prerank,purine nucleotide metabolic process (GO:0006163),0.543852626068116,0.8959741751685284,0.6111111111111112,1.0,1.0,4/19,9.15%,NUDT15;NT5C1A;ADSL;GUK1
1618,prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.5102400892208827,0.8958208555914671,0.5128205128205128,1.0,1.0,3/30,5.40%,PINK1;FBXW7;SH3GLB1
1619,prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.5181427412809619,-0.8955774456544021,0.6428571428571429,0.8305328575791356,1.0,5/31,17.17%,FZD2;GNG2;WNT11;PLCB2;MOV10
1620,prerank,protein secretion (GO:0009306),0.47763001001225713,0.895566066158423,0.6666666666666666,1.0,1.0,3/40,2.21%,RAB12;TANGO2;RAB3A
1621,prerank,dicarboxylic acid transport (GO:0006835),-0.5412891762434464,-0.8950800595639067,0.6071428571428571,0.8307770237006767,1.0,2/16,4.20%,PDPN;PRAF2
1622,prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.4805843151945369,0.8947151926226445,0.7083333333333334,1.0,1.0,7/33,8.94%,KDR;VEGFB;NR4A1;VEGFA;FLT1;SEMA6A;MAPKAPK2
1623,prerank,microtubule polymerization or depolymerization (GO:0031109),0.5497898787793223,0.8945187030393086,0.5853658536585366,1.0,1.0,3/16,11.70%,MAPT;FGF13;TPPP
1624,prerank,regulation of axonogenesis (GO:0050770),0.4887257993516327,0.8944476088824895,0.6486486486486487,1.0,1.0,2/41,2.42%,EFNB3;EPHA4
1625,prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.4670164789914206,-0.8937417265136457,0.703125,0.832813375970804,1.0,9/72,13.17%,APOE;SERPINE2;CSTB;TYMS;CST3;CLN3;ENC1;EIF2AK3;RPL13A
1626,prerank,tube closure (GO:0060606),-0.5386460063796038,-0.8937136936489071,0.6666666666666666,0.8314780170194426,1.0,7/26,18.28%,TGFB2;MTHFD1L;TGFB1;LMO4;MTHFR;DEAF1;PLXNB2
1627,prerank,primary neural tube formation (GO:0014020),-0.5386460063796038,-0.8937136936489071,0.6666666666666666,0.8314780170194426,1.0,7/26,18.28%,TGFB2;MTHFD1L;TGFB1;LMO4;MTHFR;DEAF1;PLXNB2
1628,prerank,neural tube closure (GO:0001843),-0.5343554632167914,-0.8929183610889053,0.7142857142857143,0.8323294558052472,1.0,7/29,18.28%,TGFB2;MTHFD1L;TGFB1;LMO4;MTHFR;DEAF1;PLXNB2
1629,prerank,positive regulation of protein import (GO:1904591),-0.5257183664320566,-0.8928279536604458,0.6029411764705882,0.8318371412853345,1.0,4/25,10.59%,PRKCD;FLNA;HCLS1;TGFB1
1630,prerank,negative regulation of phosphatase activity (GO:0010923),0.5503803603383184,0.8926854219120144,0.6521739130434783,1.0,1.0,2/18,5.03%,SH2D4A;SH3RF2
1631,prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.5249047986961213,0.8917268468032734,0.5961538461538461,1.0,1.0,2/21,2.28%,PINK1;SOD2
1632,prerank,endothelial cell development (GO:0001885),-0.561362793263521,-0.8911019804645058,0.66,0.8345876386580436,1.0,6/22,14.16%,COL18A1;COL15A1;ICAM1;MET;MSN;RAP1B
1633,prerank,vascular transport (GO:0010232),0.4473730616579304,0.8910578274252171,0.5909090909090909,1.0,1.0,13/59,10.82%,TFRC;SLC2A4;SLC4A3;SLC16A1;SLC38A3;ABCC9;ATP1A2;SLC29A2;SLC22A5;KCNJ8;INSR;SLC28A2;SLC4A4
1634,prerank,positive regulation of RNA metabolic process (GO:0051254),0.48174005510194773,0.8894606770366702,0.5777777777777777,1.0,1.0,3/40,12.47%,RBM20;GRSF1;SUPV3L1
1635,prerank,response to ionizing radiation (GO:0010212),-0.4719158592224782,-0.8893254622865937,0.6206896551724138,0.8374106107167556,1.0,4/59,11.50%,ANXA1;MYC;SPIDR;IKBIP
1636,prerank,positive regulation of phospholipase activity (GO:0010518),0.5083336265011579,0.889300272852518,0.6458333333333334,1.0,1.0,2/20,5.41%,PLA2G5;FLT1
1637,prerank,mismatch repair (GO:0006298),-0.55397674981831,-0.8892744382388966,0.6774193548387096,0.8367996627223651,1.0,3/23,19.65%,LIG1;POLD4;POLD3
1638,prerank,protein deacetylation (GO:0006476),0.4736599491148224,0.8887973770967909,0.65,1.0,1.0,5/43,10.46%,PHB;SIRT3;SIRT5;HDAC11;HDAC9
1639,prerank,endosome organization (GO:0007032),-0.5159847341130841,-0.8885069479112383,0.6153846153846154,0.8375082776270443,1.0,8/39,16.59%,ANXA8;CORO1C;RNF26;DNM1;PI4K2B;SNX10;SNX33;TMEM9
1640,prerank,response to reactive oxygen species (GO:0000302),0.4696925161983748,0.8884406774332431,0.6052631578947368,1.0,1.0,5/52,5.78%,PDK2;SOD2;PRDX3;MAPT;TPM1
1641,prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.47567006751984703,-0.887775661681074,0.6333333333333333,0.8381868489521139,1.0,4/48,8.21%,PLEK;CCL5;RGS16;RGS14
1642,prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.5560165695217507,0.8870627571566992,0.6595744680851063,1.0,1.0,6/16,15.75%,ADSL;AK4;AMPD3;PAICS;AK3;PPAT
1643,prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.4230294105267558,-0.8862889020118848,0.6842105263157895,0.8405456950043281,1.0,18/147,9.01%,CDH3;VIM;EREG;DDAH1;CLEC7A;CLU;PTH1R;THBS1;STAR;P2RX4;IGF1;CCL5;ASS1;NNMT;NIBAN1;MYC;HGF;RBM3
1644,prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.5629969336222863,-0.8861947900338771,0.5901639344262295,0.8400589653168867,1.0,3/17,12.14%,FCGR2B;BOK;BAX
1645,prerank,glial cell differentiation (GO:0010001),0.5103631538009742,0.885725796580647,0.5454545454545454,1.0,1.0,6/18,11.70%,GPR157;GPC1;ERBB3;PICK1;METRN;TPPP
1646,prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.4247355914700783,0.885682413704818,0.59375,1.0,1.0,3/75,5.67%,TUBA4A;CLASP1;PRKACA
1647,prerank,microtubule nucleation (GO:0007020),0.5433590126819133,0.8856056836518171,0.673469387755102,1.0,1.0,4/18,15.14%,CLASP1;TPPP;SLAIN2;TUBG1
1648,prerank,regulation of primary metabolic process (GO:0080090),-0.4363363468451852,-0.8853584989401098,0.7083333333333334,0.8412324602434689,1.0,3/112,4.47%,APOE;C1QTNF2;ID2
1649,prerank,regulation of insulin secretion (GO:0050796),0.4342446720404525,0.8852979343585942,0.7441860465116279,1.0,1.0,13/65,9.84%,SYT7;HADH;KCNJ11;GCK;KCNA5;NOS2;KCNB1;ARNTL;KCNG2;ABCC8;PICK1;ALOX5;ADCY5
1650,prerank,plasma membrane organization (GO:0007009),-0.4624257738414206,-0.8851506303755567,0.6911764705882353,0.8410334879091458,1.0,9/51,9.53%,MYOF;COL5A1;AHNAK2;SERP1;P2RX7;CXCR4;SLC9A3R1;BIN2;BIN1
1651,prerank,in utero embryonic development (GO:0001701),-0.5535988104495718,-0.8851398845548041,0.6530612244897959,0.8403560579911763,1.0,5/16,14.48%,TGFB3;TGFBR1;FGFR2;BMP2;SOX8
1652,prerank,mammary gland development (GO:0030879),-0.5906186076896149,-0.8846681907091134,0.6792452830188679,0.8405695701735997,1.0,1/15,1.50%,TGFB3
1653,prerank,snRNA processing (GO:0016180),0.5316577321728275,0.8844593380827397,0.6956521739130435,1.0,1.0,1/16,11.96%,INTS10
1654,prerank,signal release from synapse (GO:0099643),0.5103862168155657,0.8841057873406221,0.6481481481481481,1.0,1.0,1/19,2.21%,RAB3A
1655,prerank,neurotransmitter secretion (GO:0007269),0.5103862168155657,0.8841057873406221,0.6481481481481481,1.0,1.0,1/19,2.21%,RAB3A
1656,prerank,histone H3-K4 methylation (GO:0051568),0.5223860247125258,0.8838682023379388,0.6666666666666666,1.0,1.0,11/22,37.34%,BEND3;WDR5;WDR82;RBBP5;DPY30;KMT2A;KMT2C;KDM6A;ASH2L;TET2;PAXIP1
1657,prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.5498461381001821,-0.883599752389039,0.6379310344827587,0.8419107785528909,1.0,4/15,6.09%,CEMIP;F2R;CXCL10;CX3CL1
1658,prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.49087630730735154,-0.8825824620928474,0.7037037037037037,0.843077808414256,1.0,6/34,7.14%,KCNN4;KCNJ15;FLNA;KCNAB2;CD63;GNG2
1659,prerank,long-chain fatty acid metabolic process (GO:0001676),0.45561937704188255,0.8817224590773504,0.6410256410256411,1.0,1.0,10/45,8.61%,ACOT1;ACOT2;CPT2;ACADL;ACSL6;ACOX1;EPHX2;ACSL1;ALOX12;ALOX5
1660,prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.533979452845839,0.8815773690213491,0.66,1.0,1.0,4/15,11.14%,ENDOG;DFFA;KPNA1;CECR2
1661,prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.4788065409818752,-0.8802077131423057,0.6274509803921569,0.8469628627300054,1.0,6/46,17.80%,PADI2;MYO1C;ACTB;ATAD2;SERTAD1;TAF1D
1662,prerank,tRNA modification (GO:0006400),0.48493179333392217,0.880080748000142,0.7906976744186046,1.0,1.0,7/50,22.09%,AARS2;MTO1;TRMT5;LCMT2;OSGEP;CDKAL1;PUS1
1663,prerank,protein insertion into ER membrane (GO:0045048),-0.5004874715138204,-0.879695914759492,0.7241379310344828,0.8474085317769167,1.0,6/33,11.16%,HMOX1;SERP1;TRAM2;SEC61B;APP;TRAM1
1664,prerank,regulation of autophagosome assembly (GO:2000785),-0.523152542675684,-0.8790323516280857,0.6666666666666666,0.8479296788607473,1.0,2/32,6.89%,NUPR1;PIP4K2A
1665,prerank,negative regulation of cation channel activity (GO:2001258),-0.5429256571749062,-0.8787106757068985,0.6129032258064516,0.8477930840638267,1.0,4/20,11.51%,GPR35;FKBP1B;EPHB2;CALM2
1666,prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.4915457514702936,0.8777185400869731,0.6,1.0,1.0,7/36,15.94%,PINK1;FBXW7;SH3GLB1;ABLIM3;PRKN;HUWE1;TOMM7
1667,prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.38158505586050157,-0.8772233089773434,0.7922077922077922,0.8500632384571972,1.0,71/450,17.51%,AEBP1;LOXL2;IRF8;FST;SNAI1;MDFI;TCF21;SOX9;TFEC;ID2;TGIF1;DACT1;RUNX1;ID3;IL33;OSR1;SPI1;TWIST1;ZFP57;FOXP2;MYC;E2F1;PEG3;EHMT2;PCGF2;HHEX;UHRF1;GLIS2;ID4;FOXC2;NR1H4;VDR;FOXM1;FOXC1;FOXP4;RUNX3;FGFR2;BMP2;SNAI2;AURKB;MAZ;TRPS1;CHD3;FRK;GLIS3;NFATC4;SIRT7;LDB1;GLI2;CIITA;EDN1;JDP2;SOX8;DAB2;EID1;SDCBP;GLI3;PER3;PLK3;BHLHE40;WWP2;UBE2I;NR2F2;DEAF1;ARID5A;LEFTY1;IRF7;PER2;SKIL;HDAC1;CBFB
1668,prerank,organic hydroxy compound transport (GO:0015850),-0.538168692925765,-0.8767231126336357,0.625,0.8502292218462301,1.0,3/17,4.86%,NPC2;ABCC3;SLC10A3
1669,prerank,regulation of microtubule polymerization (GO:0031113),-0.4669588501531205,-0.8767166559461702,0.6507936507936508,0.8495212874400301,1.0,4/34,11.87%,PAK1;FES;MET;STMN1
1670,prerank,inositol phosphate metabolic process (GO:0043647),-0.5056247382584358,-0.876367100704824,0.6379310344827587,0.8494597286821237,1.0,1/39,0.46%,PLD4
1671,prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.4725646051675848,-0.8760147126070422,0.65,0.849312949434353,1.0,5/41,20.44%,SMARCA1;ACTB;CHD3;HDAC1;SMARCD2
1672,prerank,chemical homeostasis (GO:0048878),-0.49214484260520686,-0.8759739723180855,0.6825396825396826,0.8486738470924232,1.0,2/40,0.33%,RBP1;TREM2
1673,prerank,phosphate-containing compound metabolic process (GO:0006796),0.38940926619665794,0.8729357465879568,0.8,1.0,1.0,23/155,9.70%,FBP2;PLA2G5;PFKM;LPL;DUSP18;HK2;COQ8A;GCK;ACYP2;PPIP5K2;PPIP5K1;NUDT3;PFKFB2;INPP5A;EPHX2;DUSP8;PPA2;TIGAR;BCKDK;PLA2G4E;ITPKB;HDHD2;IP6K3
1674,prerank,DNA damage checkpoint signaling (GO:0000077),0.49744499780063856,0.8728730874439996,0.5641025641025641,1.0,1.0,3/26,9.07%,PRPF19;USP28;MAP3K20
1675,prerank,fat cell differentiation (GO:0045444),-0.47329268995945006,-0.8722998799697853,0.7352941176470589,0.8551437048543051,1.0,5/48,7.58%,GDF6;MAFB;C1QTNF3;CEBPA;INHBB
1676,prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.36954993335372766,0.8716588807432049,0.8571428571428571,1.0,1.0,60/318,18.87%,FEM1A;PINK1;NHLRC1;ASB2;TRIM72;FBXW7;ARNTL;ANKRD9;GID4;PSME4;CDC34;UBE2B;MARCHF6;UBQLN4;HERPUD1;PTTG1;DCAF11;FBXL22;UBE3B;RNF128;UBR3;KLHL8;FAF1;KLHL3;FBXO21;UBXN2A;PRKN;PSMC3;PSME3;GID8;CUL4A;RAD23A;UBE2G1;PSMD12;UBE2D1;HUWE1;COP1;RNF14;FBXO8;NPLOC4;SPSB4;ARMC8;AREL1;VPS37A;FBXW5;PSMB7;TOLLIP;RNF114;VCP;SPOP;COPS3;NEDD4L;PSMD2;RNF6;UBE3C;PPP1R11;RMND5A;UBL7;PSMA1;TTC3
1677,prerank,phosphatidylglycerol metabolic process (GO:0046471),0.5427295282983304,0.8706369731975114,0.6041666666666666,1.0,1.0,4/15,12.37%,PLA2G5;PLA2G12A;GPAM;PNPLA8
1678,prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.4418798771333246,-0.8706129364863099,0.7,0.8575553519620747,1.0,5/68,11.25%,SPI1;ZFP57;MYO1C;GPX1;ACTB
1679,prerank,regulation of protein export from nucleus (GO:0046825),-0.5348535743050878,-0.8696517551334976,0.7,0.8585362195394993,1.0,3/21,13.55%,GTSE1;GAS6;SIRT7
1680,prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4505909817348026,0.8685872488691613,0.7631578947368421,1.0,1.0,10/70,15.85%,PINK1;DCUN1D2;FBXW7;KLHL40;WFS1;CRY1;MUL1;UBE2D1;HUWE1;COMMD1
1681,prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.4789672327824508,0.8681885847992444,0.5952380952380952,1.0,1.0,1/31,0.02%,ILRUN
1682,prerank,organic acid transport (GO:0015849),-0.48486306281343294,-0.8661091128449998,0.8035714285714286,0.8649912866331719,1.0,8/54,7.25%,PDPN;SLC7A2;SLC27A3;SLC7A7;ABCC3;SLC10A3;SLC1A4;SLC25A45
1683,prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.47170213454639687,-0.8660926993161111,0.7169811320754716,0.8643418593735506,1.0,4/33,7.69%,TREM2;SIRPA;DACT1;MYC
1684,prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.421494159238059,0.8654265796956998,0.6585365853658537,1.0,1.0,5/70,4.34%,HRC;TFRC;PINK1;EIF4G1;VEGFA
1685,prerank,nucleotide metabolic process (GO:0009117),0.5134647884443996,0.8648932499679826,0.6756756756756757,1.0,1.0,5/18,10.62%,NMNAT1;AK1;GUK1;NMNAT3;AK4
1686,prerank,negative regulation of phosphorylation (GO:0042326),-0.47110894251505886,-0.8646672423120831,0.7192982456140351,0.866342062579291,1.0,16/74,13.79%,NUPR1;CDKN2B;IGFBP3;SIRPA;FBLN1;DYNLL1;NIBAN1;CORO1C;EPHB2;INHBA;TGFB1;STAP1;PID1;PRR5L;DNAJC10;LYN
1687,prerank,negative regulation of viral process (GO:0048525),-0.4449836971948147,-0.8645413115716662,0.7272727272727273,0.8658056046846597,1.0,14/51,16.34%,PTX3;CCL5;OAS3;ISG20;ZC3HAV1;MX1;FAM111A;IFITM2;RNASEL;ISG15;TRIM62;BST2;PPIA;IFIT1
1688,prerank,establishment of vesicle localization (GO:0051650),-0.546121741061948,-0.8644588713056698,0.74,0.8652606221177953,1.0,3/15,25.01%,TOR1A;RAB27A;SYT11
1689,prerank,histone modification (GO:0016570),-0.42185652791981343,-0.8636259414104133,0.7580645161290323,0.8660892532948428,1.0,10/99,14.43%,PRKCD;PADI2;EYA4;CCNA2;EHMT2;TRERF1;UHRF1;AURKB;SIRT7;PADI4
1690,prerank,skeletal muscle organ development (GO:0060538),-0.551329777411203,-0.8631007430652466,0.7457627118644068,0.8663622489233167,1.0,5/21,8.48%,BASP1;TCF21;IGSF8;MSC;MYL6
1691,prerank,regulation of protein binding (GO:0043393),-0.44232776905652227,-0.8630873282789437,0.6935483870967742,0.8656961269840212,1.0,23/103,20.22%,CTSZ;LRP1;PRKCD;DACT1;APP;ACTB;BMP2;BAX;AURKB;TIAM1;B2M;STING1;DAB2;AURKA;RACK1;IFIT1;PKD1;SLPI;CDKN1A;PLK1;TRIB3;LRPAP1;MITD1
1692,prerank,regulation of proteolysis (GO:0030162),-0.46945092652651577,-0.8627388983731209,0.6716417910447762,0.8656688700976163,1.0,10/41,16.17%,SERPINE2;CSTB;CST3;PLAUR;LTBP4;CLN3;GSAP;TBC1D10A;CASP8;PLAT
1693,prerank,cellular response to glucose stimulus (GO:0071333),0.5081567207436086,0.8619301028896216,0.6888888888888889,1.0,1.0,4/23,9.71%,KCNB1;PRKACA;PRKAA2;MLXIPL
1694,prerank,regulation of mitotic nuclear division (GO:0007088),-0.5152542865506957,-0.8618166423398387,0.75,0.866784951235159,1.0,14/41,19.82%,EREG;IGF1;MKI67;PDGFRB;CCNB1;KIF20B;EDN1;NUSAP1;AURKA;BORA;CDK5RAP2;TGFA;CCDC8;CUL7
1695,prerank,regulation of microtubule-based process (GO:0032886),0.508688523184059,0.8617820260734362,0.7380952380952381,1.0,1.0,5/32,14.53%,MAPT;CLASP1;PRKAA2;TPPP;MAP10
1696,prerank,nucleobase-containing compound catabolic process (GO:0034655),0.4689110307593936,0.8615625134401383,0.6363636363636364,1.0,1.0,5/33,12.47%,NUDT15;ENTPD5;PABPC4;ENTPD4;SUPV3L1
1697,prerank,regulation of necroptotic process (GO:0060544),0.5152988036742913,0.8613648716751394,0.5581395348837209,1.0,1.0,1/22,2.36%,SLC25A4
1698,prerank,positive regulation of ATP metabolic process (GO:1903580),-0.5264125396574966,-0.8603395695947013,0.6935483870967742,0.8689853729210444,1.0,5/28,6.19%,TREM2;NUPR1;IGF1;P2RX7;TMSB4X
1699,prerank,DNA conformation change (GO:0071103),-0.5368313889135222,-0.8603165373671344,0.6551724137931034,0.8683099290336139,1.0,2/15,9.10%,TOP2A;HHEX
1700,prerank,regulation of lamellipodium assembly (GO:0010591),-0.514456507956651,-0.860240898627492,0.7,0.8678038602457078,1.0,8/26,17.64%,WAS;RAC2;ARPC2;TWF1;ACTR3;CDC42;ABI3;ACTR2
1701,prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.4642848534666677,-0.8601364979729471,0.676923076923077,0.867335982622191,1.0,18/59,19.21%,TNFRSF1B;TGFB2;P2RX7;BID;INHBA;TGFB1;BOK;CASP3;BAX;TRADD;ITGAV;RIPK1;TNFRSF1A;CASP8;FAS;TNFSF12;NGF;CIB1
1702,prerank,mitotic cytokinetic process (GO:1902410),0.5022704719677171,0.8600549372593985,0.6458333333333334,1.0,1.0,1/19,4.44%,CHMP4C
1703,prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.5059452124190581,-0.8600154951040551,0.65,0.8668408720196558,1.0,7/24,24.13%,LIG1;POLD4;RFC2;RPS27A;POLD3;POLE;RFC5
1704,prerank,mRNA metabolic process (GO:0016071),0.4128765978667159,0.8598697446578468,0.7567567567567568,1.0,1.0,5/86,8.10%,SRRM4;PPARGC1A;PRKACA;NUDT12;TBRG4
1705,prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.5343863572569717,-0.8594681890753891,0.6896551724137931,0.8672138222061945,1.0,3/17,3.26%,ANXA1;SRPX2;HMOX1
1706,prerank,carboxylic acid transport (GO:0046942),-0.4940683795214281,-0.8590784813052598,0.6557377049180327,0.8673904920907515,1.0,8/32,13.91%,SLC6A7;SLC16A3;SLC1A4;SLC16A2;CLN3;SLC1A5;SLC7A8;SLC3A2
1707,prerank,positive regulation of developmental growth (GO:0048639),-0.47615859329175375,-0.8581036301756538,0.660377358490566,0.86870270036029,1.0,3/30,8.53%,DBN1;SHTN1;PPIB
1708,prerank,peptidyl-glutamic acid modification (GO:0018200),-0.5629985763057503,-0.8580847681897867,0.6415094339622641,0.8680499484931241,1.0,1/15,3.37%,VKORC1
1709,prerank,regulation of cellular senescence (GO:2000772),-0.520654721335791,-0.8577933779148247,0.7321428571428571,0.8678444148765323,1.0,6/23,17.32%,NEK6;TWIST1;YPEL3;B2M;CDK6;ABI3
1710,prerank,cholesterol metabolic process (GO:0008203),-0.4683018569468949,-0.8576698178366221,0.6984126984126984,0.8672305742987488,1.0,6/48,7.81%,APOE;CH25H;SOAT1;GBA;ABCG1;TSKU
1711,prerank,regulation of protein secretion (GO:0050708),-0.45181964334266106,-0.8573186559337207,0.671875,0.8671373989114958,1.0,12/84,8.32%,TREM2;APOE;TGFB3;ADAM8;TGFB2;IGF1;P3H1;CCL5;ATP13A2;ABCG1;ADAM9;MYH10
1712,prerank,posttranscriptional regulation of gene expression (GO:0010608),0.47382210789382406,0.8568949061181854,0.6744186046511628,1.0,1.0,4/38,9.57%,EIF4E;MAPKAPK5;EIF2B4;LARP4
1713,prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.5211470132251029,-0.856587673585413,0.6851851851851852,0.8675636187996745,1.0,3/28,5.53%,RAB31;KRT18;RAB34
1714,prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.430733566865868,0.85655980197068,0.7209302325581395,1.0,1.0,16/77,18.86%,FBXO31;FBXW7;PSME4;FBXL22;DMAC2;FBXO44;PSMC3;PSME3;CUL4A;CUL5;PSMD12;FBXW5;PSMB7;PSMD2;CUL2;PSMA1
1715,prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.44901495089871485,0.8562665495857161,0.6923076923076923,1.0,1.0,2/18,12.44%,VEGFA;NOTCH1
1716,prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.503693351578373,-0.854461208863873,0.7049180327868853,0.8708611963696823,1.0,7/29,11.95%,IL1RN;FXYD5;ASS1;MAPK7;AKNA;TGFB1;BMP2
1717,prerank,protein localization to chromosome (GO:0034502),0.456329661758659,0.8535786507380986,0.7222222222222222,1.0,1.0,5/30,22.70%,SLF1;BOD1;XRCC5;CHMP7;MSH2
1718,prerank,cellular response to reactive oxygen species (GO:0034614),0.41828328750880034,0.8532719910953818,0.696969696969697,1.0,1.0,5/54,5.78%,PDK2;PPIF;PRDX3;MAPT;TPM1
1719,prerank,midbody abscission (GO:0061952),0.5226699317599639,0.8528999485854798,0.6585365853658537,1.0,1.0,1/16,4.44%,CHMP4C
1720,prerank,establishment of protein localization to membrane (GO:0090150),-0.4615579043188056,-0.8522910419858427,0.7076923076923077,0.874514449887545,1.0,14/54,19.02%,NCF1;MYO1C;ZDHHC24;BID;NPC1;ZDHHC2;GOLGA7;ZDHHC15;ZDHHC12;NECTIN3;SDCBP;ZDHHC20;RAB3GAP2;EGFR
1721,prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.47933433971822037,0.8520835818297793,0.5897435897435898,1.0,1.0,1/30,0.02%,ILRUN
1722,prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.471485746194592,0.8520326985465638,0.6829268292682927,1.0,1.0,3/25,10.52%,DELE1;BAG3;DIABLO
1723,prerank,axon extension (GO:0048675),-0.5117236064181674,-0.8513592759796668,0.6666666666666666,0.8754701294386903,1.0,3/21,10.03%,ALCAM;SLIT3;MAP1B
1724,prerank,striated muscle cell differentiation (GO:0051146),-0.521930030802443,-0.8509403275152756,0.6666666666666666,0.8755277710991727,1.0,2/18,4.96%,PLD3;SDC1
1725,prerank,apoptotic process (GO:0006915),-0.3935297007965842,-0.8503027887071889,0.78125,0.8760378182859181,1.0,18/170,8.35%,GDF6;ITGB2;PTK2B;TLR2;DAP;PDE1B;RTN4;CD14;MELK;PRKCD;CASP1;CASP12;FAP;CXCR4;APAF1;MYC;PAWR;BID
1726,prerank,JNK cascade (GO:0007254),0.4500518292873241,0.8499740377525732,0.5882352941176471,1.0,1.0,8/35,18.98%,MAP3K5;UBC;MAP2K4;MAPK8;MAP3K7;MAPK10;MAP2K7;TAB3
1727,prerank,positive regulation of hydrolase activity (GO:0051345),-0.4102174558500467,-0.8499522949508632,0.8115942028985508,0.8759472721885191,1.0,19/111,11.95%,SFRP1;RGS10;CTSH;RCN3;CCL5;ARAP1;ARHGAP11A;F2R;RGS16;CX3CL1;DOCK10;RHOC;SH3BP1;CCL8;THY1;WNT11;CALM2;DOCK11;BMP2
1728,prerank,base-excision repair (GO:0006284),0.45414746508091075,0.8493062021306909,0.7111111111111111,1.0,1.0,2/44,5.63%,UNG;POLQ
1729,prerank,protein complex oligomerization (GO:0051259),0.42260374251470784,0.8491761582022176,0.7073170731707317,1.0,1.0,15/66,16.45%,OPA1;TRIM72;POLQ;TWNK;ALAD;OXA1L;LETM1;HOMER1;CUTC;DNM1L;STOML2;ATL2;BEND3;PNPT1;EHD1
1730,prerank,negative regulation of protein polymerization (GO:0032272),-0.5186294853697925,-0.8488871505947625,0.7142857142857143,0.877055438703774,1.0,7/25,16.90%,PRKCD;SSH3;STMN1;CYRIB;TWF1;KANK4;TBCD
1731,prerank,rRNA processing (GO:0006364),-0.3999426419068409,-0.8483261332573753,0.7384615384615385,0.8773695577819431,1.0,43/170,26.28%,RPL3;RPL34;RPL6;RPS16;RPL27A;RPL17;RPL39;RPL13A;RPL37A;RPL15;RPS19;RPL12;RPL41;RPL36A;RPL35A;RPL10A;RPL35;RPL14;RPL4;RPL22;RPL11;RPS24;RPL18A;WDR3;RPL19;RPL32;RPL31;RPS7;EIF6;RPS6;RPS27;RPLP1;RPL7;RPS14;RPL23;NSA2;RPL38;RPS28;RPL37;RPL26;RPL5;RPL13;RPL28
1732,prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.49250141971686273,-0.8480989293971047,0.676923076923077,0.8770572394924022,1.0,5/26,13.19%,ARAP1;WAS;MET;STMN1;PHLDB2
1733,prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.4921330028582137,-0.8479309929336915,0.6481481481481481,0.8766074634274916,1.0,4/26,17.82%,MYC;TLE3;HDAC1;PYGO2
1734,prerank,cellular metal ion homeostasis (GO:0006875),-0.44819353539183154,-0.8478506099234915,0.7424242424242424,0.8760573219703456,1.0,7/62,5.68%,CCR2;HTR2B;PTH1R;ATP1A3;CCL5;TPCN2;ATP13A2
1735,prerank,positive regulation of immunoglobulin production (GO:0002639),-0.5070913939575314,-0.8476542003180606,0.6153846153846154,0.8757192667525218,1.0,3/20,3.58%,PTPRC;TLR9;SASH3
1736,prerank,synapse assembly (GO:0007416),-0.5103322657806149,-0.8473022771676569,0.7241379310344828,0.8756570125536124,1.0,6/28,13.48%,LGI2;FZD1;FARP1;RAB29;NLGN2;SDK1
1737,prerank,selective autophagy (GO:0061912),-0.45543891385593555,-0.8471952902061196,0.7301587301587301,0.875136465413872,1.0,2/52,4.74%,VIM;DYNLL1
1738,prerank,regulation of dendrite morphogenesis (GO:0048814),0.4839321570481716,0.8468197480256895,0.6904761904761905,1.0,1.0,7/24,19.15%,TNIK;SS18L2;CUX2;CDKL5;NEDD4L;RAPGEF2;GORASP1
1739,prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.4462113517816738,-0.8462150681369516,0.7241379310344828,0.8758076190805074,1.0,16/70,15.76%,VIM;CLU;SLC2A13;THBS1;PRKCD;NIBAN1;ABCG1;RBM3;RPS4X;CASP3;TNFRSF1A;IFNGR1;POLDIP3;PICALM;GSAP;RACK1
1740,prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.48360541866316326,0.8460256611570202,0.7045454545454546,1.0,1.0,4/27,11.70%,MAPT;CLASP1;PRKAA2;TPPP
1741,prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.49453644124867535,0.8456695121550734,0.6470588235294118,1.0,1.0,2/26,7.18%,ANK1;PARD3
1742,prerank,GPI anchor biosynthetic process (GO:0006506),0.5026966590978359,0.8455328434559003,0.7073170731707317,1.0,1.0,7/26,17.99%,PYURF;PGAP2;PGAP4;PIGO;PIGP;DPM1;PIGG
1743,prerank,regulation of sprouting angiogenesis (GO:1903670),0.469705922771152,0.8447259178379826,0.7209302325581395,1.0,1.0,8/32,9.92%,VEGFA;FGF16;FGF1;PPP1R16B;SEMA6A;ALOX5;S100A1;CEACAM1
1744,prerank,cellular response to inorganic substance (GO:0071241),0.5038590886807908,0.8445409173687364,0.675,1.0,1.0,1/16,3.33%,MTR
1745,prerank,cellular response to ionizing radiation (GO:0071479),0.4468265360182476,0.8442260528632993,0.6976744186046512,1.0,1.0,10/40,22.47%,CRYAB;MAP3K20;TMEM109;YAP1;XRCC5;CLOCK;HUS1;HSF1;LIG4;TSPYL5
1746,prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.5372639891199915,-0.8432887916565672,0.7037037037037037,0.8808986644369284,1.0,6/19,11.98%,TGFB2;ARHGAP25;SH3BP1;RASAL3;EPHB2;CYRIB
1747,prerank,metal ion homeostasis (GO:0055065),-0.5102837834796219,-0.8424801366387644,0.7419354838709677,0.8816007040440504,1.0,2/21,2.36%,SELENON;FAM20A
1748,prerank,ion transport (GO:0006811),-0.43219976939918264,-0.8424584173537782,0.6964285714285714,0.8809217086526749,1.0,5/57,5.06%,KCNN4;SLC15A3;PIEZO2;SLC26A11;PLP2
1749,prerank,"base-excision repair, gap-filling (GO:0006287)",0.4850814250972459,0.8421497973857366,0.7555555555555555,1.0,1.0,1/33,2.46%,UNG
1750,prerank,Golgi to plasma membrane transport (GO:0006893),-0.49162357881862395,-0.8421065478872107,0.7543859649122807,0.8807277519908286,1.0,3/45,5.53%,STEAP2;RAB31;RAB34
1751,prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.511319500345563,-0.8417497694671046,0.75,0.8807530781755292,1.0,2/23,6.27%,PAK1;FES
1752,prerank,tRNA transport (GO:0051031),0.47343408257029534,0.8414003918758522,0.6744186046511628,1.0,1.0,7/33,31.03%,YBX1;NDC1;TOMM20;NUP62;SEH1L;NUP153;XPOT
1753,prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3920786831742661,0.8411338014952217,0.7916666666666666,1.0,1.0,5/59,8.49%,FXR1;TBC1D16;PPP1R16B;TWF2;PODXL
1754,prerank,protein targeting (GO:0006605),-0.4186674471434132,-0.8406382400780515,0.7647058823529411,0.8820273328071037,1.0,12/99,11.89%,LTBP2;NCF1;EDEM1;TSPO;MYO1C;ZDHHC24;SEC61A1;HOMER3;LAMP2;ZDHHC2;GOLGA7;ZDHHC15
1755,prerank,autophagy of mitochondrion (GO:0000422),0.4124710142238504,0.8402139278114057,0.7222222222222222,1.0,1.0,7/36,12.89%,PINK1;MAP1LC3A;WIPI1;PHB2;FUNDC2;ATG9A;PRKN
1756,prerank,modification-dependent protein catabolic process (GO:0019941),0.3618065201247678,0.8400450218563532,0.8421052631578947,1.0,1.0,33/185,18.87%,FEM1A;PINK1;ASB2;CDC34;UBE2B;UBQLN4;HERPUD1;PTTG1;UBE3B;RNF128;UBR3;KLHL8;KLHL3;FBXO21;PRKN;UBC;UBE2G1;UBE2D1;RNF14;FBXO8;NPLOC4;SPSB4;AREL1;LONP1;TOLLIP;RNF114;COPS3;NEDD4L;RNF6;UBE3C;PPP1R11;UBL7;TTC3
1757,prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.40300092387441744,0.8397775922003264,0.8275862068965517,1.0,1.0,11/67,20.27%,ZC3H8;INTS10;TAF6;RPRD1A;POLR2C;NABP1;POLR2E;RPRD1B;POLR2B;POLR2L;POLR2F
1758,prerank,modulation of chemical synaptic transmission (GO:0050804),0.436317247815724,0.8397561232726692,0.7446808510638298,1.0,1.0,5/45,6.11%,LGI1;GRM1;ATP1A2;CAMK2A;IQSEC2
1759,prerank,regulation of postsynapse organization (GO:0099175),-0.5173716825621882,-0.8387772041470146,0.6909090909090909,0.8846932717251953,1.0,2/23,3.33%,FCGR2B;ARHGAP22
1760,prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.5419466513040385,-0.838542030911571,0.7368421052631579,0.8836824467428398,1.0,7/21,16.68%,E2F1;BID;SFN;BBC3;CASP8;PMAIP1;YWHAQ
1761,prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.5419466513040385,-0.838542030911571,0.7368421052631579,0.8836824467428398,1.0,7/21,16.68%,E2F1;BID;SFN;BBC3;CASP8;PMAIP1;YWHAQ
1762,prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.40590398684584167,0.8380234919138795,0.7777777777777778,1.0,1.0,13/68,6.80%,PPARGC1A;DECR1;HADH;LPIN1;CPT2;MFN2;ACADL;PRDM16;CD36;VEGFA;EPAS1;OMA1;ACSL1
1763,prerank,ephrin receptor signaling pathway (GO:0048013),-0.4451843536951615,-0.8376614345555553,0.819672131147541,0.8846685931977575,1.0,21/68,15.32%,MMP2;PAK1;ARPC1B;SRC;ARPC5;ACTG1;ARPC4;ARPC2;DNM1;EPHB2;SDC2;ACTB;TIAM1;EPHB6;PAK3;LYN;NGEF;EFNA5;ACTR3;CDC42;SDCBP
1764,prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.4858413529907764,0.8370114282508603,0.6666666666666666,1.0,1.0,6/17,28.80%,DKC1;NOP10;CCT7;RUVBL2;TCP1;EXOSC10
1765,prerank,nucleotide-excision repair (GO:0006289),0.3859103951193895,0.8364631130031327,0.8780487804878049,1.0,1.0,23/97,23.20%,PRPF19;SLC30A9;COPS7A;UBC;POLR2C;CUL4A;RAD23A;COPS8;COMMD1;CCNH;COPS3;POLR2E;POLR2B;HUS1;POLR2L;POLR2F;CHD1L;POLB;LIG4;COPS4;COPS6;FAN1;RAD23B
1766,prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.44850143651312857,0.8355512896992715,0.6176470588235294,1.0,1.0,5/32,23.61%,HBS1L;LSM3;PATL1;EXOSC7;CNOT7
1767,prerank,regulation of vesicle-mediated transport (GO:0060627),-0.43467852539855134,-0.8353468309117056,0.8,0.8882047250950789,1.0,14/75,9.62%,HCK;PTPRC;FGR;CD22;SEPTIN5;SRC;RAB15;SPHK1;RAB8B;FES;PTPN1;RAB4B;RAB13;GAS1
1768,prerank,neuron projection extension (GO:1990138),-0.4833980163586322,-0.8350901422917196,0.7894736842105263,0.8880787932424122,1.0,5/28,16.02%,ALCAM;MAP1B;IQGAP1;SEMA3F;TNN
1769,prerank,maturation of SSU-rRNA (GO:0030490),-0.4970888300394131,-0.8348137776079773,0.7169811320754716,0.8878533374309311,1.0,6/34,24.99%,RPS16;RPS8;RPS19;WDR3;RPS14;RPS28
1770,prerank,positive regulation of cellular catabolic process (GO:0031331),-0.42768375246677537,-0.8344449540191461,0.75,0.8878818814849194,1.0,12/119,7.51%,APOE;MEFV;TNFRSF1B;ADAM8;LAPTM5;PRKCD;IGF1;P2RX7;DACT1;PTPN1;TWIST1;ADAM9
1771,prerank,snRNA transcription (GO:0009301),0.4009980984405966,0.8344336738925962,0.8,1.0,1.0,11/68,20.27%,ZC3H8;INTS10;TAF6;RPRD1A;POLR2C;NABP1;POLR2E;RPRD1B;POLR2B;POLR2L;POLR2F
1772,prerank,internal peptidyl-lysine acetylation (GO:0018393),0.4432464541922732,0.8342068369984573,0.6341463414634146,1.0,1.0,6/25,25.67%,TAF6;KAT2B;MSL3;BAG6;PHF20L1;RUVBL2
1773,prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.3793755881635601,0.8323575934193037,0.8055555555555556,1.0,1.0,23/130,20.82%,CCNG1;KMT5A;PRKAA2;MAPKAPK5;USP2;TAF6;PRKAG1;CSNK2A1;MTOR;TAF7;PRKAB1;TAF4B;RBBP7;SMYD2;PRMT5;MAPKAP1;HIPK2;HUS1;PIN1;SGK1;NBN;JMY;TAF12
1774,prerank,carboxylic acid metabolic process (GO:0019752),-0.4911525314680229,-0.8322384774743605,0.7272727272727273,0.8912232084722461,1.0,2/25,3.70%,PTGIS;TBXAS1
1775,prerank,cellular amide metabolic process (GO:0043603),0.38334070067018583,0.8317291961535433,0.717948717948718,1.0,1.0,16/88,9.03%,ACOT1;ACOT2;MIPEP;MLYCD;ACSL6;PLAAT1;ACOT13;SHMT1;PM20D1;SMPD1;THEM4;PCCA;MCCC1;PCCB;MCCC2;PLA2G4E
1776,prerank,negative regulation of JNK cascade (GO:0046329),0.46281038168122446,0.8306165313308155,0.7058823529411765,1.0,1.0,3/29,5.03%,KLHL31;PINK1;SH3RF2
1777,prerank,triglyceride metabolic process (GO:0006641),-0.49820951893196697,-0.8298016659217818,0.7454545454545455,0.8948486524612953,1.0,2/26,1.96%,APOE;APOBR
1778,prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.43040762154407286,-0.8295093657572032,0.7627118644067796,0.8947089178458406,1.0,4/56,4.29%,SFRP2;SNAI1;CLU;SRC
1779,prerank,cellular response to hypoxia (GO:0071456),0.39253126816595624,0.8284167993252146,0.9117647058823529,1.0,1.0,10/109,8.15%,ACAA2;PINK1;EGLN1;KCND2;VEGFA;EPAS1;PSME4;TIGAR;EGLN3;HIGD1A
1780,prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.5082377119998761,0.8282106128731138,0.660377358490566,1.0,1.0,6/20,10.12%,SCN4B;RANGRF;PTPN3;FXYD1;GPD1L;CAV3
1781,prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.45013565938943323,-0.8281995690238045,0.7068965517241379,0.8961947943196025,1.0,4/49,7.33%,KDELR3;SERP1;EDEM1;PDIA5
1782,prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.5068483657212156,-0.827612150208394,0.6551724137931034,0.8966136293849974,1.0,7/21,18.60%,GCNT1;RRM2;TKT;RRM1;B4GALT5;GAL3ST4;ST3GAL2
1783,prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.38164542562430565,-0.8274703481799995,0.7777777777777778,0.896211376579332,1.0,33/170,19.63%,PTPN6;NEK6;ANLN;ID2;DYNLL1;HMMR;BUB1B;E2F1;UBE2C;TPX2;CDK1;CENPE;ZFP36L2;CCNB1;HAUS4;NINL;CDC20;AURKA;PSMB8;PPP1R9B;CEP192;CEP250;PKD1;PRKAR2B;PSMB9;SDCCAG8;CDK5RAP2;KNTC1;RPS27A;PLK1;HAUS3;MAD2L1;HAUS7
1784,prerank,bicellular tight junction assembly (GO:0070830),0.46887965624460115,0.8269874508010501,0.6944444444444444,1.0,1.0,2/25,7.18%,AFDN;PARD3
1785,prerank,negative regulation of double-strand break repair (GO:2000780),0.44584088695740276,0.8268831392053276,0.7368421052631579,1.0,1.0,3/23,13.33%,POLQ;UBQLN4;SHLD1
1786,prerank,triglyceride homeostasis (GO:0070328),-0.4899903076189521,-0.8263287844719561,0.6538461538461539,0.8976745281516512,1.0,3/18,6.07%,APOE;IL18;C1QTNF3
1787,prerank,positive regulation of microtubule polymerization (GO:0031116),-0.5008126095771588,-0.8258059669283031,0.6875,0.8980461964201186,1.0,2/25,6.27%,PAK1;FES
1788,prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.4066606985445117,0.8256213710204617,0.7317073170731707,1.0,1.0,2/62,1.75%,CCNG1;PROX1
1789,prerank,regulation of transmembrane transport (GO:0034762),0.49349613358937117,0.8253876267238656,0.7209302325581395,1.0,1.0,5/17,6.39%,KCNJ3;KCNJ11;KCNJ5;KCNJ12;KCNJ2
1790,prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.4832193160532873,-0.8249758863155853,0.6981132075471698,0.8987050972253442,1.0,3/23,12.45%,OS9;EDEM1;EDEM2
1791,prerank,cellular response to hexose stimulus (GO:0071331),0.5033056171820044,0.8236671860534859,0.6590909090909091,1.0,1.0,3/18,7.22%,KCNB1;PRKACA;PRKAA2
1792,prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.5068366207438983,0.8229819374155763,0.7391304347826086,1.0,1.0,3/15,4.85%,KDR;VEGFA;FGF16
1793,prerank,regulation of ATP biosynthetic process (GO:2001169),-0.5279916022149003,-0.8220513082252215,0.7678571428571429,0.9033712724713662,1.0,1/15,0.33%,TREM2
1794,prerank,inorganic cation transmembrane transport (GO:0098662),0.3812977515921557,0.8219530591058186,0.8611111111111112,1.0,1.0,23/125,8.26%,SCN4B;HCN4;SLC9A2;NNT;ATP2A2;SCN4A;KCNN1;KCNJ11;KCND2;ABCC9;KCNK3;HCN2;KCNA5;KCNB1;ATP1A2;KCNJ12;KCNG2;KCNJ2;ABCC8;UCP3;ABCB8;KCNN2;KCNV2
1795,prerank,negative regulation of cell cycle (GO:0045786),-0.4591496600201936,-0.8218110830254849,0.7377049180327869,0.9031538659729406,1.0,11/56,11.95%,NUPR1;CEBPA;SLC9A3R1;HHEX;GAS1;INHBA;TGFB1;BTG1;FOXC1;RUNX3;BMP2
1796,prerank,anterograde trans-synaptic signaling (GO:0098916),-0.4303423018561797,-0.8214207303604291,0.796875,0.90322394098997,1.0,7/74,5.12%,NPY;GPR176;GABRQ;HTR2B;GABRE;GABRA3;CACNB3
1797,prerank,negative regulation of transferase activity (GO:0051348),0.480627694629831,0.8206761345069714,0.8108108108108109,1.0,1.0,2/24,4.16%,PRDX3;MAPT
1798,prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.44135309773296627,0.8201979840639092,0.7027027027027027,1.0,1.0,6/25,31.40%,WDR83;PRPF8;TXNL4A;PRPF4;SRSF10;DDX23
1799,prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.5255514031967051,-0.8199853218970634,0.7307692307692307,0.9050781502354556,1.0,4/16,18.95%,LEPROT;SOCS3;INPP5F;SOCS1
1800,prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.47612141286112597,-0.8197356051510917,0.8275862068965517,0.9048330382273077,1.0,4/33,8.14%,ARRB2;PHLDA3;SLC9A3R1;PTPRJ
1801,prerank,RNA export from nucleus (GO:0006405),0.3742531846176534,0.8197159692285202,0.8285714285714286,1.0,1.0,11/94,24.03%,EIF4E;WDR33;FYTTD1;SMG7;NDC1;HNRNPA2B1;UPF1;SYMPK;ALKBH5;U2AF1L4;SMG5
1802,prerank,mRNA export from nucleus (GO:0006406),0.3790433090926895,0.8192394195483573,0.8666666666666667,1.0,1.0,12/97,24.03%,EIF4E;WDR33;FYTTD1;SMG7;NDC1;HNRNPA2B1;UPF1;IWS1;SYMPK;ALKBH5;U2AF1L4;SMG5
1803,prerank,protein polymerization (GO:0051258),-0.43328254233489855,-0.8190232115470824,0.78125,0.9055014126513977,1.0,6/46,9.89%,PSTPIP1;AIF1;WAS;PREX1;UBE2C;ANG
1804,prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.44396578518418106,0.8187130271825478,0.7,1.0,1.0,5/34,23.61%,HBS1L;LSM3;PATL1;EXOSC7;CNOT7
1805,prerank,ERK1 and ERK2 cascade (GO:0070371),-0.545823390815413,-0.8184214458255656,0.7222222222222222,0.9058825000621586,1.0,6/17,8.58%,CTSH;HTR2B;SOX9;IGF1;MYC;CDK1
1806,prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.4793698235334099,-0.8182466958104748,0.74,0.9055658304034708,1.0,1/29,5.31%,RUNX1
1807,prerank,protein phosphorylation (GO:0006468),-0.3628345384981608,-0.8179799522583585,0.9506172839506173,0.9053300352210085,1.0,61/391,12.64%,GDF6;HCK;PAK1;DCLK1;DCLK3;PTK2B;PTPN6;FGR;TLR2;FAM20A;CSF1R;TLR9;NEK6;IGFBP3;TGFB2;MELK;BTK;SRC;PRKCD;PRDX4;IKBKE;PRKCB;ATP13A2;BCR;PIK3CD;FES;TLR7;TGFBR1;CDK14;CCNA2;FGFR1;GAS6;TYRO3;CDK1;CAMK1D;RPS6KA1;ILK;BIRC5;EPHB2;STK17B;APP;NUAK2;TGFB1;MERTK;STK26;PDGFRB;CDK9;MATK;WNT11;BMP2K;RUNX3;PDK3;FGFR2;GMFG;MAP4K1;BMP2;FAM20C;AURKB;CDC25B;RNASEL;EIF2AK3
1808,prerank,positive regulation of cellular metabolic process (GO:0031325),-0.4251011984383296,-0.8178179235297726,0.75,0.9048358142582846,1.0,15/71,12.04%,APOE;ARRB2;THBS1;CCL5;ANXA2;CD63;CDK1;RAB29;PRELID1;UHRF1;INHBA;TGFB1;PDGFRB;CCNB1;PID1
1809,prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.4113321557988342,-0.817230814420085,0.8305084745762712,0.9050824755319952,1.0,10/80,15.25%,ECRG4;SKP2;BUB1B;UBE2C;CDK1;CCNB1;AURKB;CDC20;AURKA;PSMB8
1810,prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.49423647807294235,-0.8171579047645595,0.7878787878787878,0.9045179400796837,1.0,10/32,5.83%,C3AR1;GPR35;CALCA;P2RY6;GPR65;HTR2B;CX3CR1;PTH1R;C5AR1;F2R
1811,prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.48292870270711824,-0.8170424282000496,0.7,0.9040166074381882,1.0,2/21,4.78%,P2RX4;IGF1
1812,prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.4560526262077306,-0.8169407053371296,0.7222222222222222,0.9034359918781754,1.0,2/38,8.14%,EREG;PTPRJ
1813,prerank,positive regulation of cellular protein localization (GO:1903829),-0.4347837902707253,-0.8168986638926645,0.7321428571428571,0.9027851679649539,1.0,9/60,12.71%,TYROBP;RTN4;MAP1A;GTSE1;CDK1;TGFB1;NDC80;EIF2AK3;GPR137B
1814,prerank,cAMP-mediated signaling (GO:0019933),-0.5141003269999743,-0.8167231203127662,0.7962962962962963,0.902410707776372,1.0,3/17,7.41%,SOX9;CAP1;MAPK7
1815,prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.4709905638620236,-0.8158804927780423,0.8245614035087719,0.9032438773475178,1.0,4/29,11.51%,CD300A;FKBP1B;PDGFRB;CALM2
1816,prerank,peptidyl-threonine phosphorylation (GO:0018107),0.4087477254451535,0.8156120999126003,0.7105263157894737,1.0,1.0,14/51,19.36%,SBK1;CAMK2A;WNK1;LMTK2;PRKCA;OXSR1;HIPK3;CSNK2A1;STK39;MAPK8;ULK1;DYRK1A;CAMK2D;HIPK2
1817,prerank,regulation of chromosome organization (GO:0033044),0.4823774603466595,0.8143321717524021,0.6578947368421053,1.0,1.0,2/18,9.30%,MAPT;CENPV
1818,prerank,transferrin transport (GO:0033572),-0.4712486520315118,-0.814279433731832,0.7258064516129032,0.9052286488397491,1.0,3/29,8.19%,TCIRG1;ATP6V0D2;ATP6V0A4
1819,prerank,phosphatidylcholine metabolic process (GO:0046470),-0.43322550338752186,-0.8140107891778491,0.7727272727272727,0.9048797475907929,1.0,3/45,3.64%,LPCAT2;PLA2G7;PLA2G15
1820,prerank,positive regulation of insulin secretion (GO:0032024),0.4761767073879656,0.8117308643184494,0.74,1.0,1.0,3/22,14.96%,GCK;ANO1;GPLD1
1821,prerank,sprouting angiogenesis (GO:0002040),-0.4586246526038635,-0.81164212135691,0.828125,0.9082769146983234,1.0,5/44,3.63%,LOXL2;PTK2B;VEGFD;ADGRA2;THBS1
1822,prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.533492294934213,-0.8115232594359286,0.7115384615384616,0.9078377119375604,1.0,2/15,5.16%,TGFB3;EFEMP2
1823,prerank,nucleotide biosynthetic process (GO:0009165),0.5110291612855696,0.8110625258069616,0.6808510638297872,1.0,1.0,5/15,15.75%,NMNAT1;ADSL;NMNAT3;RRM2B;PPAT
1824,prerank,positive regulation of dephosphorylation (GO:0035306),-0.4743112922531752,-0.8097506592009375,0.75,0.9102106104945618,1.0,7/26,12.31%,SRC;GBA;PRKCD;TGFB1;CALM2;BMP2;NSMF
1825,prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.3759277289090669,0.8085371413947006,0.8181818181818182,1.0,1.0,11/91,24.03%,EIF4E;WDR33;FYTTD1;SMG7;NDC1;HNRNPA2B1;UPF1;SYMPK;ALKBH5;U2AF1L4;SMG5
1826,prerank,cellular response to decreased oxygen levels (GO:0036294),0.4237284879404037,0.8079806388105936,0.7352941176470589,1.0,1.0,9/53,7.81%,ACAA2;PINK1;EGLN1;KCND2;VEGFA;EPAS1;TIGAR;EGLN3;PICK1
1827,prerank,prostaglandin metabolic process (GO:0006693),-0.5047890805204627,-0.8077284024231648,0.7,0.9129596991367118,1.0,9/23,14.45%,PTGIS;TBXAS1;CD74;HPGDS;DAGLB;PTGR1;PTGS1;EDN1;PLA2G4A
1828,prerank,positive regulation of transferase activity (GO:0051347),-0.3995921978723415,-0.8074625349352575,0.7941176470588235,0.9127297459647289,1.0,20/113,14.31%,TREM2;CSF1R;CD74;ROR2;MYC;FGFR1;TYRO3;MST1R;EPHB2;TGFB1;MET;MERTK;PDGFRB;FGFR2;AXL;AURKB;EPHB6;LMO4;RFC2;DDR1
1829,prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.3633728601303851,-0.8067742425072778,0.9032258064516129,0.9133557303830939,1.0,36/219,15.64%,FGD3;EMP1;EMP3;AIF1;FXYD5;RAP2B;DYNLL1;FLNA;CARMIL1;P2RX7;RAB8B;CYS1;SHTN1;TRAPPC14;SLC9A3R1;PTPRO;S1PR2;ARF4;WDR19;MACIR;STK26;FGD2;TCTN1;PMP22;RHOD;SNX10;ARFIP2;RILPL2;RAP1B;ARF6;DZIP1L;ACTR3;IFT46;SDCBP;PPP1R9B;PARVA
1830,prerank,protein autophosphorylation (GO:0046777),-0.3983449972071546,-0.8063897034054069,0.8970588235294118,0.9132492171914813,1.0,19/128,12.64%,HCK;PAK1;PTK2B;FGR;CSF1R;NEK6;MELK;SRC;ATP13A2;FES;FGFR1;TYRO3;STK17B;STK26;PDGFRB;FGFR2;MAP4K1;AURKB;EIF2AK3
1831,prerank,regulation of embryonic development (GO:0045995),-0.470130333584956,-0.8062751389954292,0.7333333333333333,0.9127817893021191,1.0,5/29,13.19%,NIBAN2;RACGAP1;CDK1;CFL1;PHLDB2
1832,prerank,cation transmembrane transport (GO:0098655),0.4571494976270879,0.8061767862692215,0.6875,1.0,1.0,9/29,10.02%,KCNJ11;SLC25A20;ABCC9;ATP1A2;ABCC8;SLC22A5;SLC25A29;KCNJ8;SLC25A19
1833,prerank,regulation of viral release from host cell (GO:1902186),-0.5042304136183586,-0.8061024978716126,0.7068965517241379,0.9123854828665111,1.0,7/20,32.83%,TRIM62;PML;TRIM26;TRIM28;DDB1;TRIM5;TRIM21
1834,prerank,protein lipidation (GO:0006497),0.40362194876070345,0.8059325984658353,0.8285714285714286,1.0,1.0,11/52,17.99%,PYURF;PGAP2;WIPI1;PGAP4;PIGO;GPLD1;ATG10;PIGP;ZDHHC5;DPM1;PIGG
1835,prerank,histone ubiquitination (GO:0016574),0.4782628788713539,0.8054971707237332,0.7435897435897436,1.0,1.0,4/19,14.94%,UBE2B;UBR2;LEO1;HUWE1
1836,prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.3917543313677819,-0.805182243913161,0.8333333333333334,0.9132735990362251,1.0,9/84,11.58%,CSF1R;CDKN2B;SRC;CCNB2;CCNA2;THY1;ACTB;CALM2;CCNB1
1837,prerank,organic substance transport (GO:0071702),-0.40693381605609524,-0.8050698516176551,0.8032786885245902,0.9126930087900504,1.0,8/84,12.68%,RCN3;GM2A;ARRDC1;MFSD12;ABCG1;PLTP;TAP1;ABCA1
1838,prerank,ncRNA processing (GO:0034470),-0.3693678163723374,-0.8039536502093756,0.8552631578947368,0.914106302291471,1.0,41/191,26.28%,RPL3;RPL34;RPL6;RPS16;RPL27A;RPL17;RPL39;RPL13A;RPL37A;RPL15;RPS19;RPL12;RPL41;RPL36A;RPL35A;RPL10A;RPL35;RPL14;RPL4;RPL22;RPL11;RPS24;RPL18A;WDR3;RPL19;RPL32;RPL31;RPS7;RPS6;RPS27;RPLP1;RPL7;RPS14;RPL23;RPL38;RPS28;RPL37;RPL26;RPL5;RPL13;RPL28
1839,prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.49946204351368073,-0.8037389539330252,0.765625,0.9137540610908108,1.0,5/34,10.59%,SOX9;TGFB2;SPI1;ATOH8;TGFB1
1840,prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.4954890683320123,0.8035223943956787,0.6875,1.0,1.0,1/15,2.34%,PRDX6
1841,prerank,proteasomal protein catabolic process (GO:0010498),0.35526614328039396,0.8031497226025432,0.9534883720930233,1.0,1.0,37/186,17.87%,NHLRC1;TRIM72;FBXW7;PRPF19;ARNTL;ANKRD9;CCDC47;GID4;PSME4;CDC34;UBE2B;MARCHF6;DCAF11;FBXL22;FAF1;UBXN2A;PRKN;FBXO44;PSMC3;PSME3;GID8;CUL4A;RAD23A;UBE2G1;PSMD12;HUWE1;COP1;SPSB4;ARMC8;AREL1;FBXW5;RNF139;PSMB7;VCP;SPOP;NEDD4L;PSMD2
1842,prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.5050468435896172,-0.802441955274334,0.8148148148148148,0.9151906649813966,1.0,4/18,9.22%,SERPINE1;MAPK7;GAS6;ICAM1
1843,prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.5231302030948707,-0.8022491116092665,0.7307692307692307,0.9147330184791092,1.0,2/16,7.74%,OS9;SEC61B
1844,prerank,axon development (GO:0061564),-0.4268291862314072,-0.8018696940597074,0.7681159420289855,0.9145736675433782,1.0,12/49,11.81%,VASH2;RTN4;MAP1A;S100A6;SHTN1;DOCK7;MAP1B;EPHB2;APP;ACTB;SLITRK4;FGFR2
1845,prerank,regulation of cation channel activity (GO:2001257),-0.4041403262456987,-0.8015654604843231,0.7741935483870968,0.9144407990903763,1.0,3/49,2.32%,CTSS;PTK2B;SELENON
1846,prerank,RNA metabolic process (GO:0016070),-0.3958571045930766,-0.8011381896347953,0.8088235294117647,0.9143430915653817,1.0,8/119,13.04%,APOBEC1;RNASE6;RNASE4;RBM3;ISG20;TENT2;RNASEL;ADARB1
1847,prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.477690970667969,-0.8010114244566074,0.7384615384615385,0.9138438325567745,1.0,5/24,22.29%,LACC1;CASP8;RPS27A;TNFAIP3;IRAK2
1848,prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.4998041263282126,-0.7994934235710672,0.7377049180327869,0.915753700123459,1.0,3/17,10.36%,PLOD2;GATM;CNDP2
1849,prerank,phospholipid dephosphorylation (GO:0046839),-0.47261215921336885,-0.7990007007180281,0.7241379310344828,0.915899352797658,1.0,6/30,19.14%,PLPP2;PLPPR3;PLPP5;MTMR11;INPP5F;PIP4P1
1850,prerank,chromatin remodeling at centromere (GO:0031055),-0.48980828398613596,-0.7988505607144155,0.78,0.915443612206524,1.0,6/19,21.60%,CENPT;MIS18A;CENPO;NPM1;CENPL;HJURP
1851,prerank,sulfur amino acid metabolic process (GO:0000096),0.47653981504775345,0.7986870500386032,0.7142857142857143,1.0,1.0,5/16,8.55%,MMUT;MTR;MSRA;TXN2;ADI1
1852,prerank,proteoglycan metabolic process (GO:0006029),0.48090222593886606,0.7984547305240456,0.782608695652174,1.0,1.0,1/18,0.24%,GAL3ST3
1853,prerank,alpha-amino acid metabolic process (GO:1901605),0.43407019177076656,0.797954275370358,0.8461538461538461,1.0,1.0,8/30,4.99%,GOT1;SLC25A13;KYAT3;MMUT;KYAT1;GOT2;SLC25A12;OAT
1854,prerank,establishment of protein localization to plasma membrane (GO:0061951),0.43391136566681066,0.7976137341593583,0.7391304347826086,1.0,1.0,7/33,9.01%,PREPL;RILPL1;AFDN;OPTN;KIF13A;BLZF1;GOLGA4
1855,prerank,cellular transition metal ion homeostasis (GO:0046916),-0.41101864446843955,-0.7969965948207587,0.75,0.9177570653372042,1.0,14/70,17.12%,SLC11A1;SLC39A8;HMOX1;ATP13A2;SLC39A6;MYC;APP;ATP6V1A;PRND;FLVCR1;SLC39A13;SLC22A17;HEPH;LCK
1856,prerank,cellular response to drug (GO:0035690),0.4926683667124066,0.7962097183772016,0.7368421052631579,1.0,1.0,1/18,1.11%,TFRC
1857,prerank,histone mRNA catabolic process (GO:0071044),-0.5329533861771782,-0.7942364473071439,0.8518518518518519,0.9218503513386579,1.0,1/15,12.56%,TENT2
1858,prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.41057388748506374,0.7941808592116161,0.8260869565217391,1.0,1.0,7/64,6.49%,ACAA2;PPIF;NDUFS3;PINK1;OPA1;NDUFA13;GHITM
1859,prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.5052260928473206,-0.7939256136385561,0.7391304347826086,0.9216258198357099,1.0,6/17,10.22%,ADA;APRT;CDA;TYMS;PNP;AMPD2
1860,prerank,establishment of spindle orientation (GO:0051294),0.4484942915215707,0.7936792259155382,0.7090909090909091,1.0,1.0,3/22,15.09%,CLASP1;GJA1;DCTN1
1861,prerank,determination of heart left/right asymmetry (GO:0061371),0.420299189009318,0.7930623339860308,0.8285714285714286,1.0,1.0,7/27,17.83%,NDRG4;NKX2-5;NOTCH1;GATA4;DAND5;SRF;TBX3
1862,prerank,DNA integrity checkpoint signaling (GO:0031570),0.4403808934168816,0.7928922123085294,0.7894736842105263,1.0,1.0,3/31,9.07%,PRPF19;USP28;MAP3K20
1863,prerank,protein stabilization (GO:0050821),0.35304764038529385,0.7925145674099539,1.0,1.0,1.0,17/154,8.77%,PPARGC1A;ANK2;PINK1;HSPD1;EPHA4;PHB;USP13;FBXW7;PEX19;CRYAB;UBE2B;WFS1;USP2;BAG3;TESC;GAPDH;CDC37L1
1864,prerank,apoptotic nuclear changes (GO:0030262),0.4443011859325309,0.7924371942994105,0.7450980392156863,1.0,1.0,4/17,11.14%,ENDOG;DFFA;KPNA1;CECR2
1865,prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.3971450537452322,0.7922810948738547,0.8333333333333334,1.0,1.0,5/38,12.44%,ACOT13;ARNTL;IL15;CIDEA;NOTCH1
1866,prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.4748235240890131,-0.7922547546109828,0.8103448275862069,0.9235470912583948,1.0,1/20,0.22%,CTSS
1867,prerank,chloride transmembrane transport (GO:1902476),-0.4909890803676863,-0.7921119043686098,0.7090909090909091,0.923026508380156,1.0,3/16,4.46%,GABRQ;GABRE;GABRA3
1868,prerank,phospholipid translocation (GO:0045332),-0.4543408436041034,-0.7919791649273702,0.7543859649122807,0.9225674273235955,1.0,5/24,14.25%,ATP8B4;P2RX7;ATP10A;ABCA1;PLSCR3
1869,prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.4093290502993901,-0.7915894781978652,0.7931034482758621,0.922481693804386,1.0,15/56,25.67%,RPS16;RPS19;RPL35A;NPM1;RPL14;CUL4B;RPL11;RPS24;RPS7;RPS6;RPL7;RPL38;RPS28;RPL26;RPL5
1870,prerank,muscle cell development (GO:0055001),-0.4573993791524562,-0.7913861913108233,0.7678571428571429,0.9220497026736393,1.0,5/30,5.16%,MYOF;MEGF10;IGF1;SDC1;EFEMP2
1871,prerank,protein-DNA complex disassembly (GO:0032986),-0.530220449290861,-0.7912182170001472,0.8571428571428571,0.9216616326923163,1.0,4/16,24.50%,MYC;SMARCD2;RPL23;SMARCB1
1872,prerank,negative regulation of cellular metabolic process (GO:0031324),0.45387923953080817,0.7908361605520919,0.7857142857142857,1.0,1.0,4/26,6.26%,PLIN5;PINK1;SIRT5;OPTN
1873,prerank,glycerophospholipid biosynthetic process (GO:0046474),0.34591607079232495,0.7906480183299405,0.9736842105263158,1.0,1.0,18/137,13.27%,PLA2G5;LPIN1;GNPAT;HDHD5;STARD7;DGKE;PHOSPHO1;PLA2G12A;AGPAT3;PIK3C2B;GPD1L;CHPT1;INPP4B;GPAM;PITPNM2;ACP6;CSNK2A1;PIP5K1B
1874,prerank,calcium ion transmembrane transport (GO:0070588),0.3854187447079614,0.7901515398918688,0.813953488372093,1.0,1.0,13/57,14.10%,ATP2A2;PHB;PMPCB;PMPCA;SPG7;AFG3L2;CACNA2D1;LETM1;MCUR1;PHB2;TRPC3;STOML2;CACNA1C
1875,prerank,regulation of dendrite development (GO:0050773),-0.48222140262351465,-0.790130727461992,0.7213114754098361,0.9226143686344327,1.0,7/21,12.31%,DBN1;PTN;CAMK1D;SDC2;LRP8;ZDHHC15;NSMF
1876,prerank,regulation of telomere capping (GO:1904353),0.45086246031265964,0.7895035737654671,0.7560975609756098,1.0,1.0,2/20,8.44%,MAPKAPK5;MAP3K4
1877,prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.4129271560164918,0.7890109281653741,0.8095238095238095,1.0,1.0,1/38,3.89%,GCK
1878,prerank,folic acid-containing compound metabolic process (GO:0006760),-0.49153058737245303,-0.7876429214496636,0.8235294117647058,0.9258811848005782,1.0,4/18,13.56%,GGH;MTHFD1L;MTHFD2;MTHFR
1879,prerank,heart morphogenesis (GO:0003007),-0.41732420823297395,-0.7875445043964405,0.8333333333333334,0.9253788605322387,1.0,5/43,6.53%,HTR2B;SOX9;TGFB2;OLFM1;TGFBR1
1880,prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.42975520334381534,0.7870035243506351,0.7142857142857143,1.0,1.0,4/20,15.97%,VEGFA;HSPA5;NOTCH1;ATF6
1881,prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.5231383174901536,-0.7866604719244629,0.7692307692307693,0.9261540837615088,1.0,2/15,7.74%,OS9;SEC61B
1882,prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.39877037523529196,-0.7864690618877684,0.8214285714285714,0.9258161006131667,1.0,9/77,11.93%,KDELR3;TMED3;RACGAP1;ARFGAP3;ARF4;KIF15;KIF11;CENPE;KDELR2
1883,prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.49177615300871724,-0.7861286312238001,0.7924528301886793,0.9256595201502846,1.0,5/18,19.17%,CEBPA;HHEX;NR2F2;CDKN1A;PLK1
1884,prerank,response to metal ion (GO:0010038),-0.44341107425889864,-0.7843167223966395,0.8135593220338984,0.9279046434854574,1.0,3/47,3.63%,LOXL2;HVCN1;THBS1
1885,prerank,defense response to virus (GO:0051607),0.35907182495014955,0.7836280362370405,0.926829268292683,1.0,1.0,4/88,4.51%,AKAP1;ABCC9;PHB;MAVS
1886,prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.4472017220604442,0.7823693417204874,0.7560975609756098,1.0,1.0,2/21,14.16%,TSFM;HTATSF1
1887,prerank,positive regulation of mRNA processing (GO:0050685),0.4585950972156725,0.7818976060267251,0.7906976744186046,1.0,1.0,1/20,2.34%,PRDX6
1888,prerank,transcription by RNA polymerase II (GO:0006366),0.35337602392883743,0.7817547956833634,1.0,1.0,1.0,31/275,16.25%,RXRG;PPARGC1A;RORC;NR4A1;NR3C2;PPARA;ESRRB;ESRRA;WDR33;ESRRG;HDAC9;ZC3H8;YBX2;INTS10;TBX5;NR0B2;NOTCH1;LEO1;TAF6;RPRD1A;TAF1A;POLR2C;GTF2I;TRIP11;TAF7;NABP1;TAF4B;THRB;RARB;CCNH;YAP1
1889,prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.5215902444063795,-0.7812371621015798,0.8,0.9318579633831946,1.0,4/25,10.59%,TGFB2;SPI1;ATOH8;TGFB1
1890,prerank,dephosphorylation (GO:0016311),-0.38281723909654986,-0.780064081606769,0.8793103448275862,0.9328746218186001,1.0,11/122,8.14%,PTPRC;PTPN6;PTPN7;PLPP2;PTPRF;PTPN18;NT5C;PTPN1;PLPPR3;PTPRO;PTPRJ
1891,prerank,regulation of telomerase activity (GO:0051972),-0.4253346963427597,-0.7786779908703209,0.7894736842105263,0.9342332677725013,1.0,4/37,15.65%,SRC;MYC;AURKB;MAPK3
1892,prerank,peptidyl-serine modification (GO:0018209),-0.3809885317343668,-0.7779054826893388,0.9104477611940298,0.9346373221918767,1.0,24/139,17.87%,DCLK3;NEK6;GALNT16;PRKCD;IKBKE;PRKCB;TGFBR1;GAS6;CDK1;CAMK1D;RPS6KA1;PDK3;MAP4K1;EIF2AK3;MAST3;AURKA;PLK2;GALNT4;POGLUT3;CLSPN;IKBKB;PKD1;BRSK1;TGFBR2
1893,prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.49198228713038056,-0.7770760740034245,0.7796610169491526,0.9352808704534809,1.0,5/16,17.33%,BOK;CASP3;BAX;ITGAV;FAS
1894,prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.43498692613940687,-0.7770375453858552,0.7936507936507936,0.9346124545283794,1.0,7/37,10.22%,NPPA;ADCY7;GUCY1A1;AK5;ADCY3;SLC35B3;AMPD2
1895,prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.4751805038349862,0.7763538583323223,0.7446808510638298,1.0,1.0,9/23,24.78%,COPS7A;UBC;CUL4A;COPS8;COPS3;COPS4;COPS6;RAD23B;PARP1
1896,prerank,cellular response to metal ion (GO:0071248),-0.41196373355097266,-0.7758507431032037,0.8873239436619719,0.9356917261506952,1.0,10/71,8.25%,HVCN1;NCF1;ADCY7;ALOX5AP;P2RX4;SLC25A24;LGMN;ATP13A2;RASA4;CPNE8
1897,prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.45774983793118623,0.7753747802651743,0.85,1.0,1.0,7/21,10.82%,ENTPD5;PFKFB2;EGF;PRKAA2;MLXIPL;INSR;SLC4A4
1898,prerank,erythrocyte differentiation (GO:0030218),-0.4597719865046566,-0.7748575989866251,0.8333333333333334,0.9365554846397471,1.0,9/36,15.81%,NCKAP1L;ID2;HCLS1;IKZF1;INHBA;CASP3;LYN;FLVCR1;RPS19
1899,prerank,cardiac ventricle morphogenesis (GO:0003208),0.41126091919982205,0.7744585605926048,0.782608695652174,1.0,1.0,7/35,5.83%,MYL3;MYL2;TNNI3;PROX1;MYH6;TPM1;TNNC1
1900,prerank,protein deubiquitination (GO:0016579),-0.3659699502463493,-0.7743004431910655,0.9682539682539683,0.9367852970353737,1.0,10/225,8.58%,ARRB2;UCHL1;IL33;USP35;SKP2;TGFBR1;OTULINL;MYC;CCNA2;CDK1
1901,prerank,histone deacetylation (GO:0016575),0.40133704331346187,0.7742633045532806,0.8372093023255814,1.0,1.0,3/45,10.46%,PHB;HDAC11;HDAC9
1902,prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.4743922205553513,-0.7740973396546565,0.7857142857142857,0.9363911308707705,1.0,2/17,8.63%,CCDC88B;MAP6
1903,prerank,regulation of protein dephosphorylation (GO:0035304),0.385725240669187,0.7738385399732174,0.7894736842105263,1.0,1.0,4/37,7.41%,PPP1R2;CAMTA1;SMPD1;PPP1R16B
1904,prerank,mitochondrion disassembly (GO:0061726),0.3951742398052353,0.773452752234617,0.8157894736842105,1.0,1.0,6/33,12.89%,PINK1;MAP1LC3A;WIPI1;FUNDC2;ATG9A;PRKN
1905,prerank,embryonic limb morphogenesis (GO:0030326),-0.4510760649619082,-0.7733738121098673,0.78,0.9366804780408945,1.0,4/26,10.79%,TGFB2;OSR1;TWIST1;AFF3
1906,prerank,nuclear envelope organization (GO:0006998),-0.465361531530726,-0.7718252339325955,0.75,0.93859865217138,1.0,3/17,17.29%,REEP4;TMEM43;TOR1A
1907,prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.4138720641184791,0.7716281392818721,0.7777777777777778,1.0,1.0,1/37,0.75%,CCNG1
1908,prerank,programmed necrotic cell death (GO:0097300),0.5085329440501558,0.7708130716943262,0.8611111111111112,1.0,1.0,2/17,6.27%,PPIF;ALKBH7
1909,prerank,mRNA transport (GO:0051028),0.35591655351126644,0.7700963245725331,0.9705882352941176,1.0,1.0,2/94,8.03%,EIF4E;WDR33
1910,prerank,protein K63-linked ubiquitination (GO:0070534),0.4224225829787889,0.7698618123875703,0.7872340425531915,1.0,1.0,10/38,24.68%,PRPF19;UBE2B;PRKN;UBE2G1;ZFP91;BFAR;HECTD1;UBE2O;STUB1;RNF5
1911,prerank,regulation of cell communication (GO:0010646),-0.4452515409417942,-0.7698438033029242,0.7833333333333333,0.9407696724960466,1.0,6/29,10.27%,ANXA1;IGFBP7;GJA5;PTPN1;TBX18;KAZALD1
1912,prerank,ventricular septum development (GO:0003281),-0.4401892632191681,-0.7692390951412733,0.8148148148148148,0.9409614098177541,1.0,5/32,9.79%,TGFB2;GJA5;TGFBR1;ROBO1;SLIT3
1913,prerank,positive regulation of response to stimulus (GO:0048584),-0.4523951518051619,-0.7676689754794138,0.8135593220338984,0.942821028451685,1.0,8/31,10.08%,FCGR2B;SELENON;TGFB2;PRKCD;MYC;CD80;ILK;YPEL3
1914,prerank,cellular response to oxidative stress (GO:0034599),-0.37995524767787126,-0.7674217904655676,0.9523809523809523,0.9424496391112269,1.0,16/108,6.74%,GPX3;NOX4;NCF1;CYBB;HMOX1;PYCR1;AIF1;CYBA;PRKCD;SLC25A24;GPX7;NCF4;ATP13A2;NCF2;SOD3;ALDH3B1
1915,prerank,energy reserve metabolic process (GO:0006112),0.4827796863001983,0.766929984194637,0.8085106382978723,1.0,1.0,4/15,11.11%,PYGM;UGP2;PHKA1;PPP1R3C
1916,prerank,rRNA metabolic process (GO:0016072),-0.3673972595424229,-0.7660122388969193,0.9402985074626866,0.9439909375123806,1.0,41/156,26.28%,RPL3;RPL34;RPL6;RPS16;RPL27A;RPL17;RPL39;RPL13A;RPL37A;RPL15;RPS19;RPL12;RPL41;RPL36A;RPL35A;RPL10A;RPL35;RPL14;RPL4;RPL22;RPL11;RPS24;RPL18A;WDR3;RPL19;RPL32;RPL31;RPS7;RPS6;RPS27;RPLP1;RPL7;RPS14;RPL23;RPL38;RPS28;RPL37;RPL26;RPL5;RPL13;RPL28
1917,prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.4040607742870129,0.7652640797449406,0.8636363636363636,1.0,1.0,2/39,3.95%,WNK2;PHB
1918,prerank,chloride transport (GO:0006821),-0.45468671873619704,-0.7652201968659411,0.8269230769230769,0.9445278791123203,1.0,5/28,6.03%,GABRQ;GABRE;GABRA3;TTYH3;CLIC1
1919,prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.4691810657410827,-0.7649736012194999,0.7833333333333333,0.9442239346123737,1.0,9/28,16.68%,E2F1;BID;BOK;SFN;BAX;BBC3;CASP8;PMAIP1;YWHAQ
1920,prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.4047787540750103,0.76465655628615,0.8285714285714286,1.0,1.0,4/38,4.83%,PLIN5;PINK1;COQ7;SIRT5
1921,prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.4052599445571618,0.7640393054745633,0.8571428571428571,1.0,1.0,2/29,8.44%,MAPKAPK5;MAP3K4
1922,prerank,response to alcohol (GO:0097305),-0.45949138392268796,-0.762906085031204,0.796875,0.9466253767309626,1.0,7/15,17.87%,CCR5;TGFBR1;SLIT3;TGFB1;SDF4;CCR7;TGFBR2
1923,prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.47564367594072493,-0.7626543772915371,0.7894736842105263,0.9462779599417901,1.0,1/17,0.77%,LPCAT2
1924,prerank,positive regulation of DNA metabolic process (GO:0051054),-0.4080849611247236,-0.7624941776955966,0.8833333333333333,0.9457447887545405,1.0,4/51,10.97%,EYA4;MYC;HGF;PDGFRB
1925,prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3219661494890939,0.7620951329801535,1.0,1.0,1.0,39/286,14.95%,FEM1A;FBXO31;NHLRC1;TRIM72;FBXW7;ARNTL;ANKRD9;GID4;PSME4;CDC34;UBE2B;MARCHF6;WFS1;HERPUD1;PTTG1;DCAF11;FBXL22;HSPA5;DNAJB2;DMAC2;UBR3;ECPAS;FAF1;UBR2;UBXN2A;PRKN;FBXO44;PSMC3;PSME3;UBC;GID8;CUL4A;RAD23A;CUL5;UBE2G1;PSMD12;UBE2D1;HUWE1;COP1
1926,prerank,myelination (GO:0042552),0.4139702176375708,0.7620925985000396,0.7714285714285715,1.0,1.0,7/34,12.73%,GPC1;CMTM8;PARD3;EIF2B4;AMIGO1;TPPP;PLP1
1927,prerank,receptor catabolic process (GO:0032801),0.42588931237571226,0.761782221234998,0.7608695652173914,1.0,1.0,3/22,10.54%,VLDLR;SH3GLB1;KIF16B
1928,prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.45360882550032394,-0.7606645141301993,0.7833333333333333,0.9475813620275338,1.0,6/23,26.12%,SPI1;CREBZF;MACROH2A2;DNMT1;TASOR;TRIM27
1929,prerank,maintenance of blood-brain barrier (GO:0035633),-0.4645234068665686,-0.7606401238857162,0.7735849056603774,0.9469296552441294,1.0,4/21,14.07%,ACTG1;LSR;ACTB;LAMC1
1930,prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.41040135613040346,0.7589672545123258,0.8611111111111112,1.0,1.0,2/27,6.74%,SVIP;KLHL40
1931,prerank,nervous system development (GO:0007399),-0.3497021482875538,-0.75890630494871,0.9846153846153847,0.9487710780026783,1.0,39/247,12.05%,FN1;DCLK1;ACAN;CAPG;MDK;PTN;ECRG4;MARCKSL1;NUMBL;NAGLU;MARCKS;ADGRA2;DACT1;IGSF8;CXCR4;APAF1;FARP1;TGFBR1;SNTG2;PDGFC;ROBO1;TYRO3;RAB29;SH3GL1;GLIS2;DLG4;SMO;MST1R;EPHB2;INHBA;TGFB1;MET;MERTK;NLGN2;NOTCH2;NBL1;SLC2A1;DAGLB;AXL
1932,prerank,protein modification by small protein removal (GO:0070646),-0.35148139789021143,-0.7576381082439294,0.9848484848484849,0.9501539196757706,1.0,10/235,8.58%,ARRB2;UCHL1;IL33;USP35;SKP2;TGFBR1;OTULINL;MYC;CCNA2;CDK1
1933,prerank,positive regulation of defense response to virus by host (GO:0002230),0.4424996679590167,0.7573866517397162,0.782608695652174,1.0,1.0,1/17,4.51%,MAVS
1934,prerank,regulation of cell differentiation (GO:0045595),-0.38773332283591433,-0.7570763624408657,0.9104477611940298,0.950252517191472,1.0,24/111,12.48%,LGALS3;CCN2;MDK;MAFB;MEGF10;ID2;RUNX1;PRKCB;FES;TGFBR1;CEBPD;FGFR1;LTBP4;SMOC1;RPS6KA1;BIN1;RUNX2;TGFB1;CDK9;RUNX3;FGFR2;SNAI2;TIAM1;TRPS1
1935,prerank,metal ion export (GO:0070839),0.46820034831494023,0.7570267108405171,0.7916666666666666,1.0,1.0,8/20,12.51%,KCNIP2;KCNA5;ATP1A2;KCND3;ATP1A1;SLC4A4;KCNQ1;KCNH2
1936,prerank,ventricular septum morphogenesis (GO:0060412),-0.41391373596110764,-0.7566316434528004,0.7758620689655172,0.9502919639867135,1.0,4/25,9.79%,TGFB2;TGFBR1;ROBO1;SLIT3
1937,prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.4404472128396344,0.7561800391968939,0.8611111111111112,1.0,1.0,4/18,6.57%,ANK2;RYR2;JPH2;TRDN
1938,prerank,negative regulation of protein modification process (GO:0031400),-0.379292598304053,-0.7559273295805549,0.8870967741935484,0.9506598517194046,1.0,14/71,14.80%,IGFBP3;SIRPA;FBLN1;P3H1;CRTAP;NIBAN1;CORO1C;EPHB2;TGFB1;PID1;PRR5L;DNAJC10;LYN;PPIA
1939,prerank,response to muscle stretch (GO:0035994),0.4597569388994947,0.7558531077420021,0.78,1.0,1.0,5/15,10.58%,TTN;RYR2;TCAP;CAV3;CSRP3
1940,prerank,peptidyl-asparagine modification (GO:0018196),-0.4325983711085925,-0.7551913921922674,0.803921568627451,0.9509598617223894,1.0,10/27,23.19%,MGAT2;ALG5;DPM2;STT3A;ST6GAL1;OSTC;RPN2;DDOST;UGGT1;ALG8
1941,prerank,melanosome localization (GO:0032400),0.4715890845460967,0.7540514921943811,0.8958333333333334,1.0,1.0,1/17,3.58%,MREG
1942,prerank,nucleocytoplasmic transport (GO:0006913),-0.40328468372370735,-0.7537865154866772,0.84,0.9522939371087824,1.0,1/37,8.21%,RGS14
1943,prerank,copper ion homeostasis (GO:0055070),0.4534822788570892,0.753012054850961,0.8205128205128205,1.0,1.0,4/15,15.85%,ANKRD9;CUTC;ABCB6;COMMD1
1944,prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.38550204407715116,0.7525438603729865,0.725,1.0,1.0,4/46,4.82%,PPIF;NDUFS3;PINK1;NDUFA13
1945,prerank,regulation of TORC1 signaling (GO:1903432),0.4113875001621619,0.7522982611441058,0.8461538461538461,1.0,1.0,4/30,12.77%,RRAGD;CLEC16A;SIK3;SESN1
1946,prerank,positive regulation of axonogenesis (GO:0050772),-0.4391530749491331,-0.752161110655783,0.7884615384615384,0.9539370103839395,1.0,5/36,8.63%,DBN1;PLXNC1;SHTN1;ROBO1;MAP6
1947,prerank,inorganic anion transport (GO:0015698),-0.47766675271594794,-0.7521272012452648,0.8571428571428571,0.9532681460715385,1.0,6/26,6.73%,SLC11A1;ENPP1;SLC26A11;TTYH3;CLIC1;RACGAP1
1948,prerank,regulation of cholesterol metabolic process (GO:0090181),-0.4642995542346348,-0.7502113674988186,0.7758620689655172,0.9555207052904797,1.0,1/19,0.51%,APOE
1949,prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.4483246845626217,-0.749657166473236,0.8,0.9554889882151679,1.0,6/17,31.94%,SRD5A3;MPDU1;ALG8;ALG9;ALG13;ALG14
1950,prerank,response to gamma radiation (GO:0010332),0.4373058970903427,0.7490474820431164,0.76,1.0,1.0,8/22,22.47%,CRYAB;MAP3K20;TMEM109;YAP1;XRCC5;HSF1;LIG4;TSPYL5
1951,prerank,skeletal muscle tissue development (GO:0007519),0.4330160825559656,0.7489032266988517,0.8536585365853658,1.0,1.0,11/26,13.00%,LMOD3;MYOZ2;KLHL41;BVES;KLHL40;MYH14;POPDC2;ACTA1;CSRP3;SVIL;ZBTB18
1952,prerank,determination of left/right symmetry (GO:0007368),-0.4832498140182342,-0.7488321021205683,0.8387096774193549,0.9560103802195884,1.0,4/15,17.15%,SMO;PKD2;LEFTY1;KIF3B
1953,prerank,neuron migration (GO:0001764),0.3799565075416893,0.7487992278699653,0.9318181818181818,1.0,1.0,5/34,10.74%,VEGFA;AUTS2;FGF13;CELSR1;CEP85L
1954,prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.4768939120070499,0.7481057322523319,0.7954545454545454,1.0,1.0,3/17,4.23%,SCN4B;ANK2;KCNA5
1955,prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.39460529567646185,0.7479398794043541,0.8958333333333334,1.0,1.0,5/32,19.31%,MAPKAPK5;MAP3K4;XRCC5;MAP2K7;HNRNPA2B1
1956,prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.4479861238672487,-0.7460365234410047,0.7358490566037735,0.959118443401368,1.0,6/19,16.59%,UAP1L1;AMDHD2;RENBP;UGDH;NANS;PMM1
1957,prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.433473993059608,0.7455376501655269,0.782608695652174,1.0,1.0,10/30,8.07%,WNK2;KCNIP2;KCNJ3;ANK2;KCNN1;KCNJ5;KCNJ12;KCNJ2;WNK1;KCNN2
1958,prerank,membrane depolarization (GO:0051899),-0.4771926592124462,-0.7453080339998522,0.8548387096774194,0.9596364074973547,1.0,3/15,5.12%,P2RX4;P2RX7;CACNB3
1959,prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.4073004074201462,0.744194991630769,0.9090909090909091,1.0,1.0,4/35,6.49%,PPIF;PINK1;OPA1;GHITM
1960,prerank,DNA replication initiation (GO:0006270),-0.4286787402988287,-0.7438248656704481,0.8245614035087719,0.9609813812024729,1.0,11/31,24.63%,MCM6;DBF4;MCM3;PRIM2;PRIM1;ORC6;MCM5;MCM4;CDT1;POLE;TOPBP1
1961,prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.47185016921516587,-0.7436951927491177,0.8679245283018868,0.9604946001773662,1.0,7/25,20.83%,CDK1;CLSPN;TAOK3;BRSK1;CDKN1A;PLK1;DONSON
1962,prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.43904455520565144,-0.7427552337076782,0.8888888888888888,0.9611356552169646,1.0,5/23,11.07%,PTK2B;GRIA3;DLG4;APP;NLGN2
1963,prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.45886084558324847,-0.7421874650115096,0.8148148148148148,0.9612585091890423,1.0,3/21,7.46%,GPR35;TLR9;FKBP1B
1964,prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.4773961829933139,-0.7421518795143482,0.8076923076923077,0.960605855974149,1.0,4/16,19.17%,CEBPA;HHEX;NR2F2;PLK1
1965,prerank,heart looping (GO:0001947),0.3888263240807238,0.7421351878174283,0.868421052631579,1.0,1.0,6/25,17.83%,NDRG4;NKX2-5;NOTCH1;GATA4;SRF;TBX3
1966,prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.46379052155269884,-0.7416754920122427,0.8679245283018868,0.9607289174636109,1.0,5/19,14.84%,ACTG1;CORO1C;LDB1;EFNA5;GPM6B
1967,prerank,peptidyl-serine phosphorylation (GO:0018105),-0.3648048857776327,-0.7407003988075902,0.9545454545454546,0.9613013322946463,1.0,17/130,15.06%,DCLK3;NEK6;PRKCD;IKBKE;PRKCB;TGFBR1;GAS6;CDK1;CAMK1D;RPS6KA1;PDK3;MAP4K1;EIF2AK3;RIPK1;MAST3;AURKA;PLK2
1968,prerank,renal water homeostasis (GO:0003091),0.4423876223465046,0.7385485716879043,0.8780487804878049,1.0,1.0,8/18,13.64%,MYO5B;ADCY1;PRKACA;WFS1;ADCY5;ADCY6;AQP1;PRKAR2A
1969,prerank,establishment of melanosome localization (GO:0032401),0.47169232647079556,0.7380832411031042,0.8409090909090909,1.0,1.0,1/15,3.58%,MREG
1970,prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.3360224147846028,0.7371274070657173,0.9722222222222222,1.0,1.0,5/89,5.22%,FXR1;CPEB3;EIF4G1;ASPH;CYFIP2
1971,prerank,regulation of cytokinesis (GO:0032465),0.3847196915991895,0.7364270506792074,0.9230769230769231,1.0,1.0,6/59,9.30%,CHMP4C;SH3GLB1;KLHL21;PRKCE;KIF13A;CENPV
1972,prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.45219462832081636,0.7362206895131704,0.8918918918918919,1.0,1.0,3/18,10.42%,AFG3L2;LETM1;MCUR1
1973,prerank,regulation of RIG-I signaling pathway (GO:0039535),0.48405618973316156,0.7360041811849724,0.868421052631579,1.0,1.0,4/15,19.03%,C1QBP;NPLOC4;USP15;PUM1
1974,prerank,error-prone translesion synthesis (GO:0042276),-0.4569365954185243,-0.7342840176339697,0.8035714285714286,0.9693347080279274,1.0,6/20,24.13%,RFC2;RPS27A;POLI;PRIMPOL;REV3L;RFC5
1975,prerank,amino acid import (GO:0043090),-0.4673643447167343,-0.7335083201968955,0.8421052631578947,0.9697420775437973,1.0,6/15,16.40%,SLC9A3R1;SLC1A3;SFXN3;SLC16A2;SLC7A8;SLC7A5
1976,prerank,muscle cell differentiation (GO:0042692),0.3968538743970131,0.7328075364666992,0.9166666666666666,1.0,1.0,10/27,17.70%,BVES;NRAP;POPDC2;FBXO40;NEBL;MYOCD;MTLN;POPDC3;TMEM204;NEB
1977,prerank,regulation of glycolytic process (GO:0006110),-0.39868667123745455,-0.7323508921235251,0.9,0.9706472433984277,1.0,3/61,5.00%,NUPR1;IGF1;P2RX7
1978,prerank,protein K48-linked ubiquitination (GO:0070936),0.38981746888598356,0.7315467106217248,0.9069767441860465,1.0,1.0,16/52,21.74%,CDC34;UBE2B;MARCHF6;KLHL3;PRKN;UBE2G1;UBE2D1;NEDD4L;RNF6;TTC3;UBE2A;BFAR;RNF146;UBE2D3;CUL3;UBE3A
1979,prerank,protein dephosphorylation (GO:0006470),0.3342906552490105,0.7297648160252812,1.0,1.0,1.0,9/116,7.79%,PPTC7;PPM1L;DUSP18;PDP2;PPP2R3A;PPM1B;DUSP8;PTPN3;PTPRM
1980,prerank,mitotic nuclear membrane organization (GO:0101024),-0.40016727984979517,-0.729238325981652,0.7843137254901961,0.973332833121994,1.0,4/50,11.58%,CCNB2;CDK1;REEP4;CCNB1
1981,prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.40016727984979517,-0.729238325981652,0.7843137254901961,0.973332833121994,1.0,4/50,11.58%,CCNB2;CDK1;REEP4;CCNB1
1982,prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.4221448533001082,-0.7286218163916426,0.8666666666666667,0.9733880006163068,1.0,5/31,11.87%,TGFB2;RASAL3;EPHB2;MET;STMN1
1983,prerank,cellular polysaccharide catabolic process (GO:0044247),0.46188926778093053,0.7274407482861599,0.8823529411764706,1.0,1.0,4/15,10.25%,PYGM;AGL;PYGB;PHKA1
1984,prerank,actin nucleation (GO:0045010),-0.44944922214575767,-0.7274299461156681,0.8666666666666667,0.9743872777533911,1.0,4/19,8.80%,ARPC1B;ARPC5;ARPC4;ARPC2
1985,prerank,protein alkylation (GO:0008213),0.451784628986512,0.726040270014899,0.8205128205128205,1.0,1.0,4/18,17.62%,EEF1AKMT1;ETFBKMT;METTL22;PCMT1
1986,prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.4057753030365853,0.7259982494821251,0.82,1.0,1.0,7/26,20.15%,MAP3K5;MAP3K20;UBC;MAPK8;MAP3K7;MAP2K7;SKP1
1987,prerank,interstrand cross-link repair (GO:0036297),-0.4264379631622817,-0.7248617869683711,0.8301886792452831,0.9769576121963779,1.0,11/40,28.51%,FAAP20;NEIL3;EXO5;FANCG;RPS27A;XPA;SLX4;FAAP24;MCM9;FANCE;DCLRE1C
1988,prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.4268490303043104,-0.724227441524512,0.8448275862068966,0.9771423567864239,1.0,4/34,8.97%,SRC;PADI2;PMEPA1;TRERF1
1989,prerank,hepaticobiliary system development (GO:0061008),0.45017738290078285,0.7241308623202573,0.8979591836734694,1.0,1.0,1/18,1.75%,PROX1
1990,prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.45233682291951216,-0.7240797393811669,0.8135593220338984,0.9766160985625121,1.0,3/19,5.65%,MMP14;IGF1;NIBAN2
1991,prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.4437169350171932,-0.7231084160238548,0.8852459016393442,0.9770403158259782,1.0,1/18,3.93%,RASSF2
1992,prerank,secondary alcohol metabolic process (GO:1902652),-0.42273792798011367,-0.7216997197332568,0.8709677419354839,0.978082849265754,1.0,6/30,7.81%,APOE;CH25H;SOAT1;GBA;ABCG1;TSKU
1993,prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.3923133063327091,-0.7208782235604109,0.9193548387096774,0.9784311745899195,1.0,11/56,19.16%,GTSE1;E2F1;CDK1;CCNB1;SFN;BAX;AURKA;PLK2;PLK3;PML;CDKN1A
1994,prerank,regulation of cholesterol transport (GO:0032374),0.4645072503436923,0.7205315863905102,0.8478260869565217,1.0,1.0,2/15,6.16%,ABCB4;OSBPL6
1995,prerank,negative regulation of GTPase activity (GO:0034260),0.3871696524804051,0.720022575082299,0.8461538461538461,1.0,1.0,2/20,7.84%,GPSM1;WNK1
1996,prerank,regulation of Golgi organization (GO:1903358),0.4310466574979596,0.7196971588935009,0.8333333333333334,1.0,1.0,1/15,4.08%,PDE4DIP
1997,prerank,regulation of establishment of endothelial barrier (GO:1903140),0.4281485684631952,0.7195452520643023,0.8958333333333334,1.0,1.0,1/15,4.34%,VEGFA
1998,prerank,neurogenesis (GO:0022008),-0.42502569336321633,-0.7195171959597744,0.8909090909090909,0.9792816655788515,1.0,3/30,6.43%,ANXA1;TGFB2;CXCR4
1999,prerank,cellular iron ion homeostasis (GO:0006879),-0.3774105357616899,-0.7189923471003344,0.9433962264150944,0.9791674888777693,1.0,4/50,7.69%,SLC11A1;HMOX1;ATP13A2;MYC
2000,prerank,regulation of protein localization (GO:0032880),-0.3932274014796862,-0.7183817745423859,0.88,0.9791522199514576,1.0,2/46,6.23%,CTSD;ITGB3
2001,prerank,regulation of transport (GO:0051049),0.4053516158011413,0.7182053344224699,0.8867924528301887,1.0,1.0,4/26,13.60%,PINK1;EPB41;PRKN;MUL1
2002,prerank,neuromuscular junction development (GO:0007528),0.4299251853213606,0.7178814739519614,0.8571428571428571,1.0,1.0,6/20,15.38%,DNAJA3;CACNB2;PPFIBP2;DOK7;DCTN1;ANK3
2003,prerank,response to hexose (GO:0009746),0.4467543159526496,0.7176917943604624,0.8409090909090909,1.0,1.0,2/16,9.34%,LPL;EIF2B4
2004,prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.4170252820040007,0.7170872285893409,0.9,1.0,1.0,5/24,17.45%,CHMP4C;RILP;LAPTM4B;TMEM50B;VCP
2005,prerank,protein targeting to membrane (GO:0006612),0.3584459286198397,0.7160346104952161,0.9736842105263158,1.0,1.0,4/69,7.18%,PXMP2;ABCD3;PEX19;PARD3
2006,prerank,DNA methylation (GO:0006306),-0.44231719298207917,-0.7155908497628911,0.8571428571428571,0.9821217957737829,1.0,2/19,8.94%,ZFP57;EHMT2
2007,prerank,positive regulation of signaling (GO:0023056),0.39836758614215384,0.7154478293313271,0.8913043478260869,1.0,1.0,4/20,12.02%,LGI1;BVES;HOMER1;TBX5
2008,prerank,cardiac conduction system development (GO:0003161),-0.4302886686593828,-0.7151022988821045,0.8275862068965517,0.9818990021843307,1.0,5/21,11.41%,NPPA;GJA5;MSC;TBX18;NOTCH2
2009,prerank,negative regulation of protein dephosphorylation (GO:0035308),0.42667121527863283,0.7150771808718582,0.9183673469387755,1.0,1.0,5/16,18.60%,PPP1R16B;BOD1;MFHAS1;YWHAE;PPP1R11
2010,prerank,regulation of myoblast differentiation (GO:0045661),0.3906101701216009,0.7149873373329284,0.9142857142857143,1.0,1.0,6/26,13.57%,SMYD1;KLHL41;RBM24;HIF1AN;NOTCH1;RIPOR2
2011,prerank,mitotic chromosome condensation (GO:0007076),0.37883255410798655,0.714380599067223,0.8979591836734694,1.0,1.0,2/26,5.19%,TTN;KMT5A
2012,prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.3520412989933919,-0.7136722264001168,0.9672131147540983,0.9828670972016994,1.0,12/87,19.86%,IL1RN;IRAK4;IL1R1;MAP3K8;PSMB8;IRAK3;MAPK3;IKBKB;MYD88;PSMB9;RPS27A;RPS6KA4
2013,prerank,positive regulation of neuron differentiation (GO:0045666),0.3830540423079809,0.7128122415913585,0.9,1.0,1.0,1/24,1.75%,PROX1
2014,prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.4097484026496123,-0.7116479654497992,0.8923076923076924,0.9845230113319999,1.0,10/38,16.77%,BUB1B;SLC9A3R1;GAS1;TGFB1;BTG1;FOXC1;ZFP36L2;ZWILCH;PLK2;BUB1
2015,prerank,neuron apoptotic process (GO:0051402),0.42149988181260706,0.7113791495880839,0.8421052631578947,1.0,1.0,3/15,10.52%,ERBB3;GAPDH;DIABLO
2016,prerank,protein N-linked glycosylation (GO:0006487),-0.3838205908103123,-0.7111358246667114,0.9811320754716981,0.9843645640498783,1.0,14/59,20.39%,SLC39A8;MGAT2;TMEM165;ALG5;PMM1;SRD5A3;DPM2;STT3A;MPDU1;ST6GAL1;OSTC;GFPT2;RPN2;DDOST
2017,prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.331030255639184,0.710730953755673,1.0,1.0,1.0,4/131,7.46%,TUBA4A;CLASP1;PRKACA;PSME4
2018,prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3538561759370976,0.7099462599976346,1.0,1.0,1.0,14/71,21.99%,PRPF19;COPS7A;UBC;POLR2C;CUL4A;COPS8;CCNH;COPS3;POLR2E;POLR2B;POLR2L;POLR2F;COPS4;COPS6
2019,prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.4383729374105648,0.7085325830062403,0.8333333333333334,1.0,1.0,3/15,6.49%,PPIF;OPA1;GHITM
2020,prerank,inorganic anion transmembrane transport (GO:0098661),-0.4076203632775473,-0.707471290723953,0.8833333333333333,0.9878686676155158,1.0,4/30,4.46%,GABRQ;SLC37A2;GABRE;GABRA3
2021,prerank,protein sumoylation (GO:0016925),-0.3885902013992469,-0.7074099279997239,0.98,0.9872413736584037,1.0,6/44,25.79%,UBE2I;PIAS3;STX1A;NUP214;TRIM28;EGR2
2022,prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.44321261270787227,0.7070880075710705,0.8863636363636364,1.0,1.0,6/18,14.66%,CD36;PPARA;TRAP1;ALOX5;ABCB7;SLC25A33
2023,prerank,positive regulation of telomere maintenance (GO:0032206),0.3976884496952585,0.7064065379831873,0.8837209302325582,1.0,1.0,6/27,20.55%,MAPKAPK5;MAP3K4;PPP1R10;MAP2K7;HNRNPA2B1;NBN
2024,prerank,heterochromatin assembly (GO:0031507),0.4502615619489207,0.706036505567121,0.875,1.0,1.0,2/18,15.43%,CENPV;BEND3
2025,prerank,regulation of viral transcription (GO:0046782),-0.403651638892707,-0.7057521068730784,0.873015873015873,0.9883412470606708,1.0,3/38,13.93%,MDFIC;CDK9;TRIM62
2026,prerank,positive regulation of viral transcription (GO:0050434),-0.43316431471690864,-0.7050017923751853,0.9672131147540983,0.9884421329301952,1.0,2/24,11.07%,MDFIC;CDK9
2027,prerank,negative regulation of metabolic process (GO:0009892),0.36130716333983803,0.7047201292279117,0.972972972972973,1.0,1.0,5/45,12.44%,ACOT13;ARNTL;IL15;CIDEA;NOTCH1
2028,prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.3378728740014884,-0.7046266562956753,1.0,0.9882160886326908,1.0,10/109,12.85%,PIK3R5;PIK3CG;PIK3CD;PIP4K2A;PLEKHA4;PI4K2B;INPP5D;PLCG2;PITPNM1;SOCS3
2029,prerank,maturation of LSU-rRNA (GO:0000470),0.39436994971105765,0.704421436637511,0.9148936170212766,1.0,1.0,1/25,7.36%,MRPL1
2030,prerank,regulation of glucose import (GO:0046324),-0.4206561481644516,-0.7032487012297708,0.8666666666666667,0.9891251351476958,1.0,2/25,4.78%,ENPP1;IGF1
2031,prerank,bile acid biosynthetic process (GO:0006699),-0.44070137396795717,-0.7032274028241482,0.8103448275862069,0.9884420802982393,1.0,1/17,1.47%,CH25H
2032,prerank,release of cytochrome c from mitochondria (GO:0001836),-0.4514727575778867,-0.7031354451823473,0.875,0.9877926104265115,1.0,5/16,12.14%,CLU;BID;BOK;SFN;BAX
2033,prerank,protein-DNA complex assembly (GO:0065004),-0.3518497207062682,-0.702811865080395,0.9838709677419355,0.9874373351312359,1.0,17/109,21.05%,SOX9;NAP1L1;MCM6;CHAF1B;PADI4;MCM3;PSMB8;BRD2;PSMB9;NPM1;RPS27A;CUL4B;XPA;CHAF1A;ORC6;MCM5;HMGB2
2034,prerank,cellular response to DNA damage stimulus (GO:0006974),0.2868544458489831,0.7015202769148893,1.0,1.0,1.0,14/288,8.94%,APBB1;UNG;FBXO31;MACROD1;POLQ;USP28;ALKBH7;RBM24;PSME4;TIGAR;SLF1;UBE2B;UBQLN4;MAPKAPK2
2035,prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.4293362829267464,0.7012199634147875,0.8076923076923077,1.0,1.0,6/20,29.41%,VPS37A;VPS4A;VPS25;VPS36;PLAA;TOM1L1
2036,prerank,NIK/NF-kappaB signaling (GO:0038061),0.3492870200701369,0.7006507870540226,0.9428571428571428,1.0,1.0,28/68,28.54%,PSME4;PSMC3;PSME3;PSMD12;COPS8;CARD10;MAP3K7;PSMB7;ZFP91;PSMD2;PSMA1;SKP1;PSMB2;AKT1;PSME1;PSMC6;PSMD11;PSMD1;PSMD3;PSMC2;PSMA6;IRAK1;PSMB6;PSMB5;PSMC1;PSMC5;BTRC;PSMB3
2037,prerank,positive regulation of axon extension (GO:0045773),-0.43039036213673176,-0.6999956966286587,0.8163265306122449,0.989744505383289,1.0,2/19,6.92%,DBN1;SHTN1
2038,prerank,proton transmembrane transport (GO:1902600),-0.4209673120488838,-0.6997622435743954,0.8518518518518519,0.9892988632204952,1.0,4/21,8.19%,HVCN1;ATP1A3;UCP2;ATP6V0A4
2039,prerank,regulation of protein ubiquitination (GO:0031396),0.32741538532565717,0.6995559038621969,1.0,1.0,1.0,8/98,10.15%,PINK1;FBXW7;SH3RF2;KLHL40;IVNS1ABP;WFS1;CRY1;DNAJB2
2040,prerank,negative regulation of cytoskeleton organization (GO:0051494),0.3937437514579666,0.6994944250392688,0.9459459459459459,1.0,1.0,8/29,15.41%,FKBP4;CLASP1;TWF2;CAV3;PRKN;SSH2;ARFGEF1;PFN2
2041,prerank,negative regulation of cell cycle process (GO:0010948),0.33059745549418024,0.6994943105064808,1.0,1.0,1.0,8/49,16.08%,TOM1L2;CHMP4C;E2F6;TFDP2;BMI1;PPP1R10;RBBP7;NME6
2042,prerank,transition metal ion transport (GO:0000041),-0.4430408898643735,-0.6988243981371288,0.8518518518518519,0.9896017132812384,1.0,2/21,3.02%,SLC11A1;SLC39A8
2043,prerank,substantia nigra development (GO:0021762),-0.41493314164457556,-0.698368843733773,0.9032258064516129,0.9893111463524964,1.0,3/31,4.74%,BASP1;PADI2;DYNLL1
2044,prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.4492336965589205,-0.6978326488887721,0.8909090909090909,0.989150869979221,1.0,3/17,17.96%,MET;STMN1;KCTD10
2045,prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.4171951674158776,-0.6975904457757364,0.875,0.9887474755381446,1.0,5/27,14.46%,DBN1;CFL1;LRP8;ZDHHC15;NGEF
2046,prerank,DNA metabolic process (GO:0006259),0.29131318628472924,0.6969815971178207,1.0,1.0,1.0,9/230,8.79%,NUDT15;UNG;POLQ;PSME4;ENDOG;CDC34;UBE2B;GMNN;HMGB3
2047,prerank,negative regulation of protein ubiquitination (GO:0031397),0.33772657636514464,0.6962932666433865,0.9459459459459459,1.0,1.0,4/45,9.99%,SH3RF2;KLHL40;IVNS1ABP;CRY1
2048,prerank,positive regulation of cell division (GO:0051781),-0.43806359340136064,-0.6956960436206517,0.9444444444444444,0.9901279239305899,1.0,7/26,15.11%,HTR2B;RACGAP1;FGFR2;AURKB;CDC25B;KIF20B;CDC42
2049,prerank,snRNA metabolic process (GO:0016073),0.4359987019480717,0.6950998481470353,0.8979591836734694,1.0,1.0,1/17,11.96%,INTS10
2050,prerank,peptidyl-threonine modification (GO:0018210),-0.3537392499881211,-0.6940427754075638,0.9846153846153847,0.9912067109717492,1.0,4/55,8.58%,GALNT16;PRKCD;TGFBR1;CDK1
2051,prerank,steroid biosynthetic process (GO:0006694),-0.3889375665608597,-0.6934944202279311,0.9016393442622951,0.9911264869236919,1.0,2/35,3.76%,CH25H;STAR
2052,prerank,protein K48-linked deubiquitination (GO:0071108),0.41282266734672163,0.6928962127410705,0.9487179487179487,1.0,1.0,5/20,23.18%,OTUD4;OTUD3;USP25;BAP1;USP20
2053,prerank,cellular response to heat (GO:0034605),0.3953899847605803,0.6917628374705519,0.8780487804878049,1.0,1.0,6/32,8.37%,MAPT;FGF1;PRKACA;CLPB;BAG3;TCIM
2054,prerank,positive regulation of glycolytic process (GO:0045821),0.42391536743589886,0.6915161957287596,0.8947368421052632,1.0,1.0,6/18,10.82%,ENTPD5;PFKFB2;PRKAA2;MLXIPL;INSR;SLC4A4
2055,prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.42391536743589886,0.6915161957287596,0.8947368421052632,1.0,1.0,6/18,10.82%,ENTPD5;PFKFB2;PRKAA2;MLXIPL;INSR;SLC4A4
2056,prerank,microtubule bundle formation (GO:0001578),-0.41023544585682725,-0.6910152616416012,0.8909090909090909,0.9929067371389944,1.0,7/25,19.17%,CAPN6;NCKAP5L;TTC26;KIF20A;CDK5RAP2;PSRC1;PLK1
2057,prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.4064532962144363,0.6909237088613522,0.9111111111111111,1.0,1.0,3/20,12.89%,OPA1;HERPUD1;PRKN
2058,prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.42996668162680185,-0.6899978236827728,0.96,0.9931729819916951,1.0,3/16,15.38%,GBA;CLN3;IRAK3
2059,prerank,lamellipodium assembly (GO:0030032),0.4005580440890482,0.6894079515969866,0.8723404255319149,1.0,1.0,4/25,12.10%,ABLIM1;ABLIM2;ABLIM3;PARVB
2060,prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3665901219613223,0.6891828399469202,0.9743589743589743,1.0,1.0,1/79,0.17%,PDK2
2061,prerank,acylglycerol biosynthetic process (GO:0046463),0.4220328660744203,0.6885985204532137,0.8974358974358975,1.0,1.0,3/16,11.82%,LPIN1;DGAT2;GPAM
2062,prerank,bile acid metabolic process (GO:0008206),-0.4322432773274594,-0.6885093380838259,0.8813559322033898,0.9942788646900199,1.0,3/19,10.50%,CH25H;CYP7B1;NPC1
2063,prerank,negative regulation of viral genome replication (GO:0045071),-0.3878821092420555,-0.6883211394763836,0.8983050847457628,0.9937124124964029,1.0,12/34,16.34%,CCL5;OAS3;ISG20;ZC3HAV1;MX1;FAM111A;IFITM2;RNASEL;ISG15;BST2;RESF1;IFIT1
2064,prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.41996349541796557,-0.6879333591868011,0.7966101694915254,0.9933484025713737,1.0,2/19,9.90%,SEMA3D;SEMA4A
2065,prerank,positive regulation of exocytosis (GO:0045921),-0.407977070316681,-0.6867244649729313,0.9,0.9937667215635355,1.0,3/26,5.68%,RAB15;SDC1;ATP13A2
2066,prerank,iron ion homeostasis (GO:0055072),-0.3652867119121758,-0.6858747349436068,0.9807692307692307,0.9938381169433916,1.0,10/52,17.10%,SLC11A1;HMOX1;ATP13A2;MYC;ATP6V1A;B2M;PICALM;FLVCR1;SLC22A17;HEPH
2067,prerank,protein kinase B signaling (GO:0043491),0.4151004535233854,0.6853790827490651,0.9111111111111111,1.0,1.0,2/18,6.76%,KDR;THEM4
2068,prerank,lipid translocation (GO:0034204),0.42661863867026667,0.6847036671515156,0.9090909090909091,1.0,1.0,1/19,1.47%,ABCB4
2069,prerank,cellular response to starvation (GO:0009267),-0.349030772796182,-0.6845231071243628,1.0,0.9945452482961278,1.0,11/131,10.83%,SFRP1;TCIRG1;DAP;ASNS;ATP6V0D2;CASTOR1;INHBB;EHMT2;NUAK2;LAMP2;STK26
2070,prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3087326712308537,0.6828642775095516,1.0,1.0,1.0,7/118,8.96%,TUBA4A;CLASP1;PRKACA;OPTN;PPP1R12B;TPD52L1;FBXL22
2071,prerank,RNA biosynthetic process (GO:0032774),0.38076651817129104,0.6825038885292385,0.9090909090909091,1.0,1.0,6/27,24.28%,TAF6;TAF7;PRMT5;TAF12;TAF4;POLA2
2072,prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3428684145910687,0.6821575588054116,0.9459459459459459,1.0,1.0,3/50,5.40%,PINK1;FBXW7;SH3GLB1
2073,prerank,negative regulation of signaling receptor activity (GO:2000272),0.42592124266818127,0.6819973817932727,0.8974358974358975,1.0,1.0,1/18,4.91%,PPARA
2074,prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.3785378545688424,-0.6819053345226578,0.9402985074626866,0.9960476284304872,1.0,1/33,1.47%,CH25H
2075,prerank,regulation of vasoconstriction (GO:0019229),0.416801077502832,0.68176194249018,0.8222222222222222,1.0,1.0,2/15,5.97%,ADRA1B;ADRA1A
2076,prerank,response to glucagon (GO:0033762),-0.407093481890888,-0.6806896047167875,0.9482758620689655,0.9965432382496614,1.0,2/15,6.24%,ADCY7;ADCY3
2077,prerank,protein acetylation (GO:0006473),0.37169958434330413,0.6806757924504654,0.8913043478260869,1.0,1.0,6/26,19.82%,MAPT;NAA35;NAA10;NAA40;CLOCK;KAT2B
2078,prerank,monocarboxylic acid transport (GO:0015718),0.382961315269368,0.6802517916312646,0.9166666666666666,1.0,1.0,3/30,3.91%,ABCB4;SLC16A1;CD36
2079,prerank,regulation of steroid metabolic process (GO:0019218),-0.4280723836724196,-0.6800959197952856,0.8928571428571429,0.9964438144129979,1.0,4/18,7.35%,APOE;STAR;ASAH1;ABCG1
2080,prerank,RNA 3'-end processing (GO:0031123),0.3209827639316337,0.6794615412730041,1.0,1.0,1.0,5/66,18.09%,WDR33;SUPV3L1;RPRD1A;PNPT1;RPRD1B
2081,prerank,regulation of mitochondrion organization (GO:0010821),-0.3826683189150089,-0.6785677142087849,0.9333333333333333,0.9972033029134261,1.0,1/44,0.33%,TREM2
2082,prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.3537838158905361,-0.6776865177648038,1.0,0.9973281221864762,1.0,7/65,17.66%,RUNX1;SPI1;FOXC1;LDB1;PSMB8;CBFB;PSMB9
2083,prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.38434220462219554,-0.6751053990513133,0.9516129032258065,0.9987671653536443,1.0,6/36,19.65%,POLD4;RFC2;RPS27A;CUL4B;XPA;POLD3
2084,prerank,aorta morphogenesis (GO:0035909),-0.4523689833408937,-0.6731842955817905,0.9074074074074074,0.9997476742912644,1.0,3/15,10.97%,LRP1;EFEMP2;PDGFRB
2085,prerank,regulation of glucose transmembrane transport (GO:0010827),0.4328177947465299,0.67288076225989,0.8529411764705882,1.0,1.0,1/15,2.61%,RTN2
2086,prerank,neurotransmitter transport (GO:0006836),0.3637052974171001,0.6722767971261391,0.9333333333333333,1.0,1.0,5/35,12.24%,RAB3A;ATP1A2;SLC29A2;SLC28A2;SLC17A7
2087,prerank,establishment of epithelial cell polarity (GO:0090162),0.40331491035252587,0.6718370057382749,0.8571428571428571,1.0,1.0,3/17,8.35%,CLASP1;PARD3;MYO18A
2088,prerank,nuclear membrane reassembly (GO:0031468),-0.3658761977870582,-0.6717446452395605,0.98,1.0,1.0,4/53,11.58%,CCNB2;CDK1;REEP4;CCNB1
2089,prerank,regulation of response to cytokine stimulus (GO:0060759),0.3919958099357925,0.6716435625910878,0.8695652173913043,1.0,1.0,2/17,5.58%,MAVS;TLE5
2090,prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.3683213305457307,-0.6714689037566078,0.9821428571428571,0.9998890730492119,1.0,6/51,15.65%,MYC;HGF;PDGFRB;AURKB;RFC2;MAPK3
2091,prerank,cell cycle G2/M phase transition (GO:0044839),0.30885719526991606,0.6711456818805244,1.0,1.0,1.0,7/119,8.96%,TUBA4A;CLASP1;PRKACA;OPTN;PPP1R12B;TPD52L1;FBXL22
2092,prerank,regulation of microtubule depolymerization (GO:0031114),0.3708242072515139,0.670553714281553,0.9069767441860465,1.0,1.0,6/24,15.28%,CLASP1;TRIM54;FGF13;MID1IP1;NAV3;APC2
2093,prerank,negative regulation of kinase activity (GO:0033673),-0.3650014728101957,-0.6704289113296978,0.9333333333333333,1.0,1.0,1/55,1.46%,PTPRC
2094,prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.42917962441709534,-0.6698771279410354,0.8936170212765957,0.999782492136541,1.0,3/15,16.30%,IGF1;EDN1;MTPN
2095,prerank,ERAD pathway (GO:0036503),-0.3447899898264462,-0.6698584554002353,0.9814814814814815,0.9990828542834015,1.0,5/76,8.51%,RCN3;OS9;EDEM1;SEC61B;FBXO17
2096,prerank,positive regulation of catabolic process (GO:0009896),-0.3511869142535382,-0.6693710217927733,0.9818181818181818,0.998767014028462,1.0,4/50,6.76%,DACT1;NKD1;GPC3;VSIR
2097,prerank,glutamate receptor signaling pathway (GO:0007215),0.4231262058955247,0.6686513029044706,0.9111111111111111,1.0,1.0,3/15,5.25%,HOMER2;GRM1;KCNB1
2098,prerank,glucose 6-phosphate metabolic process (GO:0051156),0.42546303637910055,0.668645168403429,0.8461538461538461,1.0,1.0,2/15,3.89%,HK2;GCK
2099,prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.3903902401116327,0.6682958380430599,0.8666666666666667,1.0,1.0,3/24,11.33%,TMEM117;MAP3K5;AIFM1
2100,prerank,mitotic cell cycle phase transition (GO:0044772),-0.31162722413730454,-0.6678997417710857,1.0,0.9991928088569203,1.0,42/179,19.63%,BCAT1;CDKN2B;MELK;GPR132;DYNLL1;SKP2;DBF4;CCNB2;CDK14;MYC;E2F1;CCNA2;UBE2C;CDK1;TACC3;INHBA;FOXM1;CCNB1;HAUS4;CDC25B;FBXL8;AJUBA;NINL;CCNF;AURKA;PLK2;CEP192;PLK3;ACVR1;CDK6;FBXL7;CEP250;PRKAR2B;BRSK1;SDCCAG8;BORA;CDK5RAP2;CDKN1A;PLK1;HAUS3;CUL4B;HAUS7
2101,prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.3845750262424594,-0.6668077652549537,0.8461538461538461,0.9992835101321929,1.0,2/19,12.45%,OS9;EDEM2
2102,prerank,regulation of cell cycle phase transition (GO:1901987),-0.337392410076105,-0.6661147070256758,1.0,0.9991830759940596,1.0,12/84,19.49%,GTSE1;DBF4;BUB1B;UBE2C;CDK1;CCNB1;CDC20;PSMB8;PSMB9;CDKN1A;PLK1;MAD2L1
2103,prerank,glycerophospholipid catabolic process (GO:0046475),-0.4155042952810727,-0.6648309858997359,0.8545454545454545,0.9995361115385057,1.0,2/18,3.64%,PLA2G7;PLA2G15
2104,prerank,apical junction assembly (GO:0043297),0.3658270866557688,0.6647809661712751,0.9302325581395349,1.0,1.0,2/32,7.18%,AFDN;PARD3
2105,prerank,establishment of mitotic spindle localization (GO:0040001),0.3886899302292246,0.6644748523582109,0.8936170212765957,1.0,1.0,3/23,15.09%,CLASP1;GJA1;DCTN1
2106,prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.42584778123736555,0.6641847692345,0.9111111111111111,1.0,1.0,5/16,16.74%,ADCY5;ABCA12;ANO1;GPLD1;CDK16
2107,prerank,stress-activated MAPK cascade (GO:0051403),0.33409844805901523,0.6625694866910078,0.9696969696969697,1.0,1.0,13/55,22.87%,MAP3K5;MAP3K20;UBC;MAP2K4;MAPK8;MAP3K7;MAPK10;MAP2K7;TAB3;MAP2K3;SKP1;MAP4K2;MAPK1
2108,prerank,negative regulation of ATP metabolic process (GO:1903579),-0.4389594708501252,-0.6624667816311005,0.9122807017543859,1.0,1.0,1/15,0.82%,NUPR1
2109,prerank,regulation of telomere maintenance (GO:0032204),-0.4002022494501492,-0.6616083601465584,0.8888888888888888,1.0,1.0,3/24,21.46%,MYC;PML;RAD50
2110,prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3486510831898581,-0.6614838641197981,0.9833333333333333,1.0,1.0,13/47,13.37%,MAP1A;S100A6;FARP1;SHTN1;MAP6;DOCK7;MAP1B;APP;SDC2;ACTB;SLITRK4;FGFR2;PAK3
2111,prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.39059235406203385,-0.6610235895993755,0.9193548387096774,1.0,1.0,5/37,12.85%,PIK3CG;PIK3CD;PIP4K2A;PI4K2B;SOCS3
2112,prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.4069868034648274,0.6610143301211504,0.9555555555555556,1.0,1.0,3/16,5.67%,KDR;RYR2;PRKACA
2113,prerank,amyloid-beta metabolic process (GO:0050435),-0.43137789977551994,-0.6605976788184232,0.9811320754716981,0.9996374962514784,1.0,3/15,22.61%,BACE2;PSEN2;ACE
2114,prerank,positive regulation of translation (GO:0045727),-0.32940997662643307,-0.658133657302775,1.0,1.0,1.0,6/82,10.80%,VIM;THBS1;CCL5;NIBAN1;RBM3;RPS4X
2115,prerank,embryonic organ development (GO:0048568),-0.35073168602224203,-0.6579891888243252,0.9848484848484849,1.0,1.0,8/41,15.35%,TGFB2;COL2A1;ALDH1A3;TGFB1;FGFR2;PCSK5;GLI2;GLI3
2116,prerank,L-amino acid transport (GO:0015807),0.40179953047243205,0.6577663458317422,0.9523809523809523,1.0,1.0,3/19,3.11%,SLC25A13;SLC38A3;SLC25A12
2117,prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.35609512779722496,0.6576212897279423,1.0,1.0,1.0,7/43,20.55%,FBXO31;ABRAXAS1;CCND1;BRCC3;MUS81;HUS1;NBN
2118,prerank,"DNA-templated transcription, elongation (GO:0006354)",0.33620740980122743,0.6575156087373223,1.0,1.0,1.0,12/62,25.27%,LEO1;POLR2C;CCNH;POLR2E;POLR2B;POLR1E;POLR2L;POLR2F;IWS1;CDC73;CCNK;GTF2H3
2119,prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.36693987386022886,-0.6569210696857571,0.9464285714285714,1.0,1.0,3/47,15.65%,SRC;AURKB;MAPK3
2120,prerank,oxoacid metabolic process (GO:0043436),0.4035868682663857,0.6568120119154591,0.925,1.0,1.0,6/18,15.69%,DDO;PPA2;LIPT1;THAP4;GRHPR;LIAS
2121,prerank,protein autoubiquitination (GO:0051865),0.33776595105746127,0.6567048790095742,1.0,1.0,1.0,12/51,21.74%,SH3RF2;UBE2B;KLHL24;PRKN;RNF10;UBE2A;BFAR;RNF146;UBE2D3;RNF11;CUL3;UBE3A
2122,prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.38609815007619774,-0.6565624979073914,0.9014084507042254,0.9999725923703804,1.0,1/30,4.34%,MAP1A
2123,prerank,regulation of DNA repair (GO:0006282),-0.3563435847836529,-0.6545996086015214,0.9384615384615385,1.0,1.0,7/40,21.55%,EYA4;CDK9;SIRT7;PML;EGFR;RPS3;EYA2
2124,prerank,regulation of glycogen biosynthetic process (GO:0005979),0.38520166869389044,0.6545918908208567,0.9487179487179487,1.0,1.0,6/21,12.14%,PPP1R3A;GCK;SORBS1;INSR;PPP1R3C;AKT2
2125,prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.36522023315588403,-0.6536149362075552,0.9696969696969697,1.0,1.0,6/38,19.65%,POLD4;RFC2;RPS27A;CUL4B;XPA;POLD3
2126,prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.3419207606331058,-0.6532791207995607,1.0,1.0,1.0,7/57,12.64%,PRKCD;FLNA;HCLS1;GTSE1;CDK1;TGFB1;EIF2AK3
2127,prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.33546158805213383,0.6529459724231809,1.0,1.0,1.0,10/49,20.27%,FGF16;FGF1;KIF16B;POLR2C;PTPN11;SPRED2;POLR2E;POLR2B;POLR2L;POLR2F
2128,prerank,organophosphate ester transport (GO:0015748),0.4052190741227983,0.6512783520583625,0.9545454545454546,1.0,1.0,1/20,1.09%,PITPNC1
2129,prerank,ncRNA catabolic process (GO:0034661),0.36854940415466375,0.6504544015682893,0.9512195121951219,1.0,1.0,1/23,9.76%,DIS3L
2130,prerank,regulation of defense response to virus by host (GO:0050691),0.38064687082843357,0.6502400110711867,0.95,1.0,1.0,1/22,4.51%,MAVS
2131,prerank,mRNA destabilization (GO:0061157),0.35436988758572385,0.6492241348399469,1.0,1.0,1.0,2/36,6.85%,CPEB3;RBM24
2132,prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.3977539512713657,-0.6485174717279104,0.9807692307692307,1.0,1.0,7/32,20.83%,CDK1;CLSPN;TAOK3;BRSK1;CDKN1A;PLK1;DONSON
2133,prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.3793422984235486,-0.6483360228037901,0.9272727272727272,1.0,1.0,4/19,19.43%,BOC;CDC42;CDON;NRG1
2134,prerank,regulation of synapse organization (GO:0050807),0.36261260341034357,0.647575441919074,0.9807692307692307,1.0,1.0,3/18,9.86%,EPHA4;CAMK2B;PDLIM5
2135,prerank,mesenchymal cell development (GO:0014031),-0.4272237080064123,-0.6469897739540523,0.9491525423728814,1.0,1.0,6/16,24.47%,FOXC1;SNAI2;SOX8;NRG1;HEYL;FAM172A
2136,prerank,chromosome condensation (GO:0030261),-0.3529435014328173,-0.6441999026765983,0.9583333333333334,1.0,1.0,12/33,19.17%,TOP2A;NCAPH;CDK1;NCAPG2;CCNB1;SMC2;CDCA5;SMC4;NUSAP1;PHF13;INCENP;PLK1
2137,prerank,termination of RNA polymerase II transcription (GO:0006369),0.36427405269222735,0.6438815426146064,0.9148936170212766,1.0,1.0,1/32,8.03%,WDR33
2138,prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.4109748282426869,-0.6429961534466612,0.8979591836734694,1.0,1.0,2/19,3.76%,PYCR1;STAR
2139,prerank,histone mRNA metabolic process (GO:0008334),-0.38535354057914684,-0.6423306105353201,0.9433962264150944,1.0,1.0,1/27,12.56%,TENT2
2140,prerank,sulfur compound transport (GO:0072348),-0.40085767857682897,-0.6420440323336516,0.9137931034482759,1.0,1.0,3/19,7.84%,SLC26A11;RACGAP1;SLC9A3R1
2141,prerank,signal transduction in response to DNA damage (GO:0042770),0.3346270994726922,0.6416474521020273,1.0,1.0,1.0,3/44,9.07%,PRPF19;USP28;MAP3K20
2142,prerank,positive regulation of glucose import (GO:0046326),-0.40505710043916315,-0.6407966972104527,0.8666666666666667,1.0,1.0,1/17,4.78%,IGF1
2143,prerank,telomere capping (GO:0016233),-0.4024874271281375,-0.6407537747311899,0.9818181818181818,1.0,1.0,5/15,30.46%,RAD50;TEN1;ACD;DCLRE1C;CTC1
2144,prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.3705195939158464,0.6398062185919197,0.9473684210526315,1.0,1.0,4/23,8.61%,OPA1;WFS1;HERPUD1;ALOX5
2145,prerank,lamellipodium organization (GO:0097581),0.36319969563248267,0.6372946341935972,0.9565217391304348,1.0,1.0,4/27,12.10%,ABLIM1;ABLIM2;ABLIM3;PARVB
2146,prerank,regulation of cellular amide metabolic process (GO:0034248),0.34366350681445446,0.6345362392747363,0.9777777777777777,1.0,1.0,4/27,9.34%,EIF4E;TIGAR;MAPKAPK5;EIF2B4
2147,prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.3310230485835235,0.6340592813794835,1.0,1.0,1.0,4/47,9.99%,SH3RF2;KLHL40;IVNS1ABP;CRY1
2148,prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.3113803664066582,0.6337597564513197,0.9705882352941176,1.0,1.0,7/52,25.85%,HBS1L;LSM3;PATL1;EXOSC7;CNOT7;CNOT4;CNOT6L
2149,prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.4064049215473298,-0.6335087716529517,0.94,1.0,1.0,4/21,11.01%,AK5;TYMS;RRM2;CTPS2
2150,prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.3211574554040181,0.6334267013918891,1.0,1.0,1.0,10/63,18.86%,TCF15;GATA2;PSME4;PSMC3;PSME3;PSMD12;YAP1;PSMB7;PSMD2;PSMA1
2151,prerank,neurotrophin signaling pathway (GO:0038179),0.3552346530433853,0.632949869596047,1.0,1.0,1.0,5/16,21.19%,RAPGEF1;MAGI2;RAPGEF2;KIDINS220;DDIT4
2152,prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.373506924977917,-0.6320269022219227,0.9545454545454546,1.0,1.0,1/33,4.34%,MAP1A
2153,prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.390025829542841,0.6309704338982781,0.9767441860465116,1.0,1.0,2/18,7.13%,USP28;CDIP1
2154,prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.4020587776562605,-0.6303267641199397,0.9841269841269841,1.0,1.0,5/18,17.64%,RAC2;ARPC2;ACTR3;CDC42;ACTR2
2155,prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.39246237647387705,-0.6300239884105069,0.9649122807017544,1.0,1.0,6/18,16.77%,BUB1B;AURKB;ZWILCH;PLK2;PLK3;BUB1
2156,prerank,purine-containing compound biosynthetic process (GO:0072522),0.3697297862358057,0.6285674596732489,0.9791666666666666,1.0,1.0,6/23,12.01%,ADK;SHMT1;GMPR;ADSL;AMPD3;PAICS
2157,prerank,telomere organization (GO:0032200),-0.35923573715817725,-0.6282272483546106,0.9827586206896551,1.0,1.0,5/38,23.86%,POLD4;DNA2;POLD3;RAD50;ACD
2158,prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.3402679976721374,-0.6253299827806703,1.0,1.0,1.0,6/54,17.66%,GPR132;AURKA;PSMB8;FHL1;FBXL7;PSMB9
2159,prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.4028761345050689,-0.6250003842863853,0.9824561403508771,1.0,1.0,1/16,9.37%,DLGAP5
2160,prerank,regulation of receptor internalization (GO:0002090),-0.3402525449457014,-0.624891032284381,0.9464285714285714,1.0,1.0,10/27,20.19%,ARRB2;CD63;DLG4;SDCBP;SFRP4;RIN3;AHI1;FMR1;ANKRD13A;LRPAP1
2161,prerank,protein mannosylation (GO:0035268),-0.37977042525862276,-0.6248650947012306,0.9591836734693877,1.0,1.0,1/20,6.44%,DPY19L1
2162,prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.34955844521542756,0.6243765231904765,0.9534883720930233,1.0,1.0,8/29,26.81%,UBC;CUL4A;CCNH;CHD1L;RAD23B;PARP1;GTF2H3;XPC
2163,prerank,protein exit from endoplasmic reticulum (GO:0032527),0.36115377560758233,0.6239461754805854,0.9130434782608695,1.0,1.0,2/23,8.38%,RANGRF;HERPUD1
2164,prerank,telomere maintenance via telomere lengthening (GO:0010833),0.3448470280324164,0.6235400411561003,0.9545454545454546,1.0,1.0,4/28,21.45%,DKC1;HSP90AB1;NOP10;PPP6R3
2165,prerank,telomere maintenance via telomerase (GO:0007004),0.36247201758822833,0.6225194733473535,0.9512195121951219,1.0,1.0,4/24,21.45%,DKC1;HSP90AB1;NOP10;PPP6R3
2166,prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.3290639475340781,-0.620113504613267,1.0,1.0,1.0,4/47,9.08%,PRKCD;EYA4;MYC;SPRED3
2167,prerank,cellular response to radiation (GO:0071478),-0.365655667448273,-0.6198523727959813,0.9833333333333333,1.0,1.0,2/23,19.16%,SPIDR;CDKN1A
2168,prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.31881049521119637,0.6188109230795757,1.0,1.0,1.0,11/60,25.27%,LEO1;POLR2C;CCNH;POLR2E;POLR2B;POLR2L;POLR2F;IWS1;CDC73;CCNK;GTF2H3
2169,prerank,postreplication repair (GO:0006301),-0.36779113306056144,-0.6181514005836032,0.9824561403508771,1.0,1.0,10/41,21.78%,PCLAF;FAAP20;POLD4;ISG15;RFC2;UBE2L6;RPS27A;POLD3;POLI;PRIMPOL
2170,prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.3784410678686583,-0.6174227788387191,0.9655172413793104,1.0,1.0,4/18,18.95%,SOCS3;NLRC5;IFNGR1;SOCS1
2171,prerank,positive regulation of reproductive process (GO:2000243),-0.42872195566633425,-0.6166132037252254,0.9508196721311475,1.0,1.0,3/15,10.49%,LHFPL2;INHBB;INHBA
2172,prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.33123130518199057,-0.6121242580389421,1.0,1.0,1.0,6/63,13.67%,OS9;EDEM1;SEC61B;FBXO17;EDEM2;DNAJC10
2173,prerank,macromolecule catabolic process (GO:0009057),0.3514741985199427,0.6108594608114051,0.9761904761904762,1.0,1.0,5/23,15.46%,SH3GLB1;CLPX;KIF16B;MTOR;UCHL3
2174,prerank,brain development (GO:0007420),0.29369778165634547,0.6081639135833823,1.0,1.0,1.0,12/97,14.97%,PROX1;NDUFS4;UGP2;TMX2;NDRG4;AMIGO1;SHROOM4;EML1;ABCB6;DNAJC30;CDK5RAP1;PTPN11
2175,prerank,peptidyl-lysine trimethylation (GO:0018023),0.37198562151099934,0.607464456384177,0.9772727272727273,1.0,1.0,3/23,16.71%,ETFBKMT;BEND3;ATPSCKMT
2176,prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.3627887434388033,0.6067754757962543,0.9743589743589743,1.0,1.0,7/19,20.68%,MITF;NKX2-5;SRF;MED24;MED16;MED1;MED4
2177,prerank,diacylglycerol metabolic process (GO:0046339),-0.3849590330828184,-0.6057795133187885,0.9622641509433962,1.0,1.0,2/16,9.89%,PLA2G15;ANG
2178,prerank,cellular response to light stimulus (GO:0071482),-0.3366991103758465,-0.6054461759020916,0.9836065573770492,1.0,1.0,3/45,12.24%,PRKCD;MYC;AURKB
2179,prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.36446997748389387,-0.6034368508866782,0.9032258064516129,1.0,1.0,2/22,12.52%,IGF1;C3
2180,prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.3718154632550209,-0.6022702676257434,0.9833333333333333,1.0,1.0,6/19,13.91%,SLC7A2;PRAF2;SLC1A4;SLC1A3;SLC7A8;SLC3A2
2181,prerank,positive regulation of intracellular transport (GO:0032388),0.31507242401587365,0.6019339233028957,0.9743589743589743,1.0,1.0,9/35,20.38%,PLA2G4E;ACTN2;PCNT;ABCA12;ZFAND1;EHD1;OAZ1;RIPOR1;OAZ2
2182,prerank,regulation of neurotransmitter secretion (GO:0046928),-0.3686055970725958,-0.5990845144757224,0.9818181818181818,1.0,1.0,2/18,9.02%,SEPTIN5;MCTP1
2183,prerank,"transcription, DNA-templated (GO:0006351)",-0.28510233924503847,-0.5988254775846207,1.0,1.0,1.0,7/187,11.44%,EREG;ARRB2;E2F1;CEBPD;MAF;CDK9;NFE2L3
2184,prerank,positive regulation of catalytic activity (GO:0043085),-0.3587034073026986,-0.598632071251943,0.984375,1.0,1.0,4/32,19.21%,AZIN2;MAPK3;PSEN2;CIB1
2185,prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.3777751928676944,-0.5983019621997178,0.9661016949152542,1.0,1.0,2/17,15.56%,CEBPA;NAB2
2186,prerank,response to endoplasmic reticulum stress (GO:0034976),-0.3157616249290268,-0.5978851496698198,1.0,1.0,1.0,11/93,13.67%,RCN3;THBS4;THBS1;OS9;NIBAN1;P4HB;BAX;EIF2AK3;CREB3L1;CASP4;DNAJC10
2187,prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.38288438167790906,0.5972258948768935,1.0,1.0,1.0,8/15,15.51%,RYR2;ATP1A2;PRKACA;ATP1A1;GJA1;TBX5;CACNA1C;PKP2
2188,prerank,negative regulation of catalytic activity (GO:0043086),-0.36026676460889906,-0.5921597321312151,0.9333333333333333,1.0,1.0,4/20,13.62%,TIMP1;CLN3;TMBIM1;HP
2189,prerank,negative regulation of fat cell differentiation (GO:0045599),-0.3616747596082319,-0.5919247524157185,1.0,1.0,1.0,4/29,11.24%,ENPP1;E2F1;TGFB1;ZFP36L2
2190,prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.32984596351727036,0.5915000798673578,0.975609756097561,1.0,1.0,1/20,6.93%,MOV10L1
2191,prerank,histone H2A monoubiquitination (GO:0035518),-0.37846017519694497,-0.5914794784311557,0.95,1.0,1.0,3/17,21.60%,PCGF2;CUL4B;RNF2
2192,prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.36547206010305056,-0.5903945602311653,0.9787234042553191,1.0,1.0,6/23,18.68%,ID2;FBXL8;PER3;BHLHE40;PER2;PML
2193,prerank,positive regulation of DNA repair (GO:0045739),-0.30960140813890613,-0.5891579216040955,1.0,1.0,1.0,3/38,10.64%,EYA4;SPIDR;FOXM1
2194,prerank,cardiac ventricle development (GO:0003231),-0.3771703433126652,-0.587123471549499,0.9444444444444444,1.0,1.0,1/17,4.68%,GJA5
2195,prerank,positive regulation of telomerase activity (GO:0051973),0.32322969315594885,0.5866067131710535,1.0,1.0,1.0,7/28,18.67%,MAPKAPK5;MAP3K4;DKC1;HSP90AB1;XRCC5;MAP2K7;KLF4
2196,prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.38224263862543184,0.5864494037221818,0.9473684210526315,1.0,1.0,2/15,22.55%,SNRNP200;WBP11
2197,prerank,protein localization to cell junction (GO:1902414),0.3354334918178595,0.5852244985035411,0.9545454545454546,1.0,1.0,2/15,12.04%,DSP;FERMT2
2198,prerank,DNA methylation or demethylation (GO:0044728),-0.3772077119739606,-0.5836195012651221,0.9661016949152542,1.0,1.0,1/15,8.94%,EHMT2
2199,prerank,DNA alkylation (GO:0006305),-0.3772077119739606,-0.5836195012651221,0.9661016949152542,1.0,1.0,1/15,8.94%,EHMT2
2200,prerank,cellular response to glucose starvation (GO:0042149),-0.3330405698093973,-0.583496334497034,0.9821428571428571,1.0,1.0,1/36,2.38%,ASNS
2201,prerank,response to interferon-beta (GO:0035456),-0.3579069033313136,-0.5828563226121533,0.9333333333333333,1.0,1.0,4/18,14.59%,IKBKE;IFITM2;AIM2;BST2
2202,prerank,protein K11-linked ubiquitination (GO:0070979),-0.3501332431141031,-0.5824840732336559,0.9836065573770492,1.0,1.0,2/26,8.06%,RNF26;UBE2C
2203,prerank,activation of protein kinase B activity (GO:0032148),0.3458234668055746,0.5821014213151743,0.9583333333333334,1.0,1.0,2/22,5.06%,PINK1;FGF1
2204,prerank,regulation of cilium assembly (GO:1902017),0.29631262383767537,0.5804835836059481,1.0,1.0,1.0,1/54,4.37%,TBC1D16
2205,prerank,photoperiodism (GO:0009648),-0.3559397716422237,-0.5802343679322535,1.0,1.0,1.0,6/24,18.68%,ID2;FBXL8;PER3;BHLHE40;PER2;PML
2206,prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.37659305318513814,-0.5796459829671989,0.953125,1.0,1.0,2/15,9.21%,TMEM50A;LEPROT
2207,prerank,regulation of stem cell differentiation (GO:2000736),-0.29605001516608714,-0.5785801474060116,1.0,1.0,1.0,2/76,5.31%,PTN;RUNX1
2208,prerank,histone deubiquitination (GO:0016578),0.3697271998312394,0.5767170930279845,0.9411764705882353,1.0,1.0,3/16,24.19%,USP15;BRCC3;ATXN7
2209,prerank,gene silencing by miRNA (GO:0035195),-0.3230578003189524,-0.576674768140213,1.0,1.0,1.0,5/31,23.25%,AJUBA;WTIP;MOV10;ZC3H7A;EIF6
2210,prerank,double-strand break repair via homologous recombination (GO:0000724),-0.2989413713388976,-0.5743669210908,1.0,1.0,1.0,17/70,26.78%,MCM6;SPIDR;MMS22L;MCM3;SAMHD1;MCM5;SLX4;RAD50;MCM4;RNF138;REV3L;AP5Z1;BRCA2;GINS2;RBBP8;FEN1;MCM9
2211,prerank,negative regulation of RNA splicing (GO:0033119),0.329700779816196,0.5733306429463841,0.9772727272727273,1.0,1.0,1/18,8.00%,C1QBP
2212,prerank,ribosomal small subunit biogenesis (GO:0042274),-0.3389271689227316,-0.5726010234637993,1.0,1.0,1.0,11/39,24.99%,RPS16;RPS5;RPS19;NPM1;RPS24;WDR3;RPS7;RPS6;RPS27;RPS14;RPS28
2213,prerank,positive regulation of receptor internalization (GO:0002092),-0.3588267224965318,-0.571165717811364,0.9464285714285714,1.0,1.0,2/16,6.57%,ARRB2;CD63
2214,prerank,establishment of endothelial barrier (GO:0061028),0.3177212106896067,0.5695806313690656,1.0,1.0,1.0,6/26,15.93%,AFDN;PPP1R16B;RAPGEF1;PDE4D;PDE2A;EZR
2215,prerank,histone monoubiquitination (GO:0010390),-0.34311905606770576,-0.5662064861621977,0.9615384615384616,1.0,1.0,3/23,21.60%,UHRF1;CUL4B;RNF2
2216,prerank,pre-replicative complex assembly (GO:0036388),0.28994199549220023,0.5608937738293379,1.0,1.0,1.0,21/59,27.52%,PSME4;GMNN;PSMC3;PSME3;UBC;PSMD12;PSMB7;PSMD2;PSMA1;PSMB2;PSME1;PSMC6;PSMD11;PSMD1;PSMD3;PSMC2;PSMA6;PSMB6;PSMB5;PSMC1;ORC3
2217,prerank,anterograde axonal transport (GO:0008089),0.3245842900344002,0.559726054263847,1.0,1.0,1.0,4/30,10.08%,TRAK1;KIF1C;KIF1B;TRAK2
2218,prerank,establishment of mitotic spindle orientation (GO:0000132),-0.3324478320705955,-0.5582113469669526,0.9795918367346939,1.0,1.0,5/18,21.83%,NDC80;CDK5RAP2;PLK1;MAD2L1;ITGB1
2219,prerank,regulation of cellular localization (GO:0060341),-0.3038092044030412,-0.5569046614422659,1.0,1.0,1.0,10/40,19.69%,STXBP2;FES;NR1H4;UNC13D;LYN;EFNA5;SPAG5;BRSK1;PARD6B;TRIM46
2220,prerank,DNA-dependent DNA replication (GO:0006261),0.25547801420225386,0.5556845987669615,1.0,1.0,1.0,13/115,17.87%,TWNK;PSME4;CDC34;GMNN;TEFM;MGME1;PSMC3;PSME3;UBC;PSMD12;SSBP1;PSMB7;PSMD2
2221,prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.3012373432349238,-0.5528484186621886,1.0,1.0,1.0,2/30,10.30%,WAS;SPIDR
2222,prerank,cytosolic transport (GO:0016482),-0.2742960997069405,-0.5510955527227718,1.0,1.0,1.0,10/102,16.31%,LAPTM5;MYO1D;RAB29;GAK;CLN3;BET1L;SNX1;WDR81;TBC1D10A;SNX5
2223,prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.35217381179011975,0.5504116908963731,1.0,1.0,1.0,1/21,2.82%,RAP1GAP
2224,prerank,protein methylation (GO:0006479),0.30684521588516805,0.5496389130365046,1.0,1.0,1.0,7/34,17.89%,EEF1AKMT1;ETFBKMT;METTL22;PRMT7;ATPSCKMT;PCMT1;PRMT5
2225,prerank,translesion synthesis (GO:0019985),-0.3124793278180158,-0.5475381174904365,1.0,1.0,1.0,12/38,24.13%,PCLAF;FAAP20;POLD4;ISG15;RFC2;UBE2L6;RPS27A;POLD3;POLI;PRIMPOL;REV3L;RFC5
2226,prerank,tight junction assembly (GO:0120192),-0.3090473463396508,-0.5472511984990688,0.967741935483871,1.0,1.0,3/28,10.27%,ACTG1;RAB13;LSR
2227,prerank,global genome nucleotide-excision repair (GO:0070911),0.3031832851779616,0.5450046307244932,1.0,1.0,1.0,7/26,26.81%,UBC;CUL4A;CHD1L;RAD23B;PARP1;GTF2H3;XPC
2228,prerank,protein localization to Golgi apparatus (GO:0034067),-0.3179828842861736,-0.5439727720223688,1.0,1.0,1.0,3/26,11.89%,ARL5C;GAK;ZDHHC15
2229,prerank,response to exogenous dsRNA (GO:0043330),-0.34761961179914136,-0.5429661673690444,0.9433962264150944,1.0,1.0,5/19,16.34%,COLEC12;STING1;SLC3A2;IRAK3;IFIT1
2230,prerank,protein localization to chromatin (GO:0071168),-0.363920710789808,-0.5392201012878215,0.9661016949152542,1.0,1.0,7/17,32.12%,PLK1;MACROH2A2;TASOR;MCM9;ESR1;MACROH2A1;LRWD1
2231,prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.25623442287947157,0.5344376768799952,1.0,1.0,1.0,5/74,15.09%,PREPL;ERC1;ARFRP1;TRAPPC10;DCTN1
2232,prerank,tRNA export from nucleus (GO:0006409),0.30375976235434066,0.5332134337160642,1.0,1.0,1.0,13/31,39.27%,NDC1;NUP62;SEH1L;NUP153;XPOT;RAE1;NUP88;NUP98;RAN;RANBP2;NUP35;TPR;NUP37
2233,prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.30375976235434066,0.5332134337160642,1.0,1.0,1.0,13/31,39.27%,NDC1;NUP62;SEH1L;NUP153;XPOT;RAE1;NUP88;NUP98;RAN;RANBP2;NUP35;TPR;NUP37
2234,prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.2735221508410896,0.5326015880723852,1.0,1.0,1.0,21/61,25.39%,CHMP4C;PSME4;PSMC3;PSME3;PSMD12;NABP1;PSMB7;PSMD2;PSMA1;SKP1;PSMB2;AVEN;VPS4A;USP47;PSME1;PSMC6;PSMD11;PSMD1;PSMD3;PSMC2;PSMA6
2235,prerank,positive regulation of cytokinesis (GO:0032467),-0.3305727110668164,-0.5325065405028077,0.9814814814814815,1.0,1.0,5/21,15.11%,RACGAP1;AURKB;CDC25B;KIF20B;CDC42
2236,prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.3184298201924957,0.5322594528136748,1.0,1.0,1.0,7/22,26.81%,UBC;CUL4A;CHD1L;RAD23B;PARP1;GTF2H3;XPC
2237,prerank,negative regulation of DNA metabolic process (GO:0051053),-0.3414111744491976,-0.5237043662496491,0.9841269841269841,1.0,1.0,1/21,5.65%,NIBAN2
2238,prerank,hippo signaling (GO:0035329),-0.30729585152500466,-0.5170863253974641,1.0,1.0,1.0,8/23,25.49%,CASP3;MOB1A;TEAD2;SAV1;STK3;DVL2;STK4;YWHAB
2239,prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.3088153950599598,-0.5134332510895211,1.0,1.0,1.0,5/22,28.76%,EIF2AK3;SMARCB1;ATF4;BNC1;ERBB2
2240,prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.2957208982815564,-0.5111821325751407,1.0,1.0,1.0,9/38,19.64%,DYNLL1;WDR19;IFT46;TTC26;KIF3B;IFT74;DYNC2LI1;DYNC2I1;IFT27
2241,prerank,cellular response to misfolded protein (GO:0071218),-0.2858113245736948,-0.5080943581146418,1.0,1.0,1.0,4/20,24.26%,TOR1A;AUP1;UGGT1;UBE2W
2242,prerank,maturation of 5.8S rRNA (GO:0000460),0.3000584565318845,0.5078234454218684,1.0,1.0,1.0,5/17,29.10%,LAS1L;URB1;WDR12;EXOSC10;MTREX
2243,prerank,recombinational repair (GO:0000725),0.2524813979089119,0.5024328070660204,1.0,1.0,1.0,12/58,24.98%,POLQ;NABP1;XRCC2;NSMCE1;AP5S1;HUS1;NBN;FAN1;EXD2;FBH1;PARP1;ZSWIM7
2244,prerank,cellular response to dsRNA (GO:0071359),0.33070273717228815,0.49825201835686683,1.0,1.0,1.0,1/17,4.51%,MAVS
2245,prerank,histone H3 deacetylation (GO:0070932),-0.33281287545299854,-0.4979964101439181,0.9830508474576272,1.0,1.0,3/15,17.44%,SIRT7;PER2;HDAC1
2246,prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.32028753632254536,0.4870889979441094,1.0,1.0,1.0,5/15,33.68%,TRPT1;DDX1;TSEN15;TSEN2;CSTF2
2247,prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.3031088629222489,0.4850485931677139,1.0,1.0,1.0,4/16,27.79%,HNRNPA2B1;SMG5;PARP1;TNKS2
2248,prerank,miRNA metabolic process (GO:0010586),0.2716741036881052,0.4810638406225936,1.0,1.0,1.0,2/17,21.95%,DROSHA;TARBP2
2249,prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.2946868399759668,0.46030217032286186,1.0,1.0,1.0,4/20,20.87%,PSME4;PSMB7;PSMA1;PSMB2
2250,prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.2702989013109235,0.440112624316976,1.0,1.0,1.0,4/21,25.27%,CUL4A;CHD1L;PARP1;GTF2H3
2251,prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.2702989013109235,0.440112624316976,1.0,1.0,1.0,4/21,25.27%,CUL4A;CHD1L;PARP1;GTF2H3
2252,prerank,nuclear membrane organization (GO:0071763),-0.25853474920991343,-0.4219194392883489,1.0,1.0,1.0,3/19,19.17%,TMEM43;TOR1A;PLK1
2253,prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.2494601601538583,0.4213911024726631,1.0,1.0,1.0,3/22,22.23%,LEO1;ZMYND11;CDC73
2254,prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.2604150125200561,-0.42012494457425076,1.0,1.0,1.0,3/21,19.14%,MTMR11;INPP5F;PIP4P1
2255,prerank,ribosomal small subunit assembly (GO:0000028),0.24916542149520374,0.4170555469967382,1.0,1.0,1.0,5/16,24.23%,MRPS7;ERAL1;XRCC5;MRPS11;PWP2
2256,prerank,negative regulation of telomere maintenance (GO:0032205),-0.2481487952634514,-0.40857889886545257,1.0,1.0,1.0,2/15,21.46%,SLX4;RAD50
2257,prerank,non-motile cilium assembly (GO:1905515),-0.25073591333205564,-0.40212216160590086,1.0,1.0,1.0,5/24,27.36%,CEP250;GORAB;VANGL2;TMEM107;TTC8
2258,prerank,snRNA 3'-end processing (GO:0034472),0.22965835946525825,0.4014037899906787,1.0,1.0,1.0,19/19,77.07%,EXOSC7;INTS1;EXOSC4;INTS6;INTS2;EXOSC3;INTS14;INTS7;EXOSC9;EXOSC2;INTS5;INTS12;USB1;TUT1;EXOSC8;INTS8;EXOSC5;INTS6L;TOE1
2259,prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.22869601507439552,0.39784347153246524,1.0,1.0,1.0,4/25,21.45%,DKC1;HSP90AB1;NOP10;PPP6R3
2260,prerank,histone H2A acetylation (GO:0043968),0.24889227772664407,0.3877547713640891,1.0,1.0,1.0,3/16,25.67%,NAA40;MSL3;RUVBL2
2261,prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.24383094771454697,0.3863476636587531,1.0,1.0,1.0,3/19,24.32%,LEO1;CDC73;CCNK
2262,prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.23642515266545636,-0.38375791993649827,1.0,1.0,1.0,19/19,76.40%,PARN;TUT7;CNOT6;PAN3;CNOT3;PAN2;CNOT9;TNKS1BP1;SAMD4B;TUT4;CNOT2;CNOT8;ZFP36;CNOT11;CNOT1;CNOT10;CNOT6L;CNOT4;CNOT7
2263,prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.2184634317687855,0.37186514925153974,1.0,1.0,1.0,6/22,26.02%,UBC;MAP3K7;TAB3;IRAK1;TAB1;RNF34
2264,prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.22061736546715088,-0.35970947640806733,1.0,0.9999624841495531,1.0,21/21,77.98%,RPS21;ERI2;KRI1;NOL9;ERI1;EXOSC8;EXOSC2;NOP9;PES1;EXOSC9;UTP20;RRS1;ERI3;FTSJ3;EXOSC3;NOP14;ABT1;EXOSC10;WDR12;URB1;EXOSC7
2265,prerank,ncRNA export from nucleus (GO:0097064),0.18674599239795076,0.33698052134898826,1.0,1.0,1.0,35/35,81.38%,NDC1;TSC1;NUP62;SEH1L;NUP153;XPOT;RAE1;NUP88;NUP98;RAN;RANBP2;NUP35;TPR;NUP37;NUP133;NUP43;NCBP2;NUP188;NOL6;POM121;NUP155;NUP54;NUP210;NUP107;SSB;NUP93;NUP205;SEC13;NUP160;NUP85;AAAS;PHAX;NUP50;NUP214;NPM1
